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Abstract 
Although foot problems are common in rheumatoid arthritis (RA) their prevalence and 
importance to patients, the barriers patients face accessing foot care, and the types of 
care received have not been adequately established. Previous studies were hospital 
based and/or sampled selected groups of patients and did not adequately capture the 
patient perspective regarding foot problems and the benefits of foot care. Further, the 
accuracy of the patient self-report, the basis of previous studies, is not known. 
To overcome these limitations and address the question of how to improve access to 
foot care a mixed methods approach employed three interlinked studies: a qualitative 
analysis of interviews with patients to identify relevant outcome measures; a population 
survey using these measures to establish prevalence and impact of foot problems and 
factors influencing access to foot care; and a clinical assessment of the accuracy of 
self-report which also provided a detailed description of current foot problems. 
Semi-structured interviews with patients with RA confirmed that foot problems are 
common and revealed how they impact on many aspects of patients’ lives such as 
ability to work. Patients adopt a variety of self-management strategies to manage foot 
problems and can recognise common foot pathologies. Patients’ decisions to access 
foot care or not were complex. Some considered access to foot care unnecessary but 
for others limited awareness of treatment options, lack of knowledge of how to access 
care and feet being ignored in rheumatology clinical practice emerged as barriers to 
accessing foot care. Patients who had accessed foot care prioritised their foot problems 
as an important health care need and provided a broad description of foot care 
interventions received.  Positive experience of foot care received encouraged continued 
utilisation of foot care services, while negative experiences contributed to patients’ 
decisions to discontinue interacting with foot care services. Important outcomes and 
issues raised by patients have not been previously investigated or quantified and 
therefore informed the content of the subsequent survey. 
The survey in a random population sample of RA patients demonstrated that foot 
problems were prevalent and caused substantial impact. Many reported that their foot 
problems were severe, important and that they were not coping well with them. 
However, patients reported examination of their feet to be inconsistent and discussions 
during clinical consultations in relation to foot problems were often initiated by patients 
rather than the doctor or nurse. Although the literature suggests health resources are 
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poorly accessed by men and people from socially deprived areas, in this survey two 
thirds of respondents had accessed foot care (often outside the NHS), including over 
half of the men and many from deprived areas. The survey also provides a description 
of the general and RA characteristics, prevalence of additional health problems in a 
large sample of the RA population.  
Clinical assessment of a selected sub-sample of responders to the survey provided a 
detailed description of the nature and type of current foot problems. Additionally, the 
study demonstrates that self-report of most common foot problems is reliable and can 
be utilised with a high degree of confidence. However, there is a clear indication that a 
direct examination of patients’ feet is required to detect numbness, pes planus and joint 
swelling. The number of patients with foot care needs was high and nearly half required 
immediate clinical intervention. Patient satisfaction and perceived benefits differed 
between foot care services.  
Foot problems are common, important issues for patients with RA. Access to foot care 
was more prevalent than anticipated but many patients had serious current problems, 
questioning the appropriateness and effectiveness of current foot care which is 
provided by non-specialist clinicians. Further work should investigate how specialist foot 
care services could support non-specialist clinicians and improve outcomes. 
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Chapter 1: Introduction  
This thesis investigates the prevalence, impact and care of foot problems in patients 
with rheumatoid arthritis (RA). Chapter 1 provides an overall description of the clinical 
features and management of RA and introduces foot involvement, describing features 
and symptoms that can develop as a consequence of RA. It goes on to describe the 
setting in which the research was conducted and the organisation that funded the 
research. Chapter 2 provides a detailed review of foot problems in RA, and Chapter 3 a 
detailed review of the organisation of relevant health services and access to health 
care. Chapters 4, 5 and 6 each present and discuss one of three interlinked studies 
designed to explore the patient experience, prevalence and nature of foot problems and 
finally to examine the accuracy of the self-report of foot problems. Chapter 7 draws 
together the findings from all three studies, the conclusions that follow, and the 
implications for future research and service delivery. 
 
1.0 Rheumatoid arthritis 
 
Rheumatoid arthritis (RA) is a chronic autoimmune condition causing symmetrical 
inflammatory poly-arthritis, sometimes with additional systemic features, and for which 
there is currently no cure. The aim of current clinical management of RA is therefore to 
achieve the lowest possible disease activity, ideally remission (Smolen et al, 2010). The 
lifetime prevalence of RA is estimated as 0.5% to 1.5% of populations in developed 
countries, with a peak onset of 40-60 years of age. It is three times more common in 
women (Hochberb and Spector, 1989; Crowson et al, 2011). Epidemiology data 
suggest that the prevalence of RA is reducing in women but not men (Symmons et al, 
2002). The aetiology (cause) of RA has not been fully determined. However, genetic 
predisposition and gender, infection, stress or trauma, environmental factors and more 
recently health behaviours such as smoking have been proposed as possible triggers 
(Silman, Newman and Macgregor, 1996).  
 
The initial clinical presentation of RA is most often symmetrical pain, swelling and 
stiffness of the joints, usually including the hands and feet (e.g. Grondal et al, 2008). 
Accompanying symptoms can also include flu-like symptoms, general malaise and 
fatigue. As the condition (disease) progresses, larger joints (knees, hips, elbows 
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shoulders, knees and neck) and the spine can become involved. Patients with RA have 
potentially reduced life expectancy (Gabriel et al, 2003) with mortality being associated 
with the systemic features, such as cardiovascular involvement (Wolfe et al, 1994). 
Additionally it is widely recognised additional morbidity (other health conditions) is 
common in patients with RA (e.g. Gabriel, Crowson and O’Fallon, 1999). There is also 
evidence demonstrating that the number of additional health conditions is associated 
with higher levels of disability (Verburgge, Gates and Ike, 1991). The course of RA is 
highly variable between patients. The clinical features for the majority of patients follow 
a fluctuating pattern with episodes of flares (inflammatory process become more active 
and symptoms are more severe) followed by periods of remission (symptoms reduced 
or absent) resulting in increased disability over time (Hill, 2006).  
 
The American College of Rheumatology (ARC) criteria for classification of RA (Arnett et 
al, 1988) are used as a standardised method of identifying patients. The criteria are: 
 
1. Morning stiffness lasting at least one hour  
2. Inflammatory arthritis of involving three or more joints 
3. Inflammatory arthritis of hand or wrist joints 
4. Symmetrical joint involvement  
5. Presence of rheumatoid nodules 
6. Serology - rheumatoid factor positive  
7. Radiographic evidence of erosions and/or osteopenia of the hand and/or wrist  
 
A standardised ‘diagnosis’ of RA requires the presence of 4 or more criteria, inclusion 
criteria 1 to 4 must be present for a minimum of 6 weeks. The classification of RA has 
since been revised following a joint initiative between ACR and the European League 
Against Rheumatism (EULAR) (Aletaha et al, 2010). The revised criteria were 
developed to be sensitive to patients with very early RA, who could be identified as 
being at risk of developing more severe and erosive disease; as well as supporting the 
initiation of disease modifying pharmacological therapy, and also be applicable to 
patients with established RA. The revised criteria for a classification of “definite RA” are: 
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1. Presence of synovitis in at least 1 joint and number of joints involved (score range 
0-5) 
2. Abnormal serology (presence of Rheumatoid factor (RF) or anti-citrullinated protein 
antibody (ACPA) (score range 0-3) 
3. Elevated acute response (C-reactive protein (CRP) or erythrocyte sedimentation 
rate (ESR) (score range 0-1) 
4. Duration of symptoms (score range 0-1)  
 
A total score including the four domains greater than 6 (out of possible a 10) is required 
for a diagnosis of RA. The revised criteria for diagnosis of RA can only be applied to 
patients diagnosed with very early RA after 2010. The 1987 criteria will be used to 
investigate the prevalence, impact and care of foot problems of patients with RA in this 
thesis, as most patients were diagnosed before 2010. 
 
1.1.1 Synovitis, extra-articular and systemic features 
The pathology of RA involves inflammation of joint synovium (thin membrane lining the 
joint capsule), a process referred to as synovitis. The synovial membrane and 
underlying connective tissue become infiltrated with inflammatory cells (T- and B-
lymphocytes, macrophages and neutrophils), which merge with overgrown synovial 
cells (pannus). Pannus then spreads over the articular cartilage, leading to the 
destruction of cartilage and the underlying bone becomes eroded (Firestein, 2003). 
Swelling within the joint develops due to accumulation of the by-products of the 
inflammatory process. The joint capsule becomes distended; supporting soft tissues 
(tendons and ligaments) become stretched and atrophied, eventually leading to wasting 
of adjacent muscle. The clinical symptoms of synovitis are joint pain, joint tenderness 
on direct palpation, joint swelling, warmth and joint stiffness (Grassi et al, 1998). 
Although the synovial blood supply is increased and it becomes hyperaemic (localised 
accumulation / congestion of blood), superficial joint erythema (redness) is not a 
common feature in RA, unlike in other inflammatory conditions such as gout or soft 
tissue infection. As the inflammatory process continues the joint space can become 
narrowed or lost and bone destruction accumulates, resulting in reduction of joint 
function (Shrader, 1999). 
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The clinical features of RA can also involve other tissues, non-articular structures of the 
musculoskeletal system (extra-articular features) and other organs (systemic features). 
The prevalence of extra-articular features is reported to be up to 40% of patients 
(Cimmino et al, 2000). Extra-articular features of the skin occur due to the presence of 
rheumatoid nodules and small vessel vasculitis (inflammation of the blood vessels). 
Small vessel involvement can present as splinter haemorrhages, (periungual infarcts). 
These infarcts can lead to tissue necrosis and potentially digital gangrene (Cojocaru et 
al, 2010). Neuropathies can also be a feature of RA such as diffuse peripheral sensory 
neuropathy, entrapment neuropathies (tarsal tunnel and carpal tunnel) and 
mononeuritis and mononeuritis multiplex (Agarwal et al, 2008). Patients with RA also 
have an increased risk of developing cardiovascular disease, compared with the 
general population (Soloman et al, 2003). Haematological involvement is also a clinical 
feature, with anaemia being the most common manifestation (Bowman, 2002). 
Pulmonary, oral and ocular involvement can also occur (e.g. Chanin et al, 2001). 
 
1.1.2 Consequences and impact of RA 
RA can have consequences and subsequently impact on many aspects of patients’ 
everyday lives such as: 1) activities of daily living (ADL) (walking, ability to perform 
personal hygiene, general everyday tasks); 2) participation in valued activities (leisure 
activities, social interaction); 3) perceived loss of role and identity; 4) psychological well-
being (depression, anxiety and body image); 5) ultimately quality of life (Katz, Morris 
and Yelin, 2006, Katz and Yelin, 2001; Pollard, Choy and Scott, 2005; Ryan, 1999; 
Whalley et al, 1997). RA can also have long- term economic consequences for 
individual patients. For example patients’ ability to continue with current employment 
can be threatened. Work disability and subsequent loss of reduced income has been 
well documented in patients with RA (e.g. Albers et al, 1999). There is a general 
consensus that patients with RA have greater work related disability compared with the 
general population (working age). The risk of work disability (in RA) is reported to 
increase with disease duration (Verstappen et al, 2004), age, disease severity and the 
nature of job related tasks (Albers et al, 1999; Reisine, Mcquillain and Fifiled, 1995; 
Yelin, Henke and Epstein, 1987). The long-term economic consequences in terms of 
direct costs are also considerable for health care providers (cost of service provision, 
pharmacology therapy). In 2009 the annual economic cost of RA to the National Health 
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Service (NHS) in the UK was estimated at £560 million and additional sick leave and 
work related disability was £1.8 billion (National Audit Office, 2009).  
 
1.1 Management of rheumatoid arthritis 
 
The current aims of the management in RA are to reduce inflammation, control 
symptoms, improve physical function, promote self-management, improve psychosocial 
well-being and function, monitor for drug toxicity and screen for co-morbidity (Luqmani 
et al, 2006, Luqmani et al,2009). RA is a complex condition and is widely accepted to 
require multidisciplinary approaches to care which are tailored to the individual needs of 
patients (van de Hout et al, 2003, Hennell and Luqmani, 2008). The management of RA 
is primarily divided into pharmacological and non-pharmacological interventions. 
 
1.2.1 Pharmacological management of RA 
Pharmacological treatments (arthritis medications) used to manage RA aim to reduce 
the inflammatory process and to reduce symptoms (e.g. pain). Choices of treatments 
prescribed are dependent on individual patients’ symptoms, severity of disease features 
and duration of disease (Smolen et al, 2010).The classification of drugs prescribed in 
RA consists of four categories: 1) analgesics; 2) non-steroidal anti-inflammatory drugs 
(NSAIDs); 3) disease modifying anti-rheumatic drugs (DMARDs) including biologic 
therapies; 4) glucocorticoids (steroids). Analgesics (non-opioid, compound analgesics 
and opioid analgesics) can be prescribed to provide pain relief. NSAIDs have a 
combination of both an analgesic and anti-inflammatory affect. DMARD medications 
can affect the immune response and suppress the progression of the inflammatory 
process, therefore inhibiting or preventing further joint damage. The more recent 
biologic therapies are also included in the DMARDs drug category. Biologic therapies 
suppress the immune system by targeting specific molecules on the cells of the immune 
system and bi-products of the inflammatory process secreted from joints, systemic and 
non-articular involvement. There are several different biologics now available, which 
vary in target action. Glucocorticoids are synthetic versions of the naturally occurring 
hormone cortisol. The clinical action of glucorticoids is reduction of the autoimmune 
response to inflammation. Mode of delivery can be to an individual joint or soft tissue 
(intra articular), orally or by intravenous infusion. There is substantial evidence 
demonstrating the clinical efficacy of these medications in the management of RA (e.g. 
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Kirwan, 1995) and usage in clinical practice is recommended in national guidelines 
(NICE GC79, 2009). Pharmacological management can be described as being 
monotherapy (one classification of drug prescribed) or more commonly as combination 
therapy (more than one classification of drug and/or one or more DMARDs prescribed). 
 
1.2.2 Non-pharmacological management of RA  
The non-pharmacological management of RA refers to all the other treatment 
(management) interventions (e.g. foot orthoses). Rheumatologists are considered to be 
the specialists who provide and coordinate the care for patients with RA. However, the 
disease features of RA are complex and require a multifaceted approach to 
management and to the provision of and access to care. It is widely accepted as best 
practice that a multidisciplinary team (MDT) approach to care is required (Luqmani et al, 
2009; NICE CG7, 2009). The professional remit of members of the MDT ranges from 
managing general disease symptoms (rheumatologist) to regional anatomical focus 
(e.g. podiatrists). The professionals constituting the MDT can vary between different 
health care systems. Health professionals who can be involved in the management of 
patients with RA (Kennedy et al, 2005; Luqmani et al, 2006) in the UK are: 
 
1. Rheumatology nurse specialist  
Provide advice and education regarding information about the general nature of 
RA, medication counselling, monitoring disease activity, screening and 
assessment, address issues of difficulty of activities of daily living (ADL) and 
self-management (pacing and planning, rest, relaxation, goal setting). 
2. Occupational therapist 
Support patients with regards to issues with ADL by providing devices and 
support for continued participation in valued life roles (working, relationships, 
and leisure activities) through self-management. Joint protection (especially of 
the hand and wrist) is addressed with advice on the performance of particular 
tasks, splinting and exercise.  
3. Physiotherapist 
Promote the maintenance of mobility, physical function and independence 
though therapeutic exercise (muscle strengthening, mobilisation and gait 
rehabilitation) and thermal therapies (heat, cold, hydrotherapy). 
4. Orthopaedic surgeon 
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Orthopaedic intervention is considered when irreversible joint damage has 
occurred or pathologies involving soft tissues become severe (e.g. 
tendinopathies). The overall aim of orthopaedic surgery is to reduce pain and 
improve function. 
5. Podiatrist 
Assess, provide treatment for and rehabilitate conditions of the foot and lower 
limb by assessment of biomechanical function, neurological and vascular status. 
Treatment is also provided for skin lesions (corn, callus and ulceration), nail 
pathologies, foot injuries and infections. Patient education regarding self-care, 
footwear and general foot health are also within the remit of podiatric practice. 
The aims of podiatric care is also to relieve pain, maintain function and improve 
mobility while protecting the foot from further problems (e.g. development of 
cutaneous lesions). 
6. Orthotist 
Examine, assess and treat physical and functional limitations in patients with 
long term conditions such as RA. Treatment is provided in the form of devices 
which support, correct and/or accommodate deformities (braces, foot orthoses 
and hospital issued prescribed footwear). The orthotist prescribes, fits, monitors 
and educates patients regarding the use of device / devices issued. 
7. GPs and practice nurse 
The majority of patients with RA are managed in secondary care (hospital 
outpatient departments). Patients with RA require continual monitoring of 
disease activity in particular for adverse side effects of pharmacological 
interventions. Regular blood tests are a component of monitoring, often 
conducted by primary care (community) based clinicians such as GP and 
practice nurses. 
8. Pharmacist 
Patients with RA are usually prescribed some form of pharmacological therapy. 
Pharmacists ensure the quality and suitability of pharmacological interventions 
prescribed. Advice can also be provided to the individual patient regarding how 
to take their medication and possible side effects or adverse reactions they may 
experience. 
9. Health psychologist 
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Psychological support for patients with RA is often considered part of the role of 
the rheumatology nurse specialist and occupational therapist. However, more 
recently the inclusion of the clinical psychologist as a member of the MDT has 
received attention for inclusion.  
 
1.2.3 Patient education, self-management and self-care  
Patients with RA have to live with and manage their condition on a day to day basis. In 
order for this to be achieved, patients need to be informed about the nature of the 
condition, their clinical management, when and how to access care, and what actions 
they can take to reduce the consequences and impact of living with RA. Patient 
education is widely viewed as an essential component to management of long term 
conditions. Hill (2006) defines patient education (in rheumatic diseases) as “any set of 
planned educational activities designed to improve patients’ health behaviours and 
through this their health status and ultimately their long term outcome”.  
 
Self-management is viewed as complementing traditional patient education by the use 
of problem solving skills in which the patients can identify and self-manage their own 
individual problems and needs (Bodeheimer et al, 2002b). Personalised strategies and 
techniques can then be derived and supported by health professionals to assist patients 
manage their condition. A central element of self-management is the confidence of the 
individual in their ability to carry out a behaviour or action, referred to as self-efficacy 
(Bandura, 1977). Newman, Steed and Mulligan (2004), propose self-management of 
long term condition as a continuum of actions which vary in different health states. For 
example the authors propose the object of self-management of asthma and diabetes is 
to achieve disease / condition control and stability of symptoms primarily through 
pharmacological management. In contrast the authors consider the management of the 
complex clinical features of RA such as pain and subsequent disability to be additional 
challenges to disease control. Additionally the management of RA requires active 
patient participation and concordance with treatment regimens. Additionally patients 
with RA need to develop new coping strategies to optimise clinical and personal 
outcomes. Newman, Steed and Mulligan therefore infer the management of RA 
requires a combination of pharmacological management and active participation in self-
management.  
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Structured self-management programmes such as the Arthritis Self-Management 
Programme (ASMP) have been applied in rheumatology practice. The programmes 
involve group sessions for patients led by health professions and lay educators 
(patients trained in facilitating education sessions). The benefit of the ASMP have been 
shown to include improved patient knowledge, engagement of self-management 
behaviours and reduction in pain (Lorig et al, 1985), and have additional reduction of 
health care costs in terms of health care usage (Lorig et al, 1993).  
 
Discordance in the understanding of the meaning and interpretation of self-
management can vary between health professionals. For example podiatrists generally 
consider self-management as a component of self-care, in which a patient participates 
(themselves or with non-professional support) in physical tasks to manage their foot 
health care needs (cutting their toe nails, apply emollients and using a foot file). 
Therefore the patient self-manages their general foot health. Conversely, the nurses’ 
perspective is of a more global view, in which self-management involves supporting 
strategies, skills and beliefs to manage their RA in general terms, in order to self-care 
(Hill, 2006). A result of inconsistencies in the literature with regard to definitions of self-
care and self-management, the terms will be used together in this thesis in order to 
encompass the global nature of how patients care and manage their foot problems. 
 
1.2.4 Complementary therapies 
Patient with long term conditions have been reported to develop their own informal 
methods of self-care and self-management strategies with the use of complementary 
and alternative medicines (CAMs) in addition to advice and care they receive in the 
“traditional” health care setting (Herman et al, 2004, Quandt et al, 2005). The use of 
CAMs is popular in patients with RA, with an estimated usage of between 20% - 90% of 
patients and more commonly used by women compared to men, but usage is not 
associated with ethnicity (Efthimiou and Kukar, 2010; Tamahne et al, 2014). Patients’ 
reasons for deciding to use CAMs have been proposed to be influenced by negative 
side effects of pharmacological therapies and or personal beliefs and values. Patients 
using CAMS to manage their foot problems particularly in RA, is not fully understood.  
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1.3 Foot problems in RA 
 
Speigel and Speigel (1982) consider the development of foot problems in RA is a result 
of a combination of inflammatory disease and altered mechanics. The additional 
mechanical stresses of walking in a weakened musculoskeletal environment can lead to 
pain, deformity, secondary skin pathologies and further deterioration in walking 
distance, activity levels and general wellbeing (Turner et al, 2008; Grondal et al, 2008; 
Wickerman et al, 2004). The presence of deformity also raises issues regarding the 
ability to obtain accommodative footwear. Foot involvement in RA is a complex issue, 
and requires further investigation. It would be beneficial to establish the experience of 
foot problems in RA from the patient perspective, the type and prevalence of these 
problems, and the extent to which foot care services (podiatry, orthotics and 
orthopaedic surgery) are provided and used. National guidelines (Luqmani et al, 2006) 
call for an annual review of the feet of patients with RA, indicating recognition of the 
problem in broad terms. Additionally there is emerging evidence indicating some foot 
care interventions  such as foot orthoses and prescribed footwear are effective (e.g. 
Woodburn Helliwell and Barker, 2002; Magãlhaes et al, 2006). However, the precise 
extent to which foot problems contribute to overall levels of pain and disability and the 
extent to which foot care services may contribute to improved care have not been 
determined. Furthermore, the current provision of foot care services dedicated to 
rheumatology varies widely across the UK (Redmond, Waxman and Helliwell, 2006). In 
addition, their ability to detect and diagnose rheumatological foot problems, the extent 
to which they are accessed by patients and the factors which determine access are not 
known. One exploration suggested that access to foot care in general was unrelated to 
care needs (Harvey et al, 1997), raising the possibility that social and societal barriers 
prevent appropriate foot care. Furthermore, an accurate assessment of the clinical 
features and consequences of foot problems in RA has potentially been hampered by a 
lack of standardisation of clinical assessments and failure to develop adequately valid 
foot assessment tools that can be used on a population basis. This has been addressed 
by the development of the Foot Impact Scale (FIS) (Helliwell et al, 2005), a validated 
self-report questionnaire for patients with RA. The FIS assesses the impact of foot 
problems, which can be applied to the general RA patient population to facilitate 
quantitative measurement of the impact of RA foot pathology with confidence. Best 
practice guidelines and care pathways for foot involvement in RA have been published 
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(Podiatry Rheumatology Care Association, 2008). However, evidence and expert 
opinion suggests that foot care standards are not being met (e.g. Williams et al, 2013). 
Foot care services, in particular NHS podiatry provision, have been identified as 
underused and under-resourced services (National Audit Report, 2009; Rheumatology 
Futures Group, 2009). 
 
A pilot investigation conducted by the researcher (Wilson, 1999) showed that of a 
convenience sample of 75 patients attending for medical follow-up and not specifically 
referred for podiatry review, more than 60% were assessed as requiring foot care (e.g. 
foot orthoses). Of these, only 32% were receiving foot care. The complexity of foot 
problems can justify the need for assessment in a specialist clinic (Helliwell, 2003). 
Martin and Griffith (2006) found that podiatry was the highest reported additional 
service need requested by RA patients (46%). However, a contemporary review of 
service provision undertaken at a community podiatry clinic to inform this thesis found 
only 2% of the caseload had RA. This result is compatible with a primary care review of 
RA patients in Bristol which concluded access to care packages was highly variable 
(Memel and Kirwan, 1999). This apparent disparity between the extent of foot 
involvement in RA as described in the literature and low utilisation of foot care service 
provision requires further investigation. We do not currently know the barriers to 
accessing and subsequent utilisation of foot care services. It is possible access to foot 
care may be influenced by patients’ beliefs regarding efficacy of foot care or to patients’ 
lack of knowledge of treatment options. Barriers might also arise because of 
rheumatology clinicians’ approach to the role of foot care services, or because of low 
levels of current service provision, or because of a combination of some or all of these 
reasons. It may be that foot care services concentrate provision and delivery of care to 
foot problems associated with other conditions. For example a large proportion of the 
local NHS podiatry service in Bristol focuses on foot care for problems associated with 
diabetes. Barriers of access to and utilisation of health care services can be multi-
factorial (Gulliford et al, 2002). Therefore, it would be advantageous to identify level of 
foot involvement in RA, the proportion of patients who have accessed foot care and the 
types of care received. Additionally, capturing the impact of foot problems would 
provide valuable insight into the consequences of foot problems from the patient 
perspective. These considerations led to the overall research questions for this thesis: 
“What is the impact of foot involvement in RA and what determines if patients with RA 
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receive foot care?” The literature relating to this research question will be reviewed in 
depth in Chapters 2 and 3  
 
 1.4 Research setting 
These overall research questions will be addressed through a series of interlinking 
studies which were conducted in Bristol, UK. 
 
1.4.1 General population characteristics 
Bristol has an estimated population of 432,500 and is the eighth largest city in England. 
The median age of residents is younger than the national average for England and 
Wales, 33.7 years and 39.9 years respectively with 19% under the age of 15 years and 
13% over the age of 65 years. Bristol has a slightly higher proportion of working age 
people (16-64 years) compared with the national average, 68% versus 63%. The city is 
ethnically diverse with approximately 22% of the population being classified as “non-
white British” (Bristol Research Network, 2012). Deprivation levels in Bristol are mixed 
and general unemployment rates for Bristol are better than the national average (7.0% 
and 7.6%; respectively). However, academic attainment is lower than the national 
average for England. The average life expectancy for females and males in Bristol is 
estimated at 81.9 years and 77.2 years compared with national the average of 82.3 
years and 78.2 years. Premature deaths due to cancer and cardiovascular disease 
have fallen in Bristol are over the last 10 years but are still reported to be higher than 
the national average (South West Observatory, 2012). 
 
1.4.2. Clinical setting 
The Rheumatology Departments at South Bristol (Rheumatology Centre, Bristol Royal 
Infirmary, University Hospitals Bristol NHS Foundation Trust (UHB)) and North Bristol 
(Rheumatology Department, Southmead Hospital, North Bristol NHS Trust (NBT)) 
provide all the hospital based rheumatology services to the City of Bristol. The 
departments also provide care to patients residing outside the Bristol area. Based on 
epidemiology data reported in a longitudinal observational study of adults over the age 
of 18 years (Doran et al, 2002), the estimated number of adults with RA in Bristol is 
approximately 1480. This estimation is based on falling prevalence of RA (Alamanos, 
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Voulgari and Drosos, 2006) and therefore reflects 80% of the Doran et al, data (1955 to 
1995). 
 
The NHS community health services for Bristol are supplied by Bristol Community 
Health Social Enterprise (BCH) within which there is a single NHS community podiatry 
service. Access criteria to community NHS podiatry services is for patients registered 
with a general practitioner (GP) within the BCH boundaries rather than individual 
patients’ location of residence. The BCH boundaries reflect the Bristol Local Authority 
and Bristol Clinical Commissioning Group (CCG) boundaries and include 56 GP 
practices. Some wards in North and North East Bristol are within the South 
Gloucestershire Local Authority and South Gloucestershire (CCG). Thus if a patient 
resides in South Gloucestershire CCG area but is registered with a GP within the BHC 
boundary, they would be eligible for an assessment with the BCH podiatry service. 
Orthopaedics and orthotics services are provided by both hospital sites to both the local 
and regional patient populations. The Podiatry service provision for both UHB and NBT 
is provided by BCH community services on a service level agreement. Over 90% of the 
hospital podiatry provision is dedicated to foot care for patients with diabetic foot 
diseases (e.g. foot ulceration) at both hospital sites, 8% of service provision for patients 
with renal disease at one site (NBT) and 2% allocated to rheumatology provision at one 
site (UHB). Secondary care rheumatology podiatry provision is accessed by referrals 
from members of the rheumatology multidisciplinary team (UHB) and NHS community 
podiatry service. The BCH community podiatry service currently operates an open 
access referral system. Referrals to the services are accepted from health professionals 
in both primary and secondary care in as well as self-referral by patients. In contrast 
access to orthopaedics is restricted to hospital based clinicians and general 
practitioners (GPs). Orthotic services at both sites accept referrals from hospital based 
clinicians and more recently from the BCH community musculoskeletal triage services 
(MATS). The community podiatry service does not have direct access to either hospital 
based services with the exception of secondary care based podiatry.  
 
It is possible that some patients with foot problems may self-refer for foot care in the 
private sector, particularly in relation to podiatry and orthotics. Patients may also opt to 
have orthopaedic intervention in the private sector, although it is unlikely that the same 
access route applies i.e. self-referral. The researcher’s personal knowledge of 
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independent orthopaedic service provision, suggests the majority of patients who 
access independent care are referred by their GP.  
 
Foot care services within Bristol therefore vary in terms of provision lead location 
(community or hospital based) and access. The target patient sample for the research 
studies in this thesis will sample patients with RA from both UHB and NBT 
rheumatology departments. However, the studies will also be community based to 
reflect the provision of the local primary care based podiatry services. Therefore, by 
taking only those patients registered with GPs within the BCH area, a direct comparison 
will be possible between the two hospital sites, as they will cover the same 
geographical area for primary and secondary provision. The rheumatology service 
provision in Bristol is similar to other centres in the UK in terms of multidisciplinary 
nature of care and long term RA follow-up patients (Kirwan et al, 2003). The findings 
may therefore reflect circumstances in other urban areas, although a more up to date 
survey of rheumatology and foot care services nationally may be warranted as a 
separate activity at a later date. 
 
1.5 Funding of the research 
 
The National Institute for Health Research (NIHR) funded the research in this thesis. 
The researcher was awarded a personal clinical doctoral research fellowship under the 
Clinical Academic Training Scheme for nurse, midwives and allied health professionals. 
The NIHR had no influence on the analyses, interpretation of research findings or 
publication. 
 
1.6 Thesis structure 
 
This thesis has been divided into seven chapters (including the current chapter). This 
introductory chapter is followed by two background literature review chapters. The 
background literature review chapters describe, critically appraise and discuss foot 
problems in general populations and in patients with RA, and empirical evidence and 
clinical reviews reporting non-pharmacological care of foot problems. The background 
chapters will also review the literature in relation to access and utilisation of health care 
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in general terms and to foot care services in particular. The three interlinked studies of 
the thesis are presented as three separate chapters. The aims, methods, results and 
discussion for each study will be described in the relevant chapters. The thesis 
concludes with an overall discussion chapter which draws together the findings and 
conclusions of all three studies. Additionally the final chapter will describe this thesis 
contribution to knowledge, implications to clinical practice, organisation and delivery of 
foot care for patients with RA. 
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Chapter 2: The foot in rheumatoid arthritis 
This chapter first explores foot structure, foot function and the prevalence of foot 
problems in general populations then goes on to review the literature relating to the 
prevalence, nature, consequences and impact of foot problems in rheumatoid arthritis 
(RA). It concludes with a review of empirical evidence and clinical opinions concerning 
the non-pharmacological management of the foot in RA.  
 
2.0 Background 
 
As the interface between the body and the ground, the foot has a significant role in 
human bipedal locomotion and is an essential component of the kinetic chain required 
for gait. Abnormalities involving any component of the kinetic chain can have 
consequences such as pain, altered function and subsequent deformities. In relation to 
the foot, gait abnormalities can cause “abnormal” stresses on the foot leading to 
development of foot deformity (e.g. Leardini et al, 2006). There is a substantial body of 
literature describing the influence of “abnormal” foot mechanics and development of 
foot problems in both general populations and people with specific health conditions 
(e.g. Cavanagh et al, 1997). Abnormal foot mechanics can have particularly significant 
clinical outcomes in patients with long term conditions. For example gylcosylation 
(adherence of glucose to collagen proteins) of the soft tissues in the diabetic foot can 
result in reduced skin and tendon elasticity. These features result in a limitation in the 
range of motion of the joints, abnormal loading on weight bearing, increased plantar 
pressures and subsequent callus formation, which individually and/or in combination 
can lead to ulceration (Shaw and Boulton, 1997). These clinical features, combined with 
“diabetic foot disease” (neuropathy, peripheral vascular disease and deformity) can 
have serious clinical significance and consequences (NICE NG19, 2015). However, the 
precise pathophysiology for development of foot problems in patients with diabetes is 
not fully understood (Allan, Munroe and Figgins, 2015). Nonetheless foot ulceration in 
patients with diabetes is widely recognised as the most common contributory factor for 
non-traumatic lower limb amputations (Reiber, Lipsky and Gibbons, 1998). However, 
global incidence of lower limb amputations is reported to be variable amongst 
developed and developing countries (Margolis and Jeffocate, 2013). In contrast the 
common clinical features of rheumatoid arthritis (RA) are joint pain, joint swelling and 
joint stiffness as a consequence of the inflammatory process (synovitis and joint 
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effusion), which can lead to the destruction of articular structures (Firestein, 2003; 
Smolen et al, 2007). The inflammatory process can then lead to stretching and 
distension of joints (capsular distension) and supporting soft tissues (e.g. tendons and 
ligaments). This loss of stability increases susceptibility to deformity (Jaakkola and 
Mann, 2004). 
 
However, the development of foot problems is not only limited to abnormal foot 
mechanics and function. It is widely accepted that such abnormalities increase pressure 
on soft tissues and can lead on to the formation of cutaneous lesions such as corns and 
calluses (e.g. Freeman 2002). Additionally, wearing restrictive footwear (e.g. shoes with 
a shallow or narrow toe box) can also be a contributory factor, particularly in the forefoot 
(Menz and Morris, 2005). Toe nails are a common site for pathology to develop due to 
trauma and infection (Cohen and Scher, 1992; Flint and Cain, 2014). Foot problems 
also include conditions affecting the soft tissues such as tendinopathies, plantar 
fasciitis, bursitis and Morton’s neuroma (benign fibrous lesions) (Ayub, Yale and Bibbo, 
2005). Pathological involvement of the peripheral neurovascular system adds to the 
complexity and nature of problems that can develop in the foot. 
 
Quantifying the presence of a disease (health condition) in a population is of great value 
in the planning, organisation and delivery of health care. Measuring frequency of a 
condition can elucidate how common the condition of interest is in a population or the 
rate at which it is occurring (Feigin et al, 2014). It can also be used to plan and evaluate 
strategies for prevention and to assist the clinical management of patients who have 
already developed a health condition. In epidemiology terms “frequency” of a condition 
can be measured by prevalence (the proportion of the population with a condition at a 
defined point in time or over a specific interval), incidence (rate at which new cases of a 
condition occur in a population during a specific period of time) and mortality (death as 
a result of a health condition). All three are statistical terms for describing disease 
occurrence in a population (Coggon, Barker, and Rose, 2009). Information about the 
prevalence of a condition or event can be obtained from administrative data (e.g. 
amputation rates), clinical audits (e.g. number of patients with diabetes presenting with 
ulceration), clinical assessment (e.g. microbiology positive screening for hospital 
acquired infections) and self-report by patients (e.g. questionnaires).  
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One aim of this thesis is to investigate the prevalence and impact of foot problems in 
patients with RA. For the purposes of this thesis, the prevalence of foot problems is 
regarded as the development of a foot problem at any time since being diagnosed with 
RA. What is already known about foot problems in RA and gaps in our knowledge will 
now be assessed by a review of the literature.  
 
Literature reviews may be narrative, systematic or quantitative systematic reviews 
(meta-analyses). The latter two are useful for establishing the level of evidence for the 
effectiveness of clinical interventions such as pharmacological interventions. Evidence 
generated from single studies can be limited due to small sample size. Combining the 
data from multiple studies investigating the same topic of interest and systematically 
identified to avoid omissions can therefore strengthen the evidence for the use (or non 
use) of an intervention. Additionally systematic reviews are valuable to investigate the 
evidence for a focused research or clinical question (Garg, Hackam and Tonelli, 2008). 
Although systematic reviews are generally considered providing the highest quality 
evidence they do have limitations. These include sampling and selection of studies 
(selective publication bias) and issues of heterogeneity (Eyseneck, 1994; 
Gopalakrishnan and Ganeshkumar, 2013). A narrative literature review includes a 
range of publications such as editorials (where the author synthesises information on a 
narrowly focused area of a small number of papers), commentaries (where the author 
presents their opinion), narrative overviews by acknowledged experts and studies using 
a range of methodologies investigating a topic of interest (Green, Johnson and Adams, 
2006).  
 
The areas of interest for this thesis (prevalence, impact and care of foot problems in 
RA) are broad and do not form a focused clinical question (e.g. “Are foot orthoses 
effective for reducing metatarsal pain in patients with RA?”). A pragmatic approach to 
reviewing the literature was therefore undertaken using a narrative literature review. A 
preliminary search identified literature reporting foot problems in both general and RA 
populations. To identify publications of interest the following search terms were used: 
foot, foot symptoms, foot pain, foot involvement, foot problems, rheumatoid arthritis, 
disability and impact. Databases searched for papers published in English were: 
CINHAL, MEDLINE, EMBASE and Cochrane Library. These databases were searched 
up until November 2015. Abstracts, full text articles, editorials, narrative overviews and 
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commentaries of interest were retrieved for review. Those most relevant to the area of 
interest were initially retrieved for review. These included articles reporting foot 
problems in general and RA populations or where the focus was clearly on the 
prevalence and/or nature of foot problems. A subsequent “snowballing” approach was 
then utilised to identify further studies and clinical reviews from the reference lists of 
those already obtained (Greenhalgh and Peacock, 2005). Figure 2.1 presents the 
narrative literature reviewed undertaken.  
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Figure 2.1 Narrative literature review foot problems 
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2.1. Foot problems in general populations 
 
To set foot problems in patients with RA in context, foot problems in general 
populations are first considered. The prevalence of foot problems (e.g. deformity, 
cutaneous lesions) and associated symptoms (e.g. pain) in the general population has 
been reported to increase with age, be more common in women, vary due to ethnicity 
and associated with prior use of particular footwear (Bevenuti et al, 1995; Dunn et al, 
2004; Golightly et al, 2012; Dufour et al, 2009). Foot and lower limb problems resulting 
in decreased function, which can subsequently have a negative effect on quality of life 
and wellbeing, have also been described (Chen et al, 2003; Barr et al, 2005; Gorter, 
Kuyvenhoven, and de Melker, 2000). 
 
Badlissi et al (2005) conducted a community based cross-sectional study of a random 
sample of older people (> 65 years). The aim of the study was to investigate 
association of foot problems (hallux valgus, toe deformities, pes cavus, pes planus, 
plantar fasciitis) and foot pain (self-report) with functional limitations (e.g. walking 
speed) using the self-reported Foot Health Status Questionnaire (FHSQ) (Bennett et al, 
1998). The FHSQ has been shown to have good content validity (extent the 
questionnaire accurately captures information regarding foot health status), construct 
validity (extent the questionnaire measures foot health and correlates or not with other 
questionnaires quantifying foot health) and high retest reliability (level of agreement 
between results obtained by the questionnaire at different time points in stable 
populations) (Riskowski, Hagedorn and Hannan, 2011a). However, the content validity 
of the FSHQ has been questioned as items for inclusion were developed from focus 
groups with clinicians rather than patients (Walmsley et al, 2010). Data collected by 
clinical assessment showed over half of the sample had one or more deformities in the 
toes, and hallux valgus was observed in a third of the participants. Hallux valgus, toe 
deformities and foot pain were not however associated with slower walking time. The 
authors reported the odds ratio for foot pain in participants with plantar fasciitis was 
14.4 (though with wide confidence limits of 4.2 to 50.6, indicating limited precision) and 
called for further work to investigate the risk factors and therapeutic interventions for the 
management of plantar fasciitis. However, the proportion of participants who had 
plantar fasciitis was small (6.9%). This study had a large sample size (n=713) and 
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participants were a randomly selected community based population, and provides 
evidence that structural foot deformities are common in older people. 
 
A survey of 156 randomly selected adults (women 90, men 66) conducted by 
Nancarrow (1999) investigated general health status, prevalence of self-reported foot 
pathologies and availability of health services in a rural geographical area. Data are 
presented on the report of foot arthritis, deformity (toe deformities, hallux valgus, pes 
planus), cutaneous lesions (corn or callus, toe nail problems), foot injuries and infection. 
Women reported higher prevalence than men of foot arthritis (30.8% versus 19.1%), toe 
deformities (15.1% versus 8.7%), fallen arches (14.9% versus 5.1%) and secondary 
skin lesions (corn and callus) (17.8% versus 14.5%). Infections and injuries were more 
common in men (10.2% versus 6.5%, 20.7% versus 8.7% respectively). Nancarrow 
presents data about a wider description of foot problems compared to Badlissi et al but 
the information was collected by self-report and was not confirmed with clinical 
assessment or review of clinical records. The results therefore depend upon the 
accurate recognition and appropriate reporting by respondents. 
 
A multicentre case control study (cases 2452, controls 1913) investigated foot problems 
as risk factors for fractures in adults over the age of 45 years (Keegan et al, 2002). 
Cases are defined radiological confirmed fracture of proximal humerus, tibia or fibula 
and pelvis. Controls (no fracture at defined anatomical sites) were randomly sampled 
from the same hospital centres matched for age and gender. Data were collected by a 
standardised questionnaire (self-report). Categories of foot problems reported by the 
authors included toe deformities, bunions, corns, calluses, flat feet, high arches, 
ingrown toe nails and arthritis. Of the control group, 82.1% reported to have one or 
more foot problems. A range of categories of foot problems were reported. For example 
a third reported presence of calluses and corns (34.1% and 27.3%, respectively), 
22.7% toe nail problems (ingrown toe nails and painful toe nails) and 19.4% reported to 
have bunions. Although the primary aim of the study was to investigate if foot problems 
were risk factors for fractures, the study provides further evidence that foot problems 
are common in general populations. However, prevalence data alone do not give an 
indication of clinical severity of foot problems or the clinical need for intervention.  
 
Chapter 2: Foot problems in rheumatoid arthritis 
43 
 
A population based survey of 70,497 patients from 16 European countries undertaken 
to measure the prevalence of foot problems and comprised of two phases (Burzykowski 
et al, 2003). Phase 1 used “convenience” sampling of patients attending for GP and 
dermatology clinical consultations (irrespective of reasons for consulting) within the 
participating countries. The study inclusion criterion was consenting to clinical 
examination of their feet. Of the participating countries, 15 recruited patients to Phase1. 
Recruitment for Phase 2 also utilised “convenience sampling” of patients presenting for 
dermatology clinical consultations (irrespective of reasons for consultation or initial 
diagnosis), and patients consented to both a clinical and mycological examination of 
their feet. The authors use the term “foot diseases” capturing a range of foot problems 
categories. Categories of foot diseases included presence of fungal foot disease (tinea 
pedis), orthopaedic foot problems (toe deformities, pes cavus), metatarsal corns, viral 
infections (warts), skin diseases (eczema) and vascular disease (presence of 
ulceration, tissue necrosis). Additional categories of foot problems collected in Phase 2 
included bacterial infections, connective tissue diseases (e.g. scleroderma) and toe nail 
pathologies. Women made up 57% of the sample and the most common “foot diseases” 
were: one or more orthopaedic condition (pes planus, pes cavus and toe deformities) 
which occurred in 20.4% (Phase 1) and 24.8% (Phase 2) and plantar metatarsal corns 
which occurred in 11.6% (Phase 1) and 9.6% (Phase 2). The frequencies of non-fungal 
foot diseases were broadly similar for both genders in each phase of the study (e.g. 
men 58.1%, women 56.2% in Phase 2). The study involved a large number of 
participants who had foot examinations from 16 European countries and supports the 
impression that foot problems are common in patients attending dermatology and GP 
consultations. The classification and categories of foot problems observed were similar 
for both Phase 1 and Phase 2. However, the study does have limitations. Firstly; the 
recruitment strategy was not a random sample. It is possible that patients attending 
dermatology clinics may be considered more likely to present with skin conditions (e.g. 
psoriasis). Data were collected using a standard questionnaire. However, data were 
collected by a number of assessors (physicians). A description of the training assessors 
received on the conduct of foot examinations, completing data collection forms or how 
the assessors were recruited is not given in the paper. Additionally, provision and 
access to health care varies across Europe. For example in the UK the health care 
system is publicly funded and mostly free to all at point of entry. In contrast France 
access requires initial self-funding which is later reimbursed from public funds. Although 
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this study has a very large sample size, recruiting patients from particular clinical 
settings in multiple countries with variable health care systems raise issues of 
generalisability. Finally, although the study reports high prevalence of foot problems no 
measure of severity, impact and/or clinical significance of pathologies requiring further 
treatment are reported.  
 
The reports briefly reviewed above suggest foot problems are common, vary between 
genders but do not necessarily increase with age. However, these conclusions cannot 
be definitive because of the methodological approaches of being hospital based 
studies, or community surveys of populations lacking heterogeneity, and/or age 
restricted.  
 
Mølgaard, Lundbye-Christens and Simonsen (2010) conducted a community cross 
sectional study of randomly selected adults aged 18–80 years (864 women and 807 
men). The purpose was to investigate the prevalence of foot problems, pain in the foot, 
leg and/or lower leg by self-report. Classification of foot problems included the self-
report of general foot structure: pes panus (flat foot), neutral (neither flat foot nor high 
arched) or pes cavus (high arch) and regional pain with in the foot (toes, forefoot, 
midfoot, and rearfoot) and/or Achilles tendon. Foot pain in the last month was reported 
by 30.4%, of these 19.9% described consequences of limitations in activities of daily 
living. However, the prevalence of different symptoms was different in different age 
groups. The highest prevalence of toe and ankle pain was reported by older participants 
60-80 years (10.5%, 14.1%) compared with 40-59 years (9.4%, 10.7%) and 18-39 
years (5.6%, 5.6%). Forefoot, midfoot and rearfoot pain were more common in middle 
years 40-59 years (16.1%, 9.5%, and 6.7%) versus 60-80 years (11.2%, 5.6%, and 
3.5%) and 18-39 years (10%, 9.0%, and 35%). The highest frequency of Achilles 
tendon pain was described by younger participants (18-39 years). Women reported 
more general foot pain overall (34.4%) compared to men (26.3%) in all foot pain regions 
with the exception of Achilles pain (women 4.8%, versus men 4.6%). Although this 
report is a more credible assessment of foot problems than the other more limited 
reports described above, the presence of foot pain is presented as a binary variable 
(yes / no) so an indication of severity is not apparent. The authors did report that foot 
pain limited activities of daily living (ADL) but did not use a validated scale to measure 
ADL, therefore limiting comparisons of the study findings to other populations. 
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Additional data relating to history of foot trauma, surgical intervention and/or co-
morbidities in which foot pain is a feature (inflammatory arthritis, painful peripheral 
neuropathy and peripheral vascular disease) were not collected. The potential 
confounding effects of co-morbidities are therefore a limitation. Nevertheless, significant 
associations were found between foot pain and pain in the leg and/or lower back, and 
also with foot deformities. The study therefore demonstrates that foot pain is highly 
prevalent in a random sample of adults. 
 
Hill et al (2008) conducted a two stage study of a community based cohort aimed at 
identifying the prevalence of health conditions to inform health policy and planning for a 
regional area of Australia. A total of 4,060 randomly selected individuals participated in 
the first phase (telephone interview). The second phase included attendance for a 
clinical assessment which included a self-completed questionnaire relating to 
demographics (age, gender), medical conditions (e.g. cardiovascular disease) 
musculoskeletal conditions (e.g. report of foot pain), physical activity levels (e.g. 
walking), and health related quality of life (Medical Outcomes Study Short Form 36 (SF-
36)). Clinical assessments were conducted to calculate Body Mass Indices (BMI). Of 
the original cohort, 3,206 attended for a clinical assessment. Of these, 17.4 % reported 
foot pain in the last month. Women were 40% more likely to report foot pain. Factors 
associated with foot pain were increasing age and obesity. Additionally participants 
reporting foot pain had higher scores in each domain of the SF-36 compared with 
participants reporting no foot pain. Overall the study demonstrates that foot pain is 
common and is linked to quality of life, but the SF-36 is not a specific measure of the 
impact of foot health status and reported presence of foot problems does not give an 
indication of severity and/or clinical need for intervention. The total number of 
individuals invited to participate in Phase 1 is not reported, nor are demographic data of 
non-responders (decliners). Participation bias is therefore a consideration. This could 
be further exacerbated by not having similar information for the 25% who did not attend 
for clinical assessment. 
 
An investigation about the impact of foot pain in relation to disability was conducted in a 
random sample of patients (18-80 years) from two general practices in the north of 
England (Garrow, Silman and Macfarlane, 2004). The study included self-report of foot 
problems (nail problems, callosities, corns, athletes’ foot, verrucae, bunions / hallux 
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valgus), location of musculoskeletal pain (self-reported on outline manikins of feet and 
lower leg) and foot related disability. Disability as a consequence of foot pain was 
measured using the Manchester Foot Pain and Disability Index (MFPDI (Garrow et al, 
2000)). The MFPDI is a validated scale to measure general foot pain which is not 
condition / disease specific and includes items (questions) covering three domains: 
functional limitations, pain intensity and concerns about foot appearance. Of the 4,780 
questionnaires posted 3,417 were returned. All patients reporting foot pain on the day 
the questionnaire was completed were invited for a clinical assessment including a foot 
examination. A random sample of 50 patients not reporting foot pain was also invited for 
a clinical assessment. Of the responders to the survey, 56% were female. Overall 10% 
of responders reported disabling foot pain at the time of completing the questionnaire. 
The portions of men and women reporting foot pain in the last month were similar (20% 
versus 24%). The most common sites of foot pain were plantar aspect of the heel, mid 
foot, 1st MTP joint and 1st toe. One or more foot problems were reported by two thirds of 
responders. Overall more women reported presence of corn / calluses, swollen feet and 
bunion compared to men (39% versus 20%, 16% versus, 6%, bunions 12% versus 3%; 
respectively). In contrast the proportion of men reporting athletes’ foot infections (23%) 
was higher than women (11%). The frequency of toe nail problems reported was similar 
for both genders (24% versus 24%). However, the presence of all categories of foot 
problems diagnosed by a clinician (podiatrist) was greater than the self-report. 
Sensitivity for all categories of foot problems was <58% indicating a lack of agreement 
between the self-report of foot problems and those observed by clinical assessment.  
 
This study presents the most comprehensive data regarding the prevalence and type of 
foot problems (deformities, skin conditions, infections injuries and previous surgery) of 
studies discussed so far. It confirms that foot pain is common in the general population. 
A further strength is the conduct of a foot examination in a selected sub-sample of 
patients. However, analyses demonstrate that patients may not recognise and therefore 
fail to report some foot problems for example “flat feet”. Thus data reported in the 
questionnaire may potentially be an under estimation of the prevalence of foot 
problems. Although the study target population was ‘randomly selected’ the authors do 
not report whether sampling included all the patients registered as the total number of 
patients each practice served. Generalisability of the study findings may be limited as 
gender and age are the only demographic variables presented. Nevertheless the study 
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is strengthened by the methodological approach (community based random sample), 
the use of a validated questionnaire (MFPDI), large sample size, very high response 
rate (84%) and investigated levels of agreement between the self-report of foot problem 
with foot problems assessed by a clinician. This was a novel approach to investigating 
prevalence of foot problems. 
 
2.1.1 Summary of foot problems in general populations 
Foot problems cover a wide range of pathologies such as cutaneous lesions (corn, 
callus, toe nail pathologies), deformity (hallux valgus, pes planus, pes cavus), soft 
tissue pathologies (e.g. Achilles tendinopathy), which can individually and/or in 
combination lead to foot pain. Despite methodological weaknesses in some studies, the 
literature indicates foot problems are common in the general population. However, the 
majority of the literature report foot prevalence data by self-report. As discussed in 
Chapter 1 foot problems can be important additional features of RA. A review of the 
literature reporting foot problems in RA was therefore undertaken. 
 
2.2. Foot problems in rheumatoid arthritis 
 
Vainio (1956) conducted a review of 1000 hospital-based patients with rheumatoid 
arthritis (RA) and in 16% the initial symptoms of RA involved the foot and ankle. The 
prevalence of foot problems and ankle problems was similar for women and men (91% 
versus 85%). Michelson et al (1994) conducted an observational study of a 
convenience sample of 99 patients with RA involving a clinical assessment including 
information relating to general joint involvement and functional capacity (Steinbrocker, 
Traeger and Atterman, 1949) and presence of foot pathology (foot and ankle symptoms 
and foot deformity). Of the 99 study participants, 93 are reported to have experienced 
foot and/or ankle problems at some time since being diagnosed with RA. These studies 
were both hospital based, used “convenience” sampling, were conducted a long time 
ago and are therefore not likely to reflect the current RA patient population. The 
pharmacological management of RA has undergone substantial development in the 
time since both studies were conducted and reported. While both studies raise the 
possibility of foot problems being common clinical features of RA, neither provides a 
detailed clinical description of the nature and/or severity of foot problems in RA.  
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Speigel and Speigel (1982) considers the main complications of RA in the foot are a 
result of a combination of inflammatory disease and altered foot mechanics with weight 
bearing and its consequent mechanical loads contributing to further joint damage. The 
mechanics of the foot and ankle in RA may also be influenced by a combination of foot 
joint misalignment and lower limb tendon pathologies (Dubbeldam et al, 2013). The 
additional mechanical stresses of walking in a weakened musculoskeletal environment 
can lead to pain, deformity, secondary skin pathologies, deterioration in walking and 
activity levels and reduction in general wellbeing (Turner et al, 2008; Wickerman et al, 
2004). The variable and unpredictable progression of RA coupled with complex 
anatomy, mechanics and synovitis are a challenge to the protection of foot joints from 
further damage (Smyth and Janson, 1997; Woodburn and Helliwell, 1997). There is a 
significant body of literature devoted to investigating the association between 
pathomechanics (abnormal mechanics) and foot problems in RA. A detailed review and 
critical appraisal of this highly specialist and technical topic is beyond the scope of this 
thesis. A review of the literature describing the specific clinical features of foot 
involvement in RA is presented and discussed next.  
 
2.2.1 Forefoot involvement 
Jaakkola and Mann (2004) consider forefoot pathology to initially develop as a result of 
synovitis involving the MTPs. Inflammation of the synovium leads to stretching of the 
joint capsule and supporting structures (ligaments and tendons). The loss of stability 
and the influence of weight on unstable joints further increases susceptibility to 
deformity. Smyth and Janson (1997) and Stainsby (1997) describe how instability of 
MTP joints can lead to displacement of the transverse metatarsal arch leading to 
“splaying” of the forefoot and eventual subluxation of the metatarsals. Additional 
features of forefoot involvement can also include fibro fat pad atrophy and 
displacement. Toe deformities can also occur as a result of contraction of the extensor 
tendons compensating for instability of the MTPs. The forefoot position is further 
influenced by abnormal ground reaction forces at the 1st MTP leading to the 
development of hallux valgus deformity. Deviation of the hallux then forces the lesser 
toes laterally. In an attempt to compensate for the abnormal forefoot mechanics, the 
lower limb and foot extensor tendons and soft tissues contract, contributing to 
deformities in the lesser toes (Saltzman and Vogelgesang, 1997). A review of a 
convenience hospital based sample of 200 patients with RA (194 feet) reports 59% of 
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patients were observed to have hallux valgus (bilateral or unilateral) and 28% hallux 
rigidus (bilateral or unilateral) (Kirkup, Vidigal and Jacoby, 1977) 
 
2.2.2 Midfoot and rearfoot involvement 
Description of midfoot involvement as a clinical feature of RA is predominately reported 
in clinical observation studies utilising highly complex imaging techniques and 
biomechanical assessments (e.g. Woodburn, Barker and Helliwell, 2002). Synovitis of 
the joints of the mid foot is considered by some authors to be less common compared 
with MTP involvement (Smyth and Janson, 1997). Bouysset et al (1987) report talo-
navicular involvement in 32% of patients with RA. Speigel and Speigel (1982) observed 
patients with shorter disease duration (<5 years) had fewer changes (deformity) 
involving the rearfoot compared with patients with longer disease duration (> 5years) 
(8% versus 25%). Pes planus (reduction in the medial longitudinal arch) and pes 
planovalgus (reduction in the medial longitudinal arch and valgus deformity of the 
calcaneus) are also considered to be additional features of rearfoot involvement in the 
foot (e.g. Turner et al, 2003). Additionally tibialis posterior tendon is considered to be an 
important extra-articular feature of rearfoot pathology in RA. The tendon can be a site of 
pain, tenderness and also dysfunction can result in reduction in hind foot function. The 
association of tibialis posterior dysfunction and development of pes planovalgus has 
received attention (Bouysset et al, 2003). However, the prevalence of pes planus in 
patients with RA has not been fully established. Involvement of the midfoot and /or 
rearfoot can result in alterations in foot function and subsequently result in abnormal 
gait (Turner et al, 2008)  
 
2.2.3 Extra-articular features 
Clinical features of RA are not only confined to articular joints (joint pain, joint stiffness 
and joint swelling), and associated clinical features (tendonitis, tendinopathies). 
Manifestations can also occur in the soft tissues such as: rheumatoid nodules (lesions 
comprising of granulation tissue, inflammatory cells and central fibrous tissue), 
adventitious bursa, neuritis (inflammation of the nerves) and vasculitis (inflammation of 
blood vessels) (O’Brien, Hart and Gould, 1997). Boutry et al (2003) evaluated the feet 
and hands of 30 patients with RA using magnetic resonance imaging (MRI). Over half 
of the study sample was found to have bursae present between or inferior to one or 
more MTP joints. Entrapment neuropathies and mild peripheral neuropathy also occur 
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in the feet of patients with RA. For example presence of tarsal tunnel syndrome and 
sensory peripheral neuropathy has been observed in 13% and 7% of a group of 
patients with RA (McGuigan, Burke, and Fleming, 1983). Wilson and Kirwan (2006) 
reported reduced protective sensation in the feet in 58% of patients with RA. The 
different results in these two studies may be accounted for by different methods of 
assessments (electro diagnostic versus clinical screening tool). 
 
2.2.4 Cutaneous lesions 
Corns and calluses can develop due to mechanical stress (e.g. narrow footwear), 
abnormal mechanics (e.g. deformity) and increased stress (e.g. prolonged activity) 
Freeman (2002) proposes that the formation of corns and calluses is “a normal 
physiologic response of the skin to chronic excessive pressure or friction”. Deformity 
and abnormal mechanics can be clinical features of foot problems in RA. It is therefore 
possible to postulate that patients with RA with these features may be more likely to 
develop corns and calluses. Patients with severe deformity involving weight bearing 
joints with secondary callus formation may be at risk of developing foot ulceration 
(Vogelgesang, Shurr and Saltzman, 1999). Work conducted by Firth et al (2008) 
investigating the prevalence of foot ulceration in RA supports Vogelgesang’s, Shurr’s 
and Saltzman’s clinical opinions that patients with RA can develop foot ulceration. The 
prevalence of toe nail pathologies in RA is not fully known as the topic has received 
little attention.  
 
2.2.5 Overview of clinical presentation of foot problems 
This review of the literature indicates that foot problems in RA can be complex and 
multifactorial in presentation. Publications supporting this impression thus far are 
clinical reviews supported by some empirical evidence. The empirical evidence has 
methodological weaknesses (e.g. sampling small numbers) and was generally collected 
prior to the introduction of modern treatment paradigms for RA (e.g. biologics). 
However, both clinical research and clinical reviews have value in terms of a descriptive 
overview of foot problems in RA. The use of clinical outcome measures including 
patient reported outcome measures are considered to be essential to monitor disease 
progression and evaluation of treatment interventions (e.g. van Riel and van Gestel, 
2000). The studies reviewed thus far have largely neglected the severity, consequences 
and impact of foot problems in RA. Studies reporting foot problems in more recent 
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patient samples and/or inclusion of outcome measures will be reviewed next, focussing 
on observational studies presenting data using clinical assessments (imaging 
techniques and clinical examination) and self-report by patients.  
 
2.3 Observational studies reporting foot problems in RA 
 
Rojas-Villarraga et al (2009) conducted a hospital based cross sectional study 
investigating foot related disability in 95 patients with RA. Data were collected from foot 
examinations, measures of disease severity (Disease Activity Score (DAS), Prevoo et 
al, 1995) and general disability (Health Assessment Questionnaire (HAQ)). The foot 
examination was conducted by two examiners. Overall foot deformities were observed 
in the majority of patients (82%). Presence of hallux valgus (65%), lesser toe 
deformities (75%), reduced medial longitudinal arch and transverse arch (42%) were 
common. Dorsal and/or plantar calluses were observed in 73 patients. On assessment 
of the MTPs, 46% of patients were metatarsal squeeze test positive. Similar 
observations for one or more current foot problems and hallux valgus are reported by 
Göksel Karatepe et al (2010). In regression analysis conducted after adjustment for 
age, gender and disease duration, forefoot pain was associated with disease activity 
(DAS (adjusted odds ratio / AOR = 14.4; 95% CI, 1.6 -133.2: P<0.0001)) and disability 
(HAQ (AOR= 16.6; 95% CI, 4-69.3: P < 0.0001)). However, the wide confidence 
intervals indicate lack of precision of association. Further, the authors do not provide a 
detailed account of the examiners in relation to data collection. For example, were all 
participants were examined concurrently or simultaneously by both examiners? Levels 
of interrater agreement are therefore not known. The study was hospital based and 
used “convenience” sampling. The study sample may therefore be criticised for lacking 
representation and generalisability. However, demographic (age, gender) and clinical 
characteristics (e.g. disease activity and disability) are provided. Participation bias is 
also a consideration, in that is patients experiencing foot problems may have been 
more likely to consent to take part in the study. Nonetheless data reported indicates 
deformity, presence of calluses and clinical indications of inflammatory disease were 
common in the study sample. 
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Borman et al (2012) conducted an observational study of foot involvement in a 
randomly selected sample of 100 patients with RA. Method of randomisation is not 
available in the report. Of the sample, 89% of patients reported current or past foot 
involvement at some time. On examination, the most frequent site of pain was the ankle 
(30%), followed by forefoot, hindfoot and midfoot (30%, 17% and 7%; respectively). 
Other clinical features classified as “non-pain complaints” observed were: swelling 
(68%), numbness (51%), toe nail pathologies (37%), corns (24%), bunions (14%) and 
flat foot (11%). No significant correlation was observed between current foot pain and 
age or gender. The lack of association with gender could potentially be accounted for 
by the high number of female participants (male to female ratio 1:9). However, foot pain 
was found to be weakly associated with higher BMI, longer disease duration and 
glucocorticoid therapy (r=0.24, r=0.23, r=0.24 all p=0.01). As with Rojas-Villarraga 
(2009) et al study inter-observer reliability and therefore inference of the study findings 
is a consideration (data collected by more than one assessor). Data reported by 
Borman et al (2012) provide a broad description of current foot problems in a randomly 
selected patient group. Additionally the association of disease duration with the report 
of foot pain is of interest, raising the possibility that disease duration may be an 
important determinant of the development of foot problems in RA. Disease duration, 
foot pain and swelling of the ankle have been reported to be significant predictors of 
disability (Health Assessment Questionnaire scores) in patients with RA (Baan et al, 
2011), further supporting the association of disease duration as a factor related to the 
report of foot pain.  
 
A prospective longitudinal study of patients reports the prevalence and course of 
forefoot impairments and walking disability in a cohort of patients with early RA (n=848) 
followed up over an eight year period (van der Leeden et al, 2008). Data presented are 
sub-analyses of a cohort of patients participating in the Early Arthritis Study (Jansen et 
al, 2000). Measures of foot involvement were captured by clinical examination of MTP 
joints (reported pain and clinical indication of swelling in MTP joints), radiological 
examination of joint changes (erosions, joint space narrowing) and impairment of foot 
problems (lower limb domains of HAQ). At baseline, pain and swelling in one or more 
MTPs was noted on examination in 70% of patients, reducing to 40%–50% after two 
years. One or more forefoot erosions were recorded in 19% of the study sample at base 
line increasing to 60% after 8 years. Mild walking disability was observed in 57% at 
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baseline, stabilising to 40% after one year. The study has particular strengths in relation 
to sample size. However, the attrition rate was high as only a third (n=239) of the 
original cohort attended for the study exit review. Attrition is a challenge for all 
longitudinal studies. Additionally the study assessed patients with early disease, 
focused on forefoot joint involvement and self-reported walking disability. However, the 
authors demonstrate the prevalence and severity of forefoot joint involvement 
increasing over the follow up period. The study raises an important clinical issue 
regarding the deteriorating progression of forefoot involvement in RA.  
 
A longitudinal prospective cohort study of patients with RA (n=149) conducted by 
Hooper et al (2012) aimed to determine the prognostic factors associated with forefoot 
related disability using the Foot Impact Scale - FIS (Helliwell et al, 2005). The main 
clinical variables of interest were: the presence of forefoot bursae, metatarsophalangeal 
joint hypertrophy, metatarsal head erosions (determined by ultrasound imaging), and 
disease activity (van der Heijde et al, 1993). Disease duration and presence of forefoot 
bursae were significant determinants of foot impairment (r = 0.70, p = 0.009 and r = 
0.16, p = 0.012, respectively). Disease duration, forefoot bursae and metatarsal head 
erosion were statistically significant factors associated with limitation in activity (r = 0.36, 
p = 0.002; r = 1.47, p = 0.006 and r= 1.14, p = 0.019, respectively). The limitations of 
the study relate to sampling strategy (hospital based, “convenience” sampling) and 
participation attrition (loss to follow up was 60%). However, the results support other 
studies reporting foot problems in RA that disease duration may be an important 
determinant of foot problems and foot related disability.  
 
A clinical audit conducted in New Zealand by Rome et al (2009) observed foot problems 
(skin and nail pathologies, tissue viability,) foot function and structure (Structural Index 
Score (Platto et al, 1991)), footwear suitability (Menz and Sherrigton, 2000) and self-
reported foot impairment (FIS). A convenience sample of 100 patients with RA 
attending for rheumatology medical review participated in the audit. The median 
disease duration was 15 years and female to male ratio was 4:1. Hallux valgus, lesser 
toe deformities and forefoot calluses were observed in 64%, 86%, and 63% 
respectively. Of the 100 patients who participated in the audit, 65% were classified as 
wearing inappropriate footwear. Moderate to high levels of foot impairment are 
reported. No analyses were conducted for correlation between foot pathologies and 
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impact as quantified by the FIS or patient characteristics such as age, gender, and 
disease duration and/or disease severity. The primary aims of the work were to 
investigate the nature of foot problems and the impact of foot problems to support the 
review of foot care provision for patients with RA. Identifying factors associated with or 
predictors of developing foot problems were not aims of the audit.  
 
Williams and Bowden (2004) conducted an audit of foot problems in patients with 
rheumatic diseases. The audit was not specific to RA but supports the findings of Rome 
et al that foot problems are common in patients with RA. The findings of clinical audits 
can be criticised for lacking methodological research. Additionally clinical audits can be 
considered to only be of value in relation to planning and evaluation of health care 
provision at a local level. However, the data reported in both audits are supported by 
the empirical evidence that foot problems are common, complex and can have 
functional impairment to patients with RA. 
 
2.3.1 Overview of observational studies reporting foot problems in RA 
In summary observational studies are beneficial in relation to providing an indication of 
the classification and categories of foot problems in RA. The studies discussed support 
the general clinical impression that foot problems can involve articular features (joint 
deformity), extra-articular features (bursae), cutaneous lesions (calluses) and structural 
deformity (hallux valgus). 
 
Additionally observational studies provide an indication of how frequent (common) foot 
problems are in RA. However, they do not give an indication of prevalence in the 
general RA population. Further, the classification and categories of foot problems 
reported varies. Data regarding foot problems in RA can be obtained by clinical 
assessment and self-report by patients. Self-completed questionnaires provide the 
opportunity to sample a large number of patients simultaneously (e.g. postal surveys). 
Results of questionnaires can be used to estimate prevalence of a condition (disease) 
within a defined population. In order to identify the prevalence of foot problems in RA, a 
review of the literature reporting population surveys is required. 
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2.4 Studies reporting prevalence of foot problems in RA by self-report  
 
Grondal et al (2008) conducted a survey of 1000 patients with RA using a convenience 
sample. Data were collected by self-completed questionnaires by patients. Items 
included in the questionnaire related to joint involvement (initial clinical presentation of 
RA and current joint involvement), foot problems and subjective walking difficulty. 
Patients were approached to participate in the study by direct contact with a member of 
the clinical team immediately prior to a clinical consultation. Almost all of the study 
participants were taking arthritis medications and a third were taking biologic therapies. 
Of the biologic group, the proportion reporting current foot joint involvement was 82%. 
The portion of patients in the non-biologics group was similar (79%). Of the whole study 
cohort, 71% described walking difficulty and the majority reported current foot problems 
(94%). Of these, 86% related to the forefoot, 52% rearfoot and 45% both rearfoot / 
ankle and forefoot joint involvement. The aim of the study was not to estimate the 
prevalence of foot problems in RA. Nonetheless the results of the survey indicate high 
levels of self-reported foot involvement in a large number of patients with RA.  
 
Otter et al (2010) conducted a postal survey to measure the prevalence of foot 
symptoms (foot pain, numbness, swelling and stiffness), frequency of foot assessments 
and access to foot care services (podiatry, receipt of insoles, prescribed footwear and 
foot surgery) in patients with RA. To inform the content of the survey items were derived 
from focus groups of patients with RA and health care professional (podiatrists and 
rheumatologists). The study target sample consisted of two groups: 650 members of a 
national patient support group (National Rheumatoid Arthritis Society (NRAS)) and all 
patients attending for rheumatology clinical review at one NHS hospital site during one 
month (n=390). Of the 585 patients who returned questionnaires, 68.2% reported 
moderate to severe current foot pain. The most frequently reported sites of foot pain 
were the forefoot (40.3%) and ankle (25.5%). Women reported higher levels of foot pain 
compared to men. The proportions of responders reporting stiffness, swelling and 
numbness were 31%, 23, and 11%; respectively. In univariate analyses, current foot 
pain was significantly associated with BMI, disease duration, stiffness, swelling and 
numbness (p = 0.001, p = 0.009, p = <0.001, p = <0.001, p =<0.001). These variables 
were then used to investigate statistical relationships between the dependent variable 
of interest, foot pain and potential independent predictive variables. In a multivariate 
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analysis only stiffness and swelling were significantly associated with current foot pain 
(OR 5.31, 95% CI 1.93 – 14.98 and OR 2.67, 95% CI 1.29 – 5.50, respectively). While 
supporting the growing body of literature showing foot involvement is common in 
patients with RA this study had the additional benefit of incorporating the patient 
perspective through items included in the questionnaire. However, the study does have 
some limitations. Firstly, the sampling of members of a national patients support group 
(NRAS) may be prone to membership bias particularly in relation to gender. Dures et al 
(2014) conducted a postal survey of patients with RA from 6 hospital sites and one 
national patient support group. Of the responders from the patient support group, 85% 
were female. In contrast of the responders to the survey from the combined hospital 
sites, 65% were female. Secondly, sampling patients attending for outpatient hospital 
appointments may have influenced patients’ decisions to participate. The study may 
therefore be subject to participation bias. Furthermore, patients attending outpatients 
might be more likely to represent those with more severe disease and not be 
representative of the whole patient population. Thirdly, though a higher BMI was 
identified as a factor associated with current foot pain, the reliability and accuracy of 
self-report of body weight has been questioned (Kemp et al, 2000) and so caution is 
required in the interpretation of BMI derived from self-reported weight. Nevertheless the 
study provides useful data in relation to the prevalence of foot pain in a large sample of 
patients with RA.  
 
The prevalence of foot ulceration in RA was investigated by Firth et al (2008). Data 
were initially collected through a postal survey. The accuracy of the self-report (foot 
ulceration) was investigated though review of clinical records and/or clinical 
assessment. All patients with a consultant diagnosis of RA within a fixed geographical 
boundary (n=1130) were sent a questionnaire by post. A response rate of 78% was 
achieved. Following validation the overall prevalence of foot ulceration was 9.7% and 
12.3% reported current and/or previous ulceration. Validation review was possible for 
the majority of patients reporting foot ulceration. Of these 9.7%, 33% reported more 
than one area of ulceration. The anatomical locations of ulceration were: toes 51%, 
other forefoot locations 57% and rearfoot 15%. The validation of the self-report adds 
strength to estimating the prevalence of foot ulceration in RA. However, it is not clear 
whether all the patients included had similar opportunities to access foot care services. 
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2.4.1 Overview of the self-report of foot problems in RA. 
The categories and classification of foot problems reported differs in these three studies 
but taken together they support the conclusion from observational studies and clinical 
reviews that foot problems are variable in presentation and some features are more 
prevalent than others, for example foot pain. Foot ulceration appears to be less 
prevalent. However, foot ulceration is an important clinical feature which has 
implications for patient care as these patients are at risk of developing soft tissue 
infection.  
 
The large sample sizes of all three studies are strengths. Additionally the study by Firth 
et al indicates the self-report of at least some foot problems can be utilised with a high 
degree of clinical confidence. However, levels of agreement between self-report of 
other foot problems by patients with clinical assessment by health professionals, 
requires further attention. Furthermore prevalence of foot problems does not 
necessarily provide an indication of clinical severity and/or need for care and none of 
these studies take account of the availability of foot care services in different locations. 
 
2.5 Management of foot problems in RA 
 
The non-pharmacological management of foot problems in RA can involve multiple 
interventions such as treatment of cutaneous lesions, provision of foot orthoses, 
prescribed footwear and orthopaedic surgery. Helliwell (2003) advocates a 
multidisciplinary approach to the management of foot problems in RA is required to 
achieve improved clinical outcomes for patients. 
 
2.5.1 Podiatry  
Podiatrists are allied health professionals who specialise in the assessment and 
management of conditions affecting the foot and lower limb and recognised as 
members of the multidisciplinary rheumatology team (NICE GC79, 2009). Korda and 
Baliant (2004) endorse the role of podiatry in rheumatic diseases: “Podiatrists are 
experts on foot disorders: both patients and rheumatologists can profit from the 
involvement of the podiatrist”. Best practice professional guidelines and care pathways 
for the podiatric management of foot problems in RA have been published (Podiatry 
Rheumatology Care Association, 2008; Williams et al, 2011). However, a UK based 
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survey of rheumatology services reported that the availability of dedicated specialist 
podiatry for rheumatic diseases services is variable (Redmond, Waxman and Helliwell, 
2006). Recent expert opinion has called for podiatry interventions to be targeted early in 
the disease course and for regular monitoring to achieve “tight control” of 
rheumatological foot problems to optimise outcomes (Woodburn et al, 2010). 
 
Treatments for reduction of cutaneous lesions (e.g. corns and calluses) and nail 
pathologies (ingrown toe nails) are routine interventions in podiatry practice. The MTPs 
are reported to be commonly affected joints (e.g. Grondal et al, 2008). Persistence of 
the inflammatory process, weight bearing on unstable joints and stresses experienced 
in gait can lead to increased focal pressure at the MTP joints with the formation of 
calluses (Sing, Bentley, and Trevino, 1996). Painful MTP calluses are recognised 
clinical features of foot involvement in RA (Woodburn and Helliwell, 1996), which 
require appropriate clinical management (Woodburn, Stableford and Helliwell, 2000; 
Davys et al, 2005). Siddle et al (2013) conducted a randomised controlled trial (RCT) of 
the therapeutic benefits of sharp callus debridement (reduction of callus using a scalpel 
blade) in 65 patients with RA with painful plantar calluses. The inclusion criteria were 
presence of reported painful plantar calluses and no previous exposure to sharp 
debridement. A “therapeutic approach” was adopted, including for each patient (if 
considered appropriate by the clinician): foot health education, self-management, 
casted foot orthoses, footwear advice, referral to physiotherapy and intra-articular 
glucocorticoid injection. In addition, the intervention group received sharp scalpel 
debridement at each of eight follow up reviews, if determined necessary by the 
observing clinician. Overall there were statistically significant differences between the 
groups in relation to measures of foot pain (Revised Foot Function Index, Budiman-Mak 
et al, 2006) impact of foot problem (FIS) and general disability (HAQ) at study exit (18 
months). Although RCTs generally provide reliable evidence for the clinical 
effectiveness of interventions, the findings of this study may require careful 
consideration before implementation in general and rheumatology podiatric practice. 
Firstly, the study involved a relatively small number of patients. Secondly, the 
confounding and possibly interacting influence of the multiple interventions in the 
“therapeutic approach” is not considered or controlled for in the analyses. However, 
study participants were recruited from both specialist (hospital based) podiatry clinics 
and community foot clinics reflecting the provision of NHS podiatric services.  
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2.5.2 Patient education, self-care and self-management of foot problems in RA 
The benefits and importance of patient education to support self-care and self-
management of foot pathologies, particularly concerning diabetic foot ulceration, is well 
described in the literature and widely implemented in clinical practice (Jeffcoate and 
Harding, 2003; Boulton et al, 2005; Singh, Armstrong and Lipsky, 2005). In diabetes 
Rönnemaa et al (1997) conducted an evaluation of the influence of a podiatry education 
programme. Participants were randomised in to two groups; a podiatry group (treatment 
and education, n= 267) and a control group (written instructions only, n= 263). Patients 
in the podiatry group had greater improvement in knowledge scores relating to diabetic 
foot care and self-care (p = 0.004, p < 0.001). An RCT investigated the effectiveness of 
a foot self-management education programme for self-referring patients (over 60 years 
of age) compared with usual care (NHS community podiatry only (FOOTSTEPS, 
Waxman et al, 2003). Patients in the self-management group at study exit (6 months) 
had reduced disability scores (measured by Manchester Foot Pain Disability Index, 
Garrow et al, 2000) and had less treatment interventions during the study period 
compared with the usual care group (39 and 92 treatments respectively).  
 
Waxman et al (2003) study provides useful information about the benefits of a self-
management programme for foot problems in a general patient group. The self-
management programme was subsequently evaluated in a consecutive sample (n=30) 
of patients with RA (Semple et al, 2009). However, over half of the study participants 
(57%) were unable to participate in self-care and self-management of their foot health 
needs (e.g. cut toe nails) due to functional impairment in the hands and elsewhere 
caused by their RA. Thus there is a paucity of evidence about the effectiveness of 
patient education and self-management programmes for foot involvement in RA 
(Graham, Hammond and Williams, 2011). Indeed, which strategies patients actually 
adopt for self-care and self-management of their foot health is not known. 
 
2.5.3 Foot orthoses (Insoles / orthotics) 
Published evidence and expert clinical opinion have promoted foot orthoses as 
interventions for foot involvement in RA (Gossec et al, 2006, Liqumani et al, 2006, NICE 
CG79, 2009). The use of foot orthoses as a treatment intervention for patients with RA 
is also supported by systematic reviews (Farrow, Kingsley and Scott, 2005; Hawke et 
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al, 2008; Loveday, Jackson and Geary, 2012). The rationale for the use of foot orthoses 
for foot problems in RA are to: stabilise joint function, correct non-fixed anatomical mal-
alignment, reduce pain, prevent deformity, support soft tissues, and improve or maintain 
function and range of movement (Helliwell et al, 2007). A large body of literature 
describes the evidence of the use of foot orthoses in an attempt to achieve some of 
these aims. However, a critical review conducted by Clark et al (2006) concludes that 
inconsistencies in the evidence from clinical trials are hindering the development of 
appropriate best practice guidelines for the use of foot orthoses in patients with RA. A 
more recent quantitative systematic review (meta-analyses) considered the evidence 
from 17 studies investigating the effectiveness of foot orthoses for foot and ankle 
problems in RA (Hennessy, Woodburn and Steultjens, 2012). Of the studies reviewed, 
the strength of internal and external validity was variable and the evidence that foot 
orthoses improve foot function and walking speed was inconclusive.  
 
The use of foot orthoses in clinical practice is confounded by variation in the 
assessment and prescribing of foot orthoses. Types of devices available for clinicians to 
prescribe are also dependent on local service provision. Additionally patients can be 
provided with foot orthoses by a variety of health professionals (podiatrists, orthotists, 
physiotherapists, occupational therapist) in both the public and independent health care 
(non-publically funded) and commercial sectors such as pharmacies and sports 
retailers. These self-sourced foot orthoses may or may not be appropriate for individual 
patient’s foot health care needs. In early disease the aims of foot orthoses are to 
prevent deformity, improve function and reduce pain (Forestier et al, 2009). In contrast 
in established disease, when deformity may have occurred or surgical intervention has 
been performed, the ethos of clinical care focuses on palliation, redistribution of 
pressure to prevent overloading and prevention of secondary skin lesion such as corns, 
calluses and ulceration (Hodge, Bach and Carter, 1999). However, the evidence for the 
longitudinal benefits foot orthoses in relation to preventing secondary skin pathologies 
in RA is currently limited in comparison to research conducted in diabetes. 
 
In order for the therapeutic benefits of foot orthoses to be achieved, patients have to 
use the devices issued. A major consideration in choice of foot orthoses prescription 
and selection of construction materials is the accommodation of the devices in a 
patient’s personal footwear. In some circumstances this will require patients to alter 
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their choice of footwear. In routine clinical practice patients can experience difficulties in 
accommodating foot orthoses in footwear which is both cosmetically acceptable and 
commercially available. These issues can be limiting factors in patients’ active 
participation and concordance with foot orthoses therapy.  
 
2.5.4 Prescribed footwear 
Difficulties relating to footwear are commonly reported by patients in clinical practice. 
Accommodation of deformities, foot orthoses (see 2.5.3) and fluctuating symptoms such 
as swelling and pain can be challenging for both patients and clinicians. Additional 
demands faced by patients are sourcing footwear that is comfortable, affordable and 
aesthetically acceptable (Goodacre and Candy, 2011; Naidoo et al, 2011). The use of 
prescribed footwear is commonly considered as a treatment option for general foot 
problems (e.g. congenital deformities) and those associated with RA. The therapeutic 
benefits of the use of prescribed footwear are further advocated by national, 
professional and clinical guidelines which recommend the provision of specialist 
prescribed footwear for patients with RA when required (Luqmani et al, 2006; NICE 
CG79; 2009; Podiatry Rheumatology Care Association, 2008). 
 
Fransen and Edmonds (1997) conducted an RCT of patients with RA and self-reported 
foot pain (n=30) to evaluate the effectiveness of “off the shelf” specialist footwear. In 
comparisons between base line and post-footwear issue assessments, statistically 
significant improvements in scores of disability, walking pain and walking speed were 
noted. An observational cross over design study conducted by Chalmers et al (2000) 
compared semi-rigid foot orthoses, soft foot orthoses and supportive footwear (n=24). 
The findings support the combination of foot orthoses with prescribed footwear as 
interventions for painful forefoot involvement in RA. Hennessy et al (2007) compared 
the benefits of running shoes, “off the shelf” orthopaedic footwear and control footwear 
in patients with RA and chronic self-reported forefoot pain (n=20). The study was a 
randomised single blind, cross over trial. The aim was to quantify the benefits of the 
three different types of footwear in reduction of in-shoe peak plantar pressures. Mean 
forefoot peak plantar pressures were significantly reduced by 36% in the running shoe 
and 20% in the orthopaedic footwear compared with the control shoe. Cham et al 
(2013) report prescribed extra-depth footwear with rocker sole additions are beneficial 
in reducing foot pain, disability and function measured by the Foot Function Index (FFI 
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(Budiman-Mak, Conrad and Roach, 1991)). Female patients with self-reported foot and 
ankle pain, duration of RA > one year and disease activity score (DAS >1 <2.4) were 
recruited to the trial (n=17). At study exit (30 days) significant reductions in pain, 
disability and activity limitation were reported. 
 
The emerging evidence indicates the use of foot orthoses, prescribed footwear and 
specific categories of footwear (trainers) may be beneficial interventions for foot 
involvement in RA. However, “good data are sparse” (Riskowski, Dufour and Hannan, 
2011b). One reason for a dearth of research on footwear could be the resistance of 
patients to wearing prescribed footwear (Williams and Meacher, 2001; de Boer et al, 
2009) therefore reducing participation in clinical trials. Comparisons between patients 
who have individual foot problems requiring a more bespoke (individualised) 
prescription for footwear is a further challenge to both study design and recruitment of 
patients.  
 
2.5.5 Surgery 
Orthopaedic surgery provides additional non-pharmacological interventions for the 
management of foot problems in RA. The overall aims of surgical intervention are to 
reduce pain, correct deformities and improve function. Numerous operative procedures 
have been developed for the surgical management of the RA foot. Procedures selected 
are often influenced by an individual surgeon’s personal preference and experience. 
Further, the use of non-surgical interventions such as foot orthoses and prescribed 
footwear are encouraged prior to and in conjunction with orthopaedic surgery (Trieb, 
2005). As with all surgical interventions post operative complications are 
considerations. Patients with RA may be at risk of post operative complications as they 
have advanced deformities requiring complex surgical interventions (Nassar and 
Cracchiolo, 2001). da Silva et al (2003) conducted a retrospective review of orthopaedic 
interventions in a US based cohort of 609 patients with RA. They reported that 40% had 
under gone at least one orthopaedic procedure. Overall having RA related surgery was 
associated with younger age at diagnosis, rheumatoid factor positivity and 
subcutaneous nodules. Women had significantly more surgeries overall compared with 
men (8.6/100 per person per year, 4.0/100 per person per year). However, 
pharmacological interventions in management RA and the risk of post-operative issues 
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(e.g. infection) are factors requiring consideration prior to performing orthopaedic 
surgery (den Broeder et al, 2007). 
 
There appears to be a general reducing trend in the number of orthopaedic 
interventions performed in patients with RA. This may be related to advances in medical 
and pharmacological management. A retrospective review of medical records of 
patients with RA (n=813) conducted by Shourt et al (2012), reports 23% of the cohort 
having one or more orthopaedic surgeries over a 27 year period. The cumulative 
incidence of surgery reduced between the 1980-1994 cohort (27.3%) compared with 
the 1995-2007 cohort (19.5%). However, the trend was not statistically significant 
(p=0.08). No statistically significant difference was reported in the cumulative incidence 
of foot surgeries performed between the two groups (5.6% versus 5.3% p=0.99). In 
contrast a cross sectional multicentre study (Matricali et al, 2006) reports foot surgery to 
be common in patients with RA (n=285), with an increased trend of intervention 
observed in patients earlier in disease. Female gender and younger age are reported to 
be factors associated with foot surgery (Backhouse et al, 2011). This more recent study 
reports longitudinal data of a large sample of patients with early RA. The study is 
strengthened by the large sample size (n=1237). However data were collected between 
1986 and 1998, potentially restricting the generalisability of findings to the current RA 
patient population. Nonetheless, there appears to be an overall reduction in the 
frequencies of orthopaedic procedures generally for patients with RA. However, despite 
the developments in the management of RA, foot problems are still common (see 2.3 
and 2.4). 
 
A multidisciplinary approach to foot care clinics has been advocated (Helliwell et al, 
2003). And the researcher has herself taken part in such clinics for many years. These 
clinics employ a podiatrist, a rheumatologist and orthotist, and readily available access 
to other members of the clinical team (e.g. physiotherapist). Siddle et al (2011) report 
an evaluation of a combined orthopaedic and podiatry clinic (n=41). Base line and 
follow up (two-year) measures of impact (FIS) and pain measured on a 100mm visual 
analogue scale (VAS) were recorded. Of the 22 patients who had undergone surgical 
intervention significant reductions were reported for measures of impact (activity) and 
foot pain compared with patients who had not under gone foot surgery (p=0.051, 
p=0.002). Further evaluation of multidisciplinary approaches would provide valuable 
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information about the best way to provide collaborative care for patients with RA and 
foot involvement.  
 
2.5.6 Summary of care of foot problems in RA 
Despite advances in the pharmacological management of RA to reduce disease activity 
and improve clinical outcomes, foot problems remain common. However, the 
prevalence of foot problems in the RA patient population overall has not been 
established fully. This has been hampered by limited categories and classifications of 
foot problems reported, failure to collect evidence about the severity and/or clinical 
need, and the use of patient populations that may be inherently biased towards greater 
severity of disease because they are attending specific hospital clinics and the use of 
self-report measures without validation against clinical observation. There is emerging 
evidence to support the use of non-pharmacological management of foot problems in 
RA. However, the evidence tends to focus on the clinical benefits of interventions as 
interpreted by health professionals (such as the ‘success’ of an operation). The patient 
perspective regarding their experience of foot problems and their beliefs of the 
perceived benefits and efficacy of foot care received has not been adequately explored 
Patients’ reasons for deciding whether or not to access foot care will also be important, 
therefore the next chapter considers access and utilisation of health care in general, 
and reviews the literature regarding access to and use of foot care services by patients 
with RA. 
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Chapter 3: Organisation of health care, access to services, 
barriers to foot access and the rationale for the three-phase 
research project 
Whether or not patients receive adequate foot care for their RA depends not only upon 
the effects of their condition in general and on their feet in particular, but also in what 
way foot care services are provided and whether patients can gain access to them. This 
chapter considers access to and utilisation of health care in general, and reviews the 
literature regarding access to and use of foot care services by patients with RA. Models 
and theories of access to and utilisation of health care services are reviewed and 
determinants of access and utilisation of health care in general and specific populations 
considered. The rationale for the three-phase research project presented in this thesis 
is then developed from the information reviewed in Chapters 1, 2 and 3. 
 
3.0 Introduction 
 
Concepts of “health” are considered from different perspectives by two separate but 
interlinking disciplines, clinical practice and public health. Clinical practice tends to 
focus on the health of an individual (physical, mental and functional ability). In contrast 
the remit of public health is to maintain health in populations. An additional function of 
public health is health promotion (e.g. physical activity, smoking cessation, healthy 
nutrition) to prevent ill health and premature death (Mann et al, 1994). Public health 
considers access to and provision of health care as components that facilitate health in 
populations. Access and utilisation of healthcare are widely accepted as important 
determinants of health in individuals (Field and Briggs, 2001). In order to access health 
care there is a requirement for health services to be available (Gulliford et al, 2002). 
Organisation and delivery of health care varies considerably amongst developed and 
developing countries. Universal eligibility for free health care was amongst the founding 
principles of the National Health Service (NHS) in the UK. The majority of health care 
provided by the NHS is free at point of access, though there has been the emergence 
of some financial costs to service users which vary regionally (e.g. cost of 
prescriptions). Provision of publicly funded services incurs significant financial support 
for the system not only to function but to be maintained. Thus measurements of access 
and utilisation to health care are essential for both planning and delivery of services.  
 Chapter 3: Access to health care 
66 
 
 
A preliminary review of the literature indicated that access to and use of health care in 
general terms is multi-factorial and complex. Factors acting as determinants of access 
are described and discussed extensively in the literature. Access to and use of health 
care is influenced by a number of predisposing factors (e.g. provision of services) and 
personal perceived need, the individuals perceiving / recognising the need to interact 
with health care. In relation to accessing foot care for disease specific conditions (e.g. 
RA), determinants of access to care appear to have received limited attention. A further 
narrative review of the literature was therefore undertaken. Databases searched in the 
narrative literature review were CINHAL, MEDLINE and EMBASE. These were 
searched up until November 2015. Search terms used were: access to health care, 
barriers to health care, determinants of access, health care use, health care utilisation / 
usage, fee, foot care, long term conditions and rheumatoid arthritis. Full text articles of 
interest were retrieved for review. A subsequent “snowballing” approach to identify 
further studies was then undertaken. Conducting literature reviews of complex issues 
can require a flexible and practical approach (Greenhalgh and Peacock, 2005). The 
narrative review, presented below, supported the initial impression that access to and 
use of health care in general is complex, that the evidence in relation to determinants of 
access to foot care is limited (particularly in RA) and that patients’ reasons for 
accessing foot care and their decisions to do so (or not) are poorly understood. Figure 
3.1 presents the narrative literature reviewed undertaken. 
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Figure 3.1 Narrative literature review access to health care 
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3.1 Access to and utilisation of health care services 
There are variations of the definition of the term “access” described in the literature. 
Some authors consider access as the reference to point of entry to health care whilst 
others regard access in terms of factors influencing entry or use. Additionally access 
may also be considered in relation to when care has been received (Campbell, Roland 
and Buetow, 2000) thus encompassing utilisation as a component of access to health 
care. In contrast Frenk (1992) considers access to health care to be influenced by an 
individual’s ability to request and obtain care as access is initiated by an individual’s 
perceived need to enter into the health care system. Levesque, Harris and Russell 
(2013) define access to health care as “access to a service provider or institution”. 
Penchansky and Thomas (1981) propose access to health care as a general concept 
comprising of specific dimensions (availability, accessibility, accommodation, 
affordability and acceptability). Additionally the authors consider access to health care 
not only relates to an individual’s ability to access care but also their readiness to enter 
and engage with the health system. Aday and Andersen (1974) consider access in 
terms of “having access” (ability to utilise a health service if required) and “gaining 
access” (initial introduction to the commencement of utilising a service). For the 
purpose of this thesis, access to health care is considered to comprise the point of entry 
to and use of health care. 
 
The provision of health care services does not necessarily mean that individuals who 
require care will access those services. Thus there is a requirement to consider barriers 
to accessing health care. On the whole, NHS health care in the UK does not incur any 
financial implications to service users (patients). Nevertheless there is some regional 
variation in financial costs to patients such as prescription charges. However, provision 
of publicly funded health care is not universal internationally. For example, lack of 
health insurance in the United States is widely considered to be the most common 
barrier to health care (e.g. Ahmed et al, 2001; DeVoe et al, 2007). Gulliford et al (2002) 
suggest barriers to access from service users perspective should include personal 
barriers, financial barriers and organisational barriers. Personal barriers relates to the 
individual’s recognition of the presence of a health condition, acceptance of their need 
to interact (access / utilise) health care and consent to receive care. If an individual 
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does not recognise, accept or interact with the health system, these authors consider 
barriers to care are due to individual choice rather than lack of provision. Financial 
barriers do not only encompass financial implication of funding care but also include the 
need for patients attending for clinical appointments to fund travel costs or take 
absence from paid employment. Additionally organisational barriers such as long 
waiting lists may result in a delay in patients accessing and receiving care. Goddard 
and Smith (2001) suggest barriers to health care may be influenced by service 
providers (supply side). The authors point to variation in the availability of health care 
and the quality of care provided, and these not being equitable to all groups or 
populations. Further, service users (patients) need to be informed of the availability of 
services and how to access care when needed. However, personal and organisational 
barriers are not the only issues to be considered. Carrieri and Bilger (2013) suggest the 
influence of clinicians (failing to advise), geographical location (residing in rural areas), 
organisational barriers (long waiting lists) and health beliefs (personal knowledge) are 
factors associated with underuse of health services. 
 
In order for patients to access health care the services need to be available, relevant, 
effective and equitably distributed (Gulliford et al, 2002). Further, for optimal access to 
be achieved, Rogers, Flowers and Pencheon (1999) consider the organisation of health 
care to be an additional important factor “providing the right service at the right time in 
the right place”. In contrast, variations in the equity of access to health care in terms of 
supply and standard of care received is well described (e.g. Goddard and Smith, 2001). 
Access to and utilisation of health care is therefore complex and further exemplified by 
both variations in definition and interpretation of access presented in the literature.  
 
3.1.1 Health care access and utilisation models. 
Theories, models and theoretical frameworks have received attention as approaches to 
understanding the process of access to and utilisation of health care. Theories provide 
a description of the points where decisions are made to access or the process of 
accessing health care. In contrast models are regarded as visual representations of a 
set of interlinking variables (determinants) to present or test a theory. Proposed theories 
and models of health care access and utilisation are addressed in the sociology 
literature and the psychological literature. The terms “help seeking”, “health care 
seeking” and “access and utilisation of health care” are often used interchangeably 
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within the literature. The term help seeking tends to be applied in the health psychology 
literature whereas health care seeking tends to be employed in organisation of health 
care publications, epidemiology and clinical literature. All three terms can be interpreted 
as relating to factors which may influence consulting behaviour (reasons for interacting 
with the health system). A number of theories and models as descriptors of access to 
and utilisation of health care are available in both the sociology and psychology 
literature.  
 
In one example Parsons (1951) developed the sick role theory which evolved from role 
theory. The theory proposes that when an individual becomes unwell they adopt a role 
of being ill and therefore are unable to undertake certain tasks such as stay in 
employment. Society (other individuals) accepts that the individual is unable to perform 
certain activities as a consequence of being ill and recognises that experiencing illness 
is a negative experience or event. The theory also proposes the individual is required to 
access medical care and “comply” with treatment in order to achieve improved health 
and / or recovery. Suchman’s stage of illness and medical care (1965) proposes a five 
step linear approach to access to health care when an individual experiences ill health: 
1) symptom experience; 2) assumption of sick role; 3) medical care contact; 4) 
dependant patient role; 5) recovery from illness. The pattern of illness (disease), 
medical treatments and provision of health care has changed dramatically since 
Parsons’ and Suchman’s work and therefore may not be applicable to current access to 
and use of health care. For example historically healthcare systems were organised to 
respond to acute illnesses and injury. The changing nature of health such as the 
emergence of long term conditions has required the organisation and delivery of health 
care to be reconsidered (Wagner et al, 2001). Additionally Parsons’ and Suchman’s 
work do not consider a number of further components such as health care access in 
long term conditions, or account for general characteristics as determinants of access 
(age, gender, and social deprivation), or service user satisfaction and/or personal 
priorities. 
 
The Health Belief Model (HBM) is based on aspects of health behaviour in relation to 
perceived threats and perceived barriers and benefits. It was initially developed by 
Rosenstock (1966) in response to failure of use and lack of effectiveness of a public 
health screening program for tuberculosis conducted in the United States. The model 
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was subsequently further reviewed and refined (Rosenstock, Stretcher and Becker, 
1988). The HBM focuses on perceived susceptibility (the individual’s beliefs about 
developing the health condition of interest), perceived severity (beliefs about how 
serious the condition is and what its consequences), perceived benefits (does the 
benefit of a health behaviour outweigh the cost), perceived barriers (beliefs about 
obstacles to performing the health action), cues for action (symptoms, education) and 
self-efficacy (an individual’s confidence in their ability to perform the behaviour). The 
HBM has been applied to several aspects of health relating to screening programmes, 
participation in positive health behaviours (smoking cessation, physical activity, 
reduction in alcohol consumption) and long term conditions (hypertension, diabetes and 
cardiovascular disease) (e.g. Cerkoney and Hart, 1980). In relation to RA the HBM has 
been used when investigating medication adherence. DiMatteo, Haskard and Williams 
(2007) conducted a meta-analysis of the relationship between treatment adherence and 
patients’ beliefs of disease threat, self-rated health status and objective disease 
severity. The authors concluded that severity of disease and personal awareness of 
disease severity was associated with greater patient adherence to medical care. 
However, patients with poor health (as defined by Illness Rating Scale (Roesnberg, 
Hayes and Perterson, 1988) as a consequence of a “serious” health condition (e.g. 
heart disease) were less likely to adhere to medical care. Patients’ health beliefs and 
adherence to pharmacological therapies in RA has received attention (Goodacre and 
Goodacre, 2004; Neame and Hammond, 2005) but has not been applied to investigate 
predicting behaviour in relation to access to health care. 
 
There are several other health behavioural theories and models in the psychology 
literature such as: Theory of Reasoned Action (Ajzen and Fishbein, 1980, Theory of 
Planned Behaviour (Ajzen and Madden, 1986), Social Cognitive Theory (Bandura, 
1986) and Transtheorectical Model of Health Behaviour Change (Prochaska and 
DiClemente, 1997). Indeed a substantial body of literature is devoted to understanding 
and explaining health behaviour and determinants of behaviour. Probably the most 
used model in the literature is the Health Belief Model (HBM) discussed above. Detailed 
consideration of the advantages and disadvantages of the theories and models of 
health behaviour as determinants of access to and use of health care is beyond the 
scope of this thesis. Additionally although health behavioural theory is widely used and 
referred to in the literature, there is a paucity of empirical evidence investigating the 
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comparability and predictability of the various theories and models as predictors of 
health care use. Health behavioural theories and models do have limitations. For 
example they assume that all individuals have equal access to the same information, do 
not account for the influence of social desirability, individuals’ attitudes towards health 
behaviours and/or the combined influence issues towards health behaviour and 
behaviour change (Noar and Zimmerman, 2005). 
 
Work conducted during the 1960s and 1970s led to the development of a model of 
health care utilisation (Andersen, 1995). The framework aimed to address some of the 
limitations of previous theoretical perspectives of health care usage. The model 
proposes that access to health care is dependent on three interlinking factors: 
predisposing characteristics (age, gender and marital status), enabling factors (income, 
access to health insurance, cost of access) and need factors (perceived health status, 
evaluated health status and customer satisfaction). Jacobi et al (2001) conducted a 
postal survey to measure health care use (accessed GP care, specialist care, allied 
health professional care, community social care) of patients with RA (n=757) and to 
estimate the relative contributions of gender, age, disease duration and co-morbidity to 
receiving appropriate and timely care. The authors utilised the model of health care 
utilisation as a frame work to investigate access and utilisation of health care services. 
Multivariate analyses demonstrated that age (<70 years), female gender, disease 
duration, additional morbidity and poor functional status explained most of the utilisation 
of services. Some general characteristics were also related to service utilisation. 
However, Andersen’s model was developed based on experiences and observations of 
the US health care system. The model may therefore not be applicable to other health 
care systems in terms of describing access and utilisation of health care in other 
countries.  
 
Following a narrative review of the literature it is apparent that access to and use of 
health care is complex. Although theories and models of access and utilisation provide 
a basis for understanding the processes they do not provide a full explanation why 
patients do or do not access health care. Clearly, for health care to address the needs 
of individuals and /or populations it needs to be available in an appropriate, timely and 
effective manner. However, provision of health care alone is not enough to ensure 
patients access and interact with the health care system. Perceptions of health status, 
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health care systems, and care preferences vary between individuals (Strauss et al, 
1993). It is largely accepted that general characteristics (age, gender, deprivation) and 
clinical characteristics (acute illness, long term conditions), availability, geographical 
location of services, care provided by lay support or family members and frequent 
interaction with health system (e.g. additional morbidity) are additional factors 
associated with access to health care. Further, patient (service user) satisfaction is 
widely used as a measure to assess quality of services provided and a valuable 
predictor of health related behaviour (Pascoe, 1983). Identifying factors related to and 
determinants of access to care is essential to planning, organising and delivery of 
services. Current evidence about specific characteristics as determinants of access to 
health care are considered and discussed next.  
 
3.1.2 Influence of gender on health care access and utilisation 
The literature and observations in clinical practice suggest women generally use more 
health care services than men (Hulka and Wheat, 1985; Bertakis et al, 2000; 
Courtenay, 2000). Malmusi et al (2012) report data from a national survey of self-rated 
health in which women reported significantly poorer health, reduced activity levels and 
higher prevalence of long term conditions (e.g. arthritis). Bertakis et al (2000) found 
women utilise primary care and diagnostic services more frequently than men. Hunt et 
al (1999) reports women to have higher consultation rates. However, the authors 
challenge the general assumption that consultation rates vary according to gender 
because when symptoms were experienced in long term conditions, men and women 
were equally likely to consult with a health care professional. The traditional assumption 
that women are more likely to access health care has been further challenged. A UK 
based survey conducted by Adamson et al (2003) reports the chance of men consulting 
for chest pain or self-detection of a lump in the axilla was similar compared with women. 
 
The incidence and prevalence of health conditions can vary between genders due to 
genetic, hormonal and metabolic differences. However, Denton, Prus and Walters 
(2004) argue gender differences in health are more complex than these biological 
differences alone. The authors propose that gender differences in health are influenced 
by a combination of psychosocial variables (stress and life events), the influence of 
local environment (e.g. area in which an individual resides) and health behaviours such 
as smoking. If the notion that “health” varies between genders it is possible that access 
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and utilisation of health care will also vary between men and women. This proposition is 
supported by Doyal (2001) who suggests access to health care in relation to gender is 
complex and not solely influenced by biological differences alone. Rather social, 
economic and cultural differences between men and women require consideration. 
Redondo-Sedino et al (2006) investigated health care usage in a Spanish population 
over the age of 60 years. A higher proportion of consultations with GPs were by women 
but no gender differences were observed for hospital admissions. The authors also 
suggest that being female, having more than one health condition and poorer health 
related quality of life are likely determinants of health care usage. Influences on health 
behaviours and access to health care are reported to vary between genders in patients 
with diabetic foot ulceration. For example there appears to be a tendency for women to 
be more likely to actively participate in self-care strategies. Conversely men are more 
likely to access care for acute problems (e.g. soft tissue infection). However, men are 
reported to have a more “laissez faire” / passive approach to self-care and rely on 
health professionals and family members to provide care (Hjelm, Nyberg and Apelqvist, 
2002). In spite of the reservations of some authors, it remains accepted that in general 
women tend to use health care more than men. However, this may not be the case for 
specific conditions or long term conditions such as RA. 
 
Gender as a determinant of access to health care for patients with arthritis has not been 
fully explored (Bradley, 2001). The frequency of joint replacement surgery for patients 
with inflammatory arthritis has been reported to be higher in women (e.g. da Silva et al, 
2003). However, there appears to be a tendency that women undergo orthopaedic 
procedures when they have more severe arthritis and arthritis symptoms than their 
male counter parts (Katz et al, 1994; Hawker et al, 2000; Shourt et al, 2012). 
Backhouse et al (2011) report data of a longitudinal cohort study of patients with newly 
diagnosed RA. Female gender was independently associated with increased chance of 
undergoing orthopaedic interventions and with accessing podiatry services.  
 
3.1.3 Influence of age on health care access and utilisation 
The medical needs of older people can be both complex and substantial. For example 
the proportion of older people having more than one health condition has been 
estimated to be approximately 80% (Bates et al, 1995). The management of multi-
morbidity in older people can also require complex medical and pharmacological 
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treatment (Buurman et al, 2011). Some conditions are more prevalent in older people, 
for example osteoporosis (Ginalidi, Benedelto and Martinis, 2005) and so with 
advancing age, it is reasonable to postulate individuals are more likely to develop health 
conditions and functional impairments which in turn require access to health care.  
 
Some foot problems (e.g. hallux valgus, corns, and calluses) are prevalent in both 
general and RA populations, as described in Chapter 2. However, the consequences of 
foot problems for disability and impact on activities of daily living (e.g. walking) are 
particularly relevant in the elderly (Benvenuiti et al, 1995; Griffith et al, 2010). 
Additionally older people are at high risk of developing other significant foot problems 
from non-arthritic causes (e.g. peripheral vascular disease) (Plummer and Albert, 
1996). Older people are reported to recognise common foot problems and seek 
appropriate care for the foot health care needs (Gorter, Kuyvenhoven, and de Melker, 
2000). Jacobi et al (2001) conducted a postal survey of 725 patients with RA to quantify 
access and use of additional health care services (non-rheumatology care). The 
authors conclude that overall most patients received appropriate additional care. 
However, younger patients (<70 years) were more likely to receive allied health care 
(e.g. podiatry) than older patients (>70 years). As RA is a long term condition it is 
reasonable to envisage that longer disease duration and older age may increase the 
chance of developing foot problems. Additionally these factors may also influence 
access to foot care simply through increased experience of living with the condition. To 
what extent age is a determinant of access to foot care for patients with RA therefore 
requires further investigation. 
 
3.1.4 Influence of social deprivation on health care access and utilisation 
The link between social deprivation, ill health and associated health outcomes is well 
established. Social deprivation can be measured at the individual level (e.g. personal 
income, education attainment) or area level (e.g. proportions of persons unemployed, 
social class). Alder and Newman (2002) propose social deprivation as a major 
determinant for the need of health care (e.g. limited ability to source and fund health 
care), environmental exposure to potential pathogens (e.g. industrial waste) and health 
behaviour (e.g. smoking). Further, social deprivation has been shown to be associated 
with increased hospital admissions (Zhao et al, 2011) and subsequent mortality 
(Conway et al, 2012). Comparing the findings of studies relating to access and 
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utilisation of health care the role of social deprivation is not clear, in particular in relation 
to the heterogeneity of health care systems and variations in measurement of social 
deprivation (Hussey et al, 2009). For example despite the provision of a universal 
publicly funded health service, social deprivation continues to influence health 
outcomes in the UK (Smith, Bartley and Blane, 1990; Knowles et al, 2006). Indeed, 
measures of social deprivation are widely considered in the planning, organisation, 
delivery and subsequent funding of health care services and capturing health 
inequalities not only in the UK but internationally.  
 
Measures of social deprivation have been applied in studies of patients with RA in 
relation to aetiological risk factors, assessment of health outcomes and health care 
utilisation. For example Pedersen et al (2006) investigated association of individual 
level indicators of social deprivation (education and economic status in childhood and 
adulthood) as associated risk factors of developing RA. The authors concluded that 
shorter duration of formal education was a risk factor for developing rheumatoid factor 
positive (RF positive) RA. This supports previous work by Bengtsson et al (2005). Area 
level social deprivation (Townsend Index score, Townsend, Phillimore and Beattie 
1988) has also been reported to be related to developing RF positive RA (Mackie et al, 
2012). Additionally, a relationship between higher levels of social deprivation and 
poorer health outcomes in patients with RA has been reported in terms of higher 
disease activity, poorer physical function and emotional aspects of mental health 
(Harrison et al, 2005; Margaretten et al, 2011).  
 
Utilisation of health care services by patients with RA has been shown to be associated 
with disease related features (e.g. measures of disease activity) and social deprivation 
in relation to formal education (Jacobi et al, 2001). Patients with RA who completed 
university level education were found to be statistically more likely to access allied 
health professional (AHP) services compared to patients with shorter time spent in 
formal education. Jacobi et al define access to an AHP as having accessed 
physiotherapy, occupational therapy and / or podiatry. However, it is not possible from 
the data presented to assess the influence of social deprivation as a determinant of 
access to foot care. Social deprivation may increase use of health services because of 
more severe disease, or may decrease use of health services because patients are less 
likely to make use of them. 
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3.1.5 Influence of additional morbidity on health care access and utilisation 
The number of people diagnosed and living with more than one health condition (co-
morbidity / multiple-morbidity / additional morbidity) is increasing (e.g. van der Akken et 
al, 1998; Vogeli et al, 2007). Multiple-morbidity would seem to be more common in 
older age (Wolff, Starfield and Anderson, 2002; Marengoni et al, 2011). However, a UK 
study of a national primary care data base conducted by Barnett et al (2012) reports the 
prevalence of multi-morbidity to be similar in primary care patients under 65 years 
compared with older patients. Morbidity and multiple-morbidity are reported to be more 
prevalent in deprived areas compared to more affluent areas (Eachus et al, 1996; 
Barnett et al, 2012). Individuals with multiple health conditions are considered to have 
poorer health outcomes (e.g. higher mortality rates) and to be more likely to access 
primary care (France et al, 2012) and secondary care (Glynn et al, 2011; Payne et al, 
2013). Salisbury et al (2011) conducted a retrospective cohort study investigating the 
relationship between multiple-morbidity, primary care consultation rates and continuity 
of care. While multiple-morbidity was frequent in the general population, it accounted for 
over half of all primary care clinical consultations. Similar conclusions regarding the 
association of multi-morbidity and health care utilisation are described by Westert et al 
(2001). Of interest, Westert et al report the presence of musculoskeletal diseases (back 
problems osteoarthritis, rheumatoid arthritis and/or other rheumatological problems) in 
conjunction with other long term conditions as related to increased health service 
utilisation.  
 
The presence of additional morbidity in RA is common (Mikuls, 2003; Michaud and 
Wolfe, 2007; Gullick and Scott, 2011). Nevertheless, the influence of additional 
morbidity as a determinant of health care utilisation has not been fully explored. 
Patients with RA often require regular interaction with the health care system, for 
example for monitoring of pharmacological therapy (e.g. haematological testing) and 
patients with co-morbidity may require greater contact with health care. Consequently 
co-morbidity in RA may be an additional determinant of health care use.  
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3.1.6 Influence of service user satisfaction on health care access and utilisation  
A patient’s experience of and satisfaction with care received is now considered an 
important outcome in measuring the quality of health care (e.g. Llanwarne et al, 2013). 
It is reasonable to postulate that patients who are satisfied with the care they receive 
may be more likely to continue to use services. One component of satisfaction is the 
relationship between patients and clinicians. Positive relationships between health 
service users and health care providers have been identified as a factor associated with 
further access to and utilisation of health care (Thiede, 2005). Yuen (2012) reported 
that patients with diabetes are more likely to access additional preventative care and 
screening if directly advised to do so by a clinician. However, poor communication 
between health professionals and patients can result in patients not acting on self-care 
and self-management advice (e.g. self-checking feet) (Gale et al, 2008). Patients’ 
perceptions of communication with clinicians may vary with age. Devoe, Wallace and 
Fryer (2009) propose younger patients have higher expectations of the health 
encounter in terms of appropriateness and personal control of their care. In contrast 
older patients prefer continuity of care and perceive the clinician (health professional) to 
be responsible for their health care. Additionally Campbell, Ramsay and Green (2001) 
conclude older patients more positively evaluate their health care needs being met 
during clinical consultations compared to younger patients. The authors also propose 
that older people have higher clinical consultation rates due to multiple health 
conditions, therefore have more contact with and become more familiar with their 
primary care clinicians. Patients’ perceived appraisal and satisfaction of clinical 
encounters is also reported to have an impact on concordance with medication and 
subsequent re-engagement with health care (Snelgrove, 2006). 
 
3.1.7 Summary of health care access and utilisation 
From this narrative review it is evident that access to and utilisation of health care in 
general terms is complex. A number of predisposing factors such as general 
characteristics (age, gender, social deprivation), clinical characteristics (nature of illness 
acute or long term, additional morbidity), experience and satisfaction of care received 
appear to influence individuals in their decision to access the health care system or not. 
It is acknowledged there are additional characteristics influencing access to health care 
in society at large, such as ethnicity, marginalised populations (vulnerable groups) and 
personality type. However, these additional characteristics as determinants of access or 
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barriers to health care are beyond the scope of this thesis. How access specifically to 
foot care services is influenced by the characteristics considered above in general and 
in RA patient populations are considered next.  
 
3.2. Foot problems and access to health care 
 
3.2.1 Foot problems in General Practice consultations 
In the UK general practitioners (GPs) act as gatekeepers to additional health care 
services. GP consultation rates for clinical review of foot and lower limb problems can 
therefore be seen as indicating a combination of prevalence and patient-perceived 
severity, in that patients consider their foot problems to be sufficiently significant to seek 
medical care. Consultations rates may reflect patients’ beliefs regarding the 
effectiveness of treatment. A study of GP consultations reported that 8% of all 
consultations were for foot and ankle problems (Menz et al, 2010). Jordan et al (2010) 
investigated musculoskeletal consultation rates recorded by 12 UK general practices 
over a 12 month period. The most common musculoskeletal consultation overall was 
about back problems (591 consultations per 100,000 registered patients). Although foot 
problems were the most frequent consultation category for children (14% of all 
consultations for children < 15 years), for adults the consultation rates for foot problems 
increased with age and were similar for both men and women. An earlier Dutch survey 
of GP consultation rates conducted by van der Waal et al (2006) reported 142 
consultations for lower limb problems per 1000 registered patients. Of these, the 
highest frequency was for knee complaints (14.2 per 1000) followed by foot and toe 
complaints (13.7 per 1000). Consultation rates for foot and toe problems were similar 
for both genders in children (0-18 years) and for the elderly (>80 years). Statistically 
significant differences are reported for consultation rates for foot / toe problems in 
middle age (> 30 years < 80 years) with women consulting more frequently than men. 
These studies indicate that foot problems are common but do not provide information 
about specific health conditions such as diabetes or RA, nor do they provide a 
description of the nature and severity of foot problems or the need for specialist foot 
care (e.g. podiatry or orthopaedics). 
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3.2.2 Foot problems and podiatry consultations 
Farndon et al (2009) conducted a service evaluation of podiatry in rural, semi rural and 
urban populations using the Podiatry Health questionnaire (PHQ) (Macran et al, 2003). 
The PHQ was developed by NHS regional podiatry managers and academics to 
measure clinical outcome but has not been validated. Questionnaire items relate to 
limitation in walking, foot hygiene, nail care, foot pain, impact on quality of life and 
clinician global measurement of severity of current foot problems. Data were collected 
immediately prior to the podiatry appointment from 1,047 patients (64% female). Most 
(81%) were classified as having mild or moderate foot problems. While most patients 
(75%) reported that their foot health and pain had improved or was stable after 
treatment, 25% reported an exacerbation of foot symptoms following treatment. 
Whether these results, from a non-random sample of patients who had already 
accessed podiatry, can be generalised to other NHS podiatry departments is debatable, 
but the result clearly gives cause for concern. For example a quarter of responders 
reported an exacerbation in symptoms following treatment. Further, the PHQ was 
developed by service managers with a direct interest in the provision of the service and 
without reference to clinician or patient involvement, and has not been validated. It may 
therefore omit important clinical and patient oriented outcomes.  
 
3.2.3 RA foot problems and access to foot care 
In a retrospective secondary analysis of data collected from a multicentre UK-based 
inception cohort following the first 9 years of RA, 30% accessed podiatry care, 16% 
were reviewed by an orthotist and 4% had undergone foot surgery (Backhouse et al, 
2011). Increasing age and being female were associated with accessing podiatry. In 
contrast younger females were more likely to have undergone foot surgery. Data 
relating to range of joint motion and the presence of extra-articular features (nodules) 
are presented, but other clinical features such as classification of deformity, presence of 
cutaneous lesions, reasons for access to podiatry, orthotics and orthopaedics, and care 
received are not described. Although the study is strengthened by the length of follow-
up and large sample size, patients were recruited from 1986 to 1998, before the 
introduction of modern pharmacological paradigms (e.g. biologics). Access to foot care 
of patients with early RA before modern treatment approaches were adopted may not 
reflect the current general RA population.  
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Marsman et al (2013), in a Dutch based longitudinal study of patients with RA with short 
disease duration, subsequently followed up over 15 years, found accessing podiatry to 
be more common earlier in disease (33% in first year) but the number of patients 
reviewed by orthopaedics (5%) or a multidisciplinary foot clinic (8%) was small. This 
study reported only foot care accessed in secondary care where the rheumatologist 
acts as the gate keeper, and did not record other routes of access. Access to and the 
provision of foot care, and the professional remits of service providers, varies in 
different health care systems. Additionally foot care services can also be provided in the 
independent (self-funding) sector.  
 
The work conducted by Backhouse et al and Marsden et al demonstrates the common 
occurrence of foot involvement in RA and shows that access is variable and potentially 
inadequate. However, both studies recruited patients early in disease and so the study 
findings may therefore not reflect the current general RA population. This has been 
addressed in part by Juarez et al (2010) who conducted a postal survey of a randomly 
selected sample of 1200 with inflammatory arthritis registered for medical care at one 
hospital site. Response rate to the survey was 37.7%.Of the respondents, 83% reported 
a diagnosis of RA, 14% psoriatic arthritis (PsA) and 3% ankylosing spondylitis (AS). 
The survey included an adaptation of the Arthritis and Musculoskeletal Alliance (ARMA) 
audit tool (Podiatry Rheumatology Care Association (PRCA) Standards Project, 2008) 
relating to access to foot care services, patient education on self-care of foot problems 
and overall satisfaction rates of rheumatology service provision. Of the total sample 
68% reported current foot problems, 24% had undergone a foot examination within 3 
months of diagnosis and 31% reported they had access to foot care specialists. 
However, categories and classifications of foot problems are not defined; therefore a 
detailed description of the nature and severity of foot problems is not known from these 
data. Additionally foot care specialists are not defined nor are the location of foot care 
service provision (hospital based or community base). Nevertheless Juarez et al (2010) 
work supports the literature in that foot problems appear to be common in patients with 
RA. 
 
In an observational hospital study of 100 patients with RA (Borman et al, 2012) the 
majority (89%) reported current foot problems. Ankle and/or forefoot pain was reported 
by one third of patients. Other foot problems observed and reported were: swelling in 
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the foot (68%), numbness (51%), nail pathologies (37%) and corns (24%). Nearly half 
(49%) reported difficulty in being able to self-care and self-manage their foot symptoms. 
Of those who had accessed foot care, 39 had been issued with prescribed footwear 
and/or issued with insoles but 59% of these had stopped using their devices. Although 
the study has its limitations in terms of sampling (non random sample) and was hospital 
based, it supports clinical observations that foot problems in RA are multifactorial (e.g. 
joint pain, deformity and formation of secondary skin lesions) and gave clear indications 
that patients experience difficulty with self-managing their foot problems.  
 
Otter et al (2010) conducted a postal survey of 990 patients with RA. The target sample 
for the study comprised of 650 members of a national patient support group and 340 
patients attending an outpatient rheumatology appointment during a one month period. 
A total of 585 returned completed questionnaires. Almost all of the respondents 
reported foot pain at some time since being diagnosed with RA and the majority (68%) 
reported daily moderate to severe foot pain. Of the 585 respondents, 64% had seen a 
podiatrist and 30% an orthopaedic surgeon. Over half (54%) had been prescribed foot 
orthoses and a fifth (21%) had been issued with prescribed footwear, though only 56% 
of these were still using the devices issued. A major strength of the study is the large 
sample size, although the nature of the sample selection process may have been 
biased towards those with more severe disease and greater problems with their feet. 
No information is reported in relation to non-responders clinical demographics (e.g. 
disease duration), therefore the influence of bias cannot be confirmed or refuted. Data 
were not collected investigating patients’ reasons for accessing foot care or referral 
routes of access (self-referral or clinician initiated). Previous authors have shown that 
the provision of dedicated foot care services is variable (Redmond, Waxman and 
Helliwell, 2006), and limitation in service provision may be a barrier to access. The 
relatively high access to podiatry reported by Otter et al may be due to good local 
provision of NHS specialist podiatry provision (personal communication with the author) 
and this, together with the potential response bias in the sample selection means the 
generalisability of the study findings to the wider patient population may be limited.  
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3.2.4 Foot problems and other care providers  
The assessment and management of foot problems are not confined to the remit of 
GPs but can be provided by other clinicians such as podiatrists, orthotists, 
physiotherapists and medical specialists in both public funded and private health care 
systems (Gorter, Kuyvenhoven and de Melker, 2000). The professional remit of other 
health professionals providing treatment for common foot problems includes: nail care, 
corn and callus reduction, prescribing and issuing foot orthoses and wound care (Bálint 
et al, 2003; Apelqvist and Larsson, 2000). The GP is often considered the “gate keeper” 
of access to health care in general. However, access to additional health care provided 
by AHPs (podiatry and physiotherapy), particularly in the independent (private) health 
care sector is not reliant on GP initiated referral. A community based survey of older 
people conducted by Harvey et al (1997) concluded there was a high level of need for 
professional foot care which was not met by adequate service provision and as a result 
respondents’ foot health care needs were met by family members. The extent to which 
access to independent (self-funded) foot care for patients with RA or reliance on lay 
support (family members) to provide basic foot care is not known. 
 
3.3 Barriers to accessing foot care 
 
3.3.1 Barriers in relation to Podiatry 
Best practice guidelines advocate the development and implementation of specialist 
podiatry services for managing foot problems in RA (Podiatry Rheumatology Care 
Association, 2008). However, Hendry et al (2013) propose there is a lack of podiatrists 
specialising in the management of inflammatory arthritis. Williams et al (2013) report the 
results of a survey conducted on a convenience sample of podiatrists (n=245). The 
majority of responders (93%) were classified as non-specialists clinicians (podiatrists 
not specialising in management of foot problems in rheumatic diseases) and almost all 
(97%) were unaware of the best practice guidelines. Lack of rheumatology specialist 
knowledge among non-specialist podiatrists might hinder the implementation of the 
guidelines. The reasons may be due to limited dissemination of the guidelines and each 
individual practitioner’s clinical interests (general podiatry, diabetes, sports medicine 
and non-inflammatory musculoskeletal conditions). Although continuing professional 
development (CPD) is not only essential to maintain and improve clinical standards and 
is also a statutory requirement for professional registration with the Health and Care 
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Professionals Council (HCPC). Nevertheless maintaining CPD can be a challenge for 
clinicians in terms of personal time and financial resources. Furthermore, as Hendry et 
al (2013) point out, non-specialist practitioners working in isolation may not have the 
required knowledge and skills to manage the complex clinical features of some foot 
problems in RA. Current professional expectations of the ability of non-specialists to 
manage foot problems in patients with RA may need reconsideration for best practice 
guidelines to be implemented. 
 
Lack of knowledge of the scope of podiatry practice among other health professionals 
(particularly medical practitioners) may limit referrals and hence access to foot care. As 
Brodie (2001) comments (p.175) “Podiatrists may consider themselves to be experts, 
but how many medical students in training get to know who podiatrists are or what they 
can do. How many foot problems or potential foot problems are not passed onto the 
podiatrist for lack of knowledge about the profession and its role?” Additionally, the 
wider health community needs to be knowledgeable / informed about the provision of 
and access criteria for local podiatry services. One qualitative study suggests that low 
access to podiatry may be due to lack of focus on feet during rheumatology 
consultations (Williams and Graham, 2012). The continued use of the dual titles of 
podiatry (used by the majority of NHS departments) and chiropody (used by some 
HCPC registered clinicians working in the independent sector) is an additional 
complicating factor (Vernon et al, 2005).  
 
Foot health education is a component of the podiatrists’ clinical remit (Williams et al, 
2011). A qualitative study conducted by Graham et al (2012) explored podiatrists’ 
perspectives of the nature and content of foot health education for patients with RA and 
barriers to foot health education provision. Participants considered patient education a 
key component for podiatric management of foot problems in RA. However, a number 
of barriers were identified to providing it such as lack of time, lack of resources, 
inadequate training in consultation skills and motivational interviewing techniques. The 
study found the most common time for delivery of foot health education was during 
clinical consultations, which included verbal communication supported by written 
information. There were very few who used group education sessions or patient support 
websites.  
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Patients’ knowledge of the availability of podiatry services and their experiences and 
beliefs regarding the efficacy of treatment may influence their decisions to access 
professional foot care. In a qualitative study exploring RA patients’ perceptions of foot 
health services by Hendry et al (2013), those who had accessed podiatry services 
described variations in the benefits (effectiveness) of care received. Reasons for not 
accessing podiatry included limited awareness of service provision, not knowing the 
remit of podiatric practice and limited personal financial resources. However, the study 
was conducted in Australia where health service provision is not generically publicly 
funded for the whole population. Blake, Mandy and Stew (2013) conducted a qualitative 
study exploring factors influencing the decisions of patients with RA to access podiatry. 
Decisions for “seeking help” for foot problems varied between patients’ perceived 
“benefits” and “costs”. Patients considered accessing foot care after acquired self-
management strategies failed. Thus access to podiatry care was a perceived “benefit” 
Whereas perceived “costs” were described in relation to patients considering inability to 
cope with foot problems that they accessed foot care. Inability to cope with their foot 
problems was perceived by some patients as a negative experience. Additionally 
perceived costs of accessing podiatry included time demands of attending for additional 
consultations and financial restrictions. As may be expected, patients considered that if 
their feet problems were not a primary concern, access to podiatry was not required.  
 
Taken together these studies show there are many influences on patients’ decisions to 
access foot care but the studies have not provided a clear or quantitative assessment of 
which are the main contributory factors.  
 
3.3.2 Barriers in relation to foot orthoses  
In order for the therapeutic benefits of foot orthoses to be achieved (as discussed in 
Chapter 2), devices need to be available for clinicians to prescribe and patients need to 
be able to accommodate the devices in their shoes. Foot orthoses can be provided by a 
number of health professionals within different local organisational service provision. 
Additionally patients may self-source and self-fund foot orthoses independently without 
advice from health professionals. Commissioners of health care and service providers 
often adopt the “episodes of care” (assess, treat and discharge) model (Hussey et al, 
2009). However, such an approach may not be appropriate for patients with RA who 
have fluctuations in symptoms, variable disease progression and remain in long term 
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follow up in secondary care. Patients’ foot orthoses prescriptions require timely review 
and replacement when worn out or no longer effective. Follow up care and advice on 
how to self-initiate is often needed to achieve this. As Helliwell (2003) comments: “To 
ensure the patient is satisfied with the result of the intervention (s), multiple visits may 
be necessary.”  
 
Economic pressures on publicly funded health care in the UK have also impacted on 
the issuing of foot orthoses. The trend has been to move towards cheaper, mass-
produced, “off-the-shelf” orthoses rather than using “bespoke” (individualised) orthoses. 
Even so, the majority of podiatry services are primary care based with limited resources 
for even mass-produced orthoses. In some podiatry services the only access to foot 
orthoses is via secondary care orthotic services, often only accessible through referral 
from hospital based clinicians. In order to access orthotic services for patients not 
already under secondary care follow up, community based clinicians have to request a 
referral to secondary care from the patient’s GP. The individual patient need and 
subsequent financial costs would then need to be evaluated by the referring GP. A 
further consideration is the evolvement of musculoskeletal triage assessment services 
(MATS) placed at the primary/secondary care interface. In some regions of the UK, 
access to secondary care services for non-urgent musculoskeletal conditions is 
regulated through triage and treatment by MATS, adding an extra layer of complexity. 
 
3.3.3 Barriers in relation to prescribed footwear 
There are clear clinical benefits from prescribed footwear for patients with RA who have 
foot involvement (Fransen and Edmonds, 1997). William, Rome and Nester (2007) 
suggest the therapeutic aims and benefits of prescribed footwear are “pain relief, ulcer 
prevention and improved mobility”. In order for these aims to be achieved prescribed 
footwear must be worn and used by patients. However, some patients do not embrace 
the use of prescribed footwear as treatment interventions and decline or do not use 
them following issue (Herold, and Palmer, 1992; Williams and Meacher, 2001; 
Goodacre and Candy, 2011). Reasons for not using prescribed footwear are reported to 
be variable and include poor fit, general design and being cosmetically unacceptable 
(Williams, Rome and Nester, 2007). These findings raise issues relating both to missed 
therapeutic benefits to patients but also financial implications to an already 
economically challenged publicly funded health care system. However, previous studies 
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on the use of prescribed footwear in patients with RA have tended to focus on the 
female experience. There is a paucity of information regarding the perceived benefits 
and usage of prescribed footwear from the male perspective. In contrast, a cross 
sectional study conducted by de Boer et al (2009) of 240 patients with RA (185 women) 
report on 91 patients issued with prescribed footwear and 80% of the study participants 
reported wearing the footwear daily. Taking these studies together there appears to be 
variation in the use of prescribed footwear in patients with RA. The proportion of 
patients with RA currently using prescribed footwear is not known. 
 
3.3.4 Barriers in relation to surgery 
Severe foot joint damage as a consequence of the disease process may require 
surgical intervention (Wolfe and Zwillich, 1998; Massardo et al, 2002). There are widely 
accepted benefits of orthopaedic interventions in terms of reduced pain and improved 
function but a general trend in the reduction of orthopaedic interventions for patients 
with RA has been described (Louie and Ward, 2010; Shourt et al, 2012). Weiss et al 
(2006) suggest the reduction of surgical intervention may be due to advancements in 
the clinical management of RA. However, this may not be the only factor. The general 
trend to provide health care in the outpatient rather than in-patient setting combined 
with the suggestion that foot joints are not routinely assessed in clinical practice (Bann 
et al, 2011) means opportunities for consideration of surgical intervention may be 
missed. Patients expect the clinician to raise the issues and organise intervention 
accordingly (Hudak et al, 2002). Also, the benefits of foot surgery often accrue several 
months after procedures have been performed and in the meantime during post 
surgical rehabilitation increased weight bearing will be required on the contra-lateral 
limb, in conjunction with the use of assisted devices such as crutches (Wilkinson, 
Stanely and Getty, 2004). For patients with RA who may have bilateral foot and upper 
limb joint involvement, the impact of post surgery rehabilitation may be considered 
untenable and the perceived increase in pain and disability post operatively has been 
reported to be a potential reason why patients decide not to proceed with surgery 
(Hudak et al, 2002). Qualitative data also raise the consideration of the patients’ 
perceived outcomes of surgery which appear discordant with traditional clinical 
objectives and rationale for considering foot surgery. Backhouse et al (2012) describe 
functional ability, participation in valued activities and appearance to be more important 
post operative outcomes than reduction of pain, for patients who had undergone foot 
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surgery. Thus explanations for the reduction in rates of surgery may not simply be 
related to improved medical management.  
 
3.4 Rationale for the three-phase research project 
 
3.4.1 Overview of the current evidence 
Chapters 2 and 3 have reviewed and discussed the current evidence in the literature in 
relation to the pathological and clinical occurrence of foot problems in the general 
population and in patients with RA, the benefits of foot care interventions, and how 
often these are accessed, particularly by RA patients. It is clear from these reviews that 
foot problems in RA patients are common and complex. Foot pain frequently restricts 
activity levels and the presence of deformity raises issues regarding the ability to obtain 
accommodative footwear. Furthermore general disability and loss of hand function can 
have consequences in patients’ ability to self-manage / self-care their basic foot care 
(Semple et al, 2009). A high level summary of the evidence about access to care in 
general and foot care in particular suggests that provision of foot care services is poor, 
and that access to foot care is subsequently likely to be relatively low and to occur more 
in affluent, older women with longer disease duration. 
 
Beyond these broad generalisations, when it comes to an adequate quantitative 
evaluation, the evidence base is insecure. It rests on observational hospital based 
studies using convenience (and almost certainly non-representative) sampling 
strategies which cannot be extrapolated to the general RA population. Earlier 
population surveys examining access to foot care sampled self-selecting groups (e.g. 
members of a patient support group) and used restricted outcome measures. These 
issues almost certainly omit signs and symptoms which are relevant to clinicians and 
patients. Additionally some works report the findings of service evaluations (e.g. audits) 
which relate only to particular local service provision. Furthermore these studies stretch 
back over a long time period during which the availability of musculoskeletal services in 
the UK has been transformed. The available medical management strategies have 
evolved from the late use of pharmacological therapies to the early use of 
multidisciplinary team intervention and deployment of highly effective combination drug 
treatments. In addition, no studies have clearly documented the clinical features of foot 
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problems in RA in detail, and no studies have addressed the full range of possible 
barriers to access to foot care. 
 
In order to establish the prevalence of foot problems and access to foot care in RA 
patients as a whole, a survey is required including a large cohort of patients with RA 
randomly selected from a well defined population which has equitable access to primary 
and secondary foot care services (so that issues related differential local service 
provision are excluded). The survey will need to measure foot problems, symptoms and 
outcomes relevant to patients and clinicians, to ensure patient self-report is adequately 
verified and is reliable, and to include questions relating to all the issues which might 
affect access to care. The purpose of the work presented in the following Chapters is to 
undertake and analyse such a survey and interpret the results. 
 
3.4.2 Aims of the thesis 
1. Measure the prevalence of self-reported foot problems in RA by examining a 
large sample of patients in a postal survey. 
2. Quantify the nature and types of foot problems experienced by patients.  
3. Measure the impact of current foot problems. 
4. Identify the proportion of patients who have accessed foot care services. 
5. Discover patients’ reasons for accessing or not accessing foot care services. 
6. Identify factors associated with accessing foot care. 
7. Provide a description of the foot care patients have received. 
8. Identify self-care and self-management strategies adopted by patients to 
manage foot problems.  
9. Validate self-report of current foot problems (or lack of foot problems). 
 
 
3.4.3 Methodological approach and conduct 
To meet the aims of this thesis a series of interlinked studies were conducted. The main 
study - a postal survey of a large random sample of all patients with RA within a fixed 
geographical location – would be successful only if all the relevant questions were 
included in the survey. Therefore a preceding study (semi-structured one-to-one 
interviews with patients) was undertaken using qualitative techniques to ensure this 
would be the case. However, the survey would only be successful if the patient self-
 Chapter 3: Access to health care 
90 
 
report of foot problems was accurate (or at least sufficiently accurate). The validation 
study conducted on a selected sub-sample of patients was designed to establish the 
extent of reliability (self-report), but also provided an opportunity to re-check some of 
the earlier findings. The conduct of three interlinking studies in this thesis is therefore a 
mixed method approach to addressing the aims of this thesis.  
 
3.4.4 Ensuring coverage of all the issues 
To ensure the inclusion of the patients’ experiences and important issues from the 
patients’ perspective, the use of appropriate phases and words to inform the content of 
the postal survey was the purpose of Study 1 of the research, which is presented in 
Chapter 4. This involved a detailed qualitative study using one-to-one interviews with 
patients and interacting with patients who became research partners in the 
implementation of the study, analysis of the results, and preparations for the main 
survey. The clinical content of the survey was determined by the construction of a 
recognised and defined list of foot pathologies with appropriate clinical and lay 
terminology from the qualitative data. A further aim of conducting Study 1 was to 
provide a rich description of the individual patient experience of foot problems, explore 
patients’ beliefs regarding efficacy of foot care and their reasons for accessing foot care 
or not. 
 
3.4.5 Establishing the population sampling frame 
The population sample frame needs to have equitable access to primary and secondary 
foot care services. Access to foot care services is defined for this thesis as a patient 
having been seen by a podiatrist, orthotist and/or orthopaedic surgeon. In the UK 
orthotic and orthopaedic services tend to be located within secondary care (hospital 
based). In contrast NHS podiatry services traditionally have been viewed as providing 
general foot care in primary care to local populations. However, sometimes the 
provision of specialist podiatry services can also be located in secondary care. For 
example the role of the podiatrist as an essential member of the multidisciplinary team 
to manage diabetic foot disease is widely recognised (NICE NG19, 2015). NHS primary 
care organisations (GP, AHPs and nursing) provide health care for predefined 
populations within a fixed geographical location. In contrast secondary care services 
provide health care for geographically dispersed populations. Additionally in the UK 
patients are provided with the opportunity to select which secondary care facility they 
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would like to receive care from. This has resulted in hospitals providing care to both 
local and regional populations (Jones and Mays, 2009). 
 
In order to capture and quantify access to foot care for patients with RA, a sampling 
strategy therefore needs to be conducted within a defined geographical location that 
covers both primary and secondary foot care provision. This approach has not been 
previously utilised to estimate access to foot care for patients with RA. The city of 
Bristol offers an opportunity to implement this approach. The majority of patients with 
RA in the city will be treated at one of two hospital sites, North Bristol NHS Trust (NBT) 
and University Hospitals Bristol NHS Foundation Trust (UBH). Orthotic and orthopaedic 
services are provided at both hospital sites. NHS Podiatric services for Bristol are 
provided by Bristol Community Health Social Enterprise (BCH) which cares for patients 
whose GP is located within a fixed geographical area covering the city of Bristol. 
Therefore, patients with RA who are registered with either of the hospitals and who are 
registered with a GP within the podiatry service area form the sample frame for the 
survey. The survey undertaken in this group is Study 2 of the research and is presented 
in Chapter 5. 
 
3.4.6 Ensuring reliability of self-report 
Prevalence of foot problems can be obtained by clinical assessment by health 
professionals and self-report by patients. Levels of agreement between these two 
approaches have not been previously investigated in RA. The accuracy of the self-
report data collected in Study 2 was investigated in by Study 3, in which a selected sub-
sample of patients attended for a direct clinical assessment by an independent 
podiatrist and which is presented in Chapter 6.  
 
3.4.7 Mixed methods 
A paradigm has evolved for conducting research in which qualitative and quantitative 
methods are combined and is referred to as “mixed methods”. Tashakkori and Teddlie 
(1998) describe mixed methods research as “the use of qualitative and quantitative 
methods in a single study or multi-stage study”. Creswell (2009) suggests mixed 
methods can be applied to all or some stages of the research process including 
sampling strategies, data collection, analysis, integration of the findings and/or overall 
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interpretation. Several reasons for the benefit of conducting mixed methods research 
have been proposed: 
 
1. Answer different research questions - mixed methods can be applied to 
research questions that cannot be answered by qualitative or quantitative 
approaches alone (Cresswell and Plano Clark, 2007). 
2. Confirmation (Triangulation) – findings of one method can validate or support 
the findings from another method (O’Cathain, Murphy and Nicholl, 2010). 
3. Completeness – to provide more accurate understanding and interpretation of 
the research area to aid generalisability of study findings to a larger population 
(Bryman, 2006). 
4. Offset weakness – a mixed methods approach can allow the limitations of 
qualitative and quantitative methods to be offset or neutralised therefore provide 
stronger and more accurate assumptions of the research topic findings and 
conclusions (Bryman, 2006). 
5. Inform multi-stage study design – whereby a qualitative study can be conducted 
to develop hypotheses to be tested in a follow-up quantitative phase (Doyle, 
Brady and Byrne 2009).The findings of qualitative studies can also be beneficial 
to deign quantitative tools such as questionnaires which are sensitive and reflect 
individual experiences and beliefs (Coyle and Williams, 2000).  
 
The use of mixed methods in health research has increased over recent years. A 
review conducted by O’Cathian, Murphy and Nicholl (2007) of research commissioned 
by the Health Research and Development Programme in the United Kingdom (UK) 
reported 17% of studies commissioned before 1995 used mixed method approaches 
compared with 30% funded between 2000 and 2004. The use of traditional research 
approaches (qualitative or quantitative methods) as individual enquiries may not 
address the composite nature of health, health care intervention and health care 
utilisation (O’Cathain, 2009). Additionally mixed methods can provide data to reflect the 
needs of patients at individual, local and national level (Doyle, Brady and Byrne, 2009; 
Coyle and Williams, 2000). Given the current state of knowledge, the aims of this thesis 
could be achieved only through adopting a mixed methods approach.  
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The design and conduct of mixed methods research is flexible to address individual 
research questions (Johnson and Onwuegbuzie, 2004). That is researchers can select 
the order of the conduct of research studies. For example if the topic of interest was to 
provide information regarding how many patients with RA had undergone foot surgery 
and what were the patients experience of care received. It would seem reasonable to 
collect the quantitative data first then explore the patients’ experience of care using 
qualitative techniques. As the area of interest in this thesis is the prevalence, impact 
and care of foot problems in patients with RA, it was considered appropriate to 
commence with a qualitative phase to inform the content of a postal survey. The 
rationale for conducting a postal survey was to provide information regarding the 
prevalence of foot problems in patients with RA and identify the proportions of patients 
who had accessed foot care. Johnson and Onwuegbuze (2004) guidance of the 
conduct of mixed methods research was followed in approach and design. This thesis 
therefore used a sequential concurrent design in which the research commenced with a 
qualitative study (Study 1) followed by two concurrent quantitative studies (Study 2 and 
Study 3). Additionally equal weight and importance was given to each study in relation 
to research governance, data collection and analyses and interpretation of the findings.   
 
3.4.8 Epistemological position - Pragmatism 
The processes of conducting research are determined by views: on ontology, the 
assumptions of reality (how we know what is real); epistemology, the justification of 
reality (how do we know what we know); methodology (how to go about finding out) and 
methods (practical activities of finding out) to provide knowledge (Carter and Little, 
2007). Historically the traditional paradigms of conducting health research have 
involved the application of qualitative approaches (text as data) or quantitative 
approaches (numbers as data). The qualitative paradigm is referred to as naturalist, 
constructivist, post-positive or interpretive in approach (Creswell, 2009). The aim of 
qualitative research is to have a deeper understanding of the phenomena of interest, by 
purposively sampling small numbers of respondents / cases. The main characteristics 
of utilising qualitative methods are: induction, discovery, exploration and theory or 
hypothesis generation. The researcher acknowledges to being an integral part of the 
research process in both data collection and analysis (Johnson and Onwuegbuzie, 
2004). Qualitative researchers propose that there are “multiple realities” or “multiple 
truths” and different interpretations therefore acknowledge that the findings may not be 
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generalisable to all cases in all situations. The quantitative paradigm which is referred 
to as the positive tradition seeks to identify causal relationships, generalise study 
findings based on statistical relationships, hypothesis testing and is deductive. Sample 
sizes tend to be larger and sampling strategies are applied to reduce potential sources 
of bias. The researcher is considered independent and objective as opposed to the 
qualitative researcher being subjective and immersed in the research process (Doyle, 
Brady and Byrne, 2009). 
 
If positivism and interpretism were placed at either end of a hypothetical continuum 
pragmatism would be placed in between the two extremes assuming the “middle 
ground”. Pragmatism is derived from the Greek word pragma from which practice and 
practical are derived. Pragmatism is not committed to one philosophical stand point of 
understanding reality (Dures et al, 2011) and can provide a basis for knowledge 
(Cresswell, 2009). Pragmatism is associated with mixed methods providing researchers 
with the freedom to select research methods which are the most appropriate to their 
research topic and understanding of the research questions or problems (Johnson and 
Onwuegbuzie, 2004). Following review of the literature, the researcher selected a 
pragmatic approach to this thesis.  
 
3.4.9 Collaboration with patients and clinicians  
The involvement of patients in health research is widely advocated. Patients have 
personal experience of their health conditions and treatments they receive to manage 
their conditions (Tallon, Chard, Dieppe, 2000a; Hewlett et al, 2006). These experiences 
can provide useful insights in relation to informing research study design and 
interpretation of findings. Further, patient involvement in clinical research can be 
beneficial to identify important issues for patients (Entwistle et al, 1998). Failure to 
consider the patient perspective in clinical research has been suggested as a potential 
source of bias (Tallon, Chard and Dieppe, 2000b). Additionally the agenda of the 
researcher can vary with that of the clinician. Non-clinical researchers’ duties in health 
research tend to be focused on following study protocols and determined methods. In 
contrast clinical researchers also have these responsibilities but also duty of care to 
consider (Resnik, 2009). Further, patients and clinicians can have varying perspectives 
in relation to treatment outcomes and priorities (Hewlett, 2003). It was decided that the 
inclusion of patients’, clinicians’ and clinical researchers’ perspectives would therefore 
 Chapter 3: Access to health care 
95 
 
be essential in the overall approach to the design and conduct of the 3 studies in this 
thesis. This was achieved through discussions with the researcher’s supervisory team 
and the Research Advisory Group (RAG). The RAG included representation of patients 
with RA and clinicians from both hospital sites (NBT and UHB), clinical researchers, the 
researcher and a member of her supervisory team (JK). Discussions with the RAG 
commenced with the researcher providing a summary of the background to the 
proposed works and discussed gaps in the literature in relation to foot problems in RA. 
The researcher presented the research question “What determines whether a patient 
with RA accesses or does not access foot care services?”, and the justification for the 
need of three interlinked studies being required to address the overall aims of the 
thesis. Members of the RAG provided valuable comments to the approach and conduct 
of all three studies. For example items for inclusion in the interview topic guide (Study 
1). The clinicians proposed valuable suggestions in relation to identifying patients at 
both hospital sites. Patients raised topics for further investigation. These included 
importance of foot problems (e.g. “How important are your foot problems?”), impact of 
foot problems (e.g. impact of foot problems on clothing choice) and clinical practice 
(e.g. “Has anyone examined your feet since developing RA?”). Overall, meetings with 
the RAG provided valuable comments and suggestions to the researcher particularly 
regarding overall identification and sampling strategies, content and phraseology of 
questions in the interview topic guide for Study 1. Additionally these discussions 
provided an invaluable insight from both the patients’ and clinicians’ perspective that 
could not have been appreciated a priori. 
 
3.4.10 Conclusion 
A mixed methods approach using three interlinking studies have been designed to 
investigate the prevalence, impact, and care of foot problems in patients with RA. In 
summary, Study 1 will facilitate the understanding of the impact of foot problems in 
patients with RA in relation to their personal experiences and discover patients’ reasons 
for accessing or not accessing foot care services. This information will be utilised to 
inform the content of a postal survey (Study 2). To measure the prevalence and impact 
of foot problems and identification of the proportions of patients who had accessed foot 
care. A detailed clinical description of current foot problems, patients reasons for 
accessing foot care or not, and patients’ perceptions of the benefit of foot care received 
are investigated in Study 3. Additionally Study 3 provides investigation between levels 
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of agreement between the self-report of foot problems (or absence of foot problems) 
with clinical assessment by a clinician. Chapters 4 to 6 present the results of each 
study, Chapter 7 will then discuss the results overall and their implications for 
contributions to knowledge (literature, clinical practice) and organisation and service 
provision for foot problems in patients with RA. 
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Chapter 4: Study 1 - Exploring the patient perspective of the 
impact and care of foot problems in RA.  
This chapter presents the findings of the first of three interlinking studies to address the 
overall research questions for this thesis: “What is the impact of foot involvement in RA 
and what determines if patients with RA receive foot care?” Foot problems in patients 
with RA can be complex and multi-factorial in presentation as discussed in Chapter 2. 
However, previous work has not fully captured the consequences of foot problems in 
RA from the patient perspective. Additionally, patients’ reasons for accessing or not 
accessing foot care have not been fully explored. To investigate these issues further by 
means of a population survey a clear understanding of their scope and of the potential 
range of patient experiences is required to inform the survey. A qualitative approach 
was adopted to achieve this in Study 1. 
 
4.1 Qualitative methods 
The traditional paradigms of conducting health research involve the application of 
quantitative (numbers as data) or qualitative (text as data) approaches. The quantitative 
paradigm seeks to identify causal relationships, generalise study findings based on 
statistical relationships, hypothesis test and is deductive (Sale, Lohfeld and Brazil, 
2002). Sample sizes tend to be larger and sampling strategies are applied to reduce 
potential sources of bias. The researcher is considered independent and objective as 
opposed to the qualitative researcher being subjective and immersed in the research 
process (Doyle, Brady and Byrne, 2009). The primary aim of qualitative research is to 
have a deeper understanding of the phenomena of interest, by purposively sampling 
small numbers of respondents or cases for detailed exploration (Cresswell, 2009). The 
main characteristics of utilising qualitative methods are induction, discovery, exploration 
and theory or hypothesis generation. The researcher acknowledges that they 
themselves are an integral part of the research process in both data collection and 
analysis (Johnson and Onwuegbuzie, 2004). Qualitative researchers consider that there 
are “multiple realities” or “multiple truths” and different interpretations of these 
(interpretism), and therefore acknowledge that the findings from a small number of 
individual experiences may not be generalisable to all cases in all situations. To explore 
in-depth, the personal account of the experience of foot problems in RA from the 
patients’ perspective, a qualitative approach was appropriate. 
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Semi-structured, one-to-one interviews were selected as the method for data collection. 
Focus groups were considered as an alternative approach as they can be a useful 
method in health research (Parker and Tritter, 2006). For example group work can be 
valuable as a ranking exercise to identify priorities, review service delivery or to seek a 
combined expert panel opinion. However, participants who disagree with the general 
group consensus may not feel able to voice their opinion. Additionally confidentiality 
cannot be maintained because of the presence of other participants (Kitzinger, 1995). 
As the aims of this study were to explore the in-depth individual patient experience, 
semi structured one-to-one interviews were therefore selected to avoid these issues.  
 
4.2 Aims Study 1: 
 
1. Understand the impact of foot problems in patients with RA in relation to their 
personal experiences. 
2. Discover patients’ reasons for accessing or not accessing foot care services. 
3. Utilise this information to inform the content of a postal survey. 
 
These address the thesis aims 3 and 5 described in Chapter 3 section 3.4.2 and 
also to inform the planned survey (Study 2). 
 
4.3 Methods 
 
Approval for the study was obtained from the South West 4 Medical Regional Ethics 
Committee (reference 10/H01021/46) and the University of the West of England 
Research Ethics Committee (reference HSC/10/07/54). Research and development 
approval was obtained from two hospital sites: North Bristol NHS Trust (NBT) and 
University Hospitals Bristol NHS Foundation Trust (UHB). 
 
4.3.1 Identification and sampling 
Patients with a consultant diagnosis of RA (Arnett et al, 1988) over the age of 18 years 
and who met the inclusion / exclusion criteria set out below were recruited from two 
hospital sites (NBT and UHB). Patients were approached, using the screening question 
“Do you have problems with your feet because of your RA?” and if they answered “Yes” 
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were asked whether they had accessed foot care services (podiatry, orthotics and/or 
orthopaedics) since being diagnosed with RA. The rationale for the screening questions 
was to capture the patient experience of the topic of interest (experienced foot 
problems) and to provide the opportunity to discover patients’ reasons for accessing 
foot care or not. Patients attending the UHB rheumatology department were 
approached by the researcher who has an honorary clinical contract with the 
department. Patients attending the NBT rheumatology department were approached by 
a member of the rheumatology direct care team. The study inclusion / exclusion criteria 
were: 
 
Inclusion criteria: 
1. Consultant diagnosis of RA. 
2. Reported foot problems due to their RA. 
3. Sufficient English to participate in one-to-one interviews. 
 
Exclusion criteria: 
1. Known diagnosis of additional morbidity in which foot problems can be a clinical 
feature (e.g. diabetes, multiple sclerosis, peripheral vascular disease and 
neuropathy). 
 
For patients at UHB, the researcher continued the conversation and provided more 
information about the study. Patients expressing an interest to participate at NBT were 
introduced to the researcher by a member of the rheumatology direct care team for 
further information. All patients expressing an interest (in the study) were provided with 
patient information sheet with a reply slip (agreeing to be contacted by the researcher) 
and pre-paid envelope (See Appendix A1 and A2). All patients who returned the reply 
slip were considered for recruitment.  
 
A purposive sampling strategy was applied (Marshall, 1996) using a sampling frame to 
capture a range of patient characteristics: age, gender, disease duration and whether or 
not they had accessed foot care services (podiatry, orthotics and/or orthopaedics). To 
understand patients’ reasons for accessing or not accessing foot care it was necessary 
to sample patients who had and had not accessed care. Recruiting a diverse sample of 
patients with RA with experience of foot problems facilitated a range of individual 
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experiences to be explored. Patients who filled an appropriate space in the sampling 
frame were contacted by the researcher to arrange a convenient time, date and location 
for the interview. Recruitment to the study continued until data saturation had been 
achieved, indicated by no new major issues emerging in three consecutive interviews 
(Guest, Bunce and Johnson, 2006).  
 
4.3.2 Patient descriptors 
In order to describe the participants (patients) in the study the following data were 
collected pre-interview: demographic data (hospital site, age, gender), clinical data 
(arthritis medications, disease duration, disability (Health Assessment Questionnaire, 
HAQ, Fries et al, 1980; Kirwan and Reeback, 1986) and the patient global measure 
from the Disease Activity Score (DAS, van der Heidje et al, 1993). These clinical 
descriptors of patients with RA are widely used in clinical trials. Health conditions affect 
both patients’ physical function and health related quality of life, and impact on a 
patient’s ability to lead a “normal” everyday life (Finlayson, Moyer and Sonnad, 2004). 
Sandersen et al (2011) proposed that the impact of RA may not be captured from 
clinical measures alone (e.g. disability or measures of disease activity). The authors 
formulated the “Impact Triad” whereby the impact of RA is a combination of the severity 
of RA, the patient’s ability to cope with clinical symptoms and the personal importance 
of the aspects of daily living that are affected by their RA. It would be advantageous to 
measure all of these.  
 
Patient reported outcome measures (PROMs) have been developed to evaluate foot 
health status (e.g. Budiman-Mak, Conrad and Roach, 1991; Bennett et al, 1998). These 
questionnaires have been validated and capture foot health status in relation to foot 
pain, foot function, disability and activity restriction. However, they do not provide an 
indication of severity of foot problems. The severity of skin disorders (e.g. psoriasis and 
pruritus) has received attention in the dermatology literature. The use of visual 
analogue scales (VAS) has been proposed as a method to capture severity of 
dermatological conditions (Flyström et al, 2012; Reich et al, 2012). One limitation of the 
use of VAS is they may not be suitable for patients with motor dysfunction (e.g. inability 
to hold a pen and/or mark the VAS line with a pen). Motor dysfunction involving the 
hands can be an issue for patients completing any PROMs not just VAS. Additionally, 
methods of reproducing VAS may lead to distortions in the scale and potentially lead to 
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misinterpretation of results (Snow and Kirwan, 1988). An alternative approach is the 
use of 11, 21 or 101 numerical rating scales (NRS) in which the end points (anchors) 
are the extremes of the topic of interest (e.g. feet not a problem to feet severe 
problems). NRS have been shown to have high levels of agreement with validated 
questionnaires. Additionally patients are reported to prefer completing NRS rather than 
VAS, due to simplicity of completion (van Tubergen et al, 2002). In order to provide 
information about the global impact of foot problems in patients with RA, it was decided 
to include items capturing the severity and ability to cope with foot problems. 
Quantifying severity of foot problems and patients ability to cope with foot problems is 
novel but has not been validated using NRS. However, NRS have been validated to 
capture foot pain and foot related disability in patients with RA (Budiman-Mak, Conrad 
and Roach, 1991). Therefore for ease of administration and considering patients’ 
(reported) preferences regarding completing rating scales, one 11 point numerical 
rating scale (NRS) was selected to measure the severity (magnitude) of foot problems 
(“Please circle the number which shows how much of a problem (on average) your feet 
have been in the last week”? range 0 no problem to 10 severe problem) and the global 
nature of their arthritis (“Considering all the ways your arthritis affects you, please circle 
the number which shows how well you are doing?” range 0 very well to 10 very badly). 
All study participants completed the both numerical rating scales prior to the 
commencement of the one-to-one interviews. A copy of the pre-interview data collection 
sheet is presented in Appendix D1. 
 
4.3.3 Interview process 
The one-to-one interviews were held in rooms at UHB or NBT rheumatology 
departments, whichever was most convenient for the participant. Informed written 
consent was obtained by the researcher from each participant prior to commencing the 
interview.  
 
Interviews at UHB were conducted in non-clinical rooms within the rheumatology 
department, whilst at NBT they were conducted in consulting rooms due to lack of 
availability of non-clinical rooms. Consideration was given to conducting the interviews 
in a non-hospital environment rather than the hospital outpatient departments as it is 
possible that location may influence power relations between researcher and participant 
(Elwood and Martin, 2000). However, in a study conducted by Memel et al (2002) in 
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which participants were offered a choice of location for attending an in-depth interview, 
the majority preferred to discuss their medical conditions and care in a clinical setting. 
 
The researcher endeavoured to conduct the interviews in a quiet, relaxed and informal 
environment so the participants would feel at ease. Additionally the researcher was 
aware of the importance of being interactive and sensitive to the participants’ disclosure 
of their personal experiences. The interviews lasted between 35 and 60 minutes. The 
interviews were audio recorded and transcribed verbatim. The researcher checked the 
transcripts for accuracy and anonymised names and identities. To maintain 
confidentiality all participants were allocated an identifier consisting of a code containing 
the hospital site, patient number and gender (e.g. BR 05 M).  
 
The interviews commenced with an introductory question: “Can you tell me in a couple 
of sentences about your arthritis so I can understand a bit more?” This provided 
participants with the opportunity to disclose the nature and impact of their arthritis in 
general terms. A more detailed account of the experience of foot involvement and 
accounts of access to foot care services was then explored using the interview topic 
guide (see Table 4.1). The interview topic guide was developed by the researcher 
based on the review of the literature; discussions with a research advisory group 
(consisting of patients, clinicians, and academic supervisors) and a patient research 
partner (PRP) who became an integral part of the research team. The interview topic 
guide consisted of 7 neutral questions covering three main issues: 1) experience of foot 
involvement in RA; 2) its impact on the patient’s life; 3) access to foot care services. 
The aims of the open-ended questions were to identify the extent of the overall topics of 
interest. The additional use of probes and prompts facilitated the opportunity for the 
participants and the researcher to discuss some topics in more detail. All the study 
participants were offered the opportunity to indicate if they would like to receive a 
summary of the study findings. 
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Table 4.1 Topic guide Study 1 
Question 
1: Tell me the story about your feet?  
 How important are your foot problems to you? 
 Have you discussed your foot problems with anyone? 
2: What are your foot problems?  
 Have your feet changed since developing RA? 
 Has anyone examined your feet since developing RA? 
3: How do you manage your foot problems? 
 Can you give an example? 
4: Have you had any experience of foot care services? 
 If so, how did you access care? 
5: How much do your foot problems affect your activity?  
 How do you feel about your foot problems affecting your activity levels? 
 Are you able to drive, work, and take part in leisure activities? 
 How do your foot problems affect the way you feel about things? 
6: Do they have an impact on your choice of shoes, clothes etc? 
 How does this make you feel? 
7: If we could make things better, do you have a wish list for foot care services? 
 
4.3.4 Choice of analytical methods  
Analyses of qualitative data can be inductive or deductive. Inductive analysis is 
described as data driven (bottom up) in approach whereby knowledge and ideas 
emerge directly from the data. Such analyses can be used to generate hypotheses. In 
contrast deductive analysis is described as top down. This approach to analysis 
commences with a predefined idea or hypothesis. Data are then analysed to confirm or 
refute the original idea or hypothesis (Thorne, 2000). Inductive analyses facilitate 
discovery while deductive approaches are more suited to testing of theory (Pope, 
Ziebland and Mays, 2000). As the aims of Study 1 were to understand (discover) the 
individual patient experience of foot problems and their reasons for accessing or not 
accessing foot care, an inductive approach to analysis of the data was selected. 
 
Consideration was given to the application of Interpretative Phenomenological Analysis 
(IPA) (Sokolowski, 2000; Smith and Osborn, 2003) as a method of analysis for Study 1. 
The primary aim of IPA is to enquire about the individual’s lived experience while 
recognising a process of interpretation by the researcher. Participants are recruited 
because of their experience of an event or condition. In IPA only a small number of 
participants are included, as it is a very detailed analysis with a lot of researcher 
interpretation. Therefore IPA was not applicable here where the need was to capture a 
wide range of patient experiences. 
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Inductive thematic analysis (ITA) was used to identify codes and themes arising from 
the data. Boyatzis (1998) describes thematic analysis as a method for identifying and 
reporting patterns (referred to as themes) within qualitative data and facilitates further 
interpretation of the research topic. ITA ensures a systematic approach to identifying 
common themes within and across data sets. It is also a useful approach to 
summarising large data sets to identify similarities and differences between data 
(Hayes, 2000). ITA is flexible as there is no prerequisite to have a predefined theoretical 
or epistemological position but still provides an opportunity to gain a thick description 
when researching an under investigated topic area (Braun and Clarke, 2006). 
 
4.3.5 Inductive Thematic Analysis process 
There are different descriptions of how systematic ITA should be performed (Boyatzis, 
1998; Attride-Sterling, 2001; Braun and Clark, 2006). Braun and Clarke (2006) 
recommend a six stage approach to conducting ITA: 
Stage 1: Commences with familiarisation of the data by transcribing the data (if 
required) followed by reading and re-reading the data and recording initial thoughts or 
ideas. 
Stage 2: Involves generating initial codes with codes being described as “interesting 
features” within and across the data set. Codes are then exemplified with extracts from 
the data. 
Stage 3: Codes are then grouped to form themes and supported by all data which might 
be relevant to each theme. 
Stage 4: Is the process of reviewing themes. At this stage some themes may not have 
sufficient data to be supported, may be very similar and therefore combined, or may 
contain a combination of themes and therefore need to be broken down and analysed 
as separate themes. This stage of the analysis can then be presented as creating a 
“thematic map” diagrammatically representing the links between codes and themes. 
Stage 5: Refers to the process of defining and naming themes by generating clear 
definitions and names for each theme. 
Stage 6: The final stage in the process is the presentation of the analysis in a concise 
logical approach with sufficient extracts of the data to support the findings. 
 
Attride-Sterling (2001) describes thematic analysis as a method to unpick themes in 
textual data at different levels which can be supported by the use of “thematic networks” 
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to diagrammatically represent the hierarchical order of themes. Thematic networks are 
tools to support the organising and presentation of the data and are constructed as 
web-like illustrations. The lowest order themes are referred to as “basic themes” which 
are derived from the textual data. Basic themes are then grouped in clusters into middle 
order “organising themes” which surmise conceptual assumptions of basic themes. The 
highest order or super-ordinate themes are “global themes” which summarise and 
interpret the clusters of lower order themes. Attride-Sterling (2001) proposes six steps 
for utilising thematic networks as a technique for conducting thematic analysis: 
Step 1: The reduction of the textural data into small units of meaning (codes) using a 
coding framework. 
Step 2: Identify abstract themes from the coded text and extract salient or common 
themes which are then refined to encompass the meaning of numerous segments of 
text. 
Step 3: The construction of thematic networks by arranging interlinking basic themes, 
grouped in organising themes which support the development of global themes. 
Step 4: Relates to the description and exploration of thematic networks. The networks 
are initially described with supporting textural data then reviewed to explore interwoven 
links between the themes. Networks then also become tools for the reader who is able 
to interpret the analysis using the networks as a summary guide to refer to the 
description and exploration of the analysis. 
Step 5: Presents a summary of the main themes and patterns that have emerged in the 
data analyses.  
Step 6: The final stage of the process draws together the overall findings of the 
concepts, patterns and interwoven links in the data with reference to established 
theories if indicated. 
 
For the analysis presented here a coding strategy was employed combining the two 
sets of guidance. The coding process commenced with familiarisation of the data with 
the researcher checking the interview transcripts for accuracy with the audio recordings. 
The transcripts were then read and re-read to gain an understanding of and 
familiarisation with the data. Next, the data were systematically explored and small units 
of meaning identified and given descriptive labels (codes). The data handling package 
NVivo 8 (QSR International, Melbourne, Australia) was utilised. NVivo is a software tool 
which assists in organising data and therefore supports the analysing non numerical 
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data. NVivo facilitates the coding process through a system of nodes. The codes were 
the lowest order themes extracted directly from the data. The codes were then grouped 
in similar meaning to form sub-themes, which in turn were clustered into organising 
themes, and finally organising were grouped to form global themes / underpinning 
themes to support the more abstract meaning of organising themes. Analysis was 
iterative and used constant comparison. The technique compared data sets, individually 
and across the whole data set, for emerging themes, and also sought links between 
codes and themes. In the iterative process the identification of new themes in early 
interviews could then be explored in subsequent interviews and also applied to earlier 
data sets.  
 
The terms authenticity and trustworthiness are often applied in qualitative research. 
Authenticity refers to the findings of a study being represented accurately and 
trustworthiness to enable the reader to have confidence in the research and its findings 
(Lincoln and Guba, 1985). Authenticity and trustworthiness of the analysis was 
supported by the use of quotations to illustrate the evidence supporting the findings. 
This provided an in-depth appreciation of the individual experience in the participants’ 
own language and words, rather than the researcher’s interpretation of what was said. 
The terms reliability (findings constant over time and reproducible) and validity 
(measure / capture information of what was intended to be measured) are widely used 
in quantitative research to ensure replication and repeatability of findings. In contrast 
the term “rigour” is applied in the qualitative literature. Rigour is an umbrella term to 
assess quality, trustworthiness and credibility of findings of qualitative data (e.g. 
Golafshani, 2003). Rigour was addressed through independent analysis of the data sets 
(transcripts) and agreement of the emerging themes generated. The first 2-3 transcripts 
were analysed not only by the researcher, but independently (as advocated by Mays 
and Pope, 1995) by two other researchers (Professor Sarah Hewlett and Dr Emma 
Dures) and the PRP (Enid Quest). Agreement was achieved following discussions with 
the study analysis team on emerging codes and themes before the remaining 
transcripts were analysed by the researcher. The overall emergent themes were agreed 
by all the members of the study analysis team and academic supervisors. Table 4.2 
presents the study team characteristics.  
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Table 4.2 Study team characteristics 
Team Gender Position Years of rheumatology 
experience 
OW Female Researcher / PhD student 15 years 
ED Female Rheumatology psychology researcher 5 years 
EQ Female Patient research partner RA diagnosed >20 years 
JK Male Academic rheumatologist >30years 
SH Female Academic rheumatology nurse >20 years 
 
4.3.6 Ensuring the quality of research process  
As the researcher had no previous experience of conducting qualitative research, 
training was addressed through successful completion of two level M modules in 
qualitative methods at the University of Oxford and the University of the West of 
England. Individual guidance on conducting thematic analysis was provided by an 
experienced qualitative researcher (Dr Marianne Morris) and the practicalities of 
conducting in-depth interviews was supported by the PRP and a postdoctoral 
researcher (Dr Tessa Sanderson).  
 
Reflexivity is an important consideration of qualitative research as the person 
undertaking the research is an integral part of the research process (Pillow, 2003; 
Horsburgh, 2003). A professional background as a podiatrist may influence the 
approach, design and analysis of the study. In order to reduce this potential for bias the 
researcher used reflexivity and reflective practice. The content of the interview schedule 
(topic guide) was derived from discussions with the research advisory group (patients, 
clinicians, academic supervisor), and the researcher introduced herself to potential 
participants as a clinical doctoral research fellow rather than a podiatrist. This is 
because disclosure of professional background has been reported to influence 
participants’ responses during qualitative interviews (Richards and Emslie, 2000). 
Revealing the researcher’s professional background may prevent a participant from 
feeling at ease when describing their experiences, for example some participants may 
not freely discuss negative experiences of foot care with a podiatrist. To facilitate this, if 
a participant directly asked about the researcher’s background (clinical or non-clinical), 
the researcher postponed disclosure of her background to the end of the one-to-one 
interview saying, “I am really interested to hear your experiences, we can talk about me 
at the end”. During the study this occurred only once. As a member of the clinical team 
in one of the departments where patients were recruited there was the possibility that 
the researcher may have been involved in the clinical care of a participant. Richards 
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and Schwartz (2002) suggests if the researcher is directly involved in the care of the 
participant, it is possible disclosure would change the nature of the interview and data 
obtained. This is a consideration for all clinicians conducting clinical research, but 
during Study 1 the researcher was not directly involved in the clinical care of any of the 
study participants. The researcher’s reflexive thoughts of the research process were 
recorded in field notes. 
 
Patient partner involvement also provided support to the research process. The patient 
research partner (PRP) participated in a semi-structured in-depth practice interview to 
provide some initial experience of conducting qualitative interviews prior to the study. 
The practice interview was observed by an experienced qualitative researcher (Dr 
Tessa Sanderson). The PRP and the qualitative researcher both provided valuable 
advice and comments to the researcher. The PRP also independently analysed 3 
interview transcripts, participated in study team meetings to agree the emergent themes 
of the analyses, and contributed to the interpretation of the overall study findings. The 
PRP was also a member of the research advisory group. 
 
4.4 Results 
 
4.4.1 Participants 
In total 27 patients with RA and self-reported foot problems (symptoms) were 
approached to participate in the study. Of these, 9 declined to participate - 2 indicated 
that they did not wish to attend for an additional hospital visit and 7 did not mention a 
reason. Of the 18 participants who expressed an interest in taking part in the study, 4 
could not be contacted by telephone and did not respond to written invitations and 1 did 
not attend for the arranged one to one interview. The 13 participants were distributed 
across the sampling frame (Table 4.3). 
 
Table 4.3 Sampling frame patient recruitment  
  Age (years)  Disease duration (years)  AFC 
  < 35 35-50 51–64 >64  <5 5-10 11-20 >20  Yes No 
Female  1 (1) 3 (1) 7 (3) 6 (3)  2 (2) 2 (2) 3 (0) 6 (2)  7 (4) 7 (4) 
Male  0 (0) 1 (1) 5 (3) 4 (1)  3 (3) 4 (0) 4 (2) 3 (2)  4 (4) 9 (1) 
 
Key: 
AFC = accessed foot care services Figures are: Number approached (Number participating) 
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Interviews with 13 participants were conducted. However, data were lost for one 
interview due to equipment failure. Participant characteristics are presented in Table 
4.4. Most participants were British white Caucasian, apart from one Afro-Caribbean 
participant. Working and domestic living arrangements were mentioned by all 
participants during the interviews. Of the 5 men who participated in the study, only 1 
was currently in full time employment. Of the 7 women, none were employed at the time 
of data collection. The youngest female participant disclosed her reason for not working 
was a personal choice so that she could care for a young child. Three participants lived 
alone. Participants’ perception of disease activity and severity of foot problems covered 
a wide range from 0 to 9 (10 being worst disease activity or foot problem). Five 
participants were taking biologic therapy for their RA. Data saturation seemed close 
after nine interviews and was confirmed by conducting a further three interviews 
whereby no new themes emerged.
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Table 4.4 Participant (patient) characteristics 
ID Gender Age  (Years) 
Disease 
duration (Years) 
Current medication HAQ 
Patient 
Global 
Foot 
Global 
Accessed 
Foot care 
BR02 Male 61 3 Biologics, DMARDs, GC 2.875 6 6 Yes 
BR03 Female 62 2 DMARDs, GC 0.375 2 3 No 
BR04 Male 39 2 DMARDs, GC, NSAIDs 0 1 1 No 
BR05 Male 55 27 Biologics, DMARDs, NSAIDs 2.75 8 9 Yes 
BR06 Female 61 23 DMARDS, GC, NSAIDs 2.75 7 7 Yes 
BR07 Male 54 2 Biologics, DMARDS, GC, NSAIDs 2 8 9 No 
BR08 Female 71 11 Biologics 0.375 7 1 No 
BR09 Male 72 20 DMARDs, NSAIDs 1.87 9 5 Yes 
BR10 Female 46 24 Biologics, DMARDs, NSAIDs 2.375 6 8 Yes 
NB01 Female 29 5 GC 0 0 0 No 
NB02 Female 55 7 DMARDs, NSAIDs 1.87 5 7 Yes 
NB03 Female 69 18 DMARDs 1.75 7 8 Yes 
Mean  56.2 12.0  1.56 5.5 5.3  
Range  (29 - 72) (2 - 27)  (0 - 2.875) (0 - 9) (0 - 9)  
Key: 
ID: BR = UHB patient, NB = NBT patient.                                                                                                 Patient Global = Numerical rating scale 0 (very well) - 10 (10 very badly) 
Foot Global = Numerical rating scale 0 (no problem) -10 (10 severe problem                                        HAQ= Health Assessment Questionnaire score 0-3 (3 is most disabled) 
NSAIDs = Non-steroidal anti-inflammatory drugs. 
DMARDs = Disease-modifying anti-rheumatic drugs.  
GC = Glucocorticoids. 
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Data were collected between October 2010 and April 2011. Each participant 
provided an individual account of their personal experience of the impact of foot 
symptoms (problems) in RA, and beliefs regarding access to and efficacy of foot 
care services. The findings include themes from within individual cases and across 
the whole data set on both common and individual experiences raised by the 
participants. In total, 159 codes were identified, and drawn together into 15 sub-
themes, 3 organising themes, 1 underpinning theme and 1 global theme, which are 
described below. These all related to the decision to access foot care, which 
emerged as a global theme in itself and is discussed in section 4.4.3.The coding 
tree is presented in Appendix D3. 
 
4.4.2 Impact of foot problems 
Overall, three organising themes were identified: ‘Foot symptoms’, ‘Consequences’, 
and ‘Cost’ with an underpinning theme of ‘Impact’. Within each organising theme are 
related sub-themes that represent the diversity of individual experiences, beliefs and 
values, and are independent and interlinked but mutually influential (Figure 4.1). 
Exemplars from the data are presented at the sub-theme level and labelled by the 
patient identifier consisting of a code containing the hospital site, patient number 
and gender (e.g. BR 05 M).  
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Figure 4.1 Overview of experience and 
impact of foot problems in RA 
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4.4.2.1 Foot symptoms 
The organising theme ‘Foot symptoms’ demonstrates that clinical features of foot 
problems are multi-factorial: these can be an early symptom of RA (‘Feet first ’), with 
joint and other system involvement (‘Articular involvement’, ‘Extra articular features’ 
and ‘Other features of RA’) and also include skin and nail pathologies (‘Cutaneous 
lesions’).  
 
4.4.2.1.1 Feet first: “The arthritis started in my feet” 
Participants described a range of experiences in relation to foot symptoms 
(problems) with some recalling that the first symptoms of RA were in their feet. 
Other participants described the evolvement of foot symptoms as a more gradual 
insidious clinical feature that varied in severity, consequences and impact: 
 
“The arthritis started in my feet. I thought I'd stood on a little stone. It started 
off like if you stand on a little stone on the ball of your foot it feels like a 
bruise, they call them stone bruises. It wasn't going away. It's like if you put a 
marble in your sock and then try walking on them, that kind of feeling.” 
(NB02F) 
 
“The first sign something was going on was my feet. The balls of the foot 
were really uncomfortable when I walked. It seemed to come from nowhere. 
Couldn’t understand why they [referring to feet] were playing up. The next 
thing I knew my hands were playing up as well.” (BR04M) 
 
“Then eventually it [RA] showed up in a blood test. Um … well by that time I 
was starting to get it in other places, especially in the feet, um … prevented 
me from walking [referring to foot pain] when I put my foot down.” (BR05M)  
 
“But the feet came last. But when they came you know it's over … obviously 
over a period of time but they did get very bad.” (NB03F) 
 
4.4.2.1.2 Articular involvement: “Really out of shape” 
The participants described a number of foot symptoms that are general clinical 
features of RA such as pain, swelling, stiffness and joint deformity. One patient 
reported general morning stiffness which included his feet.  
 
 
Chapter 4 Study 1: The Patient Perspective 
114 
 
“Can I describe the pain? It's more stabbing if I move the ankle. It's more a 
kind of stabbing pain and I can feel it in the actual joint.” (BR09M) 
 
“They get quite hot and swollen. My ankles swell up as well; get a lot of fluid 
on the ankle around here.” (BR10F) 
 
“But the worst thing is in the morning getting out of bed. Because [BR05 
small laugh] it takes me a long time to get out of bed. Mainly with the back. I 
mean I'm still stiff in the morning, like knee joints and like in the feet.” 
(BR05M) 
 
These participants tended to be older and have longer disease duration. Foot 
deformity was linked with the sub-theme of ‘Footwear’ (4.4.2.2.5) in the use of self-
care and self-management strategies whereby some participants were aware of 
having to be selective with their footwear to prevent secondary skin lesions. The 
practical elements of self-care and self-management adopted, relate to participants’ 
ability to conduct practical tasks such as cutting toe nails. In contrast the more 
global aspects of self-care and self-management relate to strategies, skills and 
beliefs participants adopt in order to manage their RA on a daily basis (e.g. pacing 
and planning). 
 
“Some of the toes have sort of clawed up a little bit ur and when I’ve got 
certain shoes on the knuckle, the first knuckle becomes quite sore 
if I got certain types of shoes and I might have a blister.” (BR06F) 
 
“If I’m going somewhere special I’ll take a second pair of shoes in my bag. 
When I’m sitting down nobody can see my frumpy shoes under the table” 
(NB03F) 
 
The evolving nature of foot deformity was associated with the sub-theme of 
‘Personal importance’ (4.4.2.4.1). Although joint deformity had occurred, one patient 
did not consider it to be an important feature of their RA, while for others the 
consequences of joint deformity in terms of pain, impairment and having difficulty 
sourcing comfortable footwear resulted in the need for surgical intervention.  
 
“The toe is out of … you know is at an angle. The big toe. It's gradually got 
worse, gradually got worse. But it doesn't cause me any trouble.” (BR09M) 
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“They [feet] were really, really out of shape. Every toe was … was 
straightened with a screw in. And it screwed it into the bone … er into the 
toe, every toe.” (NB03F) 
 
Conversely, some participants reported that joint deformity affecting the feet had 
never been a clinical feature for them. The absence of foot deformity was described 
by the two youngest participants and those with shorter disease duration:  
 
“They [feet] seem like normal to me … I think.”  (NB01F) 
 
4.4.2.1.3 Extra-articular: “When they are numb they're really sort of numb”  
Some participants reported additional neurological symptoms of burning and 
numbness in their feet, which were not constant. Only one patient described the 
presence of nodules on his feet (BR05) and no participants reported any other extra-
articular features being present in their feet such as bursae or a history of vasculitis: 
 
“I couldn't really feel the fact that my toes were rubbing on shoes and 
things. So then I'd realise like when I took my shoes off there was like blood 
and blisters and stuff. But that does seem to have calmed down.” (BR10F) 
 
“Yeah it's only the numbness occurs now and again. It's not all the time. But 
when they are numb they're really sort of numb yeah.” (NB02F) 
 
4.4.2.1.4 Other Features RA: “Another symptom of rheumatoid arthritis” 
Foot involvement was considered by most participants as an additional general 
feature of RA. However, this was disputed by a few participants who were surprised 
that foot symptoms could be a consequence of RA.  
 
 “I just thought it [referring to foot involvement] was symptomatic of 
rheumatoid arthritis. I just took it that it was another symptom of rheumatoid 
arthritis. Yeah it was just another one. Because I sometimes get it in the legs 
and sometimes I can’t walk.” (BR02M)  
 
 
 
 
Chapter 4 Study 1: The Patient Perspective 
116 
 
“I thought as RA was a type of arthritis it would only attack some areas. My 
nan had arthritis but it was just in her knees. So I was surprised when my 
ankle started swelling and playing up he said [consultant rheumatologist] it 
[ankle] was due to the RA”. (NB01F) 
 
Fear of feet being an additional clinical feature of RA was expressed by some. This 
was particularly evident for one patient (BR03F) who was provided with an 
information leaflet of foot symptoms and management when she was diagnosed 
with RA:  
 
 BR03: “Well they gave me a leaflet here how to look after your feet. Arthritis 
and how to look after your feet or something like that entitled. Well yes it 
made me aware of might lie ahead.”  
 Researcher: “Did you find the leaflet helpful?” 
 BR03: “Bit alarming.”  
 
Flare was mentioned as a feature of RA with some participants being more 
conscious of their foot symptoms during a flare. No participants discussed fatigue as 
a feature of RA and therefore no association was identified relating fatigue with the 
impact of foot symptoms:  
 
“And when I get that [referring to a flare] I’m more conscious of my feet. 
Yeah and I feel that they are swollen and um... it’s quite a relief to put them 
in the bath or... sometimes I just put them in a plastic bowl. When I’m not 
having a flare it’s only when I’ve walked too far or ... stood for a long time. 
And then I become aware that my toes have become a bit stiff and my heels 
hurt a bit. ... um...” (NB03F) 
 
4.4.2.1.5 Cutaneous lesions: “I can see why I’ve got callus” 
Additional symptoms that were foot specific included the development of secondary 
skin lesions (corn and callus formation, and toe nail pathologies): 
 
“I can see why I've got the callus just merely by the way when I stand up the 
position of the foot under there. The nails have gone um … awful as well ” 
(BR08F) 
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 “I was ending up with quite hard skin on the balls of my feet then.” (NB02F) 
 
Soft tissue infections were reported by two participants. Of these, one patient 
recalled an episode of athlete’s foot which they considered significant enough to 
source medical care. A second patient reported a bacterial infection in her toes as a 
result of an in-grown toe nail, which required medical review and antibiotics. No 
participants reported an episode of foot ulceration: 
 
“It’s like an athlete’s foot, yeah I get that. I had a bad bout of athlete’s foot 
about three years ago. Oh it was terrible I had to go to the walk-in centre.  It 
was on a weekend and that and um what did I get for it ... [name of topical 
anti-fungal cream]”. (BR02M) 
 
“I was getting quite a lot of um … toe nail infections. And it did … I did do one 
course of antibiotics.” (BR10F)  
 
4.4.2.2 Consequences 
The second organising theme ‘Consequences’ describes the effects of foot 
involvement in terms of: ability to complete tasks of daily living (‘activities’), work 
related disability (‘work’), walk (‘walking’); participate in sport / structured physical 
activity (‘exercise’), limitations in selection of shoes (‘footwear’) and impact on social 
interactions (‘participation’). 
 
4.4.2.2.1 Activities: “I do get problems driving” 
Some participants discussed the consequences their foot symptoms had on activity 
levels. Difficulty driving was reported, in particular driving a manual car. This related 
to the function of depressing the clutch and ability to perform an emergency stop. 
This situation appeared to vary and was associated with fluctuations of foot 
symptoms. One patient was considering changing his car from a manual to an 
automatic as a consequence of his foot symptoms: 
 
“If I get it in the feet, if I get it in the left foot I can't … depress the clutch. If I 
get it in the right foot I can't use the brake or the accelerator. Well I can use 
the accelerator because that's easier. But if you had to brake suddenly then 
it just wouldn't because you can't apply enough pressure on the brake. 
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Today I drove because … [BR05 laughs] for some reason, today is what I 
call a good day.” (BR05M) 
 
“Yeah but I do get problems driving. Yeah we're thinking when we can afford 
it we could change the car for an automatic. I couldn't put me foot on the 
clutch, couldn't get the clutch down. That's only ever happened once though. 
That's quite … yeah that's a recent thing.” (BR07M) 
 
4.4.2.2.2 Work: “I used to be able to work” 
A small number of participants considered that their foot problems had 
consequences on their ability to work. This was in relation to the nature of their 
occupations, such as standing for long periods of time, having to wear safety 
footwear or driving for long periods. For other participants this was not considered to 
be an important issue as they were either retired or not working: 
 
“I used to work. I gave up working I had quite a hectic job and I was having to 
move around quite a lot. I was up and down stairs and in and out of cabinets, 
and I just couldn't do it. So I had to give my job up.” (NB02F) 
 
“So I was falling over in the yard. And then what happened, the company had 
cameras put in everywhere and then I was sort of being sort of asked what 
the problem was with me shoes and with the boots they supplied.” (BR07M) 
 
“Couldn't go in any of the workshops because of the safety, I couldn't 
manage the safety shoes, they were too heavy for my feet.” (BR05M) 
 
“I was 60 odd at the time and I was coming up to retirement. I wasn't you 
know like 25 or 30.” (BR08F) 
 
4.4.2.2.3 Walking: “Some days I really can't walk” 
All participants discussed the issues their foot problems had on their ability to walk. 
For some the consequences of foot symptoms and walking were related to variation 
in general RA disease activity:  
 
“They're awful to walk on [feet], really, really uncomfortable. And it's just er … 
it's just everything just feels like it's grating against each other, like a bag of 
bones almost.” (BR10F) 
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“I was using a crutch at the time as I’m having problems with my hip and I 
think I went on using to support my other hip. But when I used it to support 
my right hip and the ankle pain, was very intense.” (BR06F) 
 
The majority of participants considered that the distance that they could now walk 
had reduced. Distance walked was described and related to levels of foot pain, with 
some participants having an awareness of not being able to walk on uneven 
surfaces: 
 
“Some days I really can't walk, the pain is so bad [referring to foot pain]. I've 
never broken a bone in my life. But if I had to imagine what a broken bone 
felt like, that's what it feels like when I walk.” (NB02F)  
 
“I suppose it’s [foot pain] stopped me from going for long walks.” (BR03F) 
 
“They've [pavements] got those little like nodule tiles or slabs in obviously to 
let blind people know there's … well I can't walk on [small laugh] those. Yeah 
and cobble stones I couldn't. We'd been on holiday in a little village and there 
was cobble stones and [small laugh] I said oh I can't walk down there.” 
(BR05M) 
 
The distance participants could walk was interlinked with the sub-theme of 
‘participation’ (Figure 4.1). The use of self-management techniques when walking 
were disclosed by some patients. This was particularly evident for one patient who 
described no longer being able to go for a walk with her husband. Despite applying 
a pacing technique by slowing down the speed she walked, she was not able to 
continue. Others participants planned their walking levels around being able to take 
regular rest periods by being able to sit down: 
 
“I’m not walking as much as I’d like and I’m not doing as much as I’d like. If 
my husband and I go for a walk, a little way down the road I say I’m going 
back now you carry on and I leave him to. And the pace that we go is 
incredible slow compared to what really would probably be good for you to 
you know so yes, I miss all that.” (BR06F)  
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“Because we've gone down the harbour on say like a Sunday if it's really 
nice. Because there's loads of seats.” (BR07M) 
 
Additional aids were utilised to help with mobility and walking. One participant 
described the benefit of using a shopping trolley when visiting the supermarket in 
conjunction with self-management strategies of pacing and planning: 
 
“And I might stop for a cup of tea or something half way round. But it's flat 
and the weight is all on the shopping is in the trolley. So you can lean on the 
trolley er you know” (BR10F)  
 
One participant described that even though it was painful she perceived walking as 
an important beneficial activity. Walking provided the opportunity for her to spend 
time with her young daughter as well as participating in physical activity: 
 
“Yeah so sometimes even if it [ankle] hurt a little bit I'd still force myself just 
to go out with the buggy and take her for a walk. Even if it hurt just to … 
yeah exactly just because it does help I think.” (NB01F) 
 
4.4.2.2.4 Exercise: “I’ve decided to pack it up” 
Foot symptoms also affected participants’ ability to participate in sport / exercise 
(structured physical activity). Exercise was considered to be a valued activity by 
some participants not only for the benefits of general health and psychological 
wellbeing but also as part of their social life. Not being able to participate in exercise 
was a negative experience for some. In contrast others adopted the approach of 
finding alternative leisure activities to participate in. For some participants the 
negative situation was in turn perceived as a positive situation. This was expressed 
by BR09M who felt that stopping a sport he had enjoyed for years, provided the 
opportunity to spend more time with his wife: 
 
“Because I couldn't play it.  And I remember trying once and I … I kicked the 
ball and I thought I'd broken an ankle. It wasn't in a tackle, I just kicked the 
football and oh, and I thought oh useless, and I felt useless. Because oh I 
don't know, I used to love football.” (BR05M) 
 
“Well it just hurt er to … to walk.  And I also do like … like running as well 
when I can. And so obviously I couldn't run [because of foot pain]”.  (NB01F)  
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“I play outdoor bowls you know and I've been pretty successful with it since I 
… now I've stopped this year. Well the main reason is because of the ankle. 
I've stopped and I've decided to pack it up. But also perhaps I want to do 
other things. So I've said to my wife and she said ‘Oh are you going to pack it 
in are you? You know, well you enjoy it so much.’ I said ‘Well I'm not 
bothered.’ I said ‘Because there's one thing, it's stopped us doing other 
things.” (BR09M)  
 
Participating in physical activity was described by one participant as a self-care and 
self-management strategy to reduce the symptoms of metatarsalgia. This patient 
was a keen cyclist: 
 
“When you move backwards and forwards, very, very slightly [referring to 
positioning foot on pedal]. So you don't end up with any pressures building 
up in your ankle. So that where the foot pivots the ball is right over the 
spindle, so you're putting all of the power into there. So it's almost as if 
that's your pivot point and it spreads the weight across the whole of the 
foot, or the pressure across.” (BR04M) 
 
4.4.2.2.5 Footwear: “I get dressed from the bottom up” 
Issues relating to the consequences of foot problems in relation to footwear were 
discussed at length by all participants. Many participants reported that they had to 
be selective about the shoes that they wore and recognised the importance of what 
they considered to be good shoes. This implied that there was personal awareness 
of the need for footwear to be comfortable and fit for purpose. Consequently 
footwear selection was an additional self-care and self-management strategy 
adopted:  
 
“I'm quite a comfy shoe person but I buy shoes on how they feel rather than 
what they actually look like generally.” (NB01F) 
 
Difficulties sourcing footwear that was comfortable, facilitated accommodating foot 
deformities and fluctuating symptoms such as swelling were issues for some 
participants: 
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“You have to be again careful what you put on as well. I like boots because 
I feel with boots they support my swollen ankles. Whereas I find these 
shoes, they don't. But boots I feel a bit of security there. And you have to 
make sure that they are sturdy.” (NB02F)  
 
“Well sometimes, it depends on the shoes, but you know they feel fine 
when you put them on and then like once you've worn them a few times 
you think oh that's not a good buy. And then they just get put away because 
they're just so uncomfortable to wear. But you just can't tell until you've 
actually started wearing them.” (BR10F) 
 
The visual appearance of footwear and being aesthetically acceptable was also an 
important consideration. Participants’ footwear also had consequences relating to 
their choice of clothing, and this was not gender-specific:  
 
“Awful. Awful because I was always one that wore high heels and you know 
and to wear these [referring to current footwear]. And they were … they 
looked so ... clumpy you know. I was sort of begrudgingly wearing them. It 
was. It was... because they looked so old-fashioned.” (NB03F) 
 
“Most people get dressed from the top down; I get dressed from the bottom 
up” (BR06F) 
 
“Oh yeah I wouldn't want to wear a pair of trainers say on a Saturday night if 
I had to go out. If I'm able to go out, I wouldn't wear trainers on a Saturday. 
Maybe on a Friday night but er … never on a Saturday.” (BR05M) 
 
The importance of footwear was not just confined to choice of clothing but was 
interlinked with identity and body image. Some female participants described that 
they now wore trousers, which they had not previously done before they had been 
diagnosed with RA and developed foot problems. The influence of footwear and 
clothing choice was considered to have varying importance. Some participants who 
were not in paid employment had a more laissez-faire attitude towards the issue of 
clothing choice. They felt that by not being in the work environment it was 
acceptable to dress down by wearing more casual clothes. In contrast, the 
importance of footwear in relation to body image when attending social events was 
much greater: 
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“Because you didn't look very … you never looked dressed because you had 
these sort of clumpy shoes on. You know um … so I wore from … that was 
when I started to wear trousers. I never wore them before.” (NB03F) 
 
“Yes, yes I wear trousers practically all the time (BR3 giggles) practically the 
whole time. I think it was tied in with stopping work... and general trends I 
suppose. Yes, but yes I wouldn’t say it was a problem, particularly anyway 
but the shoes, the shoes have affected what I wear, yeah. When I was your 
age it would have been quite unusual to go to work in trousers” (BR03F)  
 
“When you've got to have something like my granddaughter's wedding … oh 
what am I going to wear for shoes? Not … I can find an outfit but what am I 
going to wear for shoes?” (BR08F) 
 
The issue of footwear was also interlinked with the ability to drive as described by 
one participant who found wearing trainers beneficial for walking but not for driving:  
 
“I don't like driving the car with trainers. The extra kind of foam padding, I feel 
you can't feel the brake or the accelerator well. I don't know, it's just me.” 
(BR04M) 
 
4.4.2.2.6 Participation: “I’ll be sat and everybody else is having a conversation.” 
The consequences of foot involvement were also reported to impact on participants’ 
social lives, often resulting in the feeling of isolation. Further, ‘Participation’ was also 
related to self-care and self-management strategies utilised by participants. Some 
participants acknowledged that they may need to sit down when partaking in 
activities if they were unable to stand due to their foot symptoms. The situation was 
anticipated, planned for and strategies put in place: 
 
“But sometimes it might be standing watching football for a couple of hours. 
Well I take a chair. But I'll be sat and everybody else is having a 
conversation.” (BR10F) 
 
“Yeah because we don't go out very er … very often. No there's no point 
really. Well every time I go somewhere I've got to make sure there's 
somewhere for me to sit.”  (BR07M) 
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For some participants participation was considered in terms of not feeling they were 
fully able to perform important personal roles and therefore had negative 
consequences on their psychological wellbeing. This was particularly evident in 
BR10F’s account of how she perceived her foot problems affected her role as a 
mother of young children: 
 
“Yeah and I you know try and either leave early for school or late for school 
so that I can actually park as close as possible to drop the kids off. And 
sometimes I don't even get out of the car anymore because of my feet it's 
just um … I just drop them so that I know they don't have to cross any roads 
and they go in on their own.” (BR10F) 
 
“Because I can drive, I can do quite adventurous things and get quite a long 
way but when I get there like I find that I'm missing out on things because 
actually I can't walk up those steps onto the ramparts of the castle. But I can 
look at it. You know people take my children off and go and do things and I 
sort of miss out because I can't actually do the final bit.” (BR10F) 
  
4.4.2.3 Cost 
The third organising theme ‘cost’ shows that foot involvement can have a negative 
influence on self-esteem, body image and identity (‘Social and emotional well-
being’) and personal finances (‘Financial detriment’). 
 
4.4.2.3.1 Social and emotional well-being: “I'd look like an old lady, Nora Batty 
ankles” 
Participants referred to cost in terms of the effect on social and emotional well-being 
describing the feelings of depression, low mood and frustration in particular from the 
loss of not being able to participate in valued activities. However, some participants 
elected to participate in other activities that did not involve physical activity but 
facilitated the opportunity to socialise with others, such as joining a book club. Other 
participants related their low mood to embarrassment of the appearance of their feet 
due to the presence of deformity and swelling:  
 
“So yes in the beginning especially frustrating and you know I had sort of 
given up on an awful lot of what I did really so. And I used to do tap dancing 
which was wonderful.” (BR06F)  
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“And er … and because I couldn't do like the physical activity that I would 
usually do, like well a lot of running and stuff, that made me quite 
depressed.” (NB01F) 
 
“One of the best things about football was going for a drink with the boys 
afterwards. But I can’t play anymore. I used to join them for a pint afterwards 
but didn’t feel involved as I hadn’t been part of the team on the pitch. So I 
stopped going. Not only could I not play anymore but the loss of the social 
side, not seeing my mates and all that made me feel really low.” (BRO5M) 
 
“I probably would have stopped playing tennis by now anyway. You sort of 
move on because otherwise it’s frustrating isn’t it. You look for different 
things like a book club. I do more things like that like reading, the computer 
and so yeah this may have happened anyway but the fact that I’m getting 
older but I don’t think it would have happened so soon.” (BR03F) 
 
“Because my feet have got so wide and my toes have spaced out quite a bit. 
It doesn't look very nice either. This ankle is permanently swollen. But that 
[referring to toe deformity] looks awful as well.” (NB02F) 
 
The youngest participant felt that foot symptoms had an aging affect, making her 
feel (and assume that others perceived) she was older than she was. Other 
participants described that their choice of clothing was limited, and feeling less 
dressed had a negative impact on their body image and self-esteem. The organising 
theme cost was interlinked with the sub-theme ‘footwear’ (presented in section 
4.4.2.2.5) in relation to the aesthetics of and difficulty sourcing footwear:  
 
“I'd look like an old lady, like Nora Batty ankles, that kind of thing. Yeah it 
was horrible.” (NB01F) 
 
“It's a bit disheartening in a way because you can't get what you want. So it's 
not very often that I look at shoes. It's my least favourite thing.” (BR08F)  
 
“Yeah I think shoes for a woman are quite a big part of her life really. 
Whatever you put on you put your little matching shoes on, sort of thing.” 
(NB02F)  
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4.4.2.3.2 Financial detriment: “To carry on my job was virtually impossible” 
The organising theme of ‘cost’ was complex and multi-facetted. Some participants 
described the cost of the consequences of their foot symptoms in terms of financial 
implications. This included financial detriment as they were unable to continue with 
paid employment. Thus financial detriment was interlinked with the sub-theme 
“Work” (Section 4.4.2.2.2).   
 
“And um … basically um … offered me retirement through ill health. Which I 
took because I knew … well [BR05 small laugh] to … to carry on my job was 
virtually impossible.” (BR05M) 
 
Financial detriment was also linked with the sub-theme of ‘Activities’ (Section 
4.4.2.2.1). This is supported by consequences of foot involvement in terms of ability 
to drive a manual car. Considering changing from a manual car to an automatic was 
discussed by one patient. However, such action would incur additional financial 
costs that he felt were unachievable. For others, although they could no longer drive 
a manual car, the financial burden was reduced as they were in receipt of financial 
assistance due to their level of disability: 
 
“Yeah we're thinking when we can afford it we could change the car for an 
automatic.” (BR07M) 
 
“I've got a Motability car. I have particularly chosen a car with very 
comfortable sitting position.” (BR10F) 
 
Financial detriment also related to the cost of shoes with some participants 
considering the expensive shoes would be more helpful to self-care and self-
manage their foot symptoms: 
 
“It’s not necessarily money. I would … if … you know if they [shoes] fitted me 
and they were all comfortable I wouldn't really care you know within reason 
paying quite a bit for them.” (BR08F) 
 
Other participants reported that they were not able to wear their current shoes. One 
participant reported that even though her current footwear was uncomfortable she 
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was unable to afford to buy alternative boots or shoes. Financial detriment was 
therefore interlinked with the sub-theme of footwear (Section 4.4.2.2.5): 
 
“So I’ve thrown out, well they’re a decent pair of shoes..... they’re gone now. 
They’re in the ash bin. The ones [shoes] I’ve just thrown away, down in town 
they were sixty pounds.” (BR02M) 
 
“It's like my boots you know my low heeled boots, the ones that I've worn all 
the way through the winter, but they haven't been comfortable. But I couldn't 
afford to buy another pair so I just had to make do.” (BR10F)  
 
Some participants adopted a range of self-care and self-management strategies to 
manage their foot symptoms. These strategies were not adopted through patient 
education and self-management programmes but through individual cognitive 
processes or by trial and error. The benefits of these acquired strategies (for 
example self-sourcing insoles) were considered to negate the financial cost: 
 
“And just trying different insoles, well I don’t know over the years I, I suppose 
they’re not that expensive some of them so and I buy them as I need them. 
So if I have a shoe that’s too, too big in some respects then I buy them but 
they’re not that expensive to buy.” (BR06F) 
 
4.4.2.4 Emergence of underpinning theme: Impact 
The theme of ‘Impact’ underpins the themes of foot symptoms, consequences and 
cost, leading to decisions to access care. Impact highlights that foot problems in RA 
may not be static or constant (‘Fluctuations and combinations’) and appear to vary in 
severity and be influenced individual patient priorities (‘Personal importance’). 
 
4.4.2.4.1 Personal importance: “Sometimes you feel trapped” 
The variation of reported personal importance fluctuated around the general clinical 
features of RA. For some participants a balance was maintained, whilst for others 
the personal importance of foot symptoms were reduced when the feet were 
asymptomatic but increased when symptoms reoccurred or were more pronounced. 
Some participants perceived their foot symptoms as highly important and significant 
features of RA, with one participant reporting their foot symptoms as the most 
forefront aspect of their RA: 
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“It started … the pain really started in my feet and my hands. And then it 
seemed to go from my hands and feet for a long time. And it's come back 
with a vengeance.” (BR10F) 
 
“I think the biggest problem is the feet. Because it affects your mobility. Yeah 
sometimes you feel trapped. You know you can't do anything, can't go out 
the house, you can't do things around the house.” (BR05M) 
 
Varying levels of personal importance of the impact of foot problems were divulged. 
Some participants discussed their foot symptoms at length but considered that the 
impact of other clinical features RA, in particular other joint involvement were greater 
personal issues. The influence of participants’ RA being well-controlled also reduced 
impact and therefore the personal importance of foot symptoms:  
 
“Pain, the pain I had was unbelievable I’ve got pain now. Yeah it’s more like 
an ache. More of a sharp ache. Yeah it doesn’t. It’s a body tooth ache.” 
(BR02M) 
 
“I feel, in myself I feel really well.  And I know you might … and when I 
remember how terribly ill I was, I mean I went down to 8 stone 4 and I'd 
started off at 10 stone 10 or something, I felt terrible. Now I know I feel really 
good and I consider it [foot pain] slightly minor you know. I was glad to be 
feeling well, much better. I was glad to be mobile. Yeah in the grand scheme 
of things I consider it [foot pain] a minor inconvenience that I have to put up 
with to feel well. I feel that it's the least of my worries really, kind of thing. It's 
an inconvenience, yes it is”. (BR08F) 
 
In contrast, other participants considered higher levels of personal importance as 
their foot symptoms were having significant consequences on their levels of activity, 
choice of footwear and ability to participate socially (as reported in organising theme 
‘Consequences’ 4.4.2.2). 
 
“It's actually my feet is what's preventing me from getting around.” (BR09M) 
 
4.4.2.4.2 Fluctuations and combinations: “Not every day but the vast majority” 
The overall impact of foot symptoms varied and fluctuated, often in combination with 
other clinical features of RA. Some participants recalled that their foot symptoms 
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had resolved, whilst others described a deteriorating clinical presentation. Further, 
some participants described their feet were more symptomatic during a flare. These 
symptoms related predominately to pain and swelling (as described in the previous 
sub-theme ‘Other features of RA’ 4.4.2.1.4): 
 
“So sometimes it [foot pain] can last 6-10 days. Other times it just lasts 24 
hours or 36 hours. And some days there's no pain.” (BR05M) 
 
“I wouldn't go so far as to say every single day [referring to foot pain]. But the 
vast majority.” (BR08F) 
 
4.4.3 Decision to access foot care or not 
The unique combination for each participant’s experience of foot symptoms, 
consequences and cost, underpinned by impact, led to decisions related to 
accessing foot care. However, decisions to access or not access foot care were 
complex. Participants who had accessed foot care services prioritised their foot 
symptoms as an important health-care need. In contrast, other participants, whilst 
reporting foot symptoms and the consequences and impact of foot involvement as 
important issues, did not access foot care services.  
 
Therefore a global theme of ‘Decision to Access to Foot Care of Not’ emerged from 
180 identified codes, drawn together into 14 sub-themes and 3 organising themes: 
‘Access hindered by patient perceptions’, ‘Access perceived unnecessary by patient’ 
and ‘Access supported by patient and clinician’. A copy of the coding tree is in 
Appendix D4. Figure 4.2 presents factors influencing participants’ decisions to 
access foot care. 
 
Chapter 4 Study 1: The Patient Perspective 
130 
 
 
 
 
Figure 4.2 Decision to access foot care or not 
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4.4.3.1 Access hindered by patients’ perceptions 
The organising theme ‘Access hindered by participants’ perceptions comprised five 
basic themes: 1) ‘Another complication of RA’; 2) ‘MDT will refer if needed’; 3) ‘Lack 
of knowledge how to access foot care’; 4) ‘Feet ignored;’ 5) ‘Limited awareness of 
treatment options’. 
 
4.4.3.1.1 Another complication of RA: “He said we can do something about it” 
Participants acknowledged their foot symptoms were part of the umbrella of clinical 
features of RA. Further, many assumed that controlling and improving foot 
symptoms would be encompassed within the overall medical management of their 
RA. There was also recognition of the benefits of medication on reducing the risk of 
deformity: 
 
“Since I had the medication update or the increase with all the meds on the 
methotrexate and had a steroid injection that was about a week and a half 
ago, I've been absolutely fine … touch wood. Huge improvement within kind 
of 24 to 48 hours. It seems to have done the trick, back to pretty much my 
old self.” (BR04M) 
 
“And he said [consultant] the thing is years ago before these drugs came out 
that the chances are you would get severe deformity in the hands and feet 
and things like that but he said by catching it early enough and he said that 
we can do something about it.  And he gave me um .. methotrexate tablets.” 
(BR02M)   
 
4.4.3.1.2 MDT will refer if needed: “I leave things like that to him” 
Confidence in the clinical team (multidisciplinary team (MDT)), was emphasised. 
Participants assumed that if their foot symptoms would benefit from further 
assessment and intervention, a member of the multidisciplinary team would arrange 
a referral: 
 
“I am really grateful for the treatment I've received because it's completely 
changed my life really. And they always ask you know if you've got any 
problems, I mean every single time you come, without fail.” (BR08F)  
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“What I tend to do is wait until I see [doctor's name] and then he's the one who 
would recommend me then [referral to foot care]. It's like I've just had an 
ultrasound on my hand. So I leave things like that to him and then he will refer 
me then. Because obviously he's the expert.” (NB02F) 
 
In contrast, other participants questioned the doctor’s clinical judgement when they 
were referred to foot care services. This was evident by one patient describing how 
he was referred to orthotics when he considered the clinical reasoning and 
justification for the referral had not been explained:  
 
“And he just looked at it [foot] and he just wrote on the note.  I thought idiot.  
(BR07 laughs). What a thing to say about your doctor … well a doctor.” 
(BR07M) 
 
4.4.3.1.3 Lack of knowledge how to access foot care: “I thought they were all 
private” 
Participants had varying knowledge of foot care services in general terms. However, 
for some there was awareness that help was available if the need arose. This was 
contradicted by others regarding uncertainty about which foot care services would 
be available particularly in relation to podiatry, and how the service could be 
accessed. 
 
“No, no I was aware from this leaflet that if I did have trouble they could refer 
me to a po... po... podiatrist. Yes, I’m aware that there is help, there if I need it. 
I think if they got worse then I might seek some help, yes um I think they 
would help but ... have to be quite a lot worse before I started asking but it is 
something I’m aware of.” (BR03F) 
 
“Well I thought they were all private actually. I didn't know you could access 
them [podiatrists] in the NHS.” (BR08F) 
 
Professional titles used in relation to foot care services influenced participants’ 
perceptions in relation to professional clinical remits. This was particularly evident in 
the dual use of professional titles of podiatry and chiropody. Some participants 
considered the role of a podiatrist was for the management of a single episode of 
care such as nail surgery for an in-growing toe nail. In contrast, chiropody was 
viewed by some as a service that was sourced privately and which provided more 
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general, on-going care (toe nail cutting, corn and callus reduction). Beliefs regarding 
the benefit and efficacy of treatment received also hindered decisions to access to 
foot care:  
 
“I went to my GP and she referred me to um … they've got like a foot clinic. 
And she did some work trying to you know prevent sort of like in growing 
toenails and things like that.” (BR10F) 
 
“Started to go to a podiatrist first in the same practice [GP practice] um... but 
then I believe (BR06 giggles) that there is quite a difference yes but yep.” 
(BR06F) 
 
“I've always associated like a chiropodist with if you've got corns and things 
like that. And I don't seem to have any of those.” (BR07M) 
 
“I've heard varying things about the standard of [private chiropodists]...Yeah 
exactly. Yes and I begrudge paying for the bad. Well my husband went, for an 
example, when he had a corn between his toes. Well his toes are knobbly and 
so they rubbed together. And he had it and he went to see him [private 
chiropodist]. And it was back in next to no time, just as bad. And it kind of puts 
you off in a way.” (BR08F) 
 
The beauty industry was also utilised for basic foot care such as nail cutting. This 
was considered to be beneficial therefore the need for further professional 
intervention was not required: 
 
“So what I've been doing is going to have my um … sort of my toes and feet 
looked at you know actually just have a pedicure every sort of three months 
just to keep them in better condition. And that's really worked.” (BR10F) 
 
4.4.3.1.4 Feet ignored: “They get neglected” 
There was a common assumption by participants that feet were generally ignored by 
rheumatology clinicians. This was perceived both positively and negatively.  
Some participants reported that the feet were not included in the overall assessment 
of disease status (for example joint counts). Additionally, one patient suggested the 
clinical team acknowledged the benefits of the use splints for hand involvement but 
concluded that there was not the same emphasis placed on the management of foot 
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symptoms. Other participants appeared to question clinicians’ clinical expertise in 
conducting foot assessments.  
 
“Because it's [feet] not on any sort of thing. You know it's not on any score 
thing is it. It sort of stops at your knees doesn't it?” (BR07M) 
 
“Your feet I know they get neglected, they support you but they get 
neglected. Don’t they? You know what I mean. If it is orthotics or if it is like 
you got problems with your feet or like when they made the splints up for my 
hands and that. I’ve got splints for my hands and wrist splints and all that you 
know that was done here and that but it didn’t seem to be the same sort of 
thing for gravity on the  uh ...feet.  (BR02M) 
 
“And it's like my GP said as well, apart from if you study how somebody 
walks he said you know it's not a visible thing either is it?” (BR07M)  
 
Positive perceptions were linked with participants’ confidence in their rheumatology 
clinicians. These participants recalled their clinical consultation involving being 
asked about their feet and having their feet examined: The perception of the feet 
being ignored by the clinical team was then interpreted by some participants as 
being because there were no further care options available:  
 
 “Right at the beginning when um, when um, *[Consultant] was trying to 
decide whether I did have RA or not he gave me quite a thorough 
examination and looked at my feet then.” (BR03F) 
 
Foot symptoms were also ignored by some participants. Some participants elected 
to ignore their foot symptoms as they did not wish to proceed with treatment 
interventions, particularly prescribed footwear. There were negative perceptions of 
prescribed footwear which included the visual appearance of the shoes. Participants 
therefore declined the opportunity to be referred for orthotic review: 
 
“It’s not where I wanted to go [referred for prescribed footwear] it was another 
nail in the coffin so to speak um... yes another nail in the coffin, I didn’t want to 
go there.” (BR06M)  
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“Perhaps when I'm about 70 I might wear them [prescribed footwear]. But I 
don't want to wear shoes like that, oh no.” (BR05M) 
 
“I've been resisting going down that line [prescribed footwear]. But I … you 
know I can see myself getting there at one point.” (BR10F) 
 
Assumptions that prescribed footwear magnified the presence of foot symptoms, in 
particular the presence of deformity, were discussed. This was reflected by one 
patient who had a family member who also had RA and foot involvement. This 
patient acknowledged that his family member’s foot problems were severe requiring 
prescribed footwear. However, the aesthetic of the footwear was not referred to 
positively: 
 
“Yeah he’s got rheumatoid arthritis and his feet are terrible. His feet are 
absolutely terrible. He’s got to wear special, really special shoes. They look 
like; well they look like Frankenstein’s boots.” (BR02M) 
 
The potential for a more organised approach to review and management of foot 
symptoms to be beneficial was suggested by one patient:  
 
“Possibly to have all the people who could help you under one roof? Yes I 
think it might actually be quite helpful I mean I’m not backward in coming 
forward so I would ask for help. But there are probably people who wouldn’t 
so I think it might be once you’ve been diagnosed have someone check 
them [feet] every now and maybe a year. Um... as part of the backup 
service, which is very good in other areas, such as hydrotherapy and 
physiotherapy.” (BR03F) 
 
4.4.3.1.5 Limited awareness of treatment options: “There isn't anything that could be 
done” 
Participants reported a limited knowledge of treatment options for foot symptoms. 
Although the use of insoles had been recommended by the clinical team, previous 
negative experiences of accommodating devices in footwear were raised as a 
concern. Some participants reported the development of blisters and areas of skin 
irritation following the use of insoles provided. Others recalled difficulty 
accommodating the devices in their own footwear (self-sourced footwear). Of the 
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participants who had negative experiences of prescribed insoles, most concluded 
that alterations to the design and prescription of insoles would be not possible: 
  
“I wasn't really sure that there was anything you could do to actually relieve 
the pain particularly in the feet .Other than to reduce the activity. I've just sort 
of plodded on assuming that there isn't anything that could be done” (BR10F) 
 
“I think quite a few years ago when I first started having foot problems it was 
suggested that I try um insoles. Which were quite difficult actually because the 
type of shoes I’d got even at that point were, I just couldn’t accommodate. 
They made my shoes too uncomfortable because they were too thick. I would 
have had to have bought different types of shoes and I think at that point I 
wasn’t ready to for you know um you know the type of shoe that I probably 
needed basically.” (BR06F) 
 
Surgical intervention was discussed by some participants. However, despite 
previous successful surgery for other joint involvement, participants were reluctant 
to proceed with surgical review of their foot symptoms. A number of reasons were 
provided regarding reluctance for surgical review, which included length of time to 
recover:  
 
“About the November, year gone, I finished up having the right knee 
replacement. Which went very well, very successful.” (BR09M)  
 
“It was quite difficult to recover from that operation ...it took me quite a long 
time. Then in the end I had to use a wheelchair because I couldn’t support...  
because I’d had shoulder problems and one had been replaced at that point 
so I couldn’t really support my own weight very well. Because I wasn’t 
supposed to put it [foot] to the floor at all.” (BR06F) 
 
Concerns that further surgery would not improve foot symptoms, having undergone 
numerous surgical interventions previously were described. This was evident in 
BR09 whilst he reported significant ankle pain that was reducing his ability to walk. 
However, when surgical intervention was suggested as a treatment option, he 
declined to proceed with further surgery: 
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“But what's stopped me perhaps coming back or whatever, there's no way I 
feel like having another operation. Two reasons: I've had three and I think 
three is enough” (BR09M) 
 
4.4.3.2 Access perceived unnecessary by patient 
The second organising theme ‘Access perceived unnecessary by patient’ displays 
the varying nature of foot involvement in RA (‘Fluctuating Symptoms’ and ‘Feet not a 
problem’) in conjunction with acquired self-care and self-management strategies 
(‘Can self-manage’ and ‘Positive coping’). 
 
4.4.3.2.1 Fluctuating symptoms: “Two or three days I’ll be on crutches” 
The fluctuating nature of foot symptoms influenced decisions that access to foot 
care was not necessary. This related in particular to the short duration of foot 
symptoms for some participants who considered that as their foot symptoms were 
intermittent, it was possible their symptoms would improve or resolve. Accessing 
foot care was therefore considered unnecessary: 
 
“There will be two or three days when I’m on crutches... and then I can’t walk 
and then it leaves. Um little bit. I had a bit of pain, well a lot of pain Tuesday. 
Yeah they were quite rough then. But then it goes and I would be ok, so 
there was no need to see anyone about it [foot pain]”. (BR02M) 
 
“I couldn't really feel the fact that my toes were rubbing on shoes and things. 
So then I'd realise like when I took my shoes off there was like blood and 
blisters and stuff. But that does seem to have calmed down.” (BR10F) 
 
4.4.3.2.2 Feet not a problem: “It’s the least of my worries” 
Some participants considered that access to foot care was unnecessary as their foot 
symptoms were not a major concern. Despite having current foot problems, some 
participants described other symptoms of RA to be more important issues than their 
feet:  
 
“No not really, no. It’s probably because it’s not a big problem [feet] you know 
just uncomfortable” (BR03F) 
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“I feel that it's [feet] the least of my worries really, kind of thing.  It's an 
inconvenience, yes it is.  And um … from the shoes perspective well that's a 
nuisance but you know we get by” (BR08F)  
 
4.4.3.2.3 Can self-manage “I just know how to look after my feet” 
The ability to self-care and self-manage was also provided as a reason not to 
access foot care. Participants applied practical self-care and self-management 
strategies when their feet were symptomatic. The strategies selected were 
influenced by previous beneficial experiences of self-care and self-management 
strategies used to manage other symptoms of RA. Applying heat to painful foot 
joints was helpful for some whilst others considered cold modalities to be more 
useful. The benefit of the application of heat and cold to swollen joints was disputed 
by one patient who perceived topical modalities to be more helpful:   
 
“I just know how to look after my feet. I've always done it.” (NB02F) 
 
“What I tend to do is I keep thermal socks at home and I go and put thermal 
socks on. And that helps a bit. Just give them a rub to warm them back up and 
then put thermal socks on. Once I've got the coldness and the numbness in 
my feet I just get up and move around and try and get the circulation moving 
back in my … I think perhaps get the circulation you know once that starts 
going it's not too bad.” (NB03F) 
 
“And I just put that [ice] in a bag and put it on my shoulder or on my knee or on 
the top of the foot. And it's like even after I've had like the ice, I'll get a bowl of 
water I'll put my foot in for 20 minutes and then after 10 minutes I'll put the ice 
back on.” (BR05M) 
 
“I never really … never really found any of it helped [referring to hot and cold]. 
I used to use something like Ibuprofen gel.” (NB01F) 
 
Participants also adopted selection of footwear as acquired self-care and self-
management strategies by altering the shoes they wore for different activities. This 
took into account wearing shoes that were more comfortable and to allow for 
fluctuating symptoms such as pain, swelling and accommodating deformity. Electing 
not to wear shoes at home was also adopted as a self-care and self-management 
strategy by one patient: 
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“So I gone to a pair of shoes now that is giving me a little bit of, a bit more 
room. On there at the widest part.” (BR02M)  
 
“Oh I've got a pair of slippers or something. Don't wear shoes at home. Feet 
more comfortable when I’m not wearing shoes” (BR04M) 
 
Complementary therapies such as aromatherapy oils were found to be helpful for 
one patient. Other considered the benefits of alternative therapies although they had 
not utilised them:  
  
“Well getting into a warm bath. I use a lot of aromatherapy oils as well um … 
to try and sort of er … sort of relax my swollen joints as well. And lots of salt in 
the bath I find salt is quite good.” (NB02F) 
 
“Something like reflexology would probably be lovely” (NB03F) 
 
Massage was reported by some participants as having merits in managing foot 
symptoms. However, the need for caution regarding the amount of pressure applied 
when conducting massage needed to be considered. Applying too much pressure to 
painful, tender and swollen joints could result in symptoms being more pronounced: 
 
“It is painful and you know exactly where you can touch and how much 
pressure you can use. Whereas someone else, it's like no, no I'll just do it 
myself. (BR04 giggles) So it's easier just to do that.” (BR04M) 
 
Participants also used of additional self-care and self-management techniques such 
as filing areas of callus, and self-sourcing insoles. However, the use of some 
strategies had negative consequences by exacerbating pain levels: 
 
“I just very gently just do that with them [demonstrating using a foot file].  And I 
sort of try to keep the hard skin under control by doing that. Put cream on 
them, moisturiser. And then I give them a rub with my file.” (NB02F) 
 
“When my feet were playing up I’ve used liners [insoles]. You know the ones 
you can buy in the shops. They cost me but I didn’t mind. If they helped I didn’t 
mind how much they cost.” (BR06F) 
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 “Well I've tried the [refers to trade name] remover of hard skin on it [area of 
callus]. I've tried rasping it off. Perhaps I'm too vigorous with the rasping, I 
don't know. Sometimes it hurts after. It's a fine line between what to take off 
and what not to yeah.” (BR08F) 
 
If participants were unable to self-care and self-manage their foot care, some asked 
for help from friends or a family member; on occasions this was considered a 
negative experience as it highlighted lack of independence. Some participants 
perceived that there was reluctance for family members to assist with foot care 
(cutting toe nails):  
 
 “A friend of mine did it [cut toe nails] then for me.” [NB03F] 
 
 “I don’t like the idea of someone having to do it for me [cut toe nails]. It’s like 
I don’t like the idea of that I can’t get in the bath” (BR02M)  
 
“I'll get my wife to do it [cut toe nails].She don't like doing it. She says feet are 
horrible. (BR07M)” 
 
4.4.3.2.4 Positive Coping: “You have to try”. 
There was an interwoven salient basic theme of positive coping. This was whereby 
participants felt that a positive attitude of helping oneself by utilising self-care and 
self-management were important factors in managing foot symptoms. Other 
participants reported a more general positive approach to managing their foot 
symptoms and RA generally. Some discussed active participation and concordance 
in their care as an important factor: 
 
“Think it was a process of I knew what for example if I wore trainers they were 
more comfortable than the shoes I was wearing. I can’t go around in trainers 
all the time so, so I then started to um I bought a pair similar to this and it went 
from there really. Yes I think you’ve just got to help yourself a bit.” (BR03F) 
 
“If I felt unwell in myself generally I might think ’Oh God me feet as well on top 
of it all’. But I suppose because I'm quite … I think ’Oh well. Well I think my 
life's good actually’ (BR08 giggles) considering how awful it was at the time.” 
(BR08F) 
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“You have to try. You've got to meet … I mean you have these ops and things 
but you've got to meet them [clinicians] half way. You've got to do your bit I 
think anyway.” (NB03F) 
 
4.4.3 3: Access supported by patient and clinician 
The third organising theme ‘Access supported by patient and clinician’ illustrates the 
influence of feet being included in clinical consultations and foot symptoms being an 
important health care need (‘Can’t self-manage’, Talked about feet in clinic’, ‘Feet 
examined’ and ‘Foot problems a priority’). 
 
4.4.3.3.1 Can’t self-manage “I can't do it” 
Inability to undertake foot care [cut toe nails] was described and linked with reduced 
dexterity when RA involved the hands. General disability levels also impacted on 
participants’ ability to self-care and self-manage their foot health. When functional 
disability reduced the ability to perform foot care, participants accessed foot care 
services, in particular podiatry: 
 
“I mean I can't do it [cut toe nails] with the feet because … well again it all 
depends how much pressure I could … like sometimes there's no way I'm able 
to massage my hands because my fingers won't let me do it.” (BR05M) 
 
“But I have problems reaching my toes because I can't actually get down there 
you know for any length of time to do anything properly”. (BR10F) 
 
“When I had my hip done I couldn’t really get down to cut my toe nails and my 
husband said “oh I’ll do those for you” (BR06 laughs). Then I said no it’s all 
right I’ll go to the clinic” (BR06F) 
 
4.4.3.3.2 Talked about feet in Clinic: “He asked me” 
Being asked about foot symptoms in clinical consultations was reported. This 
recognition by the clinical team validated foot involvement as consequence of RA. 
However, not all participants recalled being asked about foot symptoms as a regular 
part of their clinical consultation. One patient (NB01F) reported that she raised the 
issues of her foot symptoms herself during a clinical consultation. 
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“He asked me he did … and this was [consultant's name] ’Did that hurt?’ you 
know. And I said it does hurt. It's difficult to walk on and you get a big callus on 
the bottom.” (NB03F)   
 
“Most of the times I've mentioned the pain in my feet because it's … that' s 
been like the joint worst with my arthritis” (NB01F) 
 
4.4.3.3.3 Feet examined: “I took my shoes off and showed the woman” 
Clinicians conducting foot examinations legitimised that foot problems can be clinical 
features of RA for some participants. Having x-rays taken of the feet was perceived 
as validation of foot problems as a clinical feature of RA, along with recognition by 
clinicians of the impact of foot pathology. One patient concluded the clinical value of 
foot x-rays at diagnosis provided an opportunity for baseline assessment and 
monitoring progression of foot problems. However, the justification for re x-raying 
feet was not fully understood by some participants: 
 
“Well I suppose because they were always checking (BR09 laughs) my feet it 
became fairly obvious that um … problems do occur with one's hands and 
fingers and feet.” (BR09M) 
 
“I had an x-ray on my feet and my hands; I think it was er as I was diagnosed, 
just to check if there were any problems or not. I think they use it as a … you 
know as a baseline.” (BR04M) 
 
“Yeah I've had like foot x-rays. The main x-rays I've had have been my hands 
and feet 'cos that's where it's been worst. But when they decide to x-ray again 
it’s not clear, it’s not clear to me.”(NB03F) 
 
Participants recalled having their feet examined whereby a member of the clinic 
team carried out a visual inspection and assessed the foot joints. In some instances 
the foot examination was instigated by the patient. The examination and inspection 
of the feet was not considered a regular occurrence in clinical reviews:  
 
 “I took my shoes off and showed the … the woman [specialist nurse]. So 
that's when she would have inspected, looked at them.” (NB01F)  
 
 “Nobody specifically has gone for my feet.” (BR02M)  
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4.4.3.3.4 Foot problems a priority: “It affects everything” 
There was a range of views expressed in relation to importance and impact of foot 
problems. For some participants, foot symptoms were considered to be a priority 
and an important health need. Although there was an acknowledgement of the 
presence of symptoms, some participants appeared to be able to cope and manage, 
therefore considered their feet were not a priority: 
 
“Um [BR05 sighs] very important. Because it [foot pain] just affects 
everything.” (BR05M) 
 
“I think with me because I look after my feet I … I don't … I don't let them get 
that bad.” (NB02F)  
 
4.4.3.4 Experience of foot care and decision to continue accessing foot care or not 
The participants who accessed foot care prioritised their foot symptoms as an 
important issue. For those who accessed foot care there was variation in the benefit 
of the care they received. Participants who perceived foot care received to be 
beneficial and therefore a positive experience, continued to access care. However, 
others had negative experiences whereby they felt that their foot health care needs 
were not fully addressed or the care they received was sub-optimal. As a 
consequence these participants discontinued accessing care. In these 
circumstances the negative experiences of foot care were therefore inter-linked with 
the sub-theme of “Access hindered by patients’ perception’ (Section 4.4.3.1): 
 
“As for going to the podiatrist then yes I suppose every six weeks or so then 
that does cost me but I think it’s worth the money really.” (BR06F) 
 
“Well they didn't cut your nails, they didn't do that. But they just really shaved 
all the skin off. But I really didn't find them very … you know I could do that 
myself.” (NB03F) 
 
4.5 Discussion  
 
4.5.1 Overall findings 
This chapter has presented a rich description of the experience of foot problems 
from the patients’ perspective. The findings of this study support previous reports 
that foot problems are common in patients with RA and have consequences for 
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patients in relation to activity, footwear, and participation. Further, these data have 
elucidated that foot problems can also incur cost to patients in terms of financial 
detriment and social and emotional well-being. Additionally, foot problems appear to 
impact on many aspects of patients’ lives, for example their ability to work. Foot 
problems can be variable and follow a fluctuating clinical pattern, including remission 
for some patients. In contrast other patients described their foot symptoms 
developed gradually and once evolved, were persistent. Furthermore, many patients 
recalled that their foot problems were early symptoms of RA and at least some 
patients can recognise clinical foot pathologies such as callus formation. 
Nonetheless, the impact of foot problems is variable and influenced by fluctuating 
personal priorities and patients’ decisions to access foot care were more complex 
than anticipated.  
 
That foot problems affect patients’ ability to walk has been described (Grondal et al, 
2008; van der Leeden et al, 2008). However, this study has highlighted that foot 
problems can also affect other activities such as ability to drive, exercise and work 
(paid employment). These findings provide new insight into the wider nature of the 
impact of foot problems. Metsios et al (2008) concluded that the evidence for the 
benefits of exercise in improving functional ability and disease-related 
characteristics in patients with RA is strong. However, if patients are unable to 
exercise due to experiencing foot problems, the clinical and personal benefits of 
physical activity for patients will not be achieved. The consequence of RA for work 
disability have been reported (Barret et al, 2000; Verstappen et al, 2004; Olofsson et 
al, 2014), but previous studies have reported predictors of work related disability 
relating to general patients demographics (e.g. gender), clinical variables (e.g. 
disease severity) and work characteristics (e.g. manual worker). However, this study 
highlights the importance of foot problems as a cause of work related disability, not 
only through problems of mobility, but also for some patients their inability to comply 
with contractual obligations of employment such as health and safety requirements 
(e.g. wearing protective footwear). The overall contribution of foot problems in 
relation to work disability in RA has not been established.  
 
The consequences of foot problems in relation to footwear were discussed by all 
patients. Some patients described difficulty in sourcing footwear that was 
comfortable, accommodated deformities and was aesthetically acceptable. 
Additionally, footwear influenced clothing choice which subsequently resulted in 
negative self-perceptions in relation to identity and body image. This confirms earlier 
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work that footwear can be an important issue for patients (Goodacre and Candy, 
2011; Naidoo et al, 2011). Gutwengier et al (1998) suggested footwear selection can 
have negative effects on self-perceived body image, especially for women. The 
findings from the present study confirm that sourcing accommodative, comfortable 
and aesthetically acceptable footwear is a challenge for patients with RA. However, 
consequences of foot symptoms in relation to footwear did not seem to be gender 
specific in the interviews in the present study. Previous work has tended to focus on 
the experience of female patients with RA and issues of footwear for male patients 
have not been previously considered. Male patients facing challenges sourcing 
accommodative footwear that is aesthetically acceptable is therefore a novel finding. 
 
Variation between patients’ and clinicians’ priorities in relation to overall treatment 
outcomes in RA has been reported (Hewlett, 2003; Sanderson et al, 2010), and 
patients and clinicians also have differing priorities in relation to outcomes of foot 
care interventions such as foot surgery. Backhouse et al (2012) propose patients 
evaluate the benefits of foot surgery in relation to post-surgical appearance of their 
feet and their ability to wear acceptable footwear. In contrast, clinicians judged the 
benefits of surgery in terms of reduction in pain and improved function. Although 
clinicians need to consider the challenges that many patients encounter in relation to 
footwear patients have additional priorities. This study highlights that patients 
consider a range personal priorities regarding having orthopaedic surgery which are 
not just related to post operative appearance and accommodating feet in footwear. 
For example some patients discussed: limited weight bearing during rehabilitation, 
length of recovery time and negative past experiences of previous orthopaedic 
surgery as important issues. Clinicians need to consider personal priorities of 
patients when planning and evaluating foot care interventions.  
 
Qualitative studies have previously reported the consequences of RA impacting on 
many aspects of patients’ personal lives (Lemmp, Scott and Kingsley, 2006; Lütze 
and Archenholtz, 2007). This study has also shown that foot problems have 
consequences for patients in relation to their everyday personal lives. Some patients 
described their foot problems affected their relationships with others and affected 
their personal roles. These experiences lead to a sense of isolation and negative 
consequences for psychological well being. The association between reduced 
functional capacity and foot problems impacting on patients’ quality of life has been 
reported (Wickerman et al, 2004). However, the findings of this study more closely 
support the conclusions of Galer, Gianas and Jensen (2000) where painful diabetic 
Chapter 4 Study 1: The Patient Perspective 
146 
 
neuropathy had negative effects on patients’ recreational activities and social 
interactions. Clearly, from previous studies but especially from the content of the 
interviews in the present study, the consequences of foot involvement in RA are 
complex and can impact on many aspects of patients’ lives, which would not be fully 
captured by functional status alone.  
 
In order to capture this wider impact of foot problems in patients with RA, the Foot 
Impact Scale (FIS) was developed by Helliwell et al (2005). The FIS comprises of 
two subscales: Foot Impact Scale Footwear / Impairment (FISIF) and Foot Impact 
Scale Activities / Participation (FISAP). The FIS includes many of the concepts 
captured in the present study under the organising theme of “Consequences”: the 
sub-themes of walking, exercise footwear, activities, and participation. However, the 
consequences of foot problems in relation to ability to work is not an item included in 
the FIS. Further the underpinning theme of “Impact” generated was influenced by 
fluctuations of symptoms and personal importance. Sanderson and colleagues 
(2011) postulate that the personal impact of RA may be influenced by patients’ 
ability to cope, the perceived severity and personal importance (Impact Triad). 
Almost all of the patients in this study described that their foot problems (at some 
time) were severe, important and that they had difficulty self-managing. Therefore 
these data support Sanderson’s proposed theory of the Impact Triad. Some of these 
items, and aspects of the impact of foot problems, are not captured by the FIS, and 
these additional items related to foot problems have not previously been explored in 
patients with RA. It would be important to include them in the survey to be 
conducted in Study 2. 
 
Factors influencing patients’ decisions to access foot care were complex. Patients 
who accessed foot care considered their foot problems to be an important health 
care need. These patients recalled having had their feet examined and discussions 
relating to foot problems had occurred during clinical consultations. Therefore some 
patients considered their foot problems were legitimised by clinicians (“Access 
supported by patients and clinicians”). In contrast, other patients reported that their 
foot problems were important issues but they had not accessed foot care. The 
organising theme of “Access hindered by patients perceptions” illustrates that some 
patients felt their feet had been ignored in clinical practice. Failure of clinicians to 
examine or discuss foot problems during consultations was considered by some 
patients to indicate that no interventions were available. Further, patients assumed 
clinicians would instigate a referral if access to foot care was indicated. This finding 
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supports similar conclusions in earlier work on foot problems (Williams and Graham, 
2012) and on fatigue (Hewlett et al, 2005). The organising theme “Access hindered 
by patients’ perceptions”, related to limited awareness of treatment options and lack 
of knowledge of how to access care. Lack of patients’ knowledge on how to access 
care has been proposed as a barrier to utilisation of foot care services (Blake, 
Mandy and Stew, 2013). However, some patients described how, although they had 
current or past experience of foot problems, access to foot care was considered 
unnecessary (“Access perceived unnecessary by patient”). These patients reported 
that their foot problems were not severe, they were able cope and could self-care 
and self-manage. This adds further support to the Impact Triad theory of Sanderson 
et al (2011) and the influence of the personal impact of foot problems on how people 
access foot care has not been previously explored. The fluctuating nature of foot 
symptoms was also an emergent basic theme sometimes causing access to care to 
be perceived as unnecessary. It is possible that if symptoms persist for a relatively 
short time period then patients may be unlikely to access foot care. Indeed, work 
conducted by Flurey et al (2014) in relation to help seeking behaviours and flares in 
the overall symptoms of RA suggests patients will only access medical care when 
symptoms are overwhelming, when they are no longer able to cope and as a last 
resort.  
 
Previous experience of foot care appeared to influence patients’ decisions whether 
or not to continue with utilising foot care services. Positive experiences of foot care 
appeared to favour continued utilisation of foot care services. In contrast, previous 
negative experiences of foot care were associated with discontinuation. These 
findings seem logical, and are supported by the Behavioural Model and Access to 
Health Care (Andersen, 1995) in which continued utilisation should be influenced by 
levels of customer (service user) satisfaction. Foot health and rheumatology 
clinicians need to consider the perceived benefits of care from the patient 
perspective. If patients are dissatisfied with care received and/or do not consider 
interventions to be effective, the clinical effectiveness of foot care cannot be 
established.  
 
4.5.1.2 Limitations and strengths of overall findings 
A total of 12 patients with RA and self-reported foot problems participated in the 
study. The sample size may be considered small, limiting generalisability of findings. 
However, the sample was purposively diverse and data saturation was achieved. 
Qualitative enquiries such as this study provide the opportunity to explore the 
Chapter 4 Study 1: The Patient Perspective 
148 
 
deeper understanding of the topic of interest (Mays and Pope, 1995). The findings of 
this study elucidated a rich description in relation to the spectrum of the experience, 
impact and care of foot problems from the patients’ perspective. A quantitative 
approach is required to establish the extent to which these experiences reflect those 
of the overall RA population, and is presented in Study 2. 
 
The conduct of the analysis was rigorous. A subset of transcripts was independently 
analysed by two experienced qualitative researchers and the patient research 
partner. Consensus was achieved by all members of the researcher’s academic 
team in relation to emergent themes from the data set. Further, the researcher 
adapted an iterative approach in which emergent themes from the initial interviews, 
not included in the topic guide could be explored in subsequent interviews. Analyses 
also involved constant comparisons comparing emergent themes from both within 
and across the whole data set.  
 
Responder validation (member checking) techniques are proposed to improve the 
rigour of qualitative research (Mays and Pope, 2000; Barbour, 2001). No responder 
validation was conducted in this study and not providing participants an opportunity 
to comment on the analyses and overall findings could be considered a limitation. 
However, the aim of this study was to inform the content of a postal survey, and was 
not to test underlying theory, or develop a patient reported outcome measure. 
Therefore additional demands on the patients’ time were considered to be 
unnecessary and consequently unethical.  
 
It is possible that patients in this study could have been describing the 
consequences and subsequent impact of more general features of RA. However, it 
was considered that this was unlikely. During the interviews the researcher used 
prompts and active listening strategies to confirm patients were disclosing 
experiences relating to foot problems. 
 
4.5.2 Informing the postal survey (Study 2) 
This study (Study 1) has provided an in-depth description of the patient experience 
of foot involvement in RA and patients’ reasons for accessing or not accessing foot 
care services. An important reason for performing this study was to inform the 
content of a subsequent postal survey (Study 2), ensuring that it included issues not 
captured by standard measures or questionnaires. The Foot Impact Scale (FIS) 
developed by Helliwell et al (2005) is a validated questionnaire designed to capture 
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the impact of foot problems in patients with RA. Overall the findings of this study 
concur with many of the items included in the FIS (e.g. footwear, activities, and 
participation). However, it is clear that some important issues relating to impact are 
not included in the FIS. In particular, some patients described that their foot 
problems were impacting on their ability to work (paid employment). Further, nearly 
all patients described their foot problems as having (at some time) been severe, and 
linked this to their inability to cope (self-manage). The survey would need to capture 
aspects of this interaction (as described in the Impact Triad). Therefore in the postal 
survey, questions in addition to the FIS would be included.  
 
Most patients described the conduct of foot examinations and the role of clinicians in 
initiating discussions regarding foot problems to be variable. When discussions 
regarding foot problems did occur, they were often patient initiated. Although an 
annual assessment of patients’ feet is recommended in national guidelines 
(Luqmani et al, 2006) the conduct of foot examinations in patients with RA is 
variable (Otter et al, 2010). It is not known how frequently clinicians ask patients 
about foot problems in clinical consultations. Therefore questions enquiring about 
the conduct of foot examinations and discussions about foot problems in clinical 
consultations would be included in the postal survey.  
 
Patients who had accessed foot care services reported a range of foot care 
interventions. However, some patients perceived that their foot health care needs 
had not been fully addressed. In order to investigate the types of foot care 
interventions received (e.g. insoles, treatment for cutaneous lesions) questions 
regarding foot care received would be required in the postal survey. The majority of 
patients reported using a variety of self-care and self-management strategies to 
manage their foot problems. This was a novel finding. The extent of self-care and 
self-management strategies that patients utilise to address their foot health needs in 
RA is currently unknown, and so questions capturing these activities would be 
included in the postal survey. 
 
Some patients who accessed foot care services had done so through independent 
sector podiatry (non NHS providers), which was a finding unexpected to the 
research team. To date the researcher’s clinical career has been within the NHS 
and has no personal clinical experience of working within the independent health 
care setting. The researcher had not considered the potential for patients to source 
and self-fund independent sector foot care. In order to fully capture access to all foot 
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care services in the postal survey questions asking if independent foot care had 
been accessed would be required.  
 
4.6 Summary  
 
The findings of this study confirm that foot problems are common in patients with RA 
and can impact substantially on many aspects of patients’ lives. Patients who had 
accessed foot care services prioritised their foot problems as an important health 
care need. However, despite having foot problems some patients had not accessed 
care. Factors associated with decisions to access and utilise foot care services or 
not appear to be multifaceted and complex. Quantifying the extent to which these 
factors affect overall access to foot care in RA patients in general would be the main 
aim of the postal survey conducted in Study 2.  
 
The data generated in Study 1 provided novel findings to inform the content of Study 
2 in relation to: (1) patients recognising common foot pathologies; (2) patients’ 
perception’ that feet can be ignored in clinical practice; (3) additional factors of 
impact emerged not included in FIS (such as ability to work); (4) a broad description 
of foot care interventions received; (5) patients adopt a range of self-care and self-
management strategies to their manage foot problems. These novel findings 
provided information for additional questions included in the survey (Section 5.2.3 
Postal Survey Box 5.1). An additional consequence of Study 1 was the inclusion of 
independent sector care (private podiatry) to the definition of foot care. As a direct 
result of Study 1, access to foot care definition used in this thesis was amended to 
having accessed NHS podiatry, independent sector podiatry, orthotics and/or 
orthopaedics. These novel findings could not have been anticipated a priori, 
supporting the value of including the patient perspective at an early stage to ensure 
all appropriate and important issues were addressed. 
 
An abstract of the Study findings Decision to Access Foot Care’ has been presented 
as a poster at the British Society for Rheumatology and British Health Professionals 
in Rheumatology conference in 2012 and the Society of Chiropodists and Podiatrist 
annual conference in 2012 (Wilson et al, 2012 Appendix J1). 
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Chapter 5: Study 2 – Survey of foot problems in patients with 
RA. 
The one-to-one interviews in Study 1 provided an initial understanding of the 
potential and scope of the presence and the impact of foot problems from the patient 
perspective, and of patients’ reasons for accessing or not accessing foot care 
services. The overall research questions for this thesis: “What is the impact of foot 
involvement in RA and what determines if patients with RA receive foot care?” In 
order to estimate the prevalence of foot problems in patients with RA and to 
measure access to foot care, a survey of a large sample representative of patients 
with RA was required. The organisation of patient care in Bristol is such that a clear 
sampling frame could be established which included all patients with RA in a defined 
geographical area who had (in theory) equal access to foot care services. Using the 
results from Study 1 as a starting point, the content of the postal survey (Study 2) 
could be designed to ensure no important aspects were omitted from the questions. 
Before the survey could be implemented, the sampling frame, sampling 
methodology, data collection plan and analysis plan were required. This chapter 
describes how these were developed, how the content of the survey questions was 
finalised, how the survey was conducted, and the analysis and results of the survey. 
 
5.1 Aims of Study 2 
1. Measure the prevalence of self-reported foot problems in RA in a large 
sample of patients using a postal survey. 
2. Quantify the nature and types of foot problems experienced by patients.  
3. Assess the impact of current foot problems. 
4. Identify the proportion of patients who have accessed foot care services. 
5. Identify factors associated with accessing foot care. 
6. Provide a description of the foot care patients have received. 
7. Identify self-care and self-management strategies adopted by patients to 
manage foot problems.  
These aims address the overarching question for Study 2 “What is the prevalence, 
impact and care of foot problems in patients with RA” and the thesis aims 1-4 and 6-
8 as described in Chapter 3 section 3.4.2. 
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5.2. Methods 
 
5.2.1. Study design 
The traditional approaches to conducting survey research are: 1) face-to-face 
structured interviews; 2) telephone interviews; 3) self-completed electronic 
questionnaires; 4) postal questionnaires (Kelly et al, 2003). Each approach was 
considered. Surveys which employ direct contact with the researcher may have 
higher participation rates and provide the opportunity to clarify ambiguous questions 
(Kelley et al, 2003), but the presence of the researcher may influence participants’ 
responses and therefore introduce an unacceptable bias (Davies et al, 2010). 
Telephone interviews provide the opportunity for sampling geographically diverse 
populations, but participation rates have been reducing with the emergence of 
market research company telephone surveys and therefore they may no longer 
reflect the general population of interest (Boland et al, 2006). Conducting the survey 
electronically was considered and the proportion of adults in the UK having access 
to the internet at home is increasing (National Statistics Omnibus Survey, 2013). 
Nonetheless, access is not universal and participation in electronic based surveys is 
influenced by gender and social deprivation (Fricker and Scholau, 2002), two issues 
which might be important to the present research question. It was therefore decided 
to use postal questionnaires as the method for data collection. This method provides 
the opportunity to: 1) sample a large population over a wide geographical area; 2) 
provide patients with the opportunity to consider responding in their own time; 3) 
maintain confidentiality and anonymity; 4) allow patients to consider their responses 
without the influence of the researcher being present. There are important potential 
biases in differential response rates (for example in relation to social deprivation), so 
consideration of response biases would be needed. 
 
5.2.2 Identifying the patient population 
Bristol has a mixed population and is the seventh largest city in the UK. It has typical 
secondary care services and long term RA follow-up patients are similar to those in 
other parts of England (Kirwan et al, 2003). The Rheumatology Departments serving 
South Bristol (Rheumatology Centre at University Hospitals Bristol NHS Foundation 
Trust (UHB)) and North Bristol (Rheumatology Department at North Bristol NHS 
Trust (NBT)) provide all the rheumatology services to the City of Bristol and the 
surrounding areas. There are slight difference in general patient demographics (e.g. 
variation in proportions of patients residing in areas of high deprivation) and foot 
care service provision (variation in podiatry service provision) between the hospitals. 
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These issues will be considered in data analysis and interpretation of the results. 
Both hospital catchment areas overlap across the middle of the city. NHS foot care 
services in Bristol are provided by secondary care based services (orthotics, 
orthopaedics) at both hospital sites. A single community based service provides 
NHS podiatry care (Bristol Community Health Social Enterprise (BCH)) and the 
boundaries of BCH fall well within the catchment area of the two hospitals taken 
together (Figure 5.1).  
 
Figure 5.1 Identifying patients with RA in Bristol within Bristol Community 
Health Boundary 
 
 
NBT 1337
884 outside BCH
453
550
448 outside BCH
Bristol
Community 
Health
Patients with rheumatoid arthritis
UHB 998
1003
Study population
Patients with rheumatoid arthritis in Bristol 
Community Health boundary
 
 
By identifying as the sampling frame all RA patients attending either hospital and 
who were registered with a GP served by BCH a postal survey would capture the 
frequency of foot problems (self-report) and access to all foot care services in one 
geographical area covering both primary and secondary care provision. The patient 
population for Study 2 was therefore defined as consultant-based diagnosis of RA 
(Arnett et al, 1988), over the age of 18 years attending for rheumatology medical 
care at UHB and NBT Rheumatology Departments within the BCH geographical 
boundary (i.e. registered with a GP within the BCH boundary).  
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Patients registered for their rheumatology medical care at UHB were identified from 
departmental databases and screened for inclusion criteria by the researcher. 
Information about patients meeting the study inclusion criteria was then recorded in 
a study data base, including: patient demographics (name, age, gender and home 
address including postcode), hospital identification number and the name of each 
patient’s consultant rheumatologist. Patients registered for their rheumatology 
medical care at NBT were identified from departmental databases and screened for 
inclusion criteria by members of the NBT rheumatology clinical team. The patient 
details (as listed above) were entered into a spreadsheet by the NBT clinical team, 
sent to the researcher by NHS password protected email, and amalgamated with 
the study database. Each patient was allocated a number by random number 
generation by the computer random number function and the list arranged in 
ascending numerical order. These random numbers were then used as the study 
identifiers (study ID). The database was stored on University computers and was 
password protected, the password known only to the researcher and her academic 
supervisor (JK) to maintain patient confidentiality. All other data manipulation and 
computation procedures used only the study ID. 
 
The RA patient population in Bristol was defined as all patients registered for 
medical care at both hospital sites (n=2335). The target population was defined as 
all patients within the BCH geographical area (n=1003) as shown in Figure 5.1. The 
study sample was a random sample of the target population.  
 
5.2.3 Questionnaire design 
The content of the questionnaire was developed from three sources. Firstly, from 
data generated from the one-to-one interviews in Study 1. Secondly, from a 
narrative review of the literature in relation to studies reporting foot problems in RA 
to identify any disparity in the nature and types of foot problems reported. Thirdly, 
the inclusion of validated questionnaires (scales) measuring the impact of foot 
problems in RA (Foot Impact Scale (FIS) Helliwell et al, 2005) and general disability 
(Health Assessment Questionnaire, HAQ, Fries et al, 1980; Kirwan and Reeback, 
1986). 
 
Box 5.1 presents the content, source and rationale for each item included in the 
questionnaire. The content of Section A (age, gender, disease duration, arthritis 
medications and additional morbidity) and Section D (HAQ) were required to 
describe the demographic and clinical characteristics of responders. Information 
Chapter 5 Study 2: Survey  
155 
about additional morbidity was also required in order to attribute foot problems to 
RA, as foot problems can be important clinical features of other long term conditions 
such as diabetes. 
 
Assessment of patients’ feet and access to foot care services is recommended in 
national guidelines (Luqmani et al, 2006). However, the findings of Study 1 indicated 
that patients’ perceive the inclusion of feet (examination and discussions) in clinical 
consultations to be variable. Additionally the findings indicated that patients feel able 
to recognise many foot problems such as callus formation and presence of 
deformity. Items in Section B of the questionnaire establish the frequency of foot 
examinations, capture all clinical features of foot problems in RA, enquire about 
which foot care services have been accessed and a description of the care received. 
This section also includes questions developed to specifically enquire about areas of 
impact omitted from current questionnaires but identified in Study 1. Section C 
comprised the two subscales of the FIS (FIS Impairment Footwear (FISIF) and FIS 
Activities Impairment (FISAP) and Section D the HAQ, all presented in their original 
formats. Each item included in the questionnaire was given a unique identification 
number, though these were not all shown on the printed questionnaire sent to the 
patients. 
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Box 5.1 Content, source and rationale of items included in postal survey  
Section Item  included Source Rationale 
A: About you Patient demographics age 
and gender (A1 & A2) 
 Data required for description of sample 
Clinical data (A3 to A5) Disease duration, arthritis 
medications and co-
morbidities 
Data required for description of sample. Co-morbidity 
data were include because some conditions have foot 
problems as clinical features e.g. diabetes 
Date survey completed 
(A6) 
 For recruitment for Study 3, this aimed for conduct of foot 
examination to be within approximately 2 months of 
completing questionnaire. It decided that this was the 
most practical minimum time interval to achieve 
recruitment for Study 3 
B: Your feet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Talked about feet (B1 to 
B3) 
Study 1 interviews 
(Section 4.4.3.3.2)  
Discussions about feet appear to influence decisions to 
access foot care 
Feet examined (B4) National guidelines, 
literature and Study 1 
interviews (Section 
4.4.3.1.4) 
Recommended in national guidelines, Study 1 findings 
indicate patients perceive variable in clinical practice 
Foot problems (B5) Literature, clinical 
observations and  Study 
1 interviews (Section 
4.4.2.1) 
To measure prevalence of foot problems in a large 
sample of patients. Was decided that patients recognise 
common foot problems 
Personal importance of 
foot problems (B6) 
Study 1 interviews 
(Sections 4.4.2.4.1& 
4.4.3.3.4) 
Additional impact of foot problems not capture by FIS 
Ability to cope with foot 
problems (B7) 
Study 1 interviews 
(Section 4.4.3.2.3) 
Additional impact of foot problems not captured by FIS 
Severity (magnitude) of 
problem (B8) 
 
Study 1 interviews 
(Sections 4.4.3.2.2 & 
4.4.3.3.4) 
Additional impact of foot problems not captured by FIS 
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B: Your feet Item  included Source Rationale 
Impact of foot problems on 
ability to work (B9) 
Created from discussions 
with PRP and Study 1 
interviews (Section 
4.4.2.2.2) 
Additional impact of foot problems not captured by FIS 
Foot care services 
accessed (10A, 10B, 10C) 
 Dependant variable 
Foot care received (B11) Best practice guidelines 
(Williams et al, 2011) 
Data required capturing description of foot care 
interventions received in sample 
Self-care and self-
management  strategies 
adopted (B12) 
Study 1 interviews 
(Sections 4.4.3.2.3) 
Data required capturing self-care and self-management 
strategies adopted by patients 
Ankle / foot surgery (B13)  Dependant variable 
Additional comments  Opportunity for responders to disclose any important 
issues relating to foot problems not covered by previous 
questions (O’Cathain and Thomas, 2004) 
C: Impact of 
foot problems 
 Foot Impact Scale (FIS) Validated Scale (Helliwell 
et al, 2005) 
Standard questionnaire to measure current impact of foot 
problems in RA 
D: Daily 
Activities 
Health Assessment 
Questionnaire (HAQ) 
Validated scale (Fries et 
al, 1980; Kirwan and 
Reesback, 1986) Gold 
standard scale of 
disability in RA. 
Standard questionnaire to include to measure current 
disability in research and clinical practice 
 
Box 5.1 continued 
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5.2.3.1 Collaboration with patients on survey content 
To maximise response rates from the postal survey detailed consideration was given to 
various aspects of the survey materials by the PRP and also by seven patients with RA 
who fed back on the second draft of the survey. Three of the patients were PRPs, two 
from UHB and one from NBT. The other patients did not have any research training and 
were invited to provide comments from outpatient rheumatology clinics at UHB. The 
purpose was to make all the information as accessible as possible for patients to 
interpret and answer (Streiner, Norman and Cairney, 2014). The review patients 
considered: the patient information sheet (PIS); instructions for completing the 
questionnaire; the wording of questions in the questionnaire; and the layout of the 
survey. Time taken to complete the draft survey by individual patients was between five 
and ten minutes. Their comments were considered before the final version of the 
questionnaire was constructed. Six points emerged from patients’ feedback on the 
questionnaire these were useful in determining the final format (Table 5.1).  
 
Table 5.1 Modifications to the draft postal survey after patient feedback 
Section of postal 
survey 
Patient Comments Research team decision 
Front sheet  Add sentence “You may want to 
sit down with a cup of coffee 
while you fill this in”  
 Included in final 
version 
Section A 
Demographic and 
clinical data 
 No comments  
Section B 
Foot problems and 
foot care 
 Re-order questions B2 and B3  
 Anchors to B7 inconsistent with 
B6 and B8 anchors  
 Re-ordered in final 
version 
 Decision not to 
change anchors to 
B7 
Section C 
FIS 
 Addition of “sometimes” as a  
response option to FIS  
 This was not 
possible as FIS is a 
validated scale 
Section D 
HAQ 
 No comments  
Overall comments  No measure of psychological 
impact of foot symptoms 
 Ring bind surveys to make it 
easier for patients with hand 
involvement  
 Decision made not 
to include as not a 
primary aim of the 
study 
 This was not 
possible due to 
financial constraints 
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A second PRP (CS) joined the researcher’s study team at the development stage of 
Study 2. The PRPs (EQ and CS) were members of the initial Research Advisory Group. 
Both PRPs actively participated in the researcher’s supervisory team meetings and 
provided valuable contribution on the content, wording and ordering of questions 
included in the survey (see Box 5.1). The final version of the questionnaire was agreed 
with all members of the researcher’s research team (academic supervisors and PRPs) 
and can be found in Appendix F2. 
 
5.2.4 Scoring the scales 
Full guidance on the scoring of the FIS (for example how to deal with missing data) has 
not been published. It was therefore considered that a pragmatic approach was 
required in relation to scoring the scale. The two subscales of the FIS, FISIF and FISAP, 
were therefore scored and reported as separate scores. Each subscale was scored for 
the number of “true” answers. (maximum 21 and maximum 30; respectively). Hooper et 
al, (2012) propose FISIF scores ≥14 and/or FISAP, scores ≥20 to indicate severe impact 
respectively. For the purpose of this study it was decided that a minimum of 90% of all 
questions had to be completed for both subscales for the scores of the FIS to be 
admissible (FISIF > 18 and FISAP > 27 questions completed). Missing values were given 
the average of the score for the other questions. It was decided if any returned FIS 
questionnaires were not sufficiently completed to meet the defined admissible criteria, 
incomplete FIS scores would be excluded from analyses. For HAQ scores to be 
considered admissible standard guidance was used (Fries et al, 1980). Scores were 
admissible if there was at least one response in a least 7 sections and the missing 
section was given the average score for the other sections. Additional measures of 
impact of (severity, ability to cope and importance) were measured using an 11 point 
numerical rating scale (e.g. 0=not important, 10=very important). Impact of foot 
problems and ability to work were captured by nominal (categorical) variables (e.g. yes, 
no or not applicable). 
 
5.2.5 Social deprivation 
The link between social deprivation (e.g. low, income, inadequate housing and 
unemployment, ill health), access to health care and associated health outcomes in 
general is well established (Smith, Bartley and Blane, 1990; Munro, 2006). Social 
deprivation has also been suggested as a risk factor for developing RA (Bengtsson et 
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al, 2005; Pedersen et al, 2006). However, the influence of social deprivation in relation 
to accessing foot care services in general or in RA populations is not known. It is also 
possible that patients from socially deprived areas would be less likely to take part in 
the survey (Urwin et al, 1998). Social deprivation can be measured using individual 
level indicators (education level, income, occupation- based indicators, and/or 
household measures) or area level indicators (capturing the social deprivation of an 
area or population in relation to crime rates, proportion of population unemployed, 
barriers to housing and services, and living environment (Macintyre, Ellaway and 
Cummings, 2002). Each approach has weaknesses, for instance, income level may not 
reflect an individual’s financial position or represent their level of disposable income. 
Grundy and Holt (2001) suggest using a combination of individual and area level 
indicators to capture health inequalities in older people.  
 
A brief review of available measures which include individual and area levels indicators 
of deprivation was therefore conducted. The Townsend Deprivation Index (Townsend, 
Phillimore and Beattie, 1988) is constructed from four domains: 1) households with a 
car; 2) overcrowded households; 3) households not owner occupied; 4) male 
unemployment. The Townsend Deprivation Index is based on the 1991 UK national 
(Census.ac.uk) and being over 20 years out of date may not reflect the current 
population of an area. The Index of Multiple Deprivation (IMD) 2007 for England 
(English Indices of Deprivation, 2007) is composed of a number of indicators to cover a 
range of measures of deprivation (economic, housing and social issues) and combine 
them in a weighted manner into a single numerical score. The IMD is calculated for 
areas with a minimum population of 1000, referred to as Lower Layer Super Output 
Areas (LSOA). The indicators / domains of the IMD 2007 are (with weight allocation 
given in brackets): 1) income deprivation (22.5%); 2) employment deprivation (22.5%); 
3) health deprivation and disability (13.5%); 4) education skills and training deprivation 
(13.5%); 5) barriers to housing and services (9.3%); 6) crime and disorder (9.3%); 7) 
living environment (9.3%) (Nobble et al, 2007). One benefit of the IMD is the ability to 
compare small neighbourhood areas at both local and national levels by ranking LSOA 
scores. However, the IMD reflects deprivation of the area and may not be applicable to 
a particular individual who lives in that area. Not all people residing in a deprived area 
will be deprived (low affluence) and not all deprived individuals will live in deprived 
areas. Nonetheless, the IMD can be used as a geographical measurement of local 
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deprivation. IMD scores are obtained from post codes and therefore negate the need to 
ask respondents for further information. The IMD 2007 was selected as a measure of 
social deprivation for Study 2. IMD scores were obtained from postcodes utilising 
GEOConvert software (http://geoconvert.mimas.ac.uk, accessed 09/10/13). (Since 
completion of this work, IMD 2010 and its associated software packages have been 
published). IMD scores were taken for the whole sampling frame and were converted 
into categories. (Category 1 least deprived (most affluent) was defined as the lowest 
20% of scores, Category 2 represent the second fifth (21%- 40%), and so on up to 
category 5 most deprived (least affluent (81-100%)). The categories were therefore an 
index of comparative deprivation within the population sample (Roberts et al, 2008). 
 
5.2.6 Response rate 
Low response rates can increase the risk of bias and reduce generalisibility (Galea and 
Tracy 2007; Lorant et al, 2007). To optimise response rate the questionnaire was 
reviewed by a convenience sample of 10 patients with RA as described above. Another 
important aspect of conducting postal surveys relates to response bias. For example 
differences in general and clinical characteristics of responders and non-responders 
can threaten the generalisability of the findings to the whole target population. In 
particular if the characteristics of responders are not similar to the characteristics of 
non-responders, systematic errors may occur. The influence of gender, age and social 
deprivation on participation rates in survey studies has been widely reported (e.g. 
Korkeila et al, 2001). Additionally this study recruited patients from two hospital sites 
with small variation in general patient characteristics and varying levels of dedicated 
podiatry provision. Each of these factors could influence the interpretation of the survey 
results, so Research Ethics Committee approval was obtained to record the following 
(anonymised) information on all patients within the target population hospital site; 
gender, age and social deprivation. Comparisons between the target population and 
study sample, and the response rates could then be made. 
 
5.2.7 Study procedures 
Ethics approval was granted by Central Bristol Medical Research Ethics Committee 
(reference 11/SW/0327) and the University of the West of England Research Ethics 
Committee (reference HLS/12/01/12). Research and development approval was 
obtained from both hospital sites (NBT and UHB).  
Chapter 5 Study 2: Survey  
162 
 
The eligible target population was defined as all patients meeting the study inclusion 
criteria. As described above, eligible patients were listed in random order. The study 
sample was identified by starting at the top of the list and progressing in batches until 
an appropriate number of responses had been received (see below). The study sample 
was the patients posted a questionnaire. Questionnaire packs were posted to patients 
at their home address. The pack included: 1) an invitation letter (signed by the patient’s 
rheumatology consultant); 2) patient information sheet (PIS); 3) a copy of the 
questionnaire; 4) a FREEPOST return envelope (see Appendix E and F1). If no 
response was received within 3 weeks, the questionnaire pack was sent again. As 
approved by the Research Ethics Committee, informed consent to participate in the 
study was inferred by the return of the questionnaire.  
 
Patients were invited in blocks of approximately 50 at a time to aid administration, 
commencing with the lowest study ID. Before a questionnaire pack was sent out, 
hospital records were checked to see if the recipient patient had a pending 
rheumatology out-patient appointment within 4 weeks. In order to reduce potential bias 
related to changes in any clinical consultation process brought about by bringing foot 
problems to mind. For example completing the questionnaire prior to a clinical 
consultation may have influenced patients to initiate discussions about their foot 
problems. If any patients had a pending rheumatology clinic appointment, a 
questionnaire pack was not sent until after the date of the pending appointment. 
 
5.3 Analysis plan and sample size 
 
5.3.1 Statistical analyses 
Descriptive statistics were used to describe the study sample. The underlying frequency 
distribution for each continuous variable was visually inspected to assess for normality 
(Pallant, 2010). Normally distributed continuous data were expressed as means and 
standard deviations (SD) or 95% confidence intervals (CI) and compared using 
independent sample t-tests. Skewed continuous data were expressed as medians with 
their inter-quartile range (IQR) and compared using the Mann-Whitney U test. For 
categorical data, proportions were calculated and expressed as percentages and were 
compared using the chi-square test applied to the original numbers. Spearman’s rank 
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order correlation coefficient (Spearman’s rho) was performed to compare how the 
additional impact scores included in the survey related to the FIS scores. P values were 
considered statistically significant if they were less than 0.05. 
 
Comparisons of the general and clinical characteristics of responders who accessed 
foot care (AFC) and responders who had not accessed foot care (NAFC) used 
descriptive and inferential statistics as stated above. The type of foot care accessed 
and the route by which this was done were analysed in relation to general and clinical 
characteristics of respondents with descriptive and inferential statistics (stated above).  
 
Multivariate analyses were undertaken to determine the statistical significance of 
contributory factors as independent variables influencing access to foot care 
(AFC/NAFC) as the dependent variable. Logistic regression was selected as the 
method for multivariate analyses as the dependent variable of interest was binary (ever 
accessed foot care versus not ever accessed foot care) and the independent variables 
were a combination of categorical and continuous variables (e.g. disease duration and 
social deprivation). Additionally, logistic regression does not assume a linear 
relationship between the dependent variable and independent variables selected for the 
model. As an assumption of logistic regression analyses is that the independent 
variable is independent of the dependent variable (Pallant, 2010), foot related variables 
were not considered for multivariate analyses (e.g. FIS scores). 
 
Initial selection of the independent variables included in the logistic regression model 
was conducted after univariate analyses identifying differences (non-foot related) 
between the accessed foot care group (AFC) and the not accessed foot care group 
(NAFC). Logistic regression analyses were then performed to assess the predictive 
ability of each independent variable by controlling for the effects of the other 
independent variables in the model. Analyses were performed utilising binary entry 
(block entry) whereby all the independent variables were entered in to the model 
simultaneously. The statistical analyses were conducted using SPSS 19.0 (SPSS Inc. 
Chicago, Illinois).  
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5.3.2 Free text data analysis 
Data in relation to arthritis medications and additional morbidity (other health conditions) 
were collected by free response text. Consensus of the classification and categorisation 
of arthritis medications and other health conditions was agreed in discussion between 
the researcher and her academic supervisor (JK).  
 
Content analysis was selected as an approach to analyse free text responses to a 
general open ended question (“If you have any other comments about foot problems in 
RA that you would like to make, please add them here?”). Content analysis is a method 
for systematically describing textual data (free text response in questionnaires), verbal 
communication (transcripts of interviews) and non-verbal communication (observations 
of video diaries) (Graneheim and Lundman, 2004). It can be applied to qualitative and 
quantitative data and be inductive (data driven) or deductive (theory driven) in approach 
(Elo and Kyngäs, 2008; Hsieh and Shannon, 2005). The guidance of O’Cathain and 
Thomas (2004) was followed: 
1. The researcher reads the free text data for familiarisation with the data. 
2. Devises a coding frame to describe the content (thematic) of the text. 
3. Assigns codes (labels) to all comments. 
4. Codes can then be entered into a data base and treated as quantitative data for 
analyses. 
 
Following reading and re-reading all the free text data for familiarisation, data relating to 
similar issues were grouped together in categories assigned with comment labels 
(codes). Comment labels of similar meaning were then grouped to form comment 
categories to produce a coding frame. All free text data (verbatim) and the coding frame 
were entered into SPSS and treated as variables in a quantitative analysis. The results 
of the content analysis are presented as descriptive statistics (frequencies, proportions 
of responders) and exemplars from the free text used to illustrate emergent comment 
categories accompanied by study identifiers (ID), gender (e.g. F- female) and age (in 
years) of the respondent. 
 
5.3.3 Sample size 
This thesis adopted a sequential concurrent research design, whereby Study 1 was 
conducted first to identify important issues from the patient perspective to inform the 
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content of a postal survey (Study 2). Recruitment for Study 2 (survey) and Study 3 
(clinical assessment) were then conducted simultaneously. Patients invited to 
participate in Study 3 were a selected sub-sample of responders to Study 2. Sample 
size estimates for Study 3 were based on the expectation that there will be a maximum 
of 5 to 6 main determinants of access to foot care, which would be adequately identified 
by multivariate analyses conducted in Study 2 (Belle, 2008). The sample size for Study 
3 was therefore based on recruiting 60 patients classified as AFC and 60 patients 
classified as NAFC in Study 2. (The methods for Study 3 are fully described in Chapter 
6). Therefore Study 2 recruitment continued until recruitment to Study 3 had been 
achieved. 
 
The Sample size requirements for Study 2 were difficult to estimate as the extent of 
variation in access to foot care (and possibly foot care needs) was unknown a priori. 
Additionally, the number of patients who were required to be invited to participate and 
the number of patients required to respond to Study 2 to achieve the forecasted sample 
size for Study 3 were not known. It was estimated (based on epidemiology data) that 
approximately 2000 patients with RA would be attending both NHS sites for their 
rheumatology care. Of these it was estimated 1,500 would be within the geographical 
area (registered with GP within BCH boundaries). A previous survey on fatigue 
conducted at one of the hospital sites achieved a response rate of 79% (Nicklin et al, 
2010) but this was initiated by direct contact with the patient at the hospital department. 
It was therefore estimated a 70% response rate might be achievable. Initially 500 
hundred patients would be randomly selected but if less than 350 responses were 
returned, further random samples of patients would be invited to participate in batches 
of 100. Recruitment to Study 2 therefore overlapped with invitations to participate in 
Study 3 and continued until recruitment to Study 3 was achieved.  
 
5.4 Results: Quantitative analysis 
 
5.4.1 Response rates  
Data were collected from December 2011 to February 2013. A flow diagram of study 
recruitment is shown in Figure 5.2. There were 1003 eligible patients in the target 
population (Figure 5.1). Recruitment stopped when 415 questionnaires were returned 
(as at that point recruitment to Study 3 had been achieved), by which time 739 survey 
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packs had been posted. Of these responses, 295 (39.9%) were returned directly and 
120 (16.2%) were returned after a reminder, giving an overall response rate of 56.2%. 
Two questionnaires (responses) were inadmissible (not adequately completed) and 413 
(55.9%) were admissible responses.  
 
Each returned questionnaire was checked for completeness by the researcher. Missing 
data were clarified by a telephone call (by the researcher) with the responder. If 
telephone contact was not achieved missing data were coded as 999. Accuracy of data 
entry was checked firstly by duplicate entry of a random sample of 10% completed 
questionnaires; and secondly by reviewing for errors using frequencies, minimum and 
maximum values for each variable. Apparent errors were checked against returned 
questionnaires and corrected. Analyses were conducted using “exclude case pairwise” 
to account for missing data. The responses of “not applicable” were coded as 888 to 
reflect completeness of the data sets.  
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Figure 5.2 Flow diagram of recruitment Study 2 (postal survey) 
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5.4.2 Characteristics of responders and non-responders 
In order to check for responder bias the general characteristics (hospital site, 
gender, age and social deprivation) of the responders were compared to those of 
the non-responders. (See Appendix F2 for questionnaire) 
 
5.4.2.1 Hospital site 
Table 5.2 illustrates the comparison of responses by hospital site. Despite 
differences patient demographics and foot care service provision, response rates 
were very similar.  
 
Table 5.2 Response rates by hospital site 
 NBT (n=381) 
Number (%) 
UHB (n=358) 
Number (%) 
Returned no reminders 137 (36.0) 158 (44.1) 
Reminder sent 244 (64.0) 200 (55.9) 
Returned after reminder 74 (30.3) 46 (23.0) 
Inadmissible 2 (1.0) 0 (0) 
Admissible questionnaires 209 (54.9) 204 (56.9) 
 
Table 5.3 presents the response rates in relation to general characteristics by 
hospital site. Overall general patient characteristics are broadly similar for both sites, 
although NBT had a lower proportion of IMD category 5 participants. 
 
Table 5.3 Response rates general characteristics by hospital site 
 Target population  Responders 
 NBT 
(n=381) 
UHB 
(n=385) 
 NBT 
(n=209) 
UHB 
(n=204) 
Female number (%) 
 
289 (75.9) 263 (73.5)  156 (74.6) 151 (74.0) 
Age mean (SD) 
 
63 (14.1) 62 (13.1)  63 (13.9) 64 (11.6) 
Social deprivation 
(IMD LSOA 
categories) 
Number (%) 
1 (least deprived) 94 (24.7) 85 (23.7)  60 (28.7) 56 (27.5) 
2 166 (43.6) 124 (34.6)  83 (39.7) 60 (29.4) 
3 89 (23.4) 74 (20.7)  51 (22.4) 48 (23.5) 
4 25 (6.6) 41 (11.5)  14 (6.7) 22 (10.8) 
5 (most deprived) 7 (1.8) 34 (9.5)  1 (0.5) 18 (8.8) 
 
5.4.2.2 Gender (A1) 
Of the 739 patients invited to participate (target population), 552 (74.7%) were 
female. Of 413 responders, 306 (74.1%) were female. The number of men invited 
was 187 (25.3%), and of these 107 (25.9%) responded. There was no statistically 
significant response bias in relation to gender       0.65, df=1, p=0.865).  
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5.4.2.3 Age (A2) 
The mean age for the target population was 62.6 years (SD =13.6; range 25 - 99); 
responders 63.5 years (SD=12.8; range 25 - 91); and non-responders 61.5 years 
(SD=14.6; range 27 - 99). Figure 5.3 presents the comparisons of age distribution 
between responders and non-responders. There was a statistically significant 
difference between responders and non-responders for age (t= -2.1, df=737, 
p=0.04), but this was small (difference between means 2 years; 95% CI 1.0, 4.1).  
 
Figure 5.3 Age distribution comparisons responders (n=413) non-responders 
(n=326) 
  
 
5.4.2.4 Social deprivation (postcodes) 
To investigate if response varied according to social deprivation comparisons of 
responders and non-responders area level deprivation were computed. IMD 2007 
categories for the target population, responders and non-responders are presented 
in Table 5.4. The majority of the target population resided in areas of relatively low 
deprivation (high affluence). Although a Chi-squared test indicated an overall 
difference between responders and non-responders in relation to social deprivation 
     14.0, df=4, p=0.007). The proportions of responders residing in categories 3, 4 
and 5 combined were equal.  
 
Table 5.4 Representation of area level deprivation in which patients reside  
Deprivation categories Target population 
 (n=739) 
Number (%) 
Responder 
(n=413) 
Number (%) 
Non-responder 
(n=326) 
Number (%) 
1 (least deprived) 179 (24.2) 116 (28.1) 63 (19.4) 
2 290 (39.2) 143 (34.6) 147 (45.1) 
3 163 (2.1) 99 (24.0) 64 (19.6) 
4 66 (8.9) 36 (8.7) 30 (9.2) 
5 (most deprived) 41 (5.5) 19 (4.6) 22 (6.7) 
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5.4.2.5 Overview of responder bias 
There was a small difference in age and in overall postcode-level social deprivation 
index between responders and non-responders. However, there were adequate 
responses from patients living in relatively high areas of deprivation. Responders 
therefore reflected the study target sample. Additionally, the general patient 
characteristics (gender, age and social deprivation) of responders and non-
responders were broadly similar for both hospital sites. Responders were 
consequently regarded as one population for subsequent analyses. The study 
responders were therefore considered to be broadly representative of the patients 
with RA in Bristol.  
 
5.4.3 RA clinical data of responders 
The clinical characteristics of responders are set out below 
 
5.4.3.1 Disease duration (A3) and age at diagnosis 
The frequency distribution of responders’ self-report of disease duration is presented 
in Figure 5.4. The median was 10 years (IQR 5 to 20, range 1- 60).  
 
Figure 5.4 Disease duration in questionnaire responders
 
The mean age at diagnosis was 50.3 years (SD=14.9; range 1 - 85). A small 
number of responders (7, 2%) reported they had been diagnosed with RA before the 
age of 16 years but none of these reported a different diagnosis (e.g. juvenile 
idiopathic arthritis).  
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5.4.3.2 Medication (A4)  
The majority of responders were taking arthritis medications (pharmacological 
therapy) for their RA (n = 394, 95.4%). The classification of arthritis medications 
were: non-steroidal anti-inflammatory drugs (NSAIDs), disease modifying anti-
rheumatic drugs (DMARDs), glucocorticoids, and biologic therapies. The frequency 
of responders taking each category of medication was: NSAIDs 128 (31.0%), 
DMARDS 339 (82.1%), glucocorticoids 122 (29.5%) and biologic therapies 74 
(17.9%). Many responders were taking more than one category of arthritis 
medications (n=210, 50.8%) (Table 5.5).  
 
Table 5.5 Frequencies and categories of RA medications (n=413)  
 
5.4.3.3 Disability (Section D) 
A total of 404 (97.8%) responders completed the Health Assessment Questionnaire 
(HAQ). Figure 5.5 presents the frequency distribution of HAQ scores. Median score 
was 1.5 but there was a wide range of reported levels of disability (IQR 0.750 to 2.0) 
with some patients (n=30, 7.4%) reporting no current disability.  
 
Figure 5.5 Frequency of HAQ scores (n=404) 
 
 NSAIDs  DMARDs Glucocorticoids Biologics Total 
Taking no RA medication - - - - 19 
Taking 1 category of RA medication 17  142  12  13 184 
Taking 2 categories of RA medication 68  147  69  28 156  
Taking 3 categories of RA medications 38  45  36 28 49  
Taking 4 categories of RA medication 5 5 5 5  5  
Total 128 339 122 74 413 
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5.4.3.4 Co-morbidities (A5) 
A total of 266 responders (64.4%) reported other health conditions (co-morbidity). Of 
these, 92 (34.6%) reported having more than one morbidity as illustrated in Table 
5.6. Table 5.7 summaries the frequencies of co-morbidities according to disease 
categories. Diabetes, an important cause of foot problems, was reported by 28 
responders (6.8%). 
 
Table 5.6 Frequency of co-morbidity categories (n=413) 
Co-morbidity category Co-morbidity category 
Number (%) 
No other co-morbidity 147 (35.6) 
1 co-morbidity 174 (42.1) 
2 co-morbidities 70 (16.9) 
3 co-morbidities 17 (4.1) 
4 co-morbidities 4 (1.0) 
5 co-morbidities 1 (0.2) 
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Table 5.7 Co-morbidity classification categories (n=413) 
Co-morbidity condition Type of  
co-morbidity  
 Number (%) 
Diabetes 
Thyroid disease 
Paget’s disease 
Osteopinia 
Endocrine 63 (15.3) 
Myocardial infarction 
Cerebrovascular accident 
Hypertension 
Arrythmia 
Deep vein thrombosis 
Raynaud’s 
Peripheral vascular disease 
Hypercholesterolemia 
Circulatory disease 137 (33.2) 
Asthma 
Chronic obstructive pulmonary 
disease 
Bronchiectasis 
Sleep apnea 
Respiratory disease 54 (13.1) 
Anxiety 
Depression 
Schizophrenia 
Mental health 13 (3.1) 
Eczema 
Psoriasis 
Herpes simplex 
Urticaria 
Dermatology 7 (1.7) 
Glaucoma 
Retinopathy 
Ocular toscocariasis 
Eye 8 (1.9) 
Basal cell carcinoma 
Breast cancer 
Prostate cancer 
Cancer 7 (1.7) 
Anaemia 
Thrombocytopenia 
Haematology 8 (1.9) 
Ulcerative colitis 
Crohn’s disease 
Hiatus hernia 
Oesophageal reflux 
Gastrointestinal 19 (4.6) 
Multiple sclerosis 
Dystonia 
Neurology 3 (0.7) 
Ankylosing spondylitis 
Juvenile idiopathic arthritis 
Gout 
Osteoarthritis 
Osteoporosis 
Giant cell arteritis 
Systemic lupus erythematosus 
Sarcoidosis 
Sjogrens 
Other rheumatological diagnosis 47 (11.4) 
Spinal stenosis 
Sciatica 
Degeneration of spin 
Back problems 12 (2.9) 
Fibromyalgia Chronic pain 6 (1.5) 
Primary bilary cirrhosis Heptology 1 (0.2) 
Tendinopathy 
Fracture 
Foot deformity not RA related 
Other musculoskeletal conditions 
 
3 (0.7) 
Chronic kidney disease Renal disease 3 (0.7) 
 Any category 266 (64.4) 
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5.4.3.5 Overview of clinical data 
Overall a wide range of disease duration and age at diagnosis of RA was reported. The 
great majority of responders were taking one or more arthritis medications and a fifth 
were taking biologic therapies. No current disability was reported by less than 10% of 
responders. Additionally, and of interest of itself, almost two thirds of responders 
reported the presence of other health conditions, and the proportion reporting diabetes 
was 6.8% (n=28).  
 
5.4.4. Foot-related characteristics 
 
5.4.4.1 Talked about feet (B1 – B3) 
The majority of responders (n=314, 76.0%) reported they had talked to someone about 
problems with their feet (Table 5.8). Of those who had talked about their feet, 230 
(73.2%) had raised the issue themselves while 84 (26.8%) reported that someone else 
had raised the issue (Table 5.9). Of these 84, 23 (26.8%) reported two categories of 
people who initiated talking about feet. The number of responders reporting three or 
more categories of people initiating discussions about feet was small (n=3, 3.6%). 
 
Table 5.8 Frequency of talked about feet (n=413) 
Talked about feet Number (%) 
Patient initiated 230 (55.7) 
Other person initiated 84 (20.3) 
Not talked about feet 99 (24.0) 
 
Table 5.9 Categories of people talking about feet (n=314)  
Person who initiated talking about feet Number (%)* 
Family  8 (2.5) 
Practice nurse 2 (0.6) 
Rheumatology nurse 13 (4.1) 
Friends 3 (1.0) 
Rheumatology Doctor 55 (17.5) 
Other 7 (2.2) 
GP 16 (5.1) 
Podiatrist / chiropodist 11 (3.5) 
Patient initiated 230 (73.4) 
*Some responders indicated more than one person who initiated discussions about feet 
 
5.4.4.2 Feet examined (B4) 
A total of 412 responders completed the question, “Has a health professional examined 
your feet?” Overall 312 (75.7%) reported having had a foot examination. Of the 100 
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who reported not to have had a foot examination, 59 (59.0%) indicated that they 
thought a foot examination should have been conducted. Table 5.10 presents the time 
period frequencies of last recalled foot examinations. Of the 312 responders who 
reported a foot examination, 150 (48.1%) reported their feet had been examined in the 
last twelve months. A small number of responders who had had a foot examination 
were unable to recall when the examination was conducted (n=31, 7.5%). Data were 
not collected on which health professionals conducted the examination. 
 
Table 5.10 Time interval of foot examinations (n=413)  
Time interval of last recalled foot examination Number (%) 
0-6 months 89 (21.6) 
>6 -12 months 61 (14.8) 
>12-18 months 34 (8.3) 
>18 months 97 (23.5) 
Can’t remember 31 (7.5) 
Never had feet examined 100 (24.3) 
Not completed 1 (0.2) 
 
5.4.4.3 Foot problems (B5)  
Almost all respondents reported they had experienced foot problems at some time 
since developing RA. Only 14 (3.4%) reported never having experienced any foot 
problems. The majority of responders (n=377, 92.1%) reported the current presence of 
one or more foot problems (Table 5.11). The rates of current foot problems between 
women and men were similar (n=279, 90.0% versus n=91, 85.8%). The highest 
frequency of foot problems was in the articular features category, followed by 
cutaneous lesions and structural deformity. Figure 5.6 presents the frequencies of the 
number of foot problems reported by individual responders. Half of responders reported 
five or more current foot problems (n=215, 52.1%). 
 
 
 
 
 
 
 
 
 
 
Chapter 5 Study 2: Survey  
176 
Table 5.11 Reported foot problems (n=413 (%)) 
Foot problem 
category 
Foot problems Foot problem 
now 
Foot problem 
ever 
Never had 
foot problems 
Articular features Pain 263 (63.7) 342 (82.8) 71 (17.2) 
Stiffness 224 (54.2) 277 (67.1) 73 (17.8) 
Swelling 218 (52.8) 286 (69.2) 127 (30.8) 
Any articular feature 305 (73.8) 373 (90.3) 40 (9.7) 
Cutaneous lesions Blisters 28 (6.8) 73 (17.7) 340 (82.3) 
 Callus 171 (41.4) 206 (49.9) 297 (50.1) 
Corns 72 (17.4) 109 (26.4) 304 (73.6) 
In-grown toe nails 59 (14.3) 106 (25.7) 307 (74.3) 
Thickened Toe nails 168 (40.7) 190 (46.0) 223 (54.0) 
Ulcers 13 (3.1) 38 (9.2) 375 (90.8) 
Any cutaneous lesions 270 (65.4) 303 (73.4) 110 (26.6) 
Structural deformity Bunions 111 (26.9) 141 (34.1) 272 (65.9) 
Fallen arches 93 (22.5) 121 (29.3) 292 (70.7) 
Misshaped toes 180 (43.6) 199 (48.2) 214 (51.8) 
Any structural deformity 238 (57.6) 265 (64.2) 148 (35.8) 
Extra-articular 
features 
Nodules 96 (23.2) 122 (29.5) 291 (70.5) 
Numbness 118 (28.6) 153 (37.0) 260 (63.0) 
Any extra articular  feature 176 (42.6) 212 (51.3) 201 (48.7) 
Other Infection 31 (7.5) 76 (18.4) 337 (81.6) 
Any foot problems  377 (91.2) 403 (97.6) 10 (2.4) 
 
 
Figure 5.6 Number of foot problems reported by individual responders (n=413) 
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5.5.4.4 Overview of foot-related characteristics  
Nearly all the responders reported one or more current foot problem and over half 
reporting to have 5 or more current foot problems. These data also indicate foot 
problems are very common in patients with RA but may fluctuate. For some patients, 
once foot problems have developed, they appear to be persistent and for others, foot 
problems appear to follow a variable clinical course. The data also suggest that patients 
considered their feet to be important health care needs as, when discussions regarding 
foot problems were conducted; they were often initiated by patients. However, although 
patients indicated that clinicians do not routinely initiate talking about feet, the majority 
(n=312, 75.7%) recalled having a foot examination at some time.  
 
5.4.5 Impact of foot problems 
The impact of foot problems was captured by the FIS and by numerical rating scales 
addressing: importance of foot problems, ability to cope with foot problems, magnitude 
(severity) of foot problems and ability to work.  
 
5.4.5.1 Foot Impact Scale (Section C) 
The FIS Impairment / Footwear (FISIF) scores from 0-21 and. the FIS Activities / 
Participation (FISAP) scores from 0-30. Of the 413 responders, 400 (96.7%) FIS scores 
were admissible. The median (IQR) FISIF and FISAP scores were 10 (6 to 14) and 16 (7 
to 23), respectively. Figure 5.7 and Figure 5.8 present the frequency distribution of the 
FISIF scores and FISAP scores.  
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Figure 5.7 Foot Impact Scale Impairment Footwear (FISIF) scores (n=400)  
 
 
 
Figure 5.8 Foot Impact Scale Activities Participation (FISAP) scores (n=400)  
 
 
 
FISIF scores were normally distributed but FISAP scores were negatively skewed. The 
proportion of responders scoring 0 on the FISAP was 12.3% (n=49).  
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5.4.5.2 Importance of foot problems (B6) 
The importance of foot problems was measured by an 11 point numerical rating scale 
range 0 (not important) to 10 (very important), which all responders completed. The 
median (IQR) score was 6 (3 to 8), with the distribution of importance scores presented 
in Figure 5.9. 
 
Figure 5.9 Importance of foot problem scores (n=413)  
 
 
5.4.5.3 Ability to cope with foot problems (B7) 
All responders completed the 11 point numerical rating measuring self-perceived ability 
to cope with foot problems (0, coping very well to 10, not coping very well). The median 
(IQR) coping score was 5 (3 to 7). The frequency distributions of coping scores are 
represented in Figure 5.10. 
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Figure 5.10 Ability to cope with foot problems (n=413)  
 
 
5.4.5.4 Magnitude of foot problems (B8)  
An 11 point numerical rating scale captured current severity (magnitude) of foot 
problems and was completed by all responders (0, no problem to 10, severe problem). 
The median (IQR) severity score was 6 (3 to 8). The frequency distribution of severity 
scores are presented in Figure 5.11. 
 
Figure 5.11 Magnitude of foot problems scores (n=413) 
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5.4.5.5 Comparisons of measures of impact 
The findings of Study 1 indicated that not all important issues regarding the impact of 
foot problems are included in the FIS, a validated questionnaire. Although the NRS 
measuring the additional impact of foot problems in RA in this survey (importance, 
ability to cope and magnitude) were developed in close consultation with patients they 
have not been formally validated. To investigate if the additional measures of impact did 
indeed provide additional information not included in the FISIF and FISAP, the 
association of additional measures of impact with the FIS sub-scale scores was 
examined.  
 
As the additional measures of impact scores were not normally distributed, Spearman’s 
rank order correlation coefficient (Spearman’s rho) was calculated to examine 
associations of impact scores. Table 5.12 presents a correlation matrix for these 
measures. There were statistically significant positive relationships between all 
measures of impact, indicating that they were probably reflecting a common construct. 
Squaring the correlation coefficient indicated that 49.8% of the variance of FISIF scores 
was explained by FISAF scores. The variance of FISIF scores explained by importance, 
ability to cope and magnitude scores were 40.4%, 41.6%, and 46.1%, respectively. The 
variance in FISAP scores explained by importance, ability to cope and magnitude was 
only moderate 26.9%, 30.5% and 31.4%, respectively, indicating that these additional 
measures of impact are providing information not included in the FIS. 
 
Table 5.12 Correlation of measures of impact of foot problems (n=400)  
   Importance 
(B6) 
Ability to 
cope (B7) 
Magnitude 
(B8) 
Spearman’s 
rho 
FISIF 
(Impairment / 
Footwear) 
Correlation Coefficient 
Explained variance % 
.636
** 
40.4 
.645
** 
41.6 
.679
** 
46.1 
FISAP 
(Activities / 
Participation) 
Correlation Coefficient 
Explained variance % 
.519
** 
26.9 
.553
** 
30.5 
.560
** 
31.4 
Importance 
(B6) 
Correlation Coefficient 
Explained variance % 
 .761
** 
57.9 
.844
** 
71.2 
Ability to cope 
(B7) 
Correlation Coefficient 
Explained variance ) 
  .841
** 
70.7 
** rho significant p= 0.01 level  
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5.4.5.6 Impact of foot problems on ability to work (B9) 
Of the 254 responders who were working, 156 (61.4%) reported foot problems 
impacting on their ability to work and 98 (38.6%) reported no impact. Higher median 
impact scores were detected in responders who reported foot problems affecting their 
ability to work (Table 5.13). The majority of responders not working indicated in free text 
responses that the reason for not being in paid employment was retirement or personal 
choice.  
 
Table 5.13 Comparisons of impact scores and ability to work (n=413)   
Impact of foot problems on ability to work 
Impact scores Yes  
(n=156) 
Median (IQR) 
No  
(n=98) 
Median (IQR) 
Not applicable 
(n=159) 
Median (IQR) 
FISIF 12.0 (10.0 to 15.0) 6.0 (3.0 to 9.5) 9.0 (5.0 to 13.0) 
FISAP 21.0 (14.0 to 24.0) 5.0 (0 to 14.0) 16.0 (7.0 to 23.5) 
Importance of foot problems (B6) 8.0 (6.0 to 10.0) 3.0 (1.0 to 6.0) 6.0 (4.0 to 8.0) 
Ability to cope with foot problems (B7) 6.0 (5.0 to 7.0) 3.0 (0.0 to 5.0) 5.0 (2.5 to 7.0) 
Magnitude of foot problems (B8) 7.0 (5.0 to 8.0) 3.0 (1.0 to 5.0) 6.0 (3.0 to 8.0) 
 
5.4.5.7 Overview of impact of foot problems  
There was a wide range of impact scores in relation to current foot problems. A number 
of responders reported that their foot problems were impacting on their personal lives in 
terms of: impairment (e.g. pain on standing), footwear (e.g. limiting choice of shoes), 
activity levels (e.g. walking) and participation in valued activities (e.g. social isolation). 
Further, some responders reported their foot problems to be very important and severe, 
and that they were not coping well with the problems (scoring 10 on the NRS). The 
relatively weak relationships between the FISIF and FISAP and the additional measures 
of impact indicate that these additional measures do capture information not included in 
the FIS. A further indication of this was that one third of responders reported that their 
foot problems were affecting their ability to work. 
 
5.4.6 Self-care and self-management of foot problems (B12) 
 A wide range of self-care and self-management strategies were reported (Table 5.14). 
Of the 413 responders, 188 (45.5%) reported having to use one or more aids (e.g. shoe 
horn, device to put on hosiery) to self-care and self-manage their foot health care 
needs. While the self-care and self-management strategies used were generally similar 
in men and women, more females reported using cutaneous treatments and 
complementary treatments. 
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At first sight the use of self-care and self-management strategies could be interpreted 
as being beneficial to their foot health. However, 79 (19.1%) responders had used self-
sourced (non-prescribed) topical keratolytics (cuticle softeners and corn plasters) which 
contain chemical agents (e.g. salicylic acid). Further, 79 (19.1%) responders had used 
hot treatments (e.g. compresses) or cold treatments (e.g. ice packs) to manage their 
foot problems. These strategies can be detrimental to foot health, particularly in relation 
to patients with impaired tissue viability, and are usually not recommended.  
 
Table 5.14 Self-care and self-management strategies used by responders 
according to gender (n=413) 
Self –care and  
self-management categories 
 Self-care and   
self-management strategies 
Female 
(n=306) 
Number (%) 
Male  
(n=107) 
Number (%) 
Aids Aid / device to put hosiery on  50 (16.3) 13 (12.1) 
 Shoe horn  101 (32.9) 36 (33.6) 
 Long handled nail scissors / nippers  55 (18.0) 19 (17.8) 
 Any aids 139 (45.4) 49 (45.8) 
Cutaneous treatments Foot file 152 (49.7) 28 (26.2) 
 Cuticle softener  24 (7.8) 4 (3.7) 
 Moisturisers 199 (65.0) 32 (29.9) 
 Hard skin corn removal plasters 43 (14.1) 8 (7.5) 
 Any cutaneous treatments 224 (73.2) 44 (41.1) 
Complementary treatments Acupuncture 14 (4.6) 5 (4.7) 
 Aromatherapy 7 (2.3) 1 (0.9) 
 Homeopathic remedies 10 (3.3) 1 (0.9) 
 Reflexology 30 (9.8) 4 (3.7) 
 Other complementary 11 (3.6) 1 (0.9) 
 Massage 51 (16.7) 7 (6.5) 
 Any complementary treatments 81 (26.5) 15 (14.0) 
Devices Bunion protectors 22 (7.2) 2 (1.9) 
 Bunion night splints 2 (0.7) 1 (0.9) 
 Foot pads 40 (13.1) 10 (9.3) 
 Padded socks 42 (13.7) 12 (11.2) 
 Insoles 176 (57.5) 59 (55.1) 
 Shoes not available in shops 46 (15.0) 11 (10.3) 
 Toe splints / separators 21 (6.9) 8 (7.5) 
 Toe protectors 35 (11.4) 6 (5.6) 
 Any devices 208 (68.0) 67 (62.6) 
Thermal treatment Heat treatments 22 (7.2) 8 (7.5) 
 Cold  43 (14.1) 6 (5.6) 
 Any thermal treatment 50 (16.3) 14 (13.1) 
Pharmacological Athlete’s foot creams 47 (15.4) 22 (20.6) 
 
5.4.7 Comparing those who have accessed foot care with those who have not 
access foot care  
Responders were categorised as having accessed foot care (AFC, 287, 69.5%) if they 
had attended one or more foot care service (NHS podiatry, independent podiatry, 
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orthotics and/or orthopaedics) or not accessed foot care (NAFC, 126, 30.5%). The AFC 
group formed a greater proportion of patients than had been anticipated from the 
literature review undertaken before the survey. 
 
5.4.7.1 Hospital Site 
Although the two hospital sites have slightly different provisions for foot care, the 
proportions of responders having accessed foot care overall were similar for each 
hospital site (Table 5.15). 
 
Table 5.15 Access to foot care according to hospital site (n=413)  
Hospital site NBT (n=209) 
Number (%) 
UHB  (n=204) 
Number (%) 
AFC 149 (71.3) 138  (67.6) 
NAFC 60 (28.7) 66 (32.4) 
 
5.4.7.2 Gender (A1) 
Of the 107 male responders, 66 (61.7%) had accessed foot care while of the 306 
female responders, 221 (72.2%) had accessed foot care. This was a statistically 
significant difference (     3.51, df=1, p=0.04). 
 
5.4.7.3 Age (A2) 
There was only a small difference between the mean age of the AFC group (64.9 years, 
SD=12.5, range 26 - 91) and that of the NAFC group (60.4 years, SD=13.0, range 25 - 
84) which was statistically significant (t=-3.35, df=411, p=0.01) (Figure 5.12)  
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Figure 5.12 Comparisons of age distribution AFC (n=287) and NAFC (n=126) 
 
5.4.7.4 Social deprivation 
The distribution of local deprivation categories for the AFC group and the NAFC group 
are shown in table 5.16 and are similar (   =4, df=4, p=0.363). In particular the 
proportions from more deprived areas (categories 3, 4 and 5) are similar for the AFC 
group (36.2%) and the NAFC group (39.7%). 
 
Table 5.16 Access to foot care according to area level deprivation in which 
patients reside (n= 413) 
Deprivation categories AFC (n=287) 
Number (%) 
NAFC (n=126) 
Number (%) 
1 (least deprived) 89 (31.0) 27 (21.4) 
2 94 (32.8) 49 (38.9) 
3 67 (23.3) 32 (25.4) 
4 25 (8.7) 11 (8.7) 
5 (most deprived) 12 (4.2) 7 (5.6) 
 
5.4.7.5 Disease duration (A3) and age at diagnosis 
The median reported disease duration for the AFC group was 12 years (IQR 6 to 21, 
range 1 - 53) and for the NAFC group was 7 years (IQR 3 to 12, range 1 - 60). The 
difference in medians of 5 was statistically significant (U =12677.5, P<0.001). The 
frequency distribution of disease duration is presented in Figure 5.13. This illustrates a 
peak in disease duration of RA between 20 - 30 years in the AFC group while only 20 
(15.9%) of the NAFC group, reported disease duration of >20 years. The mean age at 
diagnosis (of RA) for the AFC group and the NAFC group was 50.2 years (SD=14.7) 
and 50.2 years (SD=15.2), respectively. 
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Figure 5.13 Disease duration comparisons AFC (n=287) and NACF (n=126) 
 
 
5.4.7.6 Medication (A4) 
The numbers (proportions) of the AFC group taking arthritis medications were: NSAIDs 
93 (32.4%), DMARDs 230 (80.1%), glucocorticoids 79 (27.5%) and biologics 51 
(17.7%). The equivalent numbers for the NAFC group were similar: 35 (27.8%), 109 
(86.5%), 43 (34.1%) and 23 (18.3%). The number of categories of arthritis medications 
being taken by the AFC group and the NAFC group are presented in Table 5.17. The 
proportions of patients taking two or more arthritis medications were similar in both 
groups. 
 
Table 5.17 Frequency of RA medication categories (n=413) 
Number of arthritis medication AFC (n=287) 
Number (%) 
NAFC (n=126) 
Number (%) 
Not taking RA medication 13 (4.5) 6 (4.8) 
Taking 1 category of  medication 133 (46.3) 51 (40.5) 
Taking 2 categories of  medication 106 (36.9) 50 (39.7) 
Taking 3 categories of  medication 32 (11.1) 17 (13.5) 
Taking 4 categories of  medication 3 (1.0) 2 (1.6) 
 
5.4.7.7 Disability 
The HAQ was adequately completed by 404 (97.8%) responders. Incomplete HAQs 
were returned by 6 (2.1%) of the AFC group and 3 (3.4%) of the NAFC group. There 
was a wide range of reported levels of disability in both groups (Figure 6.14). The 
median (IQR) score for the AFC group was 1.625 (0.8125 to 2.0) compared to the 
NAFC group of 1.125 (0.5 to 1.875). Although the difference in medians of 0.5 between 
was statistically significant (U =14243, p=0.005), it was a relatively small difference 
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Figure 5.14 Distribution of HAQ scores for AFC (n=281) and NAFC (n=123) 
 
 
5.4.7.8 Co-morbidities (A5) 
The presence of additional morbidity (other health conditions) was reported by two 
thirds of responders (Table 5.18). An apparent tendency for the responders with 
additional health conditions to be more likely to access foot care was not statistically 
significant (  =6.73, df=3, p=0.08). Table 5.19 presents the classification and 
categories of the presence of other health conditions. Of the 28 patients reporting 
diabetes, 22 (78.6%) had accessed foot care.  
 
Table 5.18 Frequency of co-morbidity categories (n=413)  
Number of co-morbidity AFC (n=287) number in 
this category 
Number (%)  
NAFC (n=126) number in 
this category 
Number (%)  
No other co-morbidity 97 (33.8) 50 (39.7) 
1 co-morbidity 116 (40.4) 58 (46.0) 
 2 co-morbidities 56 (19.5) 14 (11.1) 
> 3 co-morbidities 18 (6.3) 4 (3.2) 
Any co-morbidity 190 (66.2) 76 (60.3)  
Chapter 5 Study 2: Survey  
188 
Co-morbidity condition Type of  
co-morbidity  
AFC  
(n=287) in this 
category 
Frequency (%) 
NAFC (n=126) 
 in this 
category 
Frequency (%) 
Diabetes 
Thyroid disease 
Paget’s disease 
Osteopinia 
Endocrine 48 (16.7) 15 (11.9) 
Myocardial infarction 
Cerebrovascular accident 
Hypertension 
Arrythmia 
Deep vein thrombosis 
Raynaud’s 
Peripheral vascular disease 
Hypercholesterolemia 
Cardiovascular 
disease 
104 (36.2) 33 (26.2) 
Asthma 
Chronic obstructive pulmonary 
disease 
Brochiectasis 
Sleep apnoea 
Pulmonary disease 39 (13.6) 15 (11.9) 
Anxiety 
Depression 
Schizophrenia 
Mental health 10 (3.5) 3 (2.4) 
Eczema 
Psoriasis 
Herpes simplex 
Urticaria 
Dermatology 7 (2.4) 0 (0) 
Glaucoma 
Retinopathy 
Ocular toscocariasis 
Eye 5 (1.7) 3 (2.4) 
Basal cell carcinoma 
Breast cancer 
Prostate cancer 
Cancer 4 (1.4) 3 (2.4) 
Anaemia 
Thrombocytopenia 
Haematology 4 (1.4) 4 (3.2) 
Ulcerative colitis 
Crohn’s disease 
Hiatus hernia 
Oesophageal reflux 
Gastrointestinal 12 (4.2) 7 (5.6) 
Multiple sclerosis 
Dystonia 
Neurology 0 (0) 3 (2.4) 
Ankylosing spondylitis 
Juvenile idiopathic arthritis 
Gout 
Osteoarthritis 
Osteoporosis 
Giant cell arteritis 
Systemic lupus erythematosus 
Sarcoidosis 
Sjogrens 
Other 
rheumatological 
diagnosis 
36 (12.5) 11 (8.7) 
Spinal stenosis 
Sciatica 
Degeneration of spine 
Back problems 8 (2.8) 4 (3.2) 
Fibromyalgia Chronic pain 5 (1.7) 1 (0.8) 
Primary bilary cirrhosis Heptology 1 (0.3) 0 (0) 
Tendonipathy 
Fracture 
Foot deformity not RA related 
Other MSK 
 
3 (1.0) 0 (0) 
Chronic kidney disease Renal disease 3 (1.0) 0 (0) 
 Any category 190 (66.2) 76 (60.3) 
Table 5.19 Co-morbidity condition categories (n=413) 
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5.4.7.9 Talked about feet (B1 – B3)  
Of the 413 responders, 314 (76%) reported to have talked about their feet to 
someone (Table 5.20). Of these, 245 (78.0%) were in the AFC group. The majority 
of the 287 responders in the AFC group indicated they had talked about their feet 
(n=245, 85.4%) while in contrast only half of the 126 in the NAFC group had talked 
about their feet with someone (n=69, 54.8%). Data were not collected in relation to 
the circumstances when discussions regarding feet occurred (e.g. during a clinical 
consultation). Further some patients may have found the question (“Have you talked 
to anyone about your feet?”) confusing as 14.6% of the AFC group did not report 
having talked to anyone about their feet.  
 
Over half of the responders reported that they themselves had initiated talking about 
feet (n=230, 55.7%), implying that foot problems are important issues for patients. 
The proportion of the AFC group initiating discussions was higher compared to the 
NAFC group (60.6% versus 44.4%).  
 
Table 5.20 Frequency of talked about feet (n=413) 
Talked about feet AFC (n=287) 
Number (%) 
NAFC (n=126) 
Number (%) 
Patient initiated 174 (60.6) 56 (44.4) 
Other person initiated 71 (24.7) 13 (10.3) 
Not talked about feet 42 (14.6) 57 (45.2) 
 
Of the 84 responders who reported that someone else initiated talking about feet, it 
was most frequently a rheumatologist (Table 5.21). The proportion of the AFC group 
reporting a rheumatology clinician had initiated discussions about feet was 60% 
(n=59). The equivalent numbers for the NAFC group was 53% (n=9). The inclusion 
of the podiatrist as a category is ambiguous, as for the question to be raised by a 
podiatrist the patient would have had to have had a clinical consultation with a 
podiatrist.  
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Table 5.21 Categories of other person initiating talking about feet* in 84 
responders  
Person who initiated talking about 
feet 
AFC (n=98)  
Number (%) 
NAFC (n=17) 
Number (%) 
Family  6 (6.1) 2 (11.8) 
Practice nurse 2 (2.0) 0 (0) 
Rheumatology nurse 12 (12.2) 1 (5.9) 
Friends 1 (1.0) 2 (11.8) 
Rheumatology Doctor 47 (48.0) 8 (47.1) 
Other 6 (8.5) 1 (5.9) 
GP 13 (13.3) 3 (17.6) 
Podiatrist / chiropodist 11 (11.2) 0 (0) 
*Some patients indicated more than one person who initiated discussions about feet 
5.4.7.10 Feet examined (B4) 
Of the 413 responders, 312 (75.5%) recalled having their feet examined (Table 
5.22). Of the AFC group (n=287), 238 (76.3%) reported having their feet examined 
in contrast to only 74 (58.7%) of the NAFC group (n=126) (  =27, df=1, p=<0.001). 
A third of responders (n=150, 36.3%) reported they had undergone a foot 
examination in the last 12 months. In the AFC group, 116 (40.4%) had their feet 
examined in the previous 12 months but only 43 (26.9%) of the NAFC group 
recalled an examination for the same time period. 
 
Of the AFC group, 49 reported they had not had their feet examined. Although it 
seems likely their feet would have been examined during their foot care 
consultation, more than half of them (n=27) went on to comment that they felt an 
examination of their feet should have been performed, suggesting that a foot 
examination was not done or patients did not recognise that their feet had been 
examined.  
 
Table 5.22 Time interval of foot examinations (n=413) responders 
Time interval of last recalled 
foot examination 
AFC (n=287) 
Number (%) 
NAFC (n=126) 
Number (%) 
0-6 months 74 (25.8) 15 (11.9) 
>6 -12 months 42 (14.6) 19 (15.1) 
>12-18 months 29 (10.1) 5 (4.0) 
>18 months 65 (22.6) 32 (25.4) 
Can’t remember 28 (9.8) 3 (2.4) 
Never had feet examined 49 (17.1) 51 (40.1) 
Not completed 0 (0) 1 (0.8) 
 
5.4.7.11 Foot problems 
Table 5.23 presents the frequencies of self-reported current and previous foot 
problems. The proportions of responders reporting any current foot problems were 
93.7% (n=269) in the AFC group versus 80.2% (n=101) in the NAFC group. This 
was a significant result (  =17, df=1, p=<0.001). Nonetheless, the great majority of 
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the AFC group and the NAFC group reported they had experienced foot problems at 
some time since developing RA. 
 
Table 5.23 Reported foot problems AFC (n=287) versus NAFC (n=126) (%) 
Foot 
problem 
category 
Foot 
problems 
Foot 
problem 
AFC 
Now 
Foot 
problem 
NAFC  
now 
Foot 
problem 
AFC 
ever 
Foot 
problem 
NAFC 
ever 
Never 
had foot 
problem 
AFC 
Never 
had foot 
problem 
NAFC 
Articular 
features Pain 
193 
(67.2) 
70 
(55.6) 
244 
(85.0) 
98 
(77.8) 
43 
(15.0) 
28 
(22.2) 
Stiffness 
162  
(56.4) 
62 
(49.2) 
191 
(66.6) 
86 
(68.3) 
96 
(33.4) 
40 
(31.7) 
Swelling 
156 
(54.4) 
62 
(49.2) 
199  
(69.3) 
87  
(69.0) 
88 
(30.7) 
39 
(31.0) 
Any articular 
feature 
220 
(76.7) 
85  
(67.5) 
263 
(91.6) 
110 
(87.3) 
24 
(8.4) 
16 
(12.7) 
Cutaneous 
lesions Blisters 
19 
(6.6) 
9 
(7.1) 
50 
(17.4) 
23 
(18.3) 
237 
(82.5) 
103 
(81.7) 
Callus 
136 
(47.4) 
35 
(27.8) 
160 
(55.7) 
46 
(36.5) 
127 
(44.3) 
80 
(63.5) 
Corns 
61 
(21.3) 
11 
(8.7) 
87 
(30.3) 
22 
(17.5) 
200 
(69.7) 
104 
(82.5) 
In-grown toe 
nails 
45 
(15.7) 
14 
(11.1) 
62 
(21.6) 
14 
(11.1) 
225 
(78.4) 
112 
(88.9) 
Thickened 
Toe nails 
127 
(44.3) 
41 
(32.5) 
141 
(49.1) 
49 
(38.9) 
146 
(50.9) 
77 
(61.1) 
Ulcers 
9 
(3.1) 
4 
(3.2) 
50 
(17.4) 
23 
(18.3) 
237 
(82,6) 
103 
(81.7) 
Any 
cutaneous 
lesions 
206 
(71.8) 
64 
(50.8) 
230 
(80.1) 
73 
(57.9) 
 
57 
(19.9) 
 
53 
(42.1) 
Structural 
deformity Bunions 
88 
(30.7) 
23 
(18.3) 
109 
(38.0) 
32 
(25.4) 
178 
(62.0) 
94 
(74.6) 
Fallen arches  
81 
(28.2) 
12 
(9.5) 
98 
(34.1) 
23 
(18.3) 
189 
(65.9) 
103 
(81.7) 
Misshaped 
toes 
145 
(50.5) 
35 
(27.8) 
158 
(55.1) 
41 
(32.5) 
129 
(44.9) 
85 
(67.5) 
Any 
structural  
deformity 
184 
(64.1) 
54 
(42.8) 
204 
(71.1) 
61 
(48.4) 
 
83 
(28.9) 
 
65 
(51.6) 
Extra-
articular 
features 
Nodules 
73 
(25.4) 
23 
(18.3) 
90  
(31.2) 
32  
(25.4) 
197 
(68.4) 
94 
(85.5) 
Numbness 
93 
(32.4) 
25 
(19.8) 
114  
(39.7) 
39  
(31.0) 
143 
(49.8) 
87 
(69.5) 
Any extra 
articular 
feature 
134 
(46.7) 
42 
(33.3) 
157 
(52.3) 
55 
(43.7) 
 
130 
(45.3) 
 
71 
(56.3) 
Other 
Infection 
25 
(8.7) 
6 
(4.8) 
62 
(21.6) 
14 
(11.1) 
225 
(78.4) 
112 
(88.9) 
Any 
problems  
269 
(93.7) 
101 
(80.2) 
284  
(99.0) 
115 
(91.3) 
3 
(1.0) 
11 
(8.7) 
 
5.4.7.12 Foot Impact Scale (Section C) 
There were 400 admissible FIS scores. The FISIF scores for the AFC group and 
NAFC group (Figure 5.15) had medians (IQRs) of 11 (7 to 14) and 8 (4 to12) 
respectively. Although this was significant (U =13284.5, p=0.01), the result indicates 
that foot problems were impacting on many patients in both groups in relation to 
impairment and footwear.  
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Figure 5.15 Frequency distribution of FISIF scores (n=400)  
 
 
Figure 5.16 presents the distribution of FISAP scores for the AFC group and NAFC 
group. The median (IQR) for the AFC group was 17 (7 to 23) and for the NAFC 
group was 13.5 (7 to 23). This result indicates that foot problems were impacting on 
many patients in terms of activity and participation.  
 
Figure 5.16 Frequency distribution of FISAP scores responders (n=400)  
 
 
5.4.7.13 Importance of foot problems (B6) 
Figure 5.17 presents the distribution of the importance scores for the AFC group and 
NAFC group. The median (IQR) importance score for the AFC group was 7 (4 to 9) 
and for the NAFC group was 5 (2 to 8) (U=14227.5, p=0.001). Though the AFC 
reported greater importance, a third (n=36, 28.9%) of the NAFC reported their foot 
problems to be important (scoring ≥8).  
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Figure 5.17 Importance of foot problem score (n=400) responders 
  
 
5.4.7.14 Ability to cope with foot problems (B7) 
Figure 5.18 presents the distribution of ability to cope with foot problems scores for 
the AFC group and the NAFC group. The median (IQR) for the AFC group was 5 (3 
to 7) and for the NAFC group was 4 (1 to 6) (U=14054.0, p<0.001). The AFC 
reported greater difficulty coping and many patients (n=61, 21%) were not coping 
well with foot problems (scoring ≥ 8) and a sixth of the NAFC group (n=18, 14.3%) 
reported not being able to cope well with foot problems.  
 
Figure 5.18 Ability to cope with foot problems score (n=400) responders 
 
 
5.4.7.15 Magnitude of foot problems (B8) 
Figure 5.19 presents the magnitude of foot problem scores for the AFC group and 
the NAFC group. The median (IQR) for the AFC group was 6 (4 to 8) and for the 
NAFC group was 5 (2 to7) (U=13653.0, p<0.001). Many patients of the AFC group 
considered their foot problems were severe (scoring ≥8) (n=80, 28%). A fifth of the 
NAFC group reported their foot problems were severe (n=18, 14.3%).  
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Figure 5.19 Severity of foot problems distribution scores (n=400)  
 
 
5.4.7.16 Comparisons of measures of impact 
Table 5.24 and Table 5.25 present the Spearman’s rank order correlation coefficient 
(Spearman’s rho) matrix for: FISIF, FISAP, importance of foot problems, ability to 
cope with foot problems and magnitude of foot problems for the AFC group and the 
NAFC group. There were statistically significant moderate relationships between all 
measures of impact for both the AFC group and the NAFC group. Approximately 
50%.of the variance in FISIF scores was explained by the FISAP scores. The 
proportion of variance for FISIF and FISAP scores explained by importance, ability to 
cope with foot problems and magnitude scores was between 28% and 63%. This 
result indicates that the additional measures of impact are providing information not 
included in the FIS. Correlations between the additional measures of impact were 
higher with explained variance between 53% and 83%. This suggests that while 
there is some overlap, these data may be reflecting some differences between the 
additional measures of impact with the FIS. 
 
Table 5.24 Correlation of measures of impact in the AFC group (n=287) 
Spearman’s 
rho 
  
FISAP 
AFC 
Importance 
AFC 
Ability to 
 cope 
AFC 
Magnitude 
AFC 
FISIF Correlation .710
**
 .614
**
 .619
**
 .645
**
 
Explained variance 
% 50.4 37.7 38.3 41.6 
FISAP Correlation  .526
**
 .565
**
 .551
**
 
Explained 
variance%  27.7 31.9 30.4 
Importance Correlation   .726
**
 .836
**
 
Explained variance 
%   52.7 69.9 
Ability to 
cope 
Correlation    .838
**
 
Explained variance 
%    70.2 
n= 278, ** p=<0.001 
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Table 5.25 Correlation of measures of impact in the NAFC group (n=126) 
Spearman’s 
rho 
  FISAP 
NAFC 
Importance 
NAFC 
Ability 
to  
cope 
NAFC 
Magnitude 
NAFC 
FISIF Correlation .709
**
 .735
**
 .771
**
 .794
**
 
Explained variance% 50.3 54.0 59.4 63.0 
FISAP Correlation  .544
**
 .574
**
 .601
**
 
Explained variance%  30.0 32.9 26.1 
Importance Correlation   .847
**
 .911
**
 
Explained variance %   71.7 83.0 
Ability to cope Correlation    .905
**
 
Explained variance %    81.2 
n=122, ** p<0.001 
 
5.4.7.17 Impact of foot problems and ability to work (B9) 
Of the 413 responders, 159 (38.5%) did not answer this because they had chosen to 
not work in paid employment (for example were retired). Reasons for not working 
were provided by self-initiated free text responses. Of the remainder in the AFC 
group (n=164) the proportion reporting foot problems affecting their ability to work 
was 62.8% (n=103). The proportion of the NAFC group indicating that foot problems 
were affecting their ability to work was similar (58.9%, n=53). The difference 
between the groups was not statistically significant (    0.38, df=1, p=0.54). Foot 
problems were affecting the ability to work in well over a third of responders. 
Further, many patients had not accessed foot care despite reporting foot problems 
affecting their ability to work (Table 5.26). 
 
Table 5.26 Impact of foot problems and ability to work 
Impact of foot problems 
affecting ability to work 
AFC (n=164) 
Number (%) 
NAFC (n=90) 
Number (%) 
Yes 103 (62.8) 53 (58.9) 
No 61 (37.2) 37 (41.1) 
 
5.4.7.18 Overview of comparison of AFC and NAFC responses 
Those responders who had accessed foot care: were female, older, had longer 
disease duration, higher levels of disability and had additional morbidity. However, 
these differences were relatively small and do not provide a strong indication of 
which patients are likely to access foot care. Overall foot problems were important 
issues for many patients in both groups. For example when discussions about feet 
are conducted; it appears they are often initiated by patients. The frequencies of 
patients initiating discussions were broadly similar for both the AFC group and the 
NAFC group. Although as might be expected, a greater proportion of the AFC group 
reported having had a foot examination (76.3% versus 58.7%) patients in both 
groups reported never having had a foot examination. A quarter of the AFC group 
Chapter 5 Study 2: Survey  
196 
reported they had not had a foot examination indicating that some patients 
considered a foot examination to be part of their rheumatology care rather than 
when foot care was accessed. This supports the notion (as identified in Study 1) that 
asking about feet and conducting a foot examination may not occur in all 
rheumatology clinical consultations. Annual review of patients’ feet and assessment 
of foot health care needs is recommended in rheumatology national guidelines 
(Luqmani et al, 2006). Validation of the self-report with rheumatology medical 
records of the conducted foot examination was not conducted in this study. 
Therefore these data are not a clinical audit of local practice meeting national 
guidelines.  
 
In relation to foot problems, almost all of the AFC group and the NAFC group 
reported having one or more current foot problems. However, despite accessing foot 
care many foot problems continued. Additionally, a third of patients reported their 
foot problems were affecting their ability to work. Of these, two thirds had accessed 
foot care. Thus despite accessing foot care a large number of patients’ ability to 
work was still restricted by their foot problems. These data therefore raise issues 
regarding the quality and/or effectiveness of care received. The quality and 
effectiveness of foot care cannot be quantified by these data but it is an issue that 
was investigated further in the embedded clinical assessment study (Study 3, 
Chapter 6) where direct examination of the feet was undertaken. It is not possible to 
draw firm conclusions regarding the clinical significance of impact of foot problems 
in this study. Nonetheless, these data further support the inclusion of additional 
measures of impact to capture aspects relevant to patients not included in the FIS. 
The detailed validation of additional measures of impact could be explored in future 
work.  
 
5.4.8 Multivariate analysis of determinants of access to foot care 
Univariate analyses comparing the AFC group and the NAFC group were conducted 
to identify non-foot related variables for inclusion in a logistic regression model 
(Table 5.27). Predictor variables with p=<0.4 were selected as variables in a series 
of logistic regression models. Selection of predictor variables which are statistically 
significant at p<0.05 may fail to identify variables of known importance (Mickey and 
Greenland, 1989). See results Table 5.27. 
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Table 5.27 Independent variables as determinants of AFC 
Variable based AFC (n=287) 
versus NAFC (n=126) 
Univariate analyses 
a
 Multivariate analyses 
b
 
Hospital site Proportions similar AFC 
versus NAFC according to 
hospital site 
Excluded from model 
Gender p=0.04 Included in model 
Age p=0.01 Included in model 
Social deprivation p=0.363 Included in model 
Disease duration p=>0.001 Included in model 
Arthritis medications Proportions similar AFC 
versus NAFC according to 
arthritis medications 
Excluded from model 
Disability p=0.005 Exclude from model, as 1 section 
captures lower limb disability 
a 
Univariate analyses of demographic and clinical variables to identify factors associated as predictors 
of AFC. 
b 
Variables with p=< 0.4 in univariate analyses were entered into a series of logistic regression models 
to identify independent predictors of AFC 
 
Logistic regression analyses were then conducted to measure the independent 
relationships of demographic (age, social deprivation and gender) and clinical 
characteristics (disease duration) to compare the adjusted odds for accessing foot 
care. Adjusted odds ratios were used for comparisons of the independent variables 
as predicators of the dependent variable (accessed foot care).  
 
Table 5.28 presents the results of the binary logistic regression analyses. Employing 
the statistical significance of p<0.05 female gender, age and disease duration made 
a statistically contribution to the model. The model as a whole explained between 
7% (Cox and Snell R square) and 10% (Nagelkerke R squared) of variance in 
access to foot care. Analyses revealed increased odds of AFC in those with longer 
disease duration of 4% (on average) and in those who were older of 2% (on 
average). This indicates an increased chance of accessed foot care for disease 
duration and age was 4% and 2% per year (on average); respectively. Although 
these results demonstrate disease duration and age to be independent factors of 
access to foot care the effect for both was mild. The strongest predictor of AFC was 
female gender, with an odds ratio of 1.72 (95% CI 1.059 2.790). The OR for gender 
indicates that when holding all the other variables constant, women were 1.7 times 
more likely to access foot care compared to men  
 
Table 5.28 Results of logistic regression analyses 
Predictive variable B (co-efficient of 
determinant) 
P Exp (B) Adjusted odds ratio (CI 
95%) 
Gender 0.542 0.03 1.719 (1.059-2.790) 
Age 0.021 0.02 1.021 (1.003-1.031) 
Disease duration 0.041 <0.01 1.042 (1.017-1.067) 
Social deprivation (average of 3 
categories) 
-0.374 0.27 0.691 (0.365-1.314) 
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5.4.9 Details of foot care services accessed 
 
5.4.9.1 Access to services 
Of the 413 responders, 287 (69.5%) had at some time accessed foot care services 
204 (71.1%) podiatry, 192 (66.7%) orthotics and 92 (32.1%) orthopaedics. Of the 
podiatry group (n=204), over half had sourced independent sector care (n=107, 
52.5%). Of AFC group, 140 (48.8%) had accessed two or more services (Table 
5.29).  
 
Table 5.29 Number of foot care services accessed (n=287 of 413) 
Foot care services accessed Number (%) 
1 Foot care service 146 (50.9) 
2 Foot care services 79 (27.5) 
3 Foot care services 61 (21.3) 
Missing data* 1(0.3) 
Total 287 
*Missing data for one respondent not completing accessed orthotics 
 
Of the 413 responders, 209 had not accessed podiatry. Of these 122 (58.4%) 
indicated that they would have liked to have been referred to podiatry. The 
equivalent numbers for orthotics group (n=214) and orthopaedic group (n=311) were 
58 (27.1%) and 43 (13.8%); respectively. Therefore of the foot care services not 
accessed, podiatry was the most frequent service responders would have liked to 
have been referred to.  
 
5.4.9.2 Foot care received (B11, B13) 
Of the group AFC (n=287), 278 (96.9%) competed the questions relating to care 
received. It is possible that 9 (2.1%) patients inadvertently failed to complete the 
questions due to the layout of the questionnaire (responses are on the reverse page 
of services accessed).  
 
The frequency of care categories received is presented in Table 5.30. Device 
prescriptions were the most frequent care category reported. However, data were 
not collected on which service provided the intervention (devices). Of 72 patients 
who had undergone foot surgery, 54 (75.0%) reported that their foot problems had 
improved after surgical intervention (in answering question B13 C in the 
questionnaire). Data were not collected on the responders, perceptions on the 
improvement of foot problems after accessing orthotics or podiatry. 
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Table 5.30 Foot care interventions received 
*Missing data 9 (3.1%) AFC group 
 
5.4.9.3 Access by hospital site 
Overall the proportions of responders accessing the separate foot care services 
were similar for both hospital sites (Table 5.31). 
 
Table 5.31 Access to foot care by hospital site 
Hospital site NBT (n=209) 
Number (%) 
UHB (n=204) 
Number (%) 
Podiatry 100 (47.8) 104 (51.0) 
Orthotics 106  (50.7) 86 (42.2) 
Orthopaedics 50 (23.9) 42 (20.6) 
 
5.4.9.4 Access to foot care by gender 
Table 5.32 presents access to foot care services according to gender. Of the 107 
male survey questionnaire responders, 46 (43%) had accessed podiatry while of the 
306 female responders, 158 (51.6%) had accessed podiatry (   = 2.74, df=1, 
p=0.124). There was also no significant difference between genders in access to 
orthotics (  =1.5, df=1, p=0.46), though a slightly larger proportion of women 
(25.2%) than men (14.1%) had accessed orthopaedics (  =6, df=1, p=0.017). 
 
Table 5.32 Access to foot care by gender 
 Female (n=306) 
Number (%) 
Male (n=107) 
Number (%) 
Podiatry (n=204) 158 (51.6) 46 (43.0) 
Orthotics (n=192) 151 (49.3) 41 (38.3) 
Orthopaedics (n=92) 77 (25.2) 15 (14.1) 
 
Foot care category Foot care interventions  
 
AFC (n=287) 
Number (%) 
Devices Hospital shoes  73 (25.4) 
Insoles  190 (66.2) 
Padding  58 (20.2) 
Toe protectors  11 (3.8) 
Any devices 222 (76.4) 
Non-pharmacological Advice  69 (24.0) 
Foot exercises  42 (14.6) 
Any non-pharmacological 93 (32.4) 
Pharmacological Antibiotics for infection   24 (8.4) 
Creams for infection   22 (7.7) 
Steroid injection   40 (13.9) 
Any pharmacological 74 (25.8) 
Treatment cutaneous 
lesion 
Nail care  53 (18.5) 
Treatment for corn /callus   62 (21.6) 
Wound care  19 (6.7) 
Any treatment cutaneous lesions 99 (34.5) 
Other Foot surgery 72 (25.1) 
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5.4.9.5 Access to foot care by age 
Figure 5.20 presents the age distribution of the AFC group in relation to individual 
foot care services accessed. Median (IQR) for age in years for each service was: 
podiatry 68 (60 to 76); orthotics 65 (53 to 73); and orthopaedics 67 (60 to74). 
 
Figure 5.20 Age distribution of responders and access to foot care services 
   
  
5.4.9.6 Access to foot care services by social deprivation 
Of the AFC group (n=287), 55 (19.2%) resided in local social deprivation categories 
4 and 5. Figure 5.21 presents access to each foot care service in relation to social 
deprivation and shows a similar distribution for all three services. 
 
Figure 5.21 Access to foot care services by social deprivation 
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5.4.9.7 Disease duration 
The median (IQR) disease duration (years) reported for the podiatry group was13 (7 
to 23), for the orthotics group was 13 (6 to 24) and for the orthopaedic group was 
greater as might be expected at 16 (10 to 28) (Figure 5.22).  
 
Figure 5.22 Disease duration distribution for foot care services accessed 
 
 
 
5.4.9.8 Medication 
The number (proportions, %) of the podiatry group (n=204) taking different types of 
arthritis medications were: NSAIDS 69 (33.8%), DMARDS 164 (80.4%), 
glucocorticoids 61 (29.9%) and biologics 34 (16.7%). The equivalent numbers for 
the orthotics (n=192) and the orthopaedics groups (n=92) were similar: NSAIDS 66 
(34.4%) versus 36 (39.1%); DMARDS 152 (79.2%) versus 69 (75.0%); 
glucocorticoids 51 (26.6%) versus 28 (30.4%); Biologics 38 (19.8%) versus 24 
(26.1%). The frequencies of medication categories being taken by the podiatry, 
orthotics and orthopaedics groups are presented in Table 5.33. They were similar 
for all three groups.  
 
Table 5.33 Frequency of RA medication categories by foot care service 
Medication category Podiatry (n=204) 
Number (%) 
Orthotics (n=192) 
Number (%) 
Orthopaedics (n=92) 
Number (%) 
Not taking RA medication 7 (3.4) 8 (4.2) 4 (4.3) 
Taking 1 category of  medication 94 (46.1) 88 (45.8) 38 (41.3) 
Taking 2 categories of  
medication 
78 (38.2) 71 (37.0) 33 (35.9) 
Taking 3 categories of  
medication 
22 (10.8) 23 (12.0) 15 (16.3) 
Taking 4 categories of  
medication 
3 (1.5) 2 (1.0) 2 (2.2) 
 
5.4.9.9 Disability 
A wide range of disability was reported by patients in all three groups (Figure 5.23). 
Median (IQR) HAQ scores for each service was: podiatry 1.625 (1.0 to 2.0), 
orthotics 1.625 (1.0 to 2.063) and orthopaedics 1.750 (1.0 to 3.0) indicating a trend 
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for patients who have accessed orthopaedics to have greater disability, as might be 
expected. 
 
Figure 5.23 Distribution of HAQ scores according to foot care services 
accessed 
 
    
 
5.4.9.10 Co-morbidities 
 
Tables 5.34 presents the self-report frequencies of additional co-morbidities by foot 
care service accessed and similar proportions of additional health conditions were 
detected for patients accessing each foot care service. Almost all (20/22, 91%) of 
the AFC patients with diabetes had accessed podiatry. See Appendix I for 
supplementary data for categories of co-morbidities according to foot care service 
accessed. 
 
Table 5.34 Frequency of co-morbidity according to foot care service accessed 
Number of co-morbidity Podiatry (n=204) 
 in this category 
Number (%) 
Orthotics (n=192)  
in this category 
Number (%) 
Orthopaedics 
(n=92) in this 
category 
Number (%) 
No other co-morbidity 59 (28.9) 66 (32.8) 26 (28.3) 
1 co-morbidity 88 (43.1) 47 (40.1) 47 (51.1) 
 2 co-morbidities 42 (20.6) 38 (19.8) 13 (14.1) 
> 3 co-morbidities 15 (7.4) 14 (7.3) 6 (6.5) 
Any co-morbidity 145 (71.1) 99 (51.6) 66 (71.7) 
 
5.4.9.11 Foot problems according to foot care service 
It was anticipated that there would be variation in categories of foot problems in 
relation to services accessed (e.g. the proportion of patients experiencing cutaneous 
lesions would be greater in the podiatry group). However, as shown in Table 5.35 
there was similar distribution of foot problems in all the foot care groups.  
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Table 5.35 Frequency of self-reported foot problem categories according to 
foot care services accessed 
 Podiatry  
(n=204) 
Number (%) 
Orthotics  
(n=192) 
Number (%) 
Orthopaedics  
(n=92) 
Number (%) 
Articular features ever 184 (90.2) 183 (95.3) 92 (100) 
Extra-articular features ever 112 (54.9) 110 (57.3) 58 (63.0) 
Cutaneous lesions  ever 169 (82.8) 154 (80.2) 79 (85.9) 
Structural deformity ever 153 (75.0) 150 (78.1) 75 (81.5) 
Other ever 44 (21.6) 44 (22.9) 21 (22.8) 
Any foot problems ever 202 (99.0) 191 (99.5) 92 (100) 
 
5.4.9.12 Summary of services received 
As might be expected patients who had accessed orthopaedics had longer disease 
duration and higher levels of disability compared to those who had accessed 
podiatry and orthotics. Patient characteristics were otherwise similar. 
 
5.4.10 Routes of access to foot care services  
 
5.4.10.1 Overview of routes of access 
Table 5.36 presents access routes to foot care services.  
 
Table 5.36 Foot care services accessed and referral route categories 
Referral route Podiatry (n=204) 
Number (%) 
Orthotics (n=192) 
Number (%) 
Orthopaedics (n=92) 
Number (%) 
Self NHS 53 (26.0) 3 (1.6) 1 (1.1) 
Privately 39 (19.1) 2 (1.0) 3 (3.3) 
GP 54 (26.5) 25 (13.0) 25 (27.2) 
Hospital 50 (24.5) 159 (82.8) 60 (65.2) 
Community nurse 2 (1.0) 0 (0) 1 (1.1) 
Other 3 (1.5) 3 (1.6) 2 (2.2) 
 
Of particular note are the patients who accessed podiatry, where nearly half (46.1%) 
had self-referred and this included 19.1% who had accessed independent sector 
care. The majority of orthotics and orthopaedic referrals had been through hospital 
based clinician referrals, indicating that most of these patients had talked about their 
foot problems with clinicians in order for a referral to be generated. However, almost 
half of the patients who had accessed podiatry had not been referred by a clinician. 
Further it would appear hospital based clinicians are more likely to refer patients to 
hospital based foot care services than the community based podiatry service. Only a 
quarter of patients who had accessed podiatry reported to have been referred by a 
hospital based clinician.  
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5.4.10.2 Gender and routes of access 
There were differences in access routes to some foot care services between 
genders (Table 5.37).  
 
Table 5.37 Access routes to foot care by gender 
Referral route Podiatry (n=204) 
(Number (%) 
 Orthotics (n=192) 
Number (%) 
 Orthopaedics (n=92) 
Number (%) 
Gender Female 
n=158 
(77.5) 
Male 
n=46 
(22.5) 
  Female 
n=151 
(78.6) 
Male 
n=41 
(23.4) 
 Female 
n=77 
(83.7) 
Male 
n=15 
(16.3) 
Self NHS 47 (29.7) 9 (20.0)  3 (2.0) 0 (0)   1 (1.3) 0 (0) 
Privately 30 (19.0) 9 (20.0)  2 (1.3) 0 (0)  2 (2.6) 1 (6.7) 
GP 35 (22.2) 19 (41.3)  19 (12.6) 6(14.6)  16 (20.7) 9 (60.7) 
Hospital 42 (26.6) 8 (17.4)  126 (83.4) 33 (80.2)  55 (71.4) 5 (33.3) 
Community nurse 2 (1.3) 0 (0)  0 (0) 0 (0)  1 (1.3) 0 (0) 
Other 2 (1.3) 1 (2.2)  1 (0.7) 2 (1.0)  2 (2.6) 0 (0) 
Missing data 0 (0) 0 (0)  1 (0.7) 0 (0)  0 (0) 0 (0) 
  
For podiatry the differences were that a greater proportion of women self-referred 
compared to men (48.7% versus 40.0%), that a greater proportion of the men 
(41.3% compared to 22.2% for women) had been referred by their GP while a lesser 
proportion (17.4% compared to 26.6% for women) had been referred via the 
hospital. These results indicate a tendency for men to discuss their foot problems 
with their GP while women are more likely to self-refer or discuss their foot problems 
with hospital based clinicians. 
 
There was a similar (more marked) pattern for referral to orthopaedics. The 
proportion of men referred to orthopaedics by GP generated referrals was greater 
than the proportion of women referred. In contrast hospital based clinicians referred 
more women than men to orthopaedics. Most referrals to orthotics are through the 
hospital, which reflects local foot care service access criteria at the time of data 
collection, when access to orthotics services was restricted to hospital based 
clinicians. In contrast referrals to orthopaedics were accepted from both hospital 
based clinicians and GPs. 
 
5.5 Qualitative analysis of patients’ experiences 
Of the 413 responders, 158 (38.3%) completed a free text response question, “If you 
have any other comments about foot problems in rheumatoid arthritis that you would 
like to make, please add them here”. Of these, 82 (51.9%) responses described 
current foot problems. Additionally, foot problems following a fluctuating clinical 
pattern were reported by 26 (16.5%), and a small number of responders (n=9, 
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11.0%) reported their current foot problems were not related to RA. The impact of 
foot problems on daily life was mentioned by 66 (41.8%) responders.  
 
The most common free text data relating to foot care services accessed related to 
orthopaedics (n=30, 19.0%). It is possible that responders who accessed 
orthopaedics may have been influenced to complete free response by the ordering 
of the questions in the questionnaire (question relating to foot surgery preceded the 
free text response question). Of the 30 responders providing free text data relating 
to orthopaedics, a third (n=8, 27%) indicated that the foot surgery was not related to 
RA. 
 
Of the 287 AFC patients 113 (39.4%) completed the free text question while 45 
(35.7%) of the 126 NAFC patients did so. 
 
In Table 5.38 presents descriptive statistics (frequencies, proportions of responders 
completing free text response question) and quotes from textual data (accompanied 
by study identifiers, gender and age) as exemplars of emergent response 
categories.  
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Table 5.38 CA free text response data 
If you have any other comments about foot problems in rheumatoid arthritis (n= 158: 38.3%) 
Response category  Response sub 
category 
Frequency 
(%) 
Qualitative data 
Foot problems (problems) Articular features 48 (30.4) “Always have pain in my foot and ankle joints. The tablets do not do anything” ID21235M33 
Extra articular features 15 (9.5) “Continuous pins and needles” ID22654F76 
Structural deformity 10 (6.3) “Big toe on Left foot has slipped sideways. 2nd toe slipped up and rubs on shoes, have to wedge 
the toes together to get shoes on. Foot falling inwards, causing pain in ankles, poor posture 
affecting knees.” ID5937F62 
Foot problems not 
related to RA 
9 (5.7) “Numbness in feet is not due to RA. Have compression on lower 4 /5 discs in my back” ID5976M76 
Fluctuating foot problems Feet first 5 (3.2) “First symptom of RA I noticed was pain in the soles of my feet after standing / walking for 
extended periods” ID22589M61 
RA medications 11 (7.0) “Had problems with pain and swelling in the feet but that has now gone since starting [name of 
biologic agent]” ID22356M64 
Flare 3 (1.9) My foot problems are always worse in a flare. I dread having to stand on them. The pain is intense 
on soles of feet and ankles.” ID20763F73 
Come and go 7 (4.4) “Foot problems come and go, few days to a week. Most problems related to stiffness which is 
almost constant.” ID1214M65 
Impact of foot problems Activities 23 (14.6) “My feet pain constantly especially after walking and standing for long periods. They will then be 
very painful the following day.” ID4436M42 
Participation 24 (15.2) “Curtails my activities due to pain after walking for a short distance. Social life affected. Extra 
weight due to limited exercise.” ID21241F74 
Footwear 14 (8.9) “Clothes I wear are governed by my footwear. Would like to wear a summer dress but can't with 
clumpy shoes. Wear sandals in to winter to save squashing my feet in shoes.” ID22654F76  
Work 2 (1.3) “Feet very painful, still trying to work but it is hard, can't give up.” ID3021F59 
Foot Impact Scale 3 (1.9) “FIS questions are very black and white and not a true reflection of how someone with RA may 
feel” ID22886F43 
Access to foot care perceived 
unnecessary by responders 
Feet not a problem 10 (6.3) “No RA in feet.” ID1362M63 
Can self-care / self-
manage 
1 (0.6) “Have to put foam between big toe and 1 next to other wise a painful corn develops” ID20671F65 
Access to foot care hindered 
by responders’ perception 
Limited awareness of 
treatment options 
3 (1.9) “Don't know what an orthotist is” ID21367F61 
Feet ignored by 
clinicians 
11 (7.0) “My RA tends to float. Get frustrated because assessments don't include my feet. Been told hands 
count. Pain in feet so bad sometimes I can't walk. But I don't have pain in my hands - this seems to 
be ridiculous.”  ID22714F58 
Past negative 
experiences of foot care 
8 (5.1) “Shoes supplied by orthotics department were too heavy. Rocker soles seem pointless. Trainers 
more helpful. Sole on orthotic shoes were too thin.” ID22981F78  
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Access to foot care supported Can’t self-care / self-
manage 
7 (4.4) Fortunately I'm not experiencing any feet problems apart from I can't bend to cut my toe nails so I 
see a podiatrist privately. Current medication having positive  effect on RA” ID10014F75 
Positive experiences of 
foot care 
5 (3.2) “The insoles I've been given are a great help.” ID23247F61 
Foot surgery Had foot surgery 17 (10.8) “Since foot surgery appearance of feet improved. Don't need to keep them covered. Still get some 
pain but much happier as feet are more comfortable” ID2721F56 
Waiting for foot surgery 3 (1.9) “Waiting for foot surgery” ID592F62 
Foot surgery not 
recommended 
2 (1.3) “Had a triple fusion, ankle replacement, fractured bone repaired. Surgery didn't work if I have 
further surgery I will lose my leg.” ID22492F64  
Foot surgery not related 
to RA 
8 (5.1) “Surgery for ankle was not because of RA but car accident as a child.” ID22982F45 
*More than one response disclose 
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In general the free text response data support the findings of Study 1 (one to one 
interviews) and did not reveal any new issues relating to foot problems in RA. They 
reinforce the view that foot problems in RA can be multi-factorial: follow a fluctuating 
clinical pattern and impact on many aspects of patients’ lives. However, a small 
number of responders indicated that their current foot problems were not related to 
RA. Further, some of the responders who had accessed orthopaedics had 
undergone surgical procedures which were not related to the consequences of RA. 
 
5.6 Discussion 
 
A total of 2335 patients with RA were identified as registered for follow up 
rheumatology care at both hospital sites (NBT and UHB) corroborating the initial 
patient population estimate of 2000. Of these 1003 (43%) were registered with a GP 
within Bristol Community Health boundaries compared to the 1500 forecasted during 
the study design. Changes in boundaries of community NHS clinical services are 
likely to account for the discrepancy between estimated and actual target population 
numbers for the geographical area. In the interim period between planning, 
designing the study and conduct of the survey, Bristol Primary Care Trust (the 
organisation providing NHS community health services), which was the basis on 
which the community size was being estimated, split to form South Gloucestershire 
Primary Care Trust and Bristol Community Health. Nonetheless the total number of 
questionnaires posted (n=739) was similar to original approximations (as outlined in 
5.3.3) 
 
This study achieved an overall response rate of 56%, similar to other postal surveys 
of patients with RA conducted in the UK (Neame and Hammond, 2005; Otter et al, 
2010). Responders and non-responders were similar in relation to: hospital site, 
gender; age, and social deprivation (local). Responders to the questionnaire 
therefore approximate a representative sample of all RA patients in Bristol, and 
provide the first opportunity to assess a population not biased by selection 
procedures. The general and RA characteristics of responders were similar to 
previous postal survey studies undertaken in other parts of the UK (Blackburn et al, 
1994; Goodacre et al, 2007; Firth et al, 2008; Sanderson et al, 2010) and so the 
findings of the study are likely to reflect the characteristics of patients with RA in the 
UK. 
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Patients with RA can experience additional health conditions (co-morbidities) and in 
the representative patient sample included here two thirds of responders reported 
additional health conditions. It is possible that even this high frequency of self-
reported co-morbidities is an under estimate of the actual prevalence, as data were 
collected by an open ended question (see Appendix F2 question A5). Nonetheless, 
two thirds of patients had co-morbidities, a finding which has implications for the 
broader practice of rheumatology, as well as the provision of foot care. 
 
An annual review of patients’ feet is recommended in national guidelines (Luqmani 
et al, 2006). However, conduct of foot examinations in clinical practice can be 
variable. Some authors suggest that because the foot is omitted from standard 
measures of disease activity such as the DAS28 (van der Heijde et al, 1993), foot 
problems may be ignored (van der Leeden et al, 2010; Wechalekar et al, 2012). The 
majority of responders in this study recalled having undergone a foot examination, 
although only a quarter reported to have had a foot examination in the preceding 
twelve months. The accuracy of patients recalling the time when foot examinations 
were conducted requires consideration. Recall bias and accuracy of self-report if an 
event or exposure of interest occurred is recognised as a challenge in epidemiology 
studies (Coughlin, 1990). Further, it is also possible that some patients may not 
have accessed health care in relation to their RA in the previous year. However, 
almost all of the study responders were taking arthritis medications, many of whom 
would require regular contact with health care professionals for example 
haematological monitoring of arthritis medications. In Bristol, such monitoring is 
usually conducted in primary care by patients’ GPs as well as hospital outpatient 
review. Nonetheless this study suggests that patients perceive the conduct of foot 
examinations to be variable and potentially inadequate. 
 
This study has shown that patients with RA experience a wide range of foot 
problems and a large majority of responders reported one or more current foot 
problems. The nature of these problems was captured in detail, following careful 
construction of the questionnaire. Comparisons with other authors reporting the 
prevalence of foot problems in postal surveys is hampered by discordance of 
descriptors of foot problems and likely bias in the study sample. For example Otter 
et al (2010) included participants attending rheumatology out-patient clinics and 
members of an RA patient support group. The authors report the prevalence of foot 
problems in relation to articular features (pain, joint swelling) and extra-articular 
features (numbness). In contrast Firth et al (2008) report the prevalence of foot 
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ulceration (self-report) in a survey of all patients registered for follow up medical 
care at one rheumatology department. The proportion of patients reporting foot 
problems in this study is slightly lower than in previous publications. Nonetheless 
these figures are only slightly lower and the prevalence of foot pain, numbness and 
ulceration reported in this study were broadly similar to earlier reports.  
 
This study provides novel data on the range of self-care and self-management 
strategies adopted by patients with RA to manage their foot problems. It is not 
known if these strategies were self-initiated or suggested by clinicians. Work 
conducted by Hjlem et al (2002) investigating health behaviour in patients with 
diabetes and foot ulceration concluded women were more likely to participate in self-
care of their feet. In contrast men tended to seek professional care, rely on family 
members and were more passive in self-care. Self-care and self-management 
strategies adopted by responders in this study were similar for both men and 
women. Health behaviours of patients with RA in relation to self-care and self-
management of foot problems has not been fully explored. 
 
Foot problems can have a substantial impact on patients’ personal lives. The 
development of the FIS (Helliwell et al, 2005) has provided a useful tool to help 
measure the impact of foot problems. To the best of the researcher’s knowledge, 
this is the first study to utilise the FIS in a postal survey. Overall, FIS scores were 
lower than previous studies (Turner et al, 2008; Hooper et al, 2012; Siddle et al, 
2011), but as discussed above are likely to be a true representation of the overall 
position. However, the findings of Study 1 indicated that not all important issues of 
the impact of foot problems are captured in the FIS. These findings are supported by 
some patients reporting in the questionnaire that their foot problems were very 
important, severe and that they were not coping well with. Further a third reported 
that their foot problems were impacting on their ability to work. Work related 
disability in patients with RA has been widely described. This study therefore 
provides new data in relation to the impact of foot problems in relation to work 
related disability. Additional questions capturing impact (e.g. ability to cope with foot 
problems) included in the questionnaire correlated only modestly with FISIF scores 
and the FISAP scores, thus indicating they provided information not included in the 
FISIF and the FISAP scales. The use of the FIS as an outcome tool in routine clinical 
practice may be hampered by the length of the questionnaire. The development of a 
shorter PROM to measure the impact of foot problems was not an aim of this thesis, 
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indeed the questionnaire became longer. Nevertheless this might usefully be 
addressed in future research.  
 
Almost two thirds of the study sample had accessed one or more foot care services. 
The number of patients who had accessed foot care was higher than anticipated. 
This may be accounted for by the broader definition of access to foot care (AFC) 
used in this study (in particular, including the independent sector). Of the patients 
who had accessed podiatry in this study, over half had accessed independent sector 
care. Access to both NHS and independent sector podiatry has not been previously 
been reported. The frequency of access to self-funded (independent sector) foot 
care was an unexpected result. Reasons for accessing independent sector foot care 
require further exploration. This will be considered in Study 3 (Chapter 6). 
 
In spite of the higher than expected access rates, many patients reporting foot 
problems, some very severe, had not accessed foot care services. In multivariate 
analyses age, gender and disease duration were independently associated with 
access to foot care, but not strongly. As expected, age and disease duration 
independently increased the odds of AFC but only by 2% and 4% per year, 
respectively. The strongest independent predictor of AFC was female gender. This 
is not an unexpected result as it has been thought that foot problems may be more 
prevalent in women (Dunn et al, 2004), and access and utilisation of health care has 
been widely thought to be higher in women (Hulka and Wheat, 1985; Bertakis et al, 
2000; Courtenay, 2000). This study supports the notion that women access foot 
health care more than men. 
 
While there was a trend for women to access all three foot care services more than 
men, there were some noticeable differences in referral routes to podiatry and 
orthopaedics. More women accessed podiatry via self-referral and more men had 
been referred by clinicians. When clinicians did the referring either to podiatry or 
orthopaedics, it was more likely to be from hospital for women and from the GP 
surgery for men. Further, the proportions of patients accessing foot care and 
initiating discussions about feet were similar for both males and females. These 
results suggest that both male and female patients discussed their foot problems in 
clinical consultations. Of the AFC group 60% reported to have discussed foot 
problems with hospital base clinicians (rheumatologist and/or rheumatology 
specialist nurse). The proportion for the NAFC group reporting to have talked about 
foot problems with hospital based clinicians was 53%. These data do raise the 
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question of why hospital based clinicians do not refer more patients for foot care. Of 
the patients who had not accessed podiatry, over half indicated that they would like 
to have been referred, a similar finding being reported by Martin and Giffiths (2006). 
 
This study has identified broad characteristics of which patients are likely to access 
foot care. Nonetheless both health care professionals and planners of health care 
need to consider the difference between statistical significance and clinical 
significance (importance). Whilst knowing which patients are likely to access foot 
care is beneficial, these characteristics (e.g. age, gender) may not reflect clinical 
need. Indeed being female, older with long disease duration may increase the 
chance of access to foot care but these factors do not capture the nature or severity 
of foot problems in patients with RA. These data alone are therefore unlikely to 
influence commissioners and planners of health care to review provision of foot care 
for patients with RA. There is currently no local integrated pathway (ICP) to foot care 
services for patients with RA and foot problems. This could be considered for 
development by both health care professionals and commissioners of health 
services locally. The development of an ICP encompassing hospital and community 
based services is a potential option. Integrated care pathways for patients with 
diabetes and foot disease are recommended (NICE NC19) and well established 
locally. The development and implementation of an ICP for the management of foot 
problems in RA could then facilitate opportunities for more efficient universal patient 
centred foot care, thus ensuring patients receive the appropriate care when there is 
clinical need.  
 
A range of care interventions was reported. The frequency of prescribed footwear 
and foot surgery were similar to earlier reports (Otter et al, 2010). A fifth of patients 
who had accessed foot care indicated they had received treatment for calluses and 
corns. The clinical effectiveness of sharp callus debridement has been questioned 
(Davys et al, 2005; Siddle et al, 2013). Only a quarter of patients reported receiving 
any foot health care education. Additionally, despite having accessed care, the 
majority of patients reported current foot problems and substantial impact. This 
study has therefore highlighted that despite accessing foot care, many patients’ foot 
problems continued. These data therefore raise questions regarding the quality of 
foot care received. Data were not collected in this study in relation to severity of foot 
problems prior to or after foot care was accessed. Therefore it is not possible from 
this study to confirm or refute the clinical benefits of the foot care received by 
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patients. The clinical effectiveness and patient-perceived benefits of foot care will be 
explored in Study 3 and presented in Chapter 6. 
 
This study has also highlighted in several ways that foot problems are important 
issues for many patients. Firstly, when discussions relating to feet were conducted, 
the majority were reportedly initiated by the patient. Secondly, foot problems clearly 
impact on many aspects of patients’ lives, such as affecting ability to work. Thirdly, 
patients reported using a wide range of self-care and self-management strategies to 
manage their foot problems and foot health needs. Patients clearly wanted to do 
something about their feet, but reservations remain about the appropriateness of 
their actions as some of the strategies utilised by patients may be detrimental, 
particularly for patients with impaired tissue viability (for example topical 
keratolytics). The important question of whether patient self-report of the presence 
of current foot problems is reliable will be addressed in Study 3 (Chapter 6).  
 
Overall, this study has provided new data in relation to: (1) providing a description of 
the general and RA characteristics of a random sample of patients with RA; (2) the 
prevalence of additional health problems in a large sample of patients with RA; (3) 
the prevalence and impact of current foot problems; (4) description of the self-care 
and self-management strategies patients adopt to care for their foot problems and 
foot health needs. 
 
5.7 Limitations and strengths 
 
Early in the data collection and analysis of the survey it became clear that it would 
have been beneficial to collect some information about when foot care services were 
accessed or if patients were under follow-up foot care. Further, the perceived 
effectiveness and benefits (patient perspective) of foot surgery (orthopaedic surgery) 
were captured, but patients’ perspectives of the effectiveness of orthotics and 
podiatry care were omitted. It was decided to address these issues in Study 3. 
 
This study is based on self-report. Some form of validation of patients’ self report is 
required to provide confidence in the overall conclusions, but this has not been 
reported in the literature. One form of validation might be through checking clinical 
records (for example additional morbidity). However, patients accessed any or all of 
hospital, community and independent sector foot care services. Validation of the 
self-report with such diverse clinical records was unachievable within the time scale 
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of this work, and may even be unfeasible. As part of this thesis, Study 3 (Chapter 6) 
includes validation of the self-report of current foot problems, together with an 
independent clinical assessment of the current state of patients’ feet and their foot 
care needs.  
 
Research ethics approval was provided to retain anonymised data in relation to 
non–responders. However, permission was only granted to retain information about 
general characteristics of non-responders (gender, hospital site and local social 
deprivation). Data relating to the prevalence, impact and care of foot problems in 
non-responders is not known. It is therefore not possible to quantify the proportion of 
non-responders who had experienced foot problems or accessed foot care or not 
since being diagnosed with RA. The potential for non-responder bias is therefore 
acknowledged. Nevertheless the study sample (responders) for Study 2 was large, 
reflected the distribution of gender hospital site and social deprivation of the target 
population, and almost all responders had foot problems at some time and reported 
substantial impact. Therefore even taking into account the possibility that some non-
responders may not experience the topic of interest in this thesis (prevalence, 
impact and care of foot problems in RA), this study demonstrates that foot problems 
are widely prevalent in a random sample of the population. 
 
There are several strengths in this study. Firstly, the population was a random 
sample of all patients registered for rheumatology care at two hospital sites, and all 
resident within a fixed geographical area. Orthotics and orthopaedic services are 
provided at both hospital sites whereas NHS podiatry is provided by one community 
service. Patients within the community service boundaries formed the study 
population as all these patients had access to all three foot care services. It is 
possible that a very small number of patients with RA might not be registered for 
care at either hospital site (for example receiving care only in the independent 
sector). However, the provision of rheumatology services in Bristol is similar to other 
areas of England (Kirwan et al, 2003). It is possible the findings of this study (Study 
2) may reflect circumstances in other urban areas although a more up to date 
national survey of foot care service provision may be warranted as a separate 
activity. 
 
This study was also strengthened by the large sample size, and to supply sufficient 
patients for Study 3, which follows. Including a responder analysis made it possible 
to check for differences between responders and non-responders in relation to: 
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hospital site, gender, age or social deprivation. The differences were in reality very 
small, indicating that, in contrast to previous publications, the responder sample was 
a good representation of the whole target population of adult patients with RA. 
Additionally, the characteristics of responders in relation to: age, gender, disease 
duration, arthritis medications and disability levels were consistent with those 
reported in previous postal surveys conducted in other areas of the UK.  
 
The value including the patient perspective in the pre-survey work in Study 1, and in 
the design and content of the survey itself has been demonstrated. This is 
evidenced by the fact that almost all returned surveys were admissible (minimal 
missing data), showing that patients found the survey items easy to understand and 
complete. Also, analysis of free text response data support the model of developed 
in Study 1 in relation to descriptors of foot problems, the impact of foot problems and 
decisions to access foot care.  
 
5.8 Summary 
 
This study reports the prevalence of a range of foot problems in a large random 
sample of all patients with RA, within a fixed geographical area. Data generated 
from a representative sample of all RA patients in Bristol support the impression that 
foot problems in RA are common and can be complex and multiple in presentation. 
Additionally foot problems can impact on many aspects of patients’ lives including 
their ability to work. This study has also demonstrated that foot problems are 
important issues for patients. Furthermore, many patients reported that their foot 
problems were: severe; important; and that they were not coping well with them. 
Additionally, discussions occurring during clinical consultations often included foot 
problems that were generated by the patients. This work also indicates that patients 
perceive the time interval of the conduct of foot examinations in clinical 
(rheumatology) consultations to be variable. Finally, although two thirds of the 
responders had accessed foot care, many patients reported current foot problems. 
This may be a reflection of the nature of foot problems in patients with RA to be 
complex, variable and follow a fluctuating clinical course. It also raises issues 
regarding the quality of care received.  
 
This work was presented at the BSR /BHPR and the College of Podiatrist annual 
meetings 2014 and has been published in abstract format (Wilson et al, 2014; 
Appendix J2). 
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The findings of Study 2 are based on self-report. The accuracy of self-report in 
surveys requires consideration. In order to address this issue, independent clinical 
consultations with patients including a foot examination were arranged. The 
opportunity was taken to explore the reasons why some patients accessed or did 
not access foot care when the services were available, and the benefits of foot care 
from the patient perspective. This is Study 3, presented in Chapter 6.  
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Chapter 6: Study 3 – Validation of self-report 
The accuracy of the description of the prevalence and impact of foot problems in 
patients with RA captured in Study 2 depends on the validity of patient self-report. 
Therefore, Study 3 collected validation data from patients who had taken part in 
Study 2, using a detailed clinical consultation questionnaire and an independent 
clinical foot examination. Study 3 also provided a detailed clinical description of 
current foot problems, information regarding foot care received and patient’s 
reasons for accessing foot care or not. 
 
Although self-report of access to health care has been suggested as a valid 
estimate of health care utilisation (Reijneveld and Stronks, 2001), surveys can be 
prone to participation and response bias. In Study 2, respondents were quite 
representative of the target population as a whole for three items that might have 
been important for responder bias: hospital site, gender and area level social 
deprivation. However, bias could have occurred because of positive or negative 
experiences of the topic of investigation, recall bias and/or because of systematic 
difference between participants who had or had not experienced the topic of 
interest. A further consideration for the accuracy of survey studies is in relation to 
the accuracy of self-report. In order to address potential biases in Study 2, a third 
study was conducted on a selected set of responders from Study 2. Patients invited 
to participate in Study 3 had either accessed foot care (AFC) or not accessed foot 
care (NAFC). Prior to the conduct of Study 2, it was considered inevitable that 
disease duration could be a strong influence on the likelihood of accessing foot care 
as patients with longer disease duration would be more likely to develop foot 
problems and subsequently have accessed foot care at some time during their 
disease trajectory. Therefore, a matching exercise was undertaken for Study 3 to 
obtain AFC and NAFC patient groups of similar disease duration. 
 
Study 3 provided the opportunity to investigate the accuracy of the self-report of foot 
problems by comparisons with foot problems observed in a clinical examination, 
hence validating the reports in Study 2. Data collection for Study 3 was conducted 
through a clinical assessment including a foot examination which captured a 
detailed clinical description of the nature and frequency of foot problems (articular 
features, extra-articular features, cutaneous lesion and structural deformity), 
assessment of function (detailed regional musculoskeletal assessment) and 
footwear adequacy. The direct clinical interview also explored further the reasons 
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patients gave for accessing or not accessing foot care, and the benefits of care 
received from their perspective. 
 
6.1 Aims of Study 3 
1. Provide a detailed clinical description of current foot problems. 
2. Validate self-report of current foot problems (or lack of foot problems) with 
clinical assessment and observation at a single time point. 
3. Discover patients’ reasons for accessing or not accessing foot care. 
4. Discover patients’ perceptions of the benefit of foot care received. 
This study addresses aims 5 and 9 of the overall thesis aims as described in 
Chapter 3 section 3.4.1. It also aims to describe current foot problems by clinical 
assessment and benefits of foot care received from the patient perspective. 
 
6.2 Methods 
 
6.2.1 Study design 
Patients invited to participate in Study 3 were selected from responders to Study 2. 
The primary aim of the Study 3 was to clinically validate the self-report of foot 
problems in order to estimate the actual (as opposed to the reported) prevalence of 
foot problems in patients with RA. It was acknowledged that earlier foot care 
consultations may have influenced the clinical accuracy of the report of current foot 
problems. Receiving a clinical diagnosis of a foot problem (e.g. presence of a 
nodule) may influence patient’s ability to identify and report foot problems. As one 
area of interest was to determine foot problem prevalence and to investigate the 
accuracy of self-report of foot problems in RA, it was decided to sample all patients.  
 
The influence of disease duration was considered a priori as the longer patients had 
been diagnosed with RA the more likely they were to have had opportunity to 
develop foot problems at some time during their disease trajectory. It is possible to 
conclude that age may have a similar association with the chance of developing foot 
problems. However, it was postulated during the study design process that age and 
disease duration would be inextricably linked. Indeed analyses of determinants of 
foot care conducted in Study 2 support this assumption as being correct. Therefore, 
a matching exercise was undertaken so that each AFC participant was ‘matched’ 
with a NAFC participant who had a similar duration of disease. The purpose of 
matching was not for pair-wise statistical analyses, but rather to obtain accurate 
information on prevalence of foot problems by investigating the accuracy of the self-
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report of current foot problems obtained in the AFC and NAFC patient groups with 
similar disease duration. Recruitment to Study 3 aimed to recruit similar numbers of 
patients in groups.  
 
6.2.2 Identifying the patient population 
A selected set of patients from within those responding to Study 2 (postal survey) 
were invited to participate in Study 3 (clinical assessment). The study recruited 
patients who reported on Study 2 questionnaires to have accessed foot care and not 
accessed foot care. The study inclusion criteria were: responder to Study 2 (postal 
survey) and able to attend for a clinical assessment. 
 
Information about Study 2 responders was entered into a database including: 
patients’ demographic data (name, gender, home address including post codes), 
disease duration (as reported in Study 2), date participated in Study 2 (date 
questionnaire returned), Study 2 identifiers and classification as AFC or NAFC. The 
Study 3 database was stored on a university computer and was password protected. 
 
Recruitment for Study 3 occurred in batches and commenced as responses to Study 
2 accumulated. Recruitment to both studies was then conducted simultaneously. 
When approximately 25 questionnaires (Study 2) had been returned, responders 
were added to the Study 3 eligible patient list. Patients study identifier, reported 
disease duration and if they had accessed foot care or not were entered into the 
Study 3 database for the matching process. The first patient on the eligible patient 
list who was AFC and had returned their questionnaire less than 2 months 
previously was ‘matched’ for disease duration with a patient from the NAFC list who 
had returned their questionnaire less than 2 months previously. Matching for 
disease duration was defined as: disease duration <5 years – matched to equal 
disease duration in years: disease duration 6 to 10 years - matched to within 1 year; 
disease duration 11 to 20 years – matched to within 2 years: and if disease duration 
was >21 years – matched within 5 years. These definitions were derived following 
discussions between the researcher and her academic supervisor (JK). If a match 
for disease duration was not achievable within batches, patients were carried 
forward and matching was conducted across subsequent batches. Additionally if a 
patient did not accept the invitation or did not attend for the clinical assessment, a 
further matching patient was identified and invited to participate from within the 
same batch of returned questionnaires. If this was not possible, a further patient was 
selected and invited to participate in subsequent batches. Selection of patients was 
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conducted by the researcher and academic supervisor (JK) together to ensure 
quality of the research process. Identification and selection of patients continued 
until equal numbers of patients in both the AFC group and the NAFC were obtained. 
An interval of approximately 8 weeks between return of the postal survey and 
attending for the clinical assessment was considered the minimum time achievable 
between responding to Study 2 and participating (attending) in Study 3, in order for 
Study 2 data to be still relevant. 
 
6.2.3. Data collection 
 
6.2.3.1 Case record form 
Items for inclusion in the case record form were initially determined by data 
generated in Study 1 (one-to-one interviews) and the final design of Study 2 (postal 
survey). Additional items were included following a review of the literature on 
regional assessment of the musculoskeletal system (Doherty et al, 1992) and best 
practice guidelines for the assessment of the foot in RA (Helliwell et al, 2007; 
Podiatry Rheumatology Care Association, 2008). A review of the literature in relation 
to validated scales measuring footwear suitability (Menz and Sherrington, 2000), 
impact of foot problems in RA (FIS, Helliwell et al, 2005) and general disability 
(HAQ) suggested further items. The inclusion of items, the ordering of the conduct of 
the clinical examination and phraseology of clinical assessment questions was 
finalised after discussions with two academic supervisors (JK and JW), the 
independent podiatrist (see 6.2.3.2) and trialling of the assessment form. The final 
version of the case record form (clinical assessment form / questionnaire) was 
agreed with all members of the research team (academic supervisors and PRPs), 
see Appendix H2. 
 
Box 6.1 presents the content, source and rationale for the items included in the 
clinical assessment form. The content of Page 1 (age, gender, disease duration, 
arthritis medications, co-morbidities and postcodes) and HAQ (Section C) were 
required to describe the demographics and clinical characteristics of the study 
participants (patients). 
 
The content of Section A was essential to capture a detailed clinical description of 
current foot problems (clinical examination and self-report), footwear suitability, 
musculoskeletal abnormalities and functional disability. These data were also 
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required to investigate the accuracy of the self-report of foot problems that patients 
reported in Study 2.  
 
The contents of Section B were designed to further understand patients’ reasons for 
accessing or not accessing foot care and perceived benefits of care received. Study 
1 had shown that these were variable and complex and appeared to influence 
patients’ decisions to continue or cease accessing foot care.  
 
Section C captured the impact of foot problems using a validated questionnaire 
(FIS) and the additional measures derived from Study 1 (e.g. ability to cope with foot 
problems) and included in Study 2. 
 
The independent podiatrist obtained written informed consent from all patients. All 
case record forms were completed and no data were imputed from patients’ 
responses in Study 2 (survey). The podiatrist asked patients to report if they had 
current foot problems as listed in question A2 and to complete a HAQ and FIS prior 
to the clinical assessment.  
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Section: Item Included Source Rationale 
Page 1: Patient’s name  Was decided independent 
podiatrist was to address patients 
by name to maintain clinical 
professionalism 
Patient demographics age and 
gender 
 Data required for description of 
sample 
Clinical data Disease duration, arthritis 
medications and co-morbidities 
Data required for description of 
sample. Was decided to include co-
morbidity data as some conditions 
have foot problems as clinical 
features e.g. diabetes 
Social deprivation Obtained from postcodes Data required for description of 
sample 
Date of research appointment   Recruitment for Study 3, aimed for 
conduct of clinical assessment and 
foot examination to be within 
approximately 2 months of 
completing postal survey (Study 2) 
 
Section: A 
 
Regional musculoskeletal 
assessment (A1) 
GALS screen (Doherty et al, 
1992) 
Data required for description of 
musculoskeletal abnormalities and 
functional disability of sample 
(Study objective 1) 
Self-report of foot problems (A2) Study 1 interviews (section 
4.4.2.1) and Study 2 postal 
survey (section 5.2.3) 
Data required to validate self-report 
with clinical observation (Study 
objective 4) 
 Assessment of foot and ankle (A3, 
A4, A5, A7 & A8) 
Best practice professional 
guidelines and expert clinical 
opinion (Podiatry Rheumatology 
Care Association, 2008; Helliwell 
et al, 2007) 
Best practice assessment 
guidelines, to provide description of 
sample (Study objective 1) 
Clinical observation of foot problems 
(A6 & A9) 
 Data required for description of 
observed foot problems in sample 
(Study objective 1) 
 Foot pathologies requiring 
intervention 
 Data required for clinical 
governance and ethics 
Box 6.1 Content, source and rational of items included in clinical assessment form 
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Box 6.1 continued 
Section Item Included Source Rationale 
 Footwear worn (A11) Validated scale (Menz and 
Sherrington, 2000) 
Standard questionnaire to measure 
footwear suitability 
Section: B Foot care services accessed (B1, B2 
&B3) 
 Data required capturing foot care 
services accessed  
Foot care received (B1, B2 & B3)  Data required capturing description 
of foot care interventions received 
in sample (Study objective 3) 
Reasons for accessing foot care 
services (B1, B2) 
 Data required for patients’’ reasons 
for accessing foot care (Study 
objective 3) 
Reasons for not accessing foot care 
services (B1, B2 & B3) 
 Data required for patients’ reasons 
for not accessing foot care (Study 
objective 3) 
Use of devices issued by foot care 
services (B2) 
Study 1 interviews (Section 
4.4.3.1.4 & 4.4.3.15)  
Data required for patients’ reasons 
for not using devices issued (Study 
objective 4)  
Additional comments (B3)  Opportunity for patients to disclose 
any important issues relating to foot 
problems not covered in CRF 
Section: C Personal importance of foot problems 
(C1) 
Study 1 interviews (Sections 
4.4.2.4.1 & 4.4.3.3.4) 
Additional impact of foot problems 
not capture by FIS 
Ability to cope with foot problems 
(C2) 
Study 1interviews (Sections 
4.4.3.2.3 & 4.4.3.3.1) 
Additional impact of foot problems 
not captured by FIS 
Severity (magnitude) of foot 
problems (C3) 
Study 1 interviews (Sections 
4.4.3.2.2 & 4.4.3.3.4) 
Additional impact of foot problems 
not captured by FIS. 
Member of patient support group PRP Data required describing sample. 
Foot Impact Scale (FIS) Validated Scale (Helliwell et al, 
2005) 
Standard questionnaire to measure 
current impact of foot problems in 
RA 
Health Assessment Questionnaire 
(HAQ) 
Validated scale (Fries et al, 1980, 
Kirwan and Reeback, 1986) Gold 
standard scale of disability in RA. 
Standard questionnaire to measure 
current disability 
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6.2.3.2 Independent clinician 
To avoid any bias that might be introduced by the researcher conducting the clinical 
assessment and foot examinations, an independent podiatrist (WB) was the observer 
who conducted all the clinical assessments and foot examinations. This observer had 
over 20 years of experience as an NHS clinical lead podiatrist in diabetes, care of the 
elderly and falls prevention. The observer was trained by the researcher and academic 
supervisors (JK and JW) in regional musculoskeletal assessment (Gait, Arms, Leg and 
Spine screen (GALS), tender swollen joint counts and passive range of motion of foot 
joints) and in the completion of a standardised case record form (CRF) for data 
collection (Appendix H2). The observer also received Good Clinical Practice training. 
Prior to the conduct of the clinical assessment and foot examination the observer had 
no knowledge of which group (AFC or NAFC) a patient belonged to. Before data were 
collected from a patient about previous access to foot care, the observer assessed 
whether the patient had foot problems that required immediate intervention. Each 
patient thought to require immediate foot care was informed of the observer’s clinical 
recommendations at the end of the research session.  
 
6.2.3.3 Clinical examination  
Assessment of patients’ general musculoskeletal and locomotor system was conducted 
using the GALS screen (Doherty et al, 1992). Box 6.2 presents a summary of the GALS 
screen conducted. The observer recorded the normality or abnormality for appearance 
and movement of each component of the GALS screen. Abnormal results (e.g. 
presence of pes planus) were recorded by free text data on the CRF, to provide a 
detailed clinical description of regional functional impairment. 
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Box 6.2 Conduct of GALS screen 
Inspection Conduct Observation / examination 
Gait Weight bearing Movement smoothness and symmetry 
Normal heel strike / toe off 
Ability to turn normally 
Observation from 
behind 
Standing  Spinal alignment normal / scoliosis (abnormal 
lateral curvature) 
Iliac crest alignment 
Rear foot alignment (calcaneous inverted / 
everted) 
Observation from 
behind 
Standing Shoulder symmetry 
Elbow extension 
Knee (presence of swelling / deformity) 
Foot arch profile (high arch (pes cavus), low 
arch profile (pes planus) 
Observation from the 
side 
Standing Spinal alignment (presence of kyphosis 
(increased thoracic convex curvature) / lordosis 
(increased lumbar concave curvature) 
Knees flexed (knee unable to extend to 0º / 
hyperextend >10º extension) 
Spine Standing Lumbar flexion (patient asked to touch their 
toes) 
Cervical flexion (patient asked to tilt head to 
bring ears to their shoulders) 
Arms Standing Abduction / external rotation of shoulders 
(patient asked to place hands behind their 
head) 
Hands Sitting on edge of 
examination couch 
Pronation (patient asked to move hands so 
palms are facing down) / supination (patient 
asked to move hands so palms are facing 
upwards) 
Presence of swelling / deformity in hands 
Power grip (patient asked to grip observer’s 
fingers) 
Precision grip (patient asked to touch each 
finger in turn with thumb) 
Metacarpal (MCP) joint  squeeze test (lateral 
compression of MCP joints to detect for 
synovitis) 
Legs Patient lying prone on 
examination couch 
Assessment of passive hip internal / external 
range of motion with patients knee flexed 
  Knees extended, boarders of patella palpated 
for tenderness / swelling) 
  Metatarsophalangeal (MTP) joint squeeze test 
(lateral compression of MTP joints to detect for 
synovitis) 
 
Foot examinations were conducted in accordance with published guidelines and expert 
clinical opinion (Helliwell et al, 2007; Podiatry Rheumatology Care Association, 2008). 
Box 6.3 presents the conduct of assessing for disease activity in the feet (e.g. joint 
swelling) and foot impairment (e.g. structural deformity). Foot joints examined were: 
Chapter 6 – Clinical assessment 
227 
ankle, talo-calcaneo joint (subtalar), talo–navicular; calcaneo-cuboid (mid tarsal joint), 
metatarsophalangeal joints (MTPs) and interphalangeal joints (IPJs). Joint range of 
motion (ROM) was assessed pragmatically by visualisation (not through quantified 
measurement). Due to the complexity in assessing planes of motion, subtalar joints and 
midtarsal joints were examined as single mortise joints. Detection of cutaenous lesions 
(e.g. callus formation) and extra-articular features (e.g. nail infarcts) was conducted by 
observation. Presence of nodules and bursae were detected by physical examination. 
 
Box 6.3 Protocol for assessing feet for disease activity and impairment 
Clinical features Examination Conduct / definition / classification 
Disease activity Joint swelling Examination of joint margins -  four finger technique 
(Scott and Houssien, 1996) 
Joint tenderness Presence of joint pain at rest on movement or direct 
pressure on joint using four finger technique (Scott 
and Houssien, 1996) 
Forefoot synovitis Lateral squeeze test MTP joints 
Foot impairment Ankle ROM Knee extended, subtalar joint held in neutral 
Full ROM: ≥20º dorsiflexion, ≥50 º plantar flexion 
Limited ROM: <20º dorsiflexion and/or <50 º plantar 
flexion 
Rigid: No dorsiflexion or plantar flexion 
Subtalar ROM Knee extended, lower third of leg stabilised, 
calcaneus held, subtalar joint moved through ROM 
Full ROM: ≥20º inversion, ≥10º eversion 
Limited ROM: <20º inversion <10º eversion 
Rigid: No inversion or eversion 
Midtarsal ROM 
 
Knee extended, subtalar joint in neutral, joint ROM 
examined at base of metatarsals. 
Normal ROM variable in the literature, joint 
examination for any ROM versus rigid (Oatis,1998) 
1st MTP ROM Knee extended, first metatarsal shaft stabilized, 
proximal phalanx of 1
st
 toe moved through plantar 
flexion and dorsiflexion 
Full ROM: ≥70º dorsiflexion, ≥45º plantar flexion 
Limited ROM: < 70º dorsiflexion, <45º plantar 
flexion 
Rigid: No dorsiflexion or plantar flexion 
Hallux valgus Stage 1: lateral displacement of the 1
st
 toe 
Stage 2: 1
st
 toe displaced and in contact with 2
nd
 toe 
Stage 3: complete dislocation of 1
st
 MTP with 1
st
 toe 
over riding or under riding lesser toes 
5
Th
 MTP exostosis Prominence of the lateral aspect of the 5
th
 MTP 
Hammer / claw toes Fixed deformity at proximal interphalangeal joint 
and/or distal interphalangeal joint 
MTP subluxation 
(dislocation) 
MTP joint prominence on plantar aspect of foot with 
clinical evidence of fibro-fat pad atrophy 
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Assessment of peripheral vascular status was conducted by palpation of pedal pulses 
(posterior tibial artery and dorsalis pedis artery) and clinical examination (e.g. poor 
tissue perfusion). Assessment of peripheral neurological status was achieved through 
self-report (e.g. tingling) and response to light touch (protective sensation). Reduced 
protective sensation was assessed using a 10g Semmes Weinstein monofilament 
(Baileys Instruments Manchester UK). A 10g monofilament was applied perpendicular 
to the skin for approximately 1.5 seconds applying a bulking force of 10g of pressure. 
Patients were asked to respond “yes” if they perceived the test. A total of 6 sites were 
tested on both feet twice (plantar aspect of the hallux and plantar aspects of the MTP 
joints). A score of ≤11 positive sites was defined as a participant (patient) having 
reduced protective sensation in a foot (Wilson and Kirwan, 2006). 
 
An assessment of participants’ footwear was conducted using a modified version of the 
Footwear Assessment Form (FAF) (Menz and Sherrington, 2000). The tool was 
developed in Australia to assess footwear suitability in relation to falls risks in older 
people. Minor modifications of the FAF to reflect differences in footwear classifications 
and styles of UK footwear (e.g. thongs / jandals to flip flops) and inclusion of additional 
styles (e.g. Lady Jane shoe (low heeled ladies shoe with a strap / T bar) were 
introduced following discussions between the researcher and observer. Although the 
FAF is an objective clinical assessment of the suitability of current footwear defined as 
“good”, “average” or “poor” (Silvester et al, 2010), there is potential for misclassification 
of the suitability of footwear (Dufour et al, 2009). For example “athletic shoe” is a broad 
term including sport and fashion athletic shoes. Fashion athletic shoes have minimal 
shock absorbing and anti-pronatory features. It was therefore possible that a study 
participant who was wearing a fashion athletic shoe may have their footwear 
misclassified as “good”. Data in relation to type of footwear worn by patients was 
collected for descriptive purposes only not for association with presence of current foot 
problems. Subsequently, patients’ footwear suitability was based on the observer’s 
clinical opinion. Classification of footwear type and suitability is presented in Box 6.4. 
The modified version is presented in question A11 in the CRF Appendix H2. 
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Box 6.4 Footwear type, definition and suitability 
Footwear type Definition Suitability 
Athletic shoe Footwear primarily aimed for partaking in sporting activities Good 
Lady Jane A ladies low shoe with a strap across the dorsal mid foot Good 
Oxford shoe Men’s formal closed in shoe with laces Good 
Prescribed 
footwear 
Hospital issued footwear not commercially available Good 
Walking shoe Light comfortable shoe suitable for regular wear and extensive 
walking 
Good 
Boot Type of footwear covering the foot and ankle which can also 
extend to the lower leg. 
Average 
Backless slipper A backless low shoe which can be “slipped on and off” the foot 
easily, mainly worn indoors 
Poor 
Court shoe A shoe with a low cut front without a fastening. Can also be 
referred to as a “pump” 
Poor 
High heel Ladies footwear in which the heel of the foot is considerably 
higher than the height of the toes 
Poor 
Flip flop Flat backless footwear attached to the foot by a thong between 
the first and second toes 
Poor 
Mule Backless shoe with or without enclosed toe box Poor 
Moccasin A flat soft leather slipper with a continuous sole extending and 
sewn to the leather upper 
Poor 
Sandal Open footwear attached to the foot by a strap or thong Poor 
Slipper A low shoe which can be “slipped on and off” the foot easily, 
mainly worn indoors 
Poor 
Ugg Boots Boots with suede uppers and fleece liners Poor 
No footwear 
worn 
Bare foot, stockings only or socks only Poor 
 
6.2.3.4 Foot care received 
Data in relation to podiatric and orthopaedic care received and perceived benefits of 
care received were recorded verbatim by the observer. In relation to orthotic 
interventions received such as pressure relief (e.g. insoles) and prescribed footwear, 
data were collected by self-report and clinical observation. The observer recorded the 
classification of devices received on the CRF according to the definitions in Box 6.5. 
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Box 6.5 Orthotic devices classification and definitions 
Device Definition 
Insole Any device placed in the shoe to support or 
cushion the foot 
Pre-moulded orthotic Mass produced orthoses / insoles designed 
and contoured to the foot 
Functional Designed and contoured to the foot to alter 
foot function and joint alignment e.g. addition 
of rear foot posting  
Total contact inlay Full length orthotic made form a cast of a 
patients’ foot (bespoke device) 
NA Not applicable as device not issued 
Stock footwear “Off the shelf” hospital issued footwear with a 
standard last (360 model of the foot), available 
in variety of widths 
Modular footwear Footwear manufactured with slight 
adjustments to standard last 
Bespoke Custom made footwear for an individual 
patient including a bespoke last 
 
6.2.4 Scoring the scales 
The HAQ, FIS and additional measures of impact (severity, ability to cope with and 
importance) were measured again at the clinical assessment visit and were scored as 
described in Chapter 5.  
 
6.2.5 Social deprivation 
Local social deprivation was captured using the Index of Multiple Deprivation (IMD) 
2007 as described in Chapter 5 section 5.2.5. The IMD scores were computed from 
patients’ postcodes in Study 2 and these scores were utilised in Study 3 
 
6.3 Study procedures 
Approval was obtained from Central Bristol Medical Research Ethics Committee 
(reference 101/SW/0327) and the University of the West of England Research Ethics 
Committee (reference HLS/12/01/12). Research and development approval was 
obtained from both hospital sites (NBT and UHB). Additional research and development 
approval was obtained from Bristol Community Health (BCH) as two Community Health 
Centres were utilised to conduct some of the research appointments for the clinical 
assessment and foot examination. The use of BCH facilities was required as an 
additional site due to limited clinical room availability at one hospital site during major 
redevelopment works. 
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An invitation to participate in Study 3 was posted to the patient’s home address. The 
invitation packs included an invitation letter (signed by the researcher), patient 
information sheet (PIS), reply slip agreeing to be contacted by the researcher and a 
return FREEPOST envelope. The invitation packs were the same for both hospital sites 
apart from the invitation letter and PIS, which were on individual department headed 
notepaper. In order to reduce bias (as discussed in Chapter 5) contact details on the 
invitation packs introduced the researcher as a clinical doctoral research fellow, not as 
a podiatrist. If no response was received after three weeks a reminder was sent. All 
patients who returned the reply slip and agreed to be contacted were telephoned by the 
researcher and provided with more information about the study. Patients agreeing to 
participate in Study 3 were then invited to attend a clinical assessment including a foot 
examination with the observer at a choice of three NHS sites (one hospital site and two 
community health centres). Patients were invited in batches to aid administration, 
including facilitation the conduct of the research appointments, which would last 30 
minutes. Informed written consent was obtained immediately prior to data collection by 
the independent podiatrist who also completed and returned case record forms (CRFs) 
to the researcher who entered all data in the study data base. 
 
6.4 Analysis plan and sample size 
 
6.4.1 Statistical analyses 
Analyses were conducted using SPSS 19.0 (SPSS Inc. Chicago. Illinois). Each CRF 
was checked for completeness by the researcher. Accuracy checking of data entry was 
checked by duplicate entry of a random sample of 10% CRFs and by inspecting 
frequency distributions and minimum and maximum values as previously described. 
Descriptive statistics were used for: general characteristics (hospital site, age gender, 
and social deprivation); RA characteristics (disease duration, arthritis medications, and 
disability), regional musculoskeletal assessment, presence of foot problems (self-report, 
clinical examination), footwear suitability, impact of foot problems and foot care services 
accessed. Normally distributed continuous data were expressed as means and 
standard deviations (SD) or 95% confidence intervals (CI). Skewed continuous data 
were expressed as medians and inter quartile range (IQR). For categorical data, 
proportions were calculated and expressed as percentages. Comparisons of general 
characteristics, RA characteristics, presence of foot problems between the AFC group 
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and the NAFC group were conducted using descriptive and inferential statistics. 
Independent samples t-tests were computed for continuous (normally distributed) 
variables. The Mann-Whitney U test was used for continuous variables, not normally 
distributed and Chi-square tests for categorical variables. P values were considered 
statistically significant if they were less than 0.05.  
 
To explore the accuracy of self-report of foot problems, comparisons were computed 
between the level of agreement of current foot problems by self-report and clinical 
examination (e.g. hallux valgus reported and hallux valgus observed). Contained in 
Appendix H2 are the current and previous foot problems which patients were asked to 
report. Responses to each question were recorded as binary variables (yes / no). 
Definitions and classifications of current foot problems observed are presented in Box 
6.6. The presence of foot problems observed was computed as binary variables (e.g. ≥ 
1 stage hallux valguses - yes / no). The self-report and clinical observation binary 
variables were calculated as proportions and expressed as percentages. 
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Box 6.6 Comparisons of current foot problems by self-report and clinical 
assessment 
Current foot problem reported Current foot problem definition observed on 
examination 
Pain Unable to define as pain is a subjective experience and 
unable to quantify by examination 
Stiffness Unable to define as no clinical measurement available 
Numbness Reduced protective sensation – scoring <11 either foot 
Swelling ≥ 1 joint swelling 
Bunions Presence of hallux valgus stage ≥ 1 
Callus (hard skin) Presence of callus - thickening of the epidermis on a weight 
bearing / pressure area / bony prominence 
Corns Small conical shaped callus on a weight bearing / pressure 
area / bony prominence 
Blisters Collection of fluid below the epidermis 
Ulcers Presence of a full thickness wound (exposing dermis or 
deeper tissues (e.g. bone) on or below the level of the 
malleoli 
Thickened toe nails Presence of onychauxic (thickening of nail plate) / 
onycogryphosis (thickening of nail plate with deformity) / 
onycomycosis (fungal involvement of nail plate with 
thickening) 
Infection Presence of bacterial / fungal infection involving epidermis 
and/or soft tissues 
In-grown toe nails Involution of nail plate (curvature of nail plate sulci / 
boarders) / convolution of nail plate (increased curvature of 
nail plate sulci / boarders) onycocryptosis (presence of 
spike of nail) 
Misshapen toes Fixed flexion deformity at ≥ 1 interphalangeal joint 
Nodules (bumps) Nodules - presence of a small palpable subcutaneous mass 
Fallen arches Presence of pes planus – flattening loss of normal medial 
longitudinal arch 
 
The Kappa statistic was used to calculate the overall percentage of agreement. The 
Kappa statistic indicates the proportion of agreement between two observers 
accounting for proportion of chance agreement. Interpretation of Kappa values are 
presented in Table 6.1 (Landis and Koch, 1977). 
 
Table 6.1 Interpretation of Kappa  
Kappa Agreement  
< 0 Less than chance agreement  
0.01-0.20 Slight agreement 
0.21-0.40 Fair agreement 
0.41-0.60 Moderate agreement 
0.61-0.80 Substantial agreement 
0.81-0.99 Almost perfect agreement 
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However, the Kappa statistic does not give an indication explaining levels of 
disagreement and can also be influenced by frequency. Thus it may not reflect level of 
agreement for rare events (e.g. foot ulceration). Additionally Sims and Wright (2005) 
recommend the use of the Kappa with caution when measuring levels of agreement 
between variables measured on different scales (e.g. self-report of numbness and 
clinically detected reduced protective sensation). 
 
The accuracy of self-report was therefore further analysed in relation to sensitivity and 
specificity: 1) “true positives” (patient reports foot problem and foot problem observed); 
2) “false positives” (patient reports foot problem but no foot problem observed): 3) “true 
negatives” (patient does not report foot problem and foot problem not observed); 4) 
“false negatives” (patient does not report foot problem but foot problems is observed). 
Accuracy of self-report was computed comparing proportions of agreement with clinical 
examination for each of the classifications of sensitivity and specificity stated above. 
 
6.4.2 Free text analyses 
Data in relation to arthritis medications, additional morbidity and foot care received were 
collected by free text response and recorded verbatim by the observer. Consensus on 
the classification and categorisation of the free text responses was reached following 
discussion between the researcher, academic supervisor (JK) and observer. A coding 
frame was derived and entered into SPSS for quantitative analyses. 
 
Content analyses (CA) were conducted on patients’ free text responses to: description 
of foot care received, perceived benefits of care, reasons for accessing or not 
accessing foot care and reasons for not utilising orthotic devices issued. The observer’s 
clinical opinions of current foot problems requiring intervention were also analysed 
using CA. A full description of the rationale and the conduct of CA is presented and 
discussed in Chapter 5. Free text data were transcribed verbatim into the study data 
base. Data relating to similar points were grouped together in codes and codes were 
subsequently merged to form comment categories to produce a coding frame. The free 
text data were entered as string variables in SPSS along with the coding frame and 
treated for variables as quantitative analyses. 
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6.4.3 Sample size 
The sample size estimate for Study 3 was based on the expectation that there might be 
5-6 main determinants of access to foot care, identified by multivariate analysis 
conducted in Study 2. Therefore Study 3 would require approximately 10 participants 
for each variable (Belle, 2008) requiring 60 patients in each group (accessed foot care, 
AFC and not accessed foot care, NAFC). It was estimated that between 350 – 500 
responders in Study 2 would be appropriate to achieve a final sample size of 120 for 
Study 3. 
 
6.4.4 Patient research partner involvement 
Collaboration with the patient research partners (PRPs) continued during the planning 
of the study design and conduct of the data collection (clinical assessment and foot 
examination). Both PRPs provided valuable comments regarding the overall approach 
to the study and actively participated in the researcher’s supervisory meetings.  
 
6.5 Results 
Data collection commenced in June 2012 and was completed in April 2013. 
 
6.5.1 Participation rates and characteristics of participants and non-participants 
Of the 413 patients who responded to the postal survey, 235 were invited to participate 
in Study 3 (Figure 6.1) and 143 (60.9%) accepted the invitation. Of these, 110 (76.9%) 
attended the research appointment for clinical assessment and foot examination, an 
overall participation rate of 46.8%.  
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Figure 6.1 Flow diagram of recruitment Study 3 
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n=110 
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research 
appointment 
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Unable to 
arrange 
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appointment 
n=22 
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Accepted invitation to 
participate in Study 3 
n=109 
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n=91 
Declined invitation to 
participate in Study 3 
n=35 
 
 
 
Accepted invitation to 
participate in Study 3 
n=34 
 
 
Declined invitation to 
participate in Study 3 
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n=44 
 
 
 
Accepted invitation 
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Declined invitation 
n=48 
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Table 6.2 compares the general characteristics (hospital site, gender, age, and 
social deprivation) and clinical characteristics (disease duration, arthritis 
medications, disability and additional morbidity) of patients who attended 
(participants) and those who did not attend (non-participants). Overall the 
proportions were broadly similar for all general and clinical characteristic variables 
between patients invited to participate, participants and non-participants. Almost all 
participants and non-participants (as reported in Study 2) were taking arthritis 
medications (98.2% versus 93.6%). Small variation was detected between the 
proportions of participants and non-participants taking biologics, glucocorticoids and 
NSAIDs. Additionally the difference in means in age (years) between participants 
and non-participants was nearly 2 years. The proportion of patients attending who 
resided in socially deprived areas was very similar to the proportion invited (and the 
proportion in the target population as shown in Chapter 5). 
 
Table 6.2 Participation general and clinical characteristics  
Variable  Total selected  
n=235 (%) 
Participants 
n=110 
(%) 
Non-participants 
n=125 
(%) 
 Hospital site UHB (%)  135 (57.5) 66 (60.0) 69 (55.2) 
Female (%)  172 (73.2) 77 (70.0) 95 (76.0) 
Age years mean (SD)  62.2 (12.6) 63.1 (11.2) 61.4 (13.7) 
Local social 
deprivation 
Category 1 
(least deprived) 
 
58 (24.7) 
 
27 (24.5) 
 
31 (24.8) 
Category 2 87 (37.0) 46 (41.8) 41 (32.8) 
Category 3 59 (25.1) 22 (20.0) 37 (29.6) 
Category 4 19 (8.1) 9 (8.2) 10 (8.0) 
Category 5 
(most deprived) 
 
12 (5.1) 
 
6 (5.5) 
 
6 (4.8) 
Disease duration years 
median (IQR) 
  
9 (5-15) 
 
8.5 (5-13) 
 
10 (5-13) 
Arthritis medications 
(%) 
NSAIDs 97 (41.3) 36 (28.8) 61 (55.5) 
DMARDs 196 (83.4) 103 (82.4) 93 (84.5) 
Glucocorticoids 70 (29.8) 42 (33.6) 28 (25.5) 
Biologics 43 (18.3) 15 (12.0) 28 (26.4) 
HAQ median (IQR)  1.5 
(0.750-2.00) 
1.25 
(0.375-2.00) 
1.562 
(0.75-1.968) 
Morbidity (%) No co-morbidity 85 (36.2) 31 (28.2) 54 (43.2) 
1 co-morbidities 99 (42.1) 43 (39.1) 56 (44.8) 
>1 co-
morbidities 
 
50 (21.3) 
 
36 (32.7) 
 
28 (22.4) 
 
6.5.1.1 Identifying study sample controlled for disease duration 
The one to one matching process implied that there would be equal numbers of 
those who had accessed foot care (AFC) and those who had not accessed foot care 
(NAFC). In the event, of the 110 patients, 65 (59%) had accessed one or more foot 
care service. This variation in the numbers in each group was due to difficulties in 
organising research appointments. Patients were also selected to provide a balance 
of disease duration between the AFC group and the NAFC groups. The median 
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(IQR) disease duration in the AFC group was 8 years (6 to 15). The median disease 
duration in the NAFC group was 7 years (4 to 12). The difference in medians of 1 
year shows that a balance for disease duration was achieved.  
 
6.5.1.2 Demographic and clinical characteristics 
Table 6.3 presents comparisons of clinical and demographic characteristics of the 
study participants by AFC group and NAFC group. Overall the proportions were 
similar for the AFC group and the NAFC group in relation to hospital site, categories 
of local social deprivation and arthritis medications. Additionally a wide range of 
current disability was reported by the study patients. The number of patients 
reporting no current disability was small (n=10, 9%). The median HAQ scores were 
similar for both the AFC group and the NAFC group (1.375 versus 1.125). 
 
Table 6.3 Demographic and clinical characteristics 
Variable  Total selected 
participants 
n=110 (%) 
AFC  
n=65 (%) 
NAFC  
n=45 (%) 
 Hospital site UHB 
(%) 
 66 (60) 39 (60) 27 (60) 
Female (%)  77 (70) 48 (74) 29 (64) 
Age years mean (SD)  63.8 (11) 65.4 (11) 61.6 (11) 
Local social 
deprivation 
Category 1 27 (25) 15 (23) 12 (27) 
Category 2 46 (42) 27 (42) 19 (42) 
Category 3 22 (20) 13 (20) 9 (20) 
Category 4 and 5 15 (14) 10 (15) 5 (11) 
RA medications (%) NSAIDs 61 (56) 37 (57) 24 (53) 
DMARDs 93 (85) 54 (83) 39 (87) 
Glucocorticoids 28 (26) 13 (20) 15 (33) 
Biologics 29 (26) 15 (23) 14 (31) 
None 3 (3) 3 (5) 0 (0) 
HAQ median (IQR)  1.25  
(0.375-2.00) 
1.375  
(0.375-2.00) 
1.125  
(0.375-1.75) 
Morbidity (%) No co-morbidity 31 (28) 17 (26) 14 (31) 
1 co-morbidities 46 (42) 24 (37) 22 (49) 
>1 co-morbidities 33 (30) 24 (37) 9 (20) 
 
Of the AFC group (n=65), 48 (74%) were female compared to 29 (64%) in the NAFC 
group (n=45). There was no statistically significant difference (   = 1.12, df=1, 
p=0.29). The mean age of patients was 63.8 years (SD=11.2, min 38, max 88). The 
mean age for the AFC group was 65.4 years (SD=11.0, min 40, max 88) and for the 
NAFC group was 61.6 years (SD=11.2, min 38, max 81) which was not statistically 
significant (t=-1.77, df=108, p=0.08). Of the 110 patients, 79 (72%) reported other 
medical conditions (co-morbidities). The proportions of patients reporting additional 
morbidity were similar for both groups. The classification and categorisation of 
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additional health problems reported by both groups is available in Appendix I 
supplementary data.  
 
6.5.1.3 Arthritis support group membership  
Almost all patients reported that they were not members of an arthritis support group 
(n=108, 98%). Of the two patients who did report to being members of a support 
group, both had accessed foot care. 
 
6.5.1.4 Overview of patient and RA characteristics 
Overall, no difference was detected between the AFC and the NAFC group in 
relation to general demographic characteristics (hospital site, gender, age and 
socio-economic status). Further, the RA characteristics were similar for both groups 
in terms of: disease duration; classification and categorisation of arthritis 
medications and disability (HAQ).  
 
6.5.2 Foot related characteristics and impact 
 
6.5.2.1 Foot problems self-report 
Table 6.4 presents the frequencies of current foot problems reported on the day of 
attendance for clinical examination. All patients reported one or more current foot 
problems. The frequencies were similar between the AFC group and the NAFC 
group for the majority of foot problem categories. However, there were differences 
between the groups for current articular features and extra-articular features. Of the 
AFC group, two thirds reported one or more articular features and one or more 
extra-articular features (currently) in their feet (n=45, 69% and n=32, 70%, 
respectively). The similar numbers for the NAFC group were 28 (43%) and 14 
(30%). This was not a statistically significant difference (   = 0.59, df=1, p=0.44). 
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Table 6.4 Foot problems self-report 
Foot problem category Foot problems Foot problems  
now AFC  
n=65 (%) 
Foot problems 
now NAFC 
n=45 (%) 
Articular features Pain 25 (39) 19 (42) 
Stiffness 31 (48)) 21 (53) 
Swelling 19 (29) 12 (27) 
Any articular feature 45 (69) 28 (43) 
Cutaneous lesions Blisters 3 (5) 2 (4) 
Callus 38 (59) 24 (53) 
Corns 10 (9) 3 (7) 
In-grown toe nails 11 (17) 6 (13) 
Thickened Toe nails 35 (54) 28 (62) 
Ulcers 0 (0) 0 (0) 
Any cutaneous lesions 54 (83) 39 (87) 
Structural deformity Bunions 22 (34) 16 (36) 
Fallen arches 21 (33) 7 (16) 
Misshaped toes 44 (68) 27 (60) 
Any structural deformity 50 (77) 30 (67) 
Extra-articular features Nodules 15 (23) 10 (22) 
Numbness 24 (37) 6 (13) 
 Any extra-articular feature 32 (70) 14 (31) 
Other Infection 4 (6) 4 (9) 
Any foot problems  65 (100) 45 (100) 
 
6.5.2.2 Impact of foot problems (Section C) 
Data were collected in relation to the impact of current foot problems at the time of 
the research appointment. All patients fully completed both sub-scales of the FIS 
(FISIF and FISAP). There was a wide range of FISIF scores in both groups (Figure 
6.2) with similar distributions. The median (IQR) FISIF scale score for the patients 
was 9 (5 to 13). The median (IQR) FISIF scale score for the AFC group was 9 (6 to 
13). The median (IQR) FISIF scale score for the NAFC group was 8 (2 to 13). The 
difference in medians of 3 between the groups was not statistically significant 
(U=1281, p=0.27). Of the AFC group, 9 (14%) scored > 16 on the FISIF scale. For 
the NAFC group 4 scored >16 (9%).  
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Figure 6.2 Frequency distribution of FISIF scores 
 
  
 
Figure 6.3 shows the distribution of FISAP scale scores for the AFC and NAFC 
groups. There was a wide range of scores in both groups with similar distributions. 
The median (IQR) FISAP scale score for patients was 15 (3 to 22). The median (IQR) 
FISAP score for the AFC group was 13 (4 to 22) and for the NAFC group was 16 (2 to 
22). This was not a statistically significant difference (u=1397, p=0.69). Of the AFC 
group, two patients scored >30 on the FISAP scale. The highest FISAP score in the 
NAFC group was 29. 
 
Figure 6.3 Frequency distribution of FISAP scores 
     
 
The median (IQR) importance of foot problems score for the patients was 6 (3 to 9). 
The median (IQR) importance score for the AFC group was 7 (3 to 10) and for the 
NAFC group was 5 (2 to 8). This was not a statistically significant difference 
(U=1164, p=0.67). Of the AFC group, 17 (26%) considered their foot problems to be 
very important (scoring 10), compared to 6 (13%) in the NAFC group. This result 
indicates that despite reporting foot problems to be very important, some patients 
AFC FIS activities participation total NAFC FIS activities participation total 
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had not accessed foot care. Figure 6.4 presents the distribution of importance 
scores for the AFC and the NAFC groups. 
 
Figure 6.4 Importance of foot problem scores 
 
  
 
The median (IQR) of patients ability to cope with foot problems score was 4 (2 to 6). 
The median (IQR) ability to cope with foot problems score for the AFC group was 4 
(2 to 6) and for the NAFC group was 3 (1 to 5), which was not a statistically 
significant difference (U=1303, p=0.33). Figure 6.5 shows the distributions of ability 
to cope with foot problems scores in both groups. Of the AFC, 7 (11%) reported to 
be coping very well with their foot problems (scoring 0). The number of the NAFC 
group reported to be coping well with their foot problems was 5 (11%). Of the ACF 
group, 7 (11%) reported not coping well with their foot problems (>8) as did 11% of 
the NAFC group (n=5). This result indicates that despite some patients reporting 
difficulty coping with their foot problems, they had not accessed foot care. 
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Figure 6.5 Ability to cope with foot problems scores 
 
 
The median (IQR) magnitude (severity) of foot problems score for the patients was 5 
(2 to 7). The median (IQR) score for the AFC group was 5 (3 to 7) as was the NAFC 
group (1 to 7). The proportion of patients reporting no severity (scoring 0) was 
higher in the NAFC group (n=7, 16% versus n= 6, 9%). Of the AFC group, 3 (5%) 
reported severe current foot problems (scoring 10).This result indicates despite 
accessing foot care a small number of patients were still experiencing severe foot 
problems. Figure 6.6 illustrates the distribution of magnitude scores.  
 
Figure 6.6 Magnitude of foot problems distribution scores 
  
 
6.5.2.3 Overview of foot related characteristics and impact 
All patients reported one or more current foot problems. The majority of the AFC 
group reported 1 or more: articular feature; cutaneous lesion; structural deformity 
and/or extra-articular feature. These results imply that despite accessing foot care, 
foot problems continued. Overall, a wide range of impact scores (FISIF, FISAP, 
importance of foot problems, ability to cope with foot problems and severity of foot 
problems) were reported by both the AFC group and the NAFC group, 
demonstrating that foot problems were impacting on many aspects of patients’ 
AFC How much of a problem are your feet NAFC How much of a problem are your feet 
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personal lives. In relation to comparisons of impact scores between the AFC group 
and the NAFC group, no statistically significant differences were detected. Some 
patients had not accessed foot care despite reporting substantial impact in terms of 
foot problems. For other patients, even though foot care had been accessed, some 
reported that their foot problems were severe. 
 
6.5.3 Clinical observation (Section A) 
 
6.5.3.1 Musculoskeletal system assessment 
Figure 6.7 presents the frequencies of the gait, arms, legs and spine - screen 
(GALS) abnormalities observed. The majority of patients were observed to have one 
or more musculoskeletal abnormality and/or restricted function. The frequency 
distribution of GALS abnormalities were broadly similar for both groups. 
  
Figure 6.7 Frequencies of GALS abnormalities 
 
 
The frequencies (proportions) of abnormalities for the components of the GALS 
screen are presented in Table 6. 5. A Chi-square test amalgamating scores 6 (AFC 
n=6, 9%; NAFC n=4, 9%) and 7 (AFC n=6, 9%; NAFC n=1, 2%) GALS 
abnormalities achieving minimum cell count of 5 was not significant statistically 
(  =5.55, df=6, p=0.48). A greater proportion of patients in the NAFC group were 
observed to have abnormal gait appearance compared with the AFC group (36% 
versus 28%). Of the AFC group, 36 (55%) had an abnormal GALS leg screen. The 
frequency for an abnormal legs screen for the NAFC group was identical (n=23, 
55%). These results show that almost all patients had restriction of function. Further, 
the proportions of functional restriction were similar for the AFC group and NAFC 
groups. 
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Table 6.5 GALS screen 
GALS screen abnormality AFC (n=65) number of 
patients in this category (%) 
NAFC (n=45) number of 
patients in this category (%) 
Gait appearance 31 (28) 16 (36) 
Arms appearance 9 (8) 6 (13) 
Arms movement 12 (19) 9 (20) 
Any arm abnormality 48 (74) 37 (82) 
Legs appearance 29 (45) 19 (42) 
Legs movement 31 (28) 15 (33) 
Any legs abnormality 36 (55) 23 (55) 
Spine appearance 18 (28) 12 (27) 
Spine movement 17 (26) 11 (24) 
Any spine abnormality 23 (35) 16 (36) 
 
6.5.3.2 Frequencies of foot problems by clinical observation 
Almost all patients had one or more foot problems (n=104, 95%): 62 (95%) of the 
AFC group and 42 (93%) of the NAFC group. Table 6.6 presents the frequencies of 
clinically observed foot problems. 
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Table 6.6 Frequencies of observed foot problems 
Foot problem 
category 
Foot problems AFC (n=65) number 
of patients in this 
category (%) 
NAFC (n=45) number 
of patients in this 
category (%) 
Extra-articular 
features 
Bursa 7 (11) 6 (13) 
Nodules 1 (2) 2 (4) 
Any extra-articular feature 8 (12) 8 (18) 
Cutaneous lesions Blisters 2 (3) 0 (0) 
Callus 35 (53) 23 (51) 
Corns 7 (11) 6 (13) 
In-grown toe nails 12 (19) 4 (9) 
Thickened toe nails 30 (46) 19 (42) 
Onycomycosis 8 (12) 5 (11) 
Any cutaneous lesions 49 (75) 32 (71) 
Structural deformity Classic daylight  8 (12) 6 (13) 
Hallux valgus  23 (35) 13 (29) 
Retracted / clawed toes 32 (49) 22 (49) 
Pes planus 18 (28) 10 (22) 
Subluxed MTPs 38 (59) 22 (49) 
5
th
 MTP exostosis 10 (15) 10 (22) 
Any structural deformity 54 (84) 35 (78) 
Any foot problems  62 (95) 42 (93) 
 
The majority of the patients had one or more cutaneous lesions (n=81, 74%). The 
frequencies of cutaneous lesions categories were similar for both the AFC group 
and the NAFC group. Of the AFC group about one half (n=35, 54%) were observed 
to have callosities. Of these: 16 (46%) had callus formation at one or more 
metatarsophalangeal joint (MTP), 5 (14%) digital (toes) callus and 11 (31%) at more 
than one site (MTP, toes or heels). The equivalent numbers for the NAFC group 
were: 23 (51%) any callus formation, 14 (61%) MTP callus, 4 (17%) digital callus 
and more than one site 5 (22%). The frequencies of thickened toe nails and 
onycomycotic nails were similar for both groups. In contrast the frequency of 
ingrown toe nails was higher in the AFC group (19% versus 9%). 
 
Of the 110 patients, 89 (81%) had one or more structural foot deformities. The 
frequencies of structural deformity categories were similar for both the AFC group 
and the NAFC group with the exception of frequencies of one or more subluxed 
MTPs and 5th MTP exostoses (n=38, 59% versus n=18, 49% and n=16, 15% versus 
n=10, 22%, respectively). A wide range of the number of subluxed MTPs and toe 
deformities (retracted / clawed) were observed in both the AFC group and the NAFC 
group. A third of the AFC group was observed to have hallux valgus (HV) (n=23, 
35%). Of these, 16 (70%) had HV bilaterally. The frequency of bilateral HV was 
lower in the NAFC group (n=5, 11%).  
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No patients had current foot ulceration. However, 9 (8%) reported foot ulceration at 
some time since being diagnosed with RA. Of these 9, 7 (78%) had accessed foot 
care. No patients had or reported an episode of systemic or skin vasculitis (digital 
infarcts, petechiae, palpable pura) and no bacterial infections were observed during 
the clinical examination. Data were not collected on recalled (self-report) previous 
episodes of bacterial foot infections. 
 
6.5.3.3 Footwear characteristics 
The classification of footwear suitability is presented in Table 6.7. No patients were 
wearing or reported their preferred footwear to be high heels (heel considerably 
higher than forefoot sole) or slippers. However, 13 (12%) of patients’ shoes had a 
heel height between 2.6cm and 5.0cm. Of these, 9 (69%) had footwear with a 
wedged sole (heel continuous with the sole). Of the remainder, four patients were 
wearing court shoes and one mule style shoes. Overall, nearly half were wearing 
“good” (appropriate / suitable) footwear (n=49, 44%). However, the frequency of 
preferred usual footwear classified as “good” was higher than the observation of 
good footwear worn. The discrepancies between the frequencies occurred due to: 
personal choice in terms of seasonal variation (n=12, 11%), employment regulations 
(n=2, 2%), fluctuating symptoms (n=1, 1%) and ease of removal for foot examination 
(n=1, 1%). A small number (n=3, 3%) said their choice of “poor” footwear was due to 
inability to tie shoe laces or buckles due to reduced function (e.g. reduced hand 
dexterity). 
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Table 6.7 Observed and preferred footwear type 
Footwear 
suitability 
Footwear 
type 
AFC (n=65) 
number of 
patients in this 
category (%) 
NAFC (n=45) 
number of 
patients in this 
category (%) 
Preferred 
footwear* 
AFC 
(n=65) 
number of 
patients in 
this category 
(%) 
Preferred 
footwear* 
NAFC 
(n=45) 
number of 
patients in 
this category 
(%) 
Good Athletic shoe 11 (17) 8 (18) 12 (19) 8 (18) 
Oxford shoe 1 (2) 0 (0) 1 (2) 1 (2) 
Prescribed 
footwear 
 
1 (2) 
 
0 (0) 
 
2 (3) 
 
0 (0) 
Walking shoe 18 (28) 9 (20) 22 (34) 14 (31) 
Any good 
footwear  
 
31 (48) 
 
17 (38) 
 
37 (57) 
 
23 (51) 
Average Boot 10 (15) 8 (18) 9 (14) 7 (16) 
Any average 
footwear 
 
10 (15) 
 
8 (18) 
 
9 (14) 
 
7 (16) 
Poor Court shoe 2 (3) 5 (9) 3 (5) 4 (9) 
Flip flop 0 (0) 2 (4) 1 (2) 1 (2) 
Mule 1 (2) 2 (4) 1 (2) 2 (4) 
Moccasin 10 (15) 8 (18) 5 (8) 6 (13) 
Sandal 10 (15) 3 (7) 6 (9) 2 (4) 
Ugg Boots 1 (2) 0 (0) 1 (2) 0 (0) 
Any poor 
footwear 
 
24 (37) 
 
20 (44) 
 
17 (26) 
 
15 (33) 
*self-report general preferred footwear 
 
Of the AFC group, 31 (48%) were classified as wearing good footwear compared 17 
(38%) of the NAFC group. However, a third the AFC (n=24, 37%) group were 
assessed to be wearing poor footwear. Data were not collected in relation to 
receiving footwear education at the time that foot care was accessed.  
 
Table 6.8 shows footwear construction characteristics. The majority of footwear had 
some form of fixation (for example laces) to facilitate individual adjustment of the 
shoes (n=87, 79%). Moderate heel counter stiffness (facilitate rear foot motion >45 
degrees) was observed in the shoes of 65 (59%) patients. The majority (n=84, 76%) 
of footwear facilitated normal 1st MTP ROM (sole flexion point at level of 1st MTP). 
Further, the majority of footwear had satisfactory tread pattern (textured) and sole 
hardness (firm) in relation to reducing slips / falls risk and shock absorbing 
properties (n=94, 86% and n=86, 78%, respectively). Comparisons of the 
frequencies of footwear construct characteristics were on the whole similar for both 
patient groups. Of the 23 patients with no shoe fixation, half were in the AFC group 
11 (48%).  
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Table 6.8 Footwear construction characteristics 
Footwear variable  AFC (n=65)  
Number of patients 
in this category (%) 
NAFC(n=45)  
Number of patients 
in this category 
(%) 
Heel height 0-2.5 cm 58 (89) 39 (87) 
2.6-5.0cm 7 (11) 6 (13) 
Fixation None 11 (17) 12 (27) 
Laces 14 (22) 17 (38) 
Straps/Buckles 15 (23) 4 (9) 
Velcro 4 (6) 0 (0) 
Other (Elastic gusset) 21 (32) 12 (27) 
Heel counter stiffness Not available 15 (23) 10 (22) 
<45 degrees 36 (55) 29 (64) 
>45 degrees 14 (22) 6 (13) 
Longitudinal sole rigidity <45 degrees 22 (34) 16 (36) 
>45 degrees 43 (66) 29 (64) 
Sole flexion point At level of 1
st
 MTP 48 (74) 36 (80) 
Before 1
st
 MTP 15 (23) 8 (18) 
No flexion 2 (3) 1 (2) 
Tread wear pattern Textured 56 (86) 38 (84) 
Smooth 9 (14) 7 (16) 
Not worn 32 (49) 27 (60) 
Partly worn 30 (46) 16 (36) 
Fully worn 3 (5) 2 (4) 
Sole hardness Soft  10 (15) 5 (11) 
Firm 53 (82) 33 (73) 
Hard 2 (3) 7 (16) 
 
6.5.3.4 Overview of clinical observation 
Almost all of the patients had one or more current foot problems and more than half 
had callosities, thickened toe nails, retracted / clawed toes and one or more 
subluxed MTP joints. Extra-articular features (nodules, bursa) occurred but less 
frequently than cutaneous lesions and structural deformity. Overall, the frequencies 
of observed foot problems were similar for both the AFC group and the NAFC group. 
These results reinforce previous reports that foot involvement is common in RA and 
multi-factorial in clinical presentation. 
 
Overall, only half of the patients were wearing “good” footwear. Further, a third of 
the AFC group were wearing “poor” footwear. Some patients’ reported they varied 
their choice of footwear to account for: seasonal variation (e.g. sandals in summer 
shoes in winter), fluctuating foot symptoms and or paid employment regulations (e.g. 
safety boots). A small number of patients elected to wear slip on shoes for 
convenience of removal when attending the research appointment, limited dexterity 
(unable to tie laces) and/or restricted mobility. 
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6.5.4 Clinical assessment (Section A) 
 
6.5.4.1 Tender joint count 
A range of tender joint count scores was observed in both groups. The number of 
patients with no tender foot joints was similar for the AFC group and the NAFC 
group (n=13, 20% versus n=12, 27%). A small number of patients scored a 
maximum tender joint count of 28 (AFC n=1 versus NAFC n=1). The median (IQR) 
tender joint count (feet) for all patients was 5.5 (1 to13). In the AFC group, the 
median (IQR) tender joint count was 5 (1 to 13) and for the NAFC group was 6 (0 to 
10), which was not significantly different (U=1382.5, p=0.62).  
 
6.5.4.2 Swollen joint count 
The median (IQR) swollen joint count (feet) for patients was 2 (0 to 8).The median 
(IQR) swollen joint counts for the AFC group and the NAFC group were similar (2 (0-
8), 2 (0-7), respectively). A third (n=39, 36%) of the patients had no swollen joints. 
Of the AFC group, 20 (31%) had no swollen joints. Of the NAFC group, 19 (42%) 
had no swollen joints.  
 
6.5.4.3 Foot joints range of motion 
The highest frequency for reduced range (passive) of motion (ROM - limited / rigid) 
was detected in assessment of the 1st MTP joints. Table 6.9 presents the 
frequencies ROM of foot joint assessments.  The proportions of the AFC group with 
reduced ROM at the ankle joint and subtalar joints (either side) in the AFC group, 
was 45% (n=29) and 32% (n=21), respectively. The same numbers for the NAFC 
group were 22% (10) versus 13 (n=6). These were statistically significant 
differences (   =5.83 df=1 p=0.02 and   =5.17 df=1 p=0.02, respectively). Of the 
AFC, group 13 (20%) had reduced ROM at the mid tarsal joint and 58 (89%) 
reduced ROM at either 1st MTP joint. The same numbers for the NAFC group were 4 
(9%) and 37 (82%), respectively, which were not significant differences (   = 2.51 df 
=1 p=0.11 and (   = 1.13 df=1 p=0.29). The highest frequency for reduced PROM 
(limited / rigid) was detected in assessment of the 1st MTP joints. Overall, the 
frequencies for full PROM of all joints were higher in the NAFC group. 
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Table 6.9 Frequencies of ROM joint assessment 
Joint ROM  AFC (n=65) 
Frequency (%) 
NAFC (n=45) 
Frequency (%) 
Ankle joint Full ROM bilateral 36 (55) 35 (78) 
Reduced ROM unilateral 3 (5) 1 (2) 
Reduced ROM bilateral* 26 (40) 9 (20) 
Subtalar joint Full ROM bilateral 44 (68) 39 (87) 
Reduced ROM unilateral 5 (8) 1 (2) 
Reduced ROM bilateral 16 (25) 5 (11) 
Midtarsal joint Full ROM bilateral 52 (80) 41 (91) 
Reduced ROM unilateral 4 (6) 0 (0) 
Reduced ROM bilateral 9 (14) 4 (9) 
1
st
 MTP Full ROM bilateral 7 (11) 8 (18) 
Reduced ROM unilateral* 8 (12) 1 (2) 
Reduced ROM bilateral 50 (77) 36 (80) 
*Reduced ROM (limited / rigid) 
 
6.5.4.4 Metatarsophalangeal joint squeeze test 
Over half of the patients (n=63, 57%) were metatarsophalangeal (MTP) squeeze 
positive and 48 (44%) squeeze test positive bilaterally. Table 6.10 illustrates the 
frequencies of unilateral and bilateral MTP positive squeeze test frequencies. A 
significant difference was detected between the AFC group and the NAFC group in 
relation to frequencies of MTP squeeze test positive results (  = 6.02, df=2, 
p=0.05). This result indicates that the AFC group was more likely to have foot 
problems in relation to the MTP area. 
 
Table 6.10 MTP squeeze test positive frequencies 
 AFC (n=65) 
Frequency (%) 
NAFC (n=45) 
Frequency (%) 
MTP squeeze test positive unilateral 5 (8) 10 (22) 
MTP squeeze test positive bilateral 33 (51) 15 (33) 
 
6.5.4.5 Vascular assessment 
The majority of patients had palpable pedal pulses bilaterally (Table 6.11) but 4 had 
no palpable pedal pulses (dorsalis pedis or posterior tibial). Of these, one patient 
had severe lower leg and foot odema. For the remainder (n=3), the independent 
podiatrist concluded that these patients’ vascular status did not require further 
investigation. 
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Table 6.11 Frequencies of bilateral palpable foot pulses 
 AFC (n=65) 
Frequency (%) 
NAFC (n=45) 
Frequency (%) 
Dorsalis pedis non-palpable 4 (6) 4 (9) 
Dorsalis pedis palpable 60 (92) 40 (89) 
Posterior tibial non-palpable 9 (14) 2 (4) 
Posterior tibial palpable 55 (85) 43 (96) 
 
6.5.4.6 Neurological assessment 
Reduced protective sensation was detected in the feet of 21 (19%) patients, of 
whom 14 had accessed foot care. Of the 5 patients with diabetes, one had reduced 
protective sensation. This patient had accessed foot care. Data regarding other 
clinical features of neurological symptoms were collected by self-report. The majority 
of patients reported one or more current neurological symptoms in their feet (n=99, 
90%). Table 6.12 presents the number of current neurological symptoms. The report 
of one or more neurological symptoms was similar for the AFC and NAFC groups. 
 
Table 6.12 Frequencies of neurological foot symptoms 
Neurological foot symptoms AFC (n=65) 
Frequency (%) 
NAFC (n=45) 
Frequency (%) 
No neurological symptoms 5 (8) 6 (13) 
1 neurological symptom 8 (12) 6 (13) 
2 neurological symptoms 15 (23) 10 (22) 
3 neurological symptoms 10 (15) 9 (20) 
4 neurological symptoms 11 (17) 10 (22) 
≥5 neurological symptoms 16 (25) 4 (8) 
Any neurological symptoms 60 (92) 39 (88) 
 
A wide range of categories of neurological symptoms was reported by patients 
(Table 6.13). The frequencies of all neurological symptom descriptors were similar 
for both the AFC group and the NAFC group with the exception of sharp sensation 
and numbness (n=39, 60% versus n=19, 42%, n=31, 48% versus n=12, 27%, 
respectively). However, sharp sensation and dull ache can also be descriptions of 
somatic pain (activation of pain receptors in the skin or musculoskeletal tissues). 
These data indicate that neurological foot symptoms appear to be common in 
patients with RA. 
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Table 6.13 Categories of neurological foot symptoms 
Neurological foot symptoms AFC (n=65) number of 
patients in this category 
Frequency (%) 
NAFC (n=45) number of 
patients in this category 
Frequency (%) 
Sharp 39 (60) 19 (42) 
Burning 38 (59) 20 (44) 
Dull ache 44 (69) 30 (67) 
Numbness 31 (48) 12 (27) 
Tingling 32 (49) 21 (47) 
Other 12 (19) 11 (24) 
No neurological symptoms 5 (8) 6 (13) 
 
6.5.4.7 Overview of clinical examination 
The presence of inflammation in the feet was common as two thirds of the patients 
had swollen joints and approximately half were metatarsal squeeze test positive. 
Overall many patients had reduced range of motion (ROM) at one or more foot joint 
and the majority had reduced 1st MTP ROM (bilaterally), supporting previous reports 
that 1st MTP dysfunction is common in patients with RA. Almost all of the patients 
had an adequate peripheral vascular supply to the feet. A fifth of the patients were 
concluded to have reduced protective sensation (light touch). However, the majority 
reported to have one or more current neurological symptoms involving the feet.  
 
6.5.5 Foot problems requiring intervention 
Of the 110 patients, 45 (41%) were considered to require foot care. Of the AFC 
group nearly half were concluded to require foot care (n=30, 46%) compared to a 
third in the NAFC (n=15, 33%). The frequencies of foot care treatment categories 
required are shown in Table 6.14. There was a tendency for patients in the AFC 
group to require more complex care (> 1 treatment category). However, this was not 
significant (amalgamating 2 and 3 treatment categories required to achieve 
minimum cell count of 5 (  =2.22, df=2, p=0.33).  
 
Table 6.14 Frequencies of treatment categories 
Categories of foot problems 
requiring intervention 
AFC (n=65) number of 
patients in this category 
Number (%) 
NAFC (n=45) number of 
patients in this category 
Number (%) 
No treatment required 35 (54) 30 (67) 
1 treatment category 19 (29) 11 (24) 
2 treatment categories 10 (15) 4 (9) 
3 treatment categories 1 (2) 0 (0) 
 
Table 6.15 presents the independent podiatrist’s clinical conclusions for 
recommending assess to foot care. Interventions required were similar for both 
groups (corn /callus reduction   =1.49, df=1, p=0.22; treatment for toe nail 
pathologies   =0.117, df=1, p=0.74; tissue viability   =0.95, df=1, p=0.33; 
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biomechanical / insoles / orthotics/   =0.95, df=1, p=0.33; and self-care   =0.7, 
df=1, p=0.4). Nonetheless, these results indicate that despite having accessed foot 
care two thirds of patients’ foot health care needs continued particularly in relation to 
cutaneous lesions (e.g. callus and toe nail pathologies). Data were not collected in 
relation to if any of the AFC group intended to continue to access and/or if they had 
a foot care appointment pending. However, these data show that a third of the 
NAFC group would benefit from receiving foot care.  
 
Table 6.15 Foot problems requiring intervention by group* 
Foot problems requiring 
intervention 
AFC (n=65) number of 
patients in this category (%) 
NAFC (n=45) number of 
patients in this category (%) 
Callus / corn reduction 11 (17) 7 (16) 
Treatment for toe nail pathologies 23 (35) 11 (24) 
Tissue viability 4 (6) 1 (2) 
Biomechanical / insoles / orthotics 4 (6) 1 (2) 
Self care 1 (2) 0 (0) 
Total interventions required 43 (66) 20 (44) 
*More than one intervention required 
 
Of the 45 patients assessed as requiring foot care, 24 (53%) (11 AFC, 13 NAFC) 
were considered to require immediate intervention and were provided with an NHS 
podiatry self-referral form. The independent podiatrist arranged an urgent referral for 
one patient (NAFC) to the community podiatry service for care as they were 
classified as high risk (impaired tissue viability and neuropathy). These data further 
indicate that despite accessing foot care some patients’ foot health care needs were 
not being addressed in the current system. 
 
Additionally three patients with persistent articular foot problems (pain, stiffness and 
swelling) were advised by the independent podiatrist to contact the rheumatology 
specialist nurse via their telephone helpline for advice. Another two patients were 
recommended to arrange a consultation with their GP regarding peripheral micro 
vascular problems (chilblains / erythema pernio) for one and for assessment of an 
area of eczema on the dorsal aspect of one foot for the other.  
 
6.5.5.1 Overview of foot problems requiring intervention 
One third of the NAFC group and nearly half of the AFC group were considered to 
require additional foot care. The most frequent interventions required (by both 
groups) were for reduction of corns and/or calluses and treatment of toe nail 
pathologies. However, there was a tendency for the AFC group to require more 
complex care. Half of those requiring additional care were felt to have immediate 
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foot health care needs; therefore the research podiatrist provided a self-referral form 
to the local NHS podiatry service. A greater number of the NAFC group required 
immediate foot care compared with the AFC group (n=13, 29% versus n=11, 17%). 
Further, one of the NAFC group was assessed to be high risk (peripheral vascular 
disease and neurological symptoms) in terms of their foot health. Thus, despite 
having accessed foot care, many patients’ foot health care needs continued 
 
6.5.6 Validation of self-report foot problems with clinical examination 
observation 
Validation of self-report was examined for the overall study sample and not 
according to AFC versus NAFC. Variables selected for analyses are presented in 
Box 6.6. The time differential between data collection by self-report and clinical 
examination was approximately 10 minutes. Figure 6.8 illustrates the frequencies 
(prevalence) of current foot problems observed on examination.  
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 Figure 6.8 Frequency of current foot problems observed  
 
 
 
The highest frequencies of foot problems observed were: misshapen toes (clawed / 
retracted) 76 (69%), swelling (one or more swollen joints) 71 (65%) and callus 58 
(53%). The observed frequencies of hallux valgus; pes planus and nodules were 36 
(33%), 28 (26%) and 18 (16%), respectively. Of the 78 patients who had nail 
problems, 13 had onycomycosis (fungal infection involving the nail plate). No 
patients had ulceration, bacterial infection or fungal, infection involving the skin. 
These data provide a description of: articular features (e.g. swelling), extra-articluar 
features (e.g. numbness), cutaneous lesions (e.g. callus) and structural deformity 
(e.g. hallux valgus) currently present in nested set of patients from a random sample 
of patients with RA in Bristol. 
 
6.5.6.1 Comparisons of self-report and clinical observation of foot problems 
Table 6.16 presents the level of agreement between self-report of current foot 
problems with clinical observation. Overall, excellent levels of agreement (kappa 
>0.81) were detected for the presence of: corns (kappa=0.91), in-grown toe nails 
(kappa=0.89) and bunions / hallux valgus (kappa=0.96). In relation to the presence 
of: nodules, calluses, and misshapen toes levels of agreement were substantial 
(kappa= 0.6-0.80). The kappa coefficients for agreement on the presence of: 
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blisters; thickened toe nails; and infection / onycomycosis were moderate 
(kappa=0.41-0.60). Levels of agreement between self-report and clinical observation 
for the presence of numbness and fallen arches / pes planus were fair (kappa=0.12-
0.4) and less than chance agreement for swelling (kappa<0.01). No patient reported 
the presence of current foot ulceration and none were observed by the independent 
podiatrist. Levels of agreement between the self-report and clinical observation for 
the presence of foot pain and stiffness were not able to be calculated, as these 
clinical features resist accurate clinical assessment. 
 
Table 6.16 Comparisons of current foot problems self-report and clinical 
observation  
Foot 
problem 
category 
Foot 
problems 
Foot problems 
now 
self-report 
Frequency (%) 
Foot problems 
observed 
Frequency (%) 
Agreement  
self-report and 
observation 
Frequency (%) 
Kappa 
(k level of 
agreement) 
Articular 
features 
Pain 44 (40.0) 
1 1 
†
 
Stiffness 52 (47.3) 
1 1 
†
 
Swelling 31 (28.2) 71 (64.5)  55 (49.1) 0.097** 
Extra-
articular 
features 
Nodules 
(bumps) 
 
25 (22.7) 
 
18 (16.4) 
 
101 (91.8) 
 
0.724** 
Numbness 30 (27.3) 21 (19.1) 87 (79.1) 0.418** 
Cutaneous 
lesions 
Blisters 5 (4.5) 2 (1.8) 107 (97.3) 0.560** 
Callus 62 (56.4) 58 (52.7) 92 (83.6) 0.670** 
Corns 13 (11.8) 13 (11.8) 108 (98.2) 0.913** 
In-grown toe 
nails 
 
17 (15.5) 
 
16 (14.5) 
 
107 (97.3) 
 
0.893** 
Thickened 
Toe nails 
 
63 (57.3) 
 
49 (44.5) 
 
88 (80.0) 
 
0.606** 
Ulcers 0 (0) 0 (0) 110 (100) † 
Structural 
deformity 
Bunions / 
hallux valgus 
 
38 (34.5) 
 
36 (32.7) 
 
108 (98.2) 
 
0.959** 
Fallen arches  28 (25.5) 28 (25.5) 84 (76.4) 0.377** 
Misshaped 
toes 
72 (65.5) 76 (69.1) 94 (85.5) 0.670** 
Other Infection / 
onycomycosis 
 
8 (7.3) 
 
13 (11.8) 
 
101 (91.8) 
 
0.529** 
1 
Unable to quantify through clinical examination / observation 
† Unable to calculate k 
**p<0.005 
 
The kappa value is a statistical measure of levels of agreement and does not take 
into account the clinical importance of false negative reporting (e.g. failure of 
patients to report bacterial infections). Further, the kappa value is also influenced by 
prevalence (proportion of sample with outcome of interest) therefore it is possible 
that the statistical validity of self-report in relation to clinical significance of rare 
events may therefore be misleading. Levels of agreement between self-report and 
clinical observations of the presence of foot problems in terms of false negative 
results (failure of patients to report a foot problem when foot problem observed) are 
therefore required. 
Chapter 6 – Clinical assessment 
258 
 
6.5.6.2 Comparisons of false negative self-report with clinical observation. 
Comparisons of current foot problems by self-report and clinical observation are 
illustrated in Figure 6.9 in terms of proportions in level of agreement. The frequency 
of false negatives was 0% for the presence of hallux valgus and blisters. Further, the 
frequency of false negatives  for level of agreement of: nodules; callus; corns; 
ingrown-toe nails, thickened toe nails and misshapen toes were < 14%.These 
results show that if patients report any of these foot problems, their report is likely to 
be correct due to few false negatives. 
 
Figure 6.9 Comparisons of current foot problems self-report and observation 
 
 
*Self-report/observation 
 
Of the patients, 13 were observed to have onycomycosis involving one or more toe 
nails. Of these, 7 (54%) failed to self-report the presence of fungal infections 
involving toe nails. Thus the presence of onycomycosis by self-reports is not 
reliable. Variation in levels of agreement was most notable for swelling. Of the 71 
(65%) of patients observed (clinical examination) to have joint swelling (one or more 
swollen foot joint), 48 (68%) failed to self-report the presence of swelling. Of the 21 
(19%) patients classified as having reduced sensation, the proportion of false 
0.0 
10.0 
20.0 
30.0 
40.0 
50.0 
60.0 
70.0 
80.0 
90.0 
100.0 
P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 (
%
) 
Self report and observed foot problems. 
No/No*  
(True negative) 
Yes/No* 
(False Positive) 
No/Yes* 
(False negative) 
Yes/Yes* 
(True Positive) 
Chapter 6 – Clinical assessment 
259 
negatives was 33% (n=7). This result indicates that some patients were unaware of 
reduced sensation in their feet; therefore the self-report of numbness is not reliable. 
Of the 28 patients observed to have pes planus, 13 (46%) failed to self-report having 
fallen arches. 
 
6.5.6.3 Overview comparisons of foot problems self-report and observation 
Given these results, the self-report of: nodules; callus, corns, ingrown-toe nails, 
thickened toe nails, hallux valgus and misshapen toes appears to be reliable. This 
suggests self-report can be utilised with a high degree of confidence. Although 
levels of agreement were moderate for the presence of infection, half of the patients 
who had onycomycosis did not report the presence of infection. It is possible that 
these patients did not perceive or recognise fungal nail dystrophy as an infection. 
However, levels of agreement for more complex foot problems (e.g. pes planus) 
were only fair and patients substantially under-reported features of disease activity 
(e.g. joint swelling). Additionally, disparity was detected between self-report and 
positive clinical findings of numbness (reduced protective sensation / light touch). 
The wording of the questions in relation to presence of fallen arches, numbness and 
swelling may have been ambiguous to some patients and questions relating to the 
self-report of these foot problems may need refinement. Overall these data indicate 
that self-report of many foot problems in RA is reliable. Therefore these data are 
considered to be a legitimate description of the nature and prevalence of current foot 
problems in a selected sample of patients with RA. However, for more complex foot 
problems (e.g. pes planus), and for important clinical observations such as joint 
swelling, numbness and fungal infections, false negatives may mislead and direct 
assessment of the feet is required.  
 
6.5.7 Accessed foot care services (Section B) 
Of the 65 patients who reported they had accessed foot care, 33 (51%) had 
accessed two or more services (Table 6.17).  
 
Table 6.17 Number of different foot care services accessed 
Foot care services accessed AFC =65 Frequency (%) 
1 Foot care service 32 (49) 
2 Foot care services 19 (30) 
≥ 3 Foot care services 14 (22) 
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6.5.7.1 Access to separate foot care services 
Of the AFC group (n=65): 26 (40%) had accessed NHS podiatry, 27 (42%) 
independent podiatry, 44 (68%) orthotics and 17 (26%) orthopaedics. A small 
number of the AFC group had accessed all foot care services (n=2, 3%). Of the 26 
patients who had accessed podiatry, 7 (27%) had accessed both NHS and 
independent podiatry services. Data were not collected on the number of occasions 
each participant accessed the different foot care services 
 
Table 6.18 presents the frequency of foot care services accessed by category of 
referral route. A range of referral routes to NHS podiatry was detected with a third of 
patients accessing the service by self-referral (n=8, 31%). Of the 27 patients, who 
accessed independent podiatry, almost all (n=25, 93%) had done so through self-
referral. However, a small number of patients reported that accessing independent 
podiatry was influenced by GP recommendation (n=2, 7%). Of the 44 who had 
accessed orthotics, 42 (96%) had been referred by hospital based clinicians. In 
contrast of the 17 who had accessed orthopaedics, 11 (65%) reported they were 
referred by their GP. These data indicate that hospital based clinicians are more 
likely to refer patients to orthotics (hospital based) than podiatry (primary care 
based). This implies hospital clinicians consider devices (insoles / foot orthoses 
and/or prescribed footwear) as key foot care interventions. However, one third of 
patients (34%) required immediate intervention for cutaenous lesions (calluses / 
corns and/or nail pathologies) and only the minority (5%) required review for foot 
devices.   
 
Table 6.18 Foot care services accessed and referral route categories overall 
Referral route NHS Podiatry 
(n=26) 
Frequency (%) 
Independent 
podiatry 
(n=27) 
Frequency 
(%) 
Orthotics 
 (n=44) 
Frequency (%) 
Orthopaedics 
(n=17) 
Frequency (%) 
Self 8 (31) 25 (93) 0 (0) 0 (0) 
GP 12 (46) 2 (7)  0 (0)  11 (65) 
Hospital 5 (19) 0 (0) 42 (96) 5 (29) 
Physiotherapist 2 (8) 0 (0) 1 (2) 0 (0) 
Other 1 (4) 0 (0) 1 (2) 1 (6) 
* 2 patients accessed NHS podiatry by more than one referral route 
 
6.5.7.2 Comparisons of patient characteristics according to foot care services 
accessed 
Table 6.19 presents the patient characteristics (gender, age, social deprivation, 
hospital site, disease duration and disability) in relation to each foot care service 
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accessed. Overall the characteristics of patients who had accessed each service 
were broadly similar.  
 
Table 6.19 Comparisons of patients’ characteristics in relation to foot care 
services accessed  
Variable Podiatry NHS 
(n=26) 
Frequency (%) 
Independent 
podiatry 
(n=27) 
Frequency (%) 
Orthotics 
 (n=44) 
Frequency 
(%) 
Orthopaedics 
(n=17) 
Frequency (%) 
Female 19 (73) 20 (74) 34 (77) 12 (71) 
Mean age (years) (SD)  
66 (12.9) 
 
68.1 (11.2) 
 
63 (11.9) 
 
66.6 (10.5) 
Local social 
deprivation categories 
 4 and 5 
 
 
3 (12) 
 
 
5 (19) 
 
 
5 (11) 
 
 
5 (29) 
UHB (%) 17 (65) 18 (67) 24 (55) 11 (65) 
Median Disease 
duration 
 years (range) 
 
10.5 
(min 1, max 51) 
 
8 
(min 1, max 51) 
 
8.5 
(min, max 51) 
 
10 
(min 6, max 30) 
Median HAQ (range) 1.625 
(min 0, max 
2.500) 
1.250 
(min 0,  
max 2.250) 
1.500 
(min 0, max 
2.250) 
1.500 
(min 0,  
max 2.750) 
 
6.5.7.3 Overview of access to foot care services 
Of the 65 patients who had accessed foot care services, half had accessed more 
than one service. The most frequently accessed service was orthotics. The number 
of patients who had accessed all four foot care services was small but a third of 
patients who had accessed NHS podiatry reported they had also accessed 
independent sector podiatry.  
 
A range of referral routes were reported by patients who accessed NHS podiatry. In 
contrast, almost all patients who accessed orthotics had been referred by hospital 
based clinicians. Conversely, access to orthopaedics was reported to be generated 
by similar proportions of GP and hospital based clinicians. These results reflect local 
access criteria to NHS provided foot care services. However, there was a tendency 
for hospital based clinicians to be more likely to refer patients to hospital based foot 
care services (e.g. orthotics) rather than NHS primary care services (e.g. podiatry). 
 
The mean patient age and median disease duration were similar for all services 
accessed. There was a tendency for a higher proportion of UHB patients to access 
NHS podiatry, independent podiatry and orthopaedics. However, data were not 
collected in relation to the time at which foot care services were accessed. Thus 
comparisons of patient characteristics at point of access are unknown. Patient 
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characteristics as determinants of access to foot care therefore need to be 
considered with caution.  
 
6.5.8 Description of reasons for accessing or not accessing foot care, and 
care received (Section B) 
Patients’ reasons for accessing and not accessing foot care and their description of 
care received were recorded verbatim as textual data by the observer. These 
responses to open ended questions produced “quasi-qualitative data” which were 
subsequently analysed by content analysis.  
 
6.5.8.1 Reasons for accessing foot care 
A wide range of reasons was given for accessing NHS podiatry and independent 
sector podiatry (Table 6.20). However, a small number of patients were unsure why 
they had been referred (n=2, 8%). Of the independent podiatry group (n=27), over 
half reported reasons related to treatment for corns and or / calluses and inability to 
self-care (e.g. cut toe nails) (n=17, 63%). Additionally, 6 (22%) patients reported 
their reason for accessing private care had been influenced by: convenience; 
continuity of care provided by the same clinician; and dissatisfaction of care 
provided by the NHS podiatric service (e.g. refusal to cut toe nails). 
 
“NHS wouldn’t cut my toe nails. Age concern would because I’ve got RA.” 
ID4239F72 
 
Table 6.20 Reasons for access to NHS and independent podiatry 
Reason for access Podiatry NHS 
(n=26) 
Frequency (%) 
Podiatry independent 
(n=27) 
Frequency (%) 
Biomechanical assessment 2 (8) 0 (0) 
Corn / callus 2 (8) 11 (41) 
Unable to cut toe nails 7 (27) 6 (22) 
Ingrown toe nails 6 (23) 1 (4) 
Infection 1 (4) 0 (0) 
Pain 4 (15) 2 (7) 
Referred by clinician 3 (12) 2 (7) 
Ulceration 1 (4) 0 (0) 
Convenience / continuity of care / 
negative experience of NHS 
 
0 (0) 
 
6 (22) 
*More than one reason provided 
 
Data were not collected on the reasons for accessing orthotics and orthopaedics as 
local access to these foot care services are restricted to clinician-generated referrals 
only. It was therefore considered that accessing orthotics and orthopaedics would 
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have occurred if further assessment for care (intervention) was required as a result 
of clinical consultations rather than patients perceiving the need for intervention. 
 
6.5.8.2 Reasons for not accessing foot care 
Patients who had not accessed NHS podiatry, independent podiatry and/or orthotics 
were asked their reasons for not accessing each service (Table 6.21). Of the 84 who 
had not accessed NHS podiatry care, 58 (69%) perceived access to NHS podiatry to 
be unnecessary (e.g. feet not a problem). However, for 25 (30%) access to NHS 
podiatry was hindered by their perceptions (e.g. lack of knowledge how to access 
NHS podiatry). Two (2%) were currently considering accessing NHS podiatry as 
they were unable to self-care (cut toe nails). 
 
Table 6.21 Reasons for not accessing NHS podiatry care (n=84, 76%)* 
Reason category  Reason Frequency 
(%) 
Qualitative data 
Access perceived 
unnecessary by 
patients 
Feet not a problem 50 (60) “Don't feel I need to [see a podiatrist.]” 
ID3827F67 
Foot care supported 
by family 
2 (2) 
 
“My son always does them [referring to 
foot care] and the feet are the best bit of 
my body.” ID3012M76 
Accessed 
independent care 
6 (7) “Have always had private [podiatry] 
care.” ID158F76 
Access hindered by 
patients’ perception 
Lack of knowledge 
how to access NHS 
podiatry care 
11 (13) “Didn't know you could get it [podiatry] 
on the NHS unless you had bad 
problems, like diabetes.” ID23039F81 
Feet ignored by 
patients and clinicians 
3 (4) “No one in rheumatology suggested it. 
Surgical podiatrist is referring me to 
NHS podiatry so I don't have to pay.” 
ID23919F65 
MDT will refer if 
needed 
10 (12) Always come to the doctor about my 
foot pain. He's never suggested I go 
anywhere.” ID21558M63 
Unwilling to ask for 
additional care 
1 (1) “I'm ashamed to ask [for podiatry] I think 
I’m enough of a burden to them 
[referring to NHS].” ID23566F72 
Appointment 
pending  
Been referred 1 (1) “They [hospital clinician] have referred 
me to a podiatrist - not been seen yet.” 
ID5070F38 
Considering access Thinking about it 2 (2) Thinking about it [accessing NHS 
podiatry]. Can't manage toe nails 
because of hands.” ID4674F69 
*More than one reason provided 
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Of the 83 patients who had not accessed independent podiatry, the majority (n=77, 
93%) felt it to be unnecessary (Table 6.22), 10 (13%) because they were under the 
care of the NHS podiatry service. A small number (7) indicated limited personal 
financial resources as barriers to access independent podiatry care. 
 
Table 6.22 Reasons for not accessing independent podiatry (n=83, 76%)* 
Reason category  Reason Frequency 
(%) 
Qualitative data 
Access perceived 
unnecessary by 
patients 
No need 64 (77) “Never had a problem for a podiatrist to 
deal with.” ID1427F66 
Foot care 
supported by 
family 
3 (4) “Don't need to my husband or 
granddaughter cut my toe nails.”  
ID22177F58 
Accessed NHS 
care 
10 (12) “See NHS podiatrist so no need to.” 
ID2048F58 
Access hindered by 
patients’ perception 
Limited awareness 
of treatment 
options 
1 (1) “When I had foot problems just thought it 
was the RA and nothing could be done.” 
ID22356M64 
Limited knowledge 
of access 
1 (1) “Lack of time and a job to get to see one 
[independent podiatrist].”  
ID2767F52 
MDT will refer if 
needed 
2 (2) “No one [referring to MDT] recommended 
I saw one [independent podiatrist].” 
ID3012F59 
Previous negative 
experiences 
2 (2) Tried a few years ago but it was very 
expensive [independent podiatry] and 
didn’t help [referring to foot pain].” 
ID3266F72 
Financial cost Can’t afford it 7 (8) “Would like to get them [feet] tidied up but 
can't afford to go privately.” ID677F57 
Considering access Thinking about it 1 (1) “Feet are alright at the moment, would go 
[independent podiatry] if nails were bad.” 
ID2112F69 
*More than one reason provided 
 
Table 6.23 presents the reasons given by 66 patients who had not accessed 
orthotics. One third felt access to the service to be unnecessary as their feet were 
not a problem and they were able to self-source footwear and/or insoles. The 
majority gave reasons for not accessing care which were related to limited 
knowledge of orthotic treatment options, and clinicians not referring patients for 
care. The aesthetics of prescribed footwear was mentioned by one patient as a 
barrier to accessing orthotics.  
 
“Don't want to wear those shoes,” ID20648F74 
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Table 6.23 Reasons for not accessing orthotics (n=66, 60%)* 
Reason category  Reason Frequency 
(%) 
Qualitative data 
Access perceived 
unnecessary by 
patients 
 Feet not a problem 11 (17) “Don't need to see them [orthotics]” 
ID3620F70 
Can get shoes 8 (12) “Been able to manage with shoes”  
ID350F74 
Self-sourced insoles  3 (5) “I buy my own gel insoles which work 
really well” ID1427F66 
Access hindered by 
patients’ perception 
Limited awareness 
of treatment options 
5 (8) “Don't know who they are or what 
they do [referring to othtotics” 
ID3827F67 
Feet ignored by 
patients and 
clinicians 
33 (50) “They said I wouldn't like the shoes, 
so I didn't peruse it” ID4239M72 
Appointment pending  Been referred 1 (2) “Been referred but not had 
appointment yet” ID1512F40 
Podiatry review  See podiatrist first 1 (2) “They [rheumatology clinicians] want 
me to see the podiatrist first” 
ID5070F38 
*More than one reason disclosed 
 
6.5.8.3 Foot care received 
Of those patients who had accessed NHS podiatry (n=26), the majority (n=20, 77%) 
had received treatment for cutaneous lesions (toe nail care and reduction of corns or 
calluses) (Table 6.24). No patient reported having received any foot orthoses or 
insoles from the podiatry service. Of the two patients (8%) who were referred to 
another health professional, both had been reviewed in a multidisciplinary 
rheumatology foot clinic, which includes a podiatrist. Both had been referred to 
orthotics for foot orthoses and one to NHS community podiatry for treatment for toe 
nail problems; both reported to have appointments which were pending.  
 
Table 6.24 categories of care received from NHS and independent podiatry 
Foot care received NHS podiatry 
(n=26) 
Frequency (%)* 
Independent podiatry 
(n=27) 
Frequency (%) 
Assessment only 6 (23) 1 (4) 
Biomechanical assessment 6 (23) 4 (15) 
Cutanous lesions  20 (77) 22 (81) 
Referred to another health professional 2 (8) 0 (0) 
Tissue viability 2 (8) 0 (0) 
* 6 (23.1%) patients accessed NHS podiatry reported to have received more than one foot care 
category 
 
Of those patients accessing independent podiatry (n=27), 22 (81%) reported having 
received treatment for cutaneous lesions (toe nail care and/or reduction of corns 
and/or calluses). The number of the independent podiatry group issued with foot 
devices (insoles or foot orthoses) was small (n=2, 7%).  
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Of those patients in the orthotics group (n=44), the majority (n=42, 96%) had been 
issued with insoles (non-contoured devices) or moulded foot orthoses (contoured 
devices to foot). Of these, only 15 (36%) were currently using the devices. A variety 
of reasons were given for not using the foot devices, ranging from difficulty 
accommodating the devices in footwear to resolution of foot problems (Table 6.25). 
Of the 11 patients issued with prescribed footwear, only 3 patients continued to wear 
their prescribed footwear and only one patient wore the prescribed footwear to the 
research appointment (see Table 6.7). Reasons for not using prescribed footwear 
included negative perceptions of appearance and poor fit. 
 
Table 6.25 Reasons for not using devices issued (n=27, 64%)* 
Orthotic 
device 
category  
Reason Frequency 
(%) 
Qualitative data 
Insoles/ foot 
orthoses  
(n=27) 
Difficulty accommodating 
devices in footwear 
14 (60) 
 
“Couldn't wear shoes that would 
accommodate insoles” ID221F39 
Not comfortable 2 (7) “They [insoles] were not very 
comfortable” ID1164F60 
Not effective 6 (22) “I used to wear them [insoles] all the 
time but they don't make much 
difference now.” ID22982F45 
Devices for prescribed 
footwear, not wearing 
prescribed footwear 
2 (7) “They[insoles] were for prescribed 
shoes - not wearing prescribed shoes.” 
ID22982F45 
Did not receive devices 
supplied 
2 (7) “They [orthotist] made me a temporary 
insole but not followed up. Was in so 
much pain I didn't follow it up.” 
21026F64 
Foot problems resolved 1 (4) “My feet are much better, so don’t need 
them [insoles].” ID4550F69 
Prescribed 
footwear 
(n=8) 
Negative perceptions of 
appearance 
6 (75) “They [prescribed footwear] look so big, 
didn't like the look of them.” ID3767F79 
Poor fit 2 (25) “Too big, couldn't wear them 
[prescribed shoes] and couldn't be 
bothered to go back and argue about 
shoes.” ID2767F32 
*More than one reason disclosed 
 
A total of 17 patients had been referred to orthopaedics for assessment of their foot 
problems. Of these, 6 did not have any surgical intervention. Of the 11 patients who 
did undergo foot surgery, the majority had surgery involving the forefoot (n=10). A 
variety of forefoot surgery was described: correction of toe deformities (n=4); hallux 
valgus surgery (n=3); surgery involving MTP joints (n=3). Surgery of the ankle joint 
was reported by one patient. 
 
6.5.8.4 Patients’ experiences of foot care received 
Of those patients in the NHS podiatry (n=26), the majority reported benefits (n=19, 
73%). 
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“Very helpful [referring to NHS podiatry care], once you get past the 
receptionist” ID2048F58  
 
Podiatric care not improving foot problems was reported by a few patients (n=2) who 
felt they had received care by clinicians with limited experience and had difficulty 
with timely access to care when their feet were symptomatic. 
 
“Nice [referring to podiatrists] but inexperienced and always someone 
different. Couldn’t get the appointments when I needed them.” ID23064F54 
 
Two patients who had been discharged from the service to self-care reported that 
they were unable to self-care due to reduced function and disability. A minority of 
the NHS podiatry group been assessed and no treatment provided (n=2) and one 
found the treatment received painful. 
 
“It helped [podiatric care] but they said I couldn’t come again because I can 
manage [foot care] but I can’t.” ID23713.1F51 
 
The majority of independent podiatry group (n=27) reported that the care they 
received was beneficial (n=24). However, some patients (n=3) reported that their 
foot problems persisted despite and questioned the financial value of the care 
received.  
 
“Cost £220 [independent foot care] and it didn’t work. Would not recommend   
it.” ID 21737F69 
 
Data were not collected on patients’ experience and benefits of interventions 
provided by orthotics services. However, while almost the entire orthotics group had 
been issued with insoles or foot orthoses, only a third continued to use the devices 
issued. Further, of the patients issued with prescribed footwear only a quarter 
currently wore the footwear provided. These results suggest foot orthoses (insoles) 
were often not beneficial and positive experiences from the patient perspective were 
the lowest of any of the foot care services.  
 
Of the 11 patients who had undergone foot surgery, 6 reported that they found 
surgical intervention beneficial. 
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“They look much better [feet] and they feel much better. Glad I had it [hallux 
valgus surgery] done.” 23831F61 
 
In contrast, negative experiences and lack of improvement in symptoms after 
surgical intervention reported by 5 patients and as a consequence 2 patients were 
reluctant to consider further orthopaedic intervention. 
 
“It was a wonderful place [referring to hospital site] but don't think I would do 
it again [surgery]. It's not benefited me much. My toes are now numb and I 
can walk much less since the surgery” 20690F77 
 
6.5.8.5 Additional comments 
All patients were asked if they would like to make any additional comments relating 
to their feet and 74 (68%) did so (Table 6.26). The most frequent additional 
comments category was foot symptoms with some patients describing their foot 
symptoms fluctuating. Further foot symptoms were important issues particularly in 
relation to ability to work. The use of self-care and self-management strategies (e.g. 
hot / cold therapies) was reported by a small number of patients (n=8). Despite foot 
problems being important issues for some patients, a range of barriers to accessing 
foot care were reported (n=11), including they felt their feet had been ignored in 
clinical consultations. Further, a small number considered that their foot problems 
were very important and planned to discuss their foot health care needs with 
clinicians (n=5). Foot problems not being an issue or of low priority was expressed 
by a small number (n=7).  
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Table 6.26 Additional comments  
Do you have anything else you want to tell me about your feet? Frequency (n=74: 67%) * 
Comment 
category 
Comment label Frequency 
(%) 
Qualitative data 
 Foot symptoms Feet first 10 (14) “In the beginning feet very painful but not 
anymore.” ID23617F52 
Pain 7 (9) “Feet just hurt don't want to put them on the 
ground. It's like your feet have been beaten 
with metal rods.” ID22589M61 
Swelling / 
stiffness 
3 (4)  “Feet swell at the end of the day. Have a 
bath in the morning to ease the stiffness in 
the feet and at end of day to ease the 
swelling.” ID218181F51 
Cutaneous 
lesions 
7 (9) “Callus has been there for years - think it’s to 
do with standing for long periods on hard 
floors at work” ID23304M47 
Deformity 3 (4) “Feet are quite deformed  and recurring ulcer 
L 4th toe” ID2048F58 
Fluctuations 18 (24)  “Today is a good day some days they [feet] 
are so bad I can't walk” ID21575M46 
Feet and flare 1 (1) “Feels like I'm walking on pebbles. They 
[feet] are problem if I have a flare.” 
ID23977M54 
 Feet a priority 3 (4) “My hands and feet are my biggest problem.” 
ID4550F69 
Impact of foot 
symptoms 
Ability to work 3 (4) “I'm an HGV driver can't do more than an 
hour [driving] because of my legs and feet.” 
ID10012M64 
Footwear 7 (9)  “Problems with footwear had to wear 
slippers to work.” ID21866F53 
Activities  4 (5) “The feet are not as bad as my hands and 
shoulders but I really suffer if I do anything in 
the form of activity and they [feet] make me 
slow.” ID23963M56 
Self-care and self-
management 
Hot / cold 
therapies 
2 (3) “Used to the pain in my feet. It's usually bad 
in the morning I put ice packs on them [feet] 
every day” ID3266F72 
Pacing and 
planning 
1 (1) “Have to try and pace myself to avoid having 
pain. If I stand for too long or do too much on 
my feet that's when they get very painful.” 
ID23064F54 
Self-source 
insoles pads 
4 (5) “I buy pads from the catalogue. I buy things 
that will make my feet more comfortable 
even tried tubegrip” ID3021F59 
Weight loss 1 (1) “Lost a bit of weight which has helped 
swelling in the ankles.” ID23831F61 
Foot problems a 
priority 
Will discuss feet 5 (7)  “Getting shoes is difficult thinking about 
getting some made privately. Will talk to 
consultant to see if I can get shoes through 
NHS.” ID23989M71 
Access to foot care 
hindered by patients 
perception 
 
Do not want 
hospital shoes 
1 (1) “Have been offered prescribed footwear 
twice. It's difficult to get shoes but not keen 
to have prescribed shoes. Surgical podiatrist 
said they wouldn't help.” ID23919F65 
Limited 
knowledge of 
foot care 
1 (1) “If only I had known orthotics could provided 
safety boots then I would not have had 
surgery done.” ID2887M75 
Feet ignored by 
clinicians and 
patients 
5 (7) “They [rheumatologists] don't check our feet 
so it's difficult to know what help available 
and when to ask for it.”  ID2149F55 
Concerned 
about 
intervention 
2 (3) “I need the bunion done at some point but 
I’ve heard the op is very painful.” ID2339M62 
Negative 
experiences 
2 (3) “It was like walking on pebbles which is when 
I saw the orthotist but didn't get on with 
insoles.” ID1852F73 
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Table 6.26 continued 
Comment 
category 
Comment label Frequency 
(%) 
Qualitative data 
Access to foot care  
perceived 
unnecessary by 
patients 
Feet not a 
problem 
7 (9) “I don't have any problems with my feet my 
hands are the worst.” ID1148M64 
Foot surgery Been referred 3 (4) “Waiting to see surgeon about feet.” 
ID1148M64 
Surgery not 
related to RA 
2 (3) “Had bunion surgery before RA.” ID350F74 
Positive 
experience 
3 (4) “It's mostly in my hands and feet and wanted 
to take part [in the study] as foot surgery has 
helped so much and wanted to let you 
know.” ID1559F40 
 Surgery not 
performed 
3 (4) “Assessed for bunion  surgery but couldn't be 
done due to poor circulation” ID165F72 
 
6.5.8.6 Overview of access to foot care services and care received 
A wide range of reasons for accessing NHS podiatry was provided; the majority 
were for current foot symptoms requiring further assessment and treatment. In 
contrast the most frequently reported reasons for accessing independent podiatry 
was for reduction of corns, calluses and toe nails. Further, some patients reported 
they had accessed independent care for convenience (flexibility of appointments) 
and/or they had had previous negative experiences of NHS care.  
 
The majority of patients who had not accessed podiatry care (NHS or independent) 
did not consider their foot problems required podiatric intervention. A small number 
of patients who were unable to self-care and self-manage (foot problems) reported 
their foot health needs were met by family members; therefore access to care was 
not required. In contrast the most frequent category for not accessing orthotics was 
due to access hindered by patients’ perceptions. These reasons ranged from 
negative perceptions of prescribed footwear, limited knowledge of service and 
treatment options and feet being ignored in clinical practice. 
 
Overall, the majority of patients who had accessed NHS and independent podiatry 
care found the treatment they received to be beneficial. The majority of patients who 
had accessed NHS podiatric care reported they had received care for cutaneous 
lesions. None had been issued with insoles or foot orthoses. A similar frequency of 
care received was described by the independent podiatry group, although a small 
number had received insoles or foot orthoses as part of their care. Only half of the 
patients who had undergone foot surgery considered their foot problems had 
improved. Almost all of the patients who had accessed orthotics had been issued 
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with insoles or foot orthoses. However, only a third continued to use the devices. 
Further, of the patients who had been issued with prescribed footwear (hospital 
issued shoes) the majority had discontinued to wear the footwear provided. The 
number of patients choosing to discontinue using the devices or footwear issued 
suggests relatively less benefit and /or more disaffection from orthotics. 
 
Analysis of open response questions and free text data support the findings from 
Study 1 (one to one interviews) and Study 2 (postal survey); that foot problems are 
common in patients with RA and impact on many aspects of their lives. Further, 
access to foot care is variable and despite accessing care many patients’ reported 
current foot problems.  
 
6.6 Discussion 
The participants for this study were selected from a sample of patients (responders 
to Study 2). Responders to Study 2, source sample for study 3 were representative 
of the local population of patients with RA. Approximately equal numbers of those 
who had accessed foot care (AFC) and had not accessed foot care (NAFC) were 
included, and the two groups had similar disease durations. The issue of disease 
duration was considered important for several reasons. The pharmacological 
management of RA has evolved in recent years with the introduction of new 
treatment paradigms (e.g. biologics therapies) and now aims to achieve the lowest 
disease activity and ideally remission of the disease process as early as possible 
(e.g. Smolen et al, 2010). It is possible that patients who were diagnosed before the 
introduction of modern treatment paradigms (i.e. those with longer disease duration) 
would be more likely to develop disease features in the feet compared with patients 
with shorter disease duration. It was therefore postulated that, not only due to the 
cumulative effects of the disease, but also because of these changes in 
management, patients with longer disease duration would be at increased risk of 
developing foot problems. Analyses were not performed to investigate the 
association of disease duration and presence of foot problems. Overall, the 
proportions of patients observed to have one or more: extra-articular features, 
cutaneous lesions and structural deformity were similar for both the AFC group and 
the NAFC group.  
 
Of the 235 patients invited to participate in the study, 110 attended - an overall 
participation rate of 47%. There were no systematic differences between those 
patients who were invited and those who attended in relation to the general 
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characteristics (hospital sites, age, gender and local deprivation) and RA 
characteristics (disease duration, mean age diagnosed with RA and current 
disability). This suggests the findings can be related to the whole sample of those 
who were invited, and in turn may represent a true sample of the overall RA patient 
population.  
 
As with the survey results (Study 2), almost all reported taking one or more arthritis 
medications and nearly two thirds reported additional morbidity. Additionally, as with 
Study 2 results, no important differences were detected between the AFC and 
NAFC groups in relation to hospital sites, age, gender or local deprivation. 
Furthermore the clinical characteristics (arthritis medications and general disability) 
of both groups were broadly similar. The findings of this study will therefore be 
discussed in general for the study sample. The exceptions will be in discussing: 
patients’ reasons for accessing or not accessing foot care, description of care 
received and patients’ perceptions of the benefits of foot care received.  
 
In comparisons with earlier (probably non-representative) studies reporting foot 
problems in patients with RA, there were differences in general characteristics (e.g. 
age and gender) and clinical characteristics (e.g. disease duration and arthritis 
medications) of the patients. For example, the mean age of Study 3 participants was 
higher than earlier reports whereas the proportion of women was lower (Rojas-
Villaraga et al, 2009; Bowen et al, 2010; Baan et al, 2011). However, disease 
duration and classification and categorisation of arthritis medications reported by the 
study patients were broadly similar to earlier studies (Rojas-Villaraga et al, 2009; 
Rome et al, 2009; Borman et al, 2012). Variation in general and clinical 
characteristics of participants recruited from heterogeneous samples is not 
unexpected.  
 
All patients reported one or more current foot problems, the majority reported 
presence of cutaneous lesions (e.g. calluses) and/or structural deformity (e.g. 
bunions). The report of articular features (e.g. foot pain) and extra-articular features 
(e.g. nodules) involving the feet was less frequent. There is a dearth of 
observational studies checking data in relation to the accuracy of the self-report of 
foot problems in patients with RA and data reported in earlier (probably non-
representative) studies on the frequency of foot problems by clinical assessment 
(direct clinical examination, clinical observation and/or using imaging techniques) did 
not include patient self-report. This was probably because self-report was not 
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required for the purpose of the study. Rojas-Villarraga et al (2009) investigated the 
impact of foot problems on quality of life, disease activity and general disability using 
validated measures (e.g. HAQ). The authors report pain on forefoot movement was 
strongly associated with disease activity and general disability. As the self-report of 
foot problems has not been validated or developed as a PROM, it would seem 
appropriate for the report not to consider self-report as an approach for data 
collection. Further, if the self-report of a clinical feature does not address the 
fundamental aims of a study, the omission of this approach to data collection would 
seem reasonable. Borman et al (2012) did collect and present data from patient 
completed questionnaires and clinical assessment. However, the questionnaire 
used by Borman et al captured self-report but on a limited number of foot problem 
categories (e.g. pain, stiffness and numbness). In the present study we used Study 
1 and Study 2 and contributions from our PRPs to ensure we covered a full range of 
self-report foot problem categories. 
 
A majority of patients (74%) was observed to have one or more cutaneous lesions 
(calluses, corns and/or toe nail pathologies) and a similar proportion (82%) was 
observed to have one or more structural foot deformity (hallux valgus, toe 
deformities, pes planus, subluxed MTPs and/or 5th MTP exostosis). None of the 
patients had current foot ulceration but 8% reported a previous episode of foot 
ulceration at some time since being diagnosed with RA. The prevalence of foot 
ulceration in RA has been reported to be 9.7% (Firth et al, 2008) but the sample of 
patients in the present study, while providing evidence that foot ulceration can be a 
clinical feature of RA, suggests it is not very wide spread at any particular point in 
time. The proportions of patients with calluses, hallux valgus and lesser toe 
deformities were 53%, 33%, and 49% respectively. Rome et al (2009) report the 
findings of a clinical audit of 100 patients with RA. Of the audit participants, 63% 
were observed to have calluses, 64% hallux valgus and 86% lesser toe deformities. 
Similar data are reported by Rojas-Villarraga et al (2009) for calluses and hallux 
valgus. It is likely that the sampling strategy (“convenience” sampling) adopted by 
these authors accounts for the higher proportion of foot abnormalities reported. 
 
A range of neurological symptoms was reported by patients and a fifth had reduced 
protective sensation on examination. Peripheral sensory impairment can lead to 
painless trauma which can lead to serious clinical outcomes for some patients such 
as development of ulceration and potentially lower limb amputations. Reduced 
sensation may not be recognised by patients and self-report for this was unreliable. 
Chapter 6 – Clinical assessment 
274 
Screening for sensory deficit is widely implemented in podiatric practice in the UK. 
Mild sensory impairment has been described as a clinical feature in patients with RA 
(Wilson and Kirwan, 2006). The proportion of patients with reduced sensation in 
Study 3 was lower than a previous study conducted by Wilson and Kirwan (2006), 
but this earlier study was hospital-based, utilised a “convenience” sampling strategy 
and was conducted prior to the introduction of new arthritis medications (e.g. 
biologic therapies).  
 
Only half of the patients were wearing good footwear, which was self-sourced 
commercial/retail footwear. Patients with RA wearing inadequate (poor) footwear 
has been observed in earlier works (Williams and Bowden, 2004; Rome et al, 2009). 
Adequate footwear is an important factor in optimal foot health particularly for 
patients with diabetes (Boulton and Jude, 2004; Cavanagh, 2004; Maciejewski et al, 
2004). The evidence to support the benefits of footwear for patients with RA has 
predominately focused on prescribed footwear (hospital issued) with the exception 
of a small study conducted by Hennessy, Burns and Penkala (2007). A link between 
wearing poor footwear and direct negative consequences for patients with RA 
seems sensible but has not been unequivocally established (Riskowski, Dufour and 
Hannan, 2011b). This study indicates that many patients’ current footwear was poor 
but neither the reasons why patients chose to wear inadequate (poor) footwear nor 
any association of footwear with foot problems were investigated in this study. 
These issues could be investigated in future work. 
 
A wide range of pathological changes due to RA were assessed in this study. A 
general assessment of patients’ musculoskeletal system was performed using the 
GALS screen (Doherty et al, 1992). Almost all patients had one or more GALS 
screen abnormality, as would be expected in a sample of patients with RA. The 
GALS screen has been proposed to be a valid tool for identifying patients with 
symptoms of RA and recommended as a clinical screening tool in primary care 
(Plant et al, 1993). Three quarters of patients had one or more tender joints in their 
feet, two thirds had one or more swollen joints and over half were MTP squeeze test 
positive. The clinical significance of a positive MTP squeeze as an indication of 
disease activity is not clear cut (Scott, 2002; Wiesinger et al, 2013) but nevertheless 
these data indicate that many patients had clinical indications of inflammation in 
their feet at the time of the clinical assessment. 
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The classification and categorisation of foot problems in previous observational 
studies has tended to concentrate on structural deformity (e.g. toe deformities) and 
presence of cutaneous lesions (e.g. callus). The present study reports a wider range 
of features including cutaenous lesions (e.g. callus), articular features (e.g. structural 
deformity, lesser toe deformities), extra-articluar features (e.g. nodules), presence of 
inflammation by clinical examination (e.g. tender joint counts), joint mobility (ROM) 
and neurovascular status (e.g. protective sensation). There is also a broad 
description of the patients in relation to general characteristics (hospital site, age, 
gender, local deprivation and additional morbidity) and RA characteristics (disease 
duration, mean age RA diagnosed, arthritis medications and current disability). The 
findings of this study support the literature that foot problems in RA are common and 
can be multi-factorial in clinical presentation. However, severity and frequency of 
foot problems reported in this study are slightly less than in previous reports. It 
seems reasonable to suggest that this study reports the most comprehensive 
description of the general demographic characteristics, clinical characteristics and 
current foot problems in patients with RA to date.  
 
Data in relation to the prevalence of foot problems in RA can be obtained through 
self-report by patients and clinical assessment by health professionals. For example 
Otter et al (2010) present prevalence data of foot problems obtained through a 
postal questionnaire of patients with RA. In contrast several observational studies 
report the prevalence of foot problems through clinical assessment (e.g. Borman et 
al, 2012). However, levels of agreement between these two approaches have not 
been established in RA. This study therefore facilitated the opportunity to investigate 
the levels of agreement between the self-report of foot problems and clinical 
assessment. The self-report of foot problems were recorded in response to the 
question “Since you were diagnosed with RA, do you have any of the following 
problems with your feet?”  
 
High agreement occurred for most foot problems. However, agreement for 
numbness and pes planus was only fair and only chance agreement was detected 
for joint swelling using the Kappa value as a statistical measurement of inter-rater 
agreement. However, the Kappa value can be influenced by frequencies and 
therefore may not reflect levels of agreement for less common problems. 
Additionally the Kappa value does not give an indication of false negative reporting; 
that is patients failing to report a foot problem detected by clinical assessment. 
Investigation of levels of agreement for true positives, true negatives, false 
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negatives and false positives indicated that the self-report of many foot problems is 
reliable (e.g. bunions reported and hallux valgus observed). However, a third of 
patients who had reduced sensation did not report numbness. A similar situation 
was detected for pes planus where half did not report fallen arches. It is possible 
that some patients may have had a low medial longitudinal arch profile before being 
diagnosed with RA and therefore did not identify this as a foot problem since being 
diagnosed with RA. The most surprising result was for joint swelling in the feet. The 
clinician observed joint swelling in more than 65% of patients but only a third of 
these patients reported joint swelling. It is possible that patients did not interpret the 
question “Do you have swelling in your feet?” as the question was intended (“Do you 
have joint swelling in your feet?”). Hewlett et al (1995) reach similar conclusions 
regarding patients’ ability to recognise joint swelling. Overall these data demonstrate 
that the self-report of most foot problems is reliable and can therefore be used with a 
high degree of confidence. However, a direct examination is required for numbness, 
pes planus and most importantly for joint swelling, and the observed prevalence 
reported in Study 3 should be taken as the correct value rather than the self-report 
prevalence in Study 2. 
 
In relation to foot care accessed, the general characteristics (age, gender, hospital 
site, social deprivation) and RA characteristics (disease duration, disability) were 
similar for all foot care services (orthotics, orthopaedics and podiatry). Additionally, 
over half of the patients had accessed more than one foot care service. The service 
most frequently accessed was podiatry. The proportions of patients who had 
accessed NHS and independent sector podiatry were similar. A range of reasons 
was given for accessing independent sector podiatry including negative experiences 
of NHS podiatry services. The fact that patients may choose independent sector 
podiatry due to negative past experiences and dissatisfaction of NHS podiatry 
services has been reported previously (White and Mulley, 1989). Andersen’s model 
for health care utilisation (Andersen, 1985) includes the influence of patient 
(consumer) satisfaction with care received and influences further interaction and use 
of health care. Previous experiences of foot care also emerged in Study 1 as an 
important contributing factor to the decision to access further care.  
 
Over half the patients who had accessed care did so for cutaneous lesions. The 
clinical effectiveness of sharp callus debridement in the RA foot has received 
attention (Davys et al, 2005). A combined approach to the management of painful 
callosities (e.g. self-care and foot orthoses) is proposed by Siddle et al (2013). The 
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findings of this study indicate that patients consider the presence of callus to be an 
important health care need as this was the most frequent reason given for accessing 
podiatry services. Further, many considered treatment for cutaneous lesions to be 
so personally important that they self-funded care.  
 
There is evidence supporting the clinical benefits of foot orthoses for patients with 
RA (e.g. Woodburn, Barker and Helliwell, 2003). Of the podiatry group (NHS and 
independent sector), no patients reported to have received foot orthoses. The 
researcher’s clinical experience is that there is currently a dearth of orthotics/insoles 
available to the local NHS podiatry service. This may explain the low rates of 
orthotics/insoles issued. There may be a disincentive for independent sector 
practitioners to prescribe foot devices because of additional financial costs to 
patients. The majority of patients (96%) who had accessed orthotics received foot 
orthoses but only a third were using the devices issued. Reasons for cessation were 
varied such as difficulty accommodating the devices in footwear and not being 
effective. In order for the therapeutic benefits of insoles/orthotics to be achieved, 
patients need to be able to accommodate the devices in their footwear. As many 
patients were wearing “poor” footwear, it is possible that prescribing insoles/orthotics 
would not be achievable or appropriate unless footwear suitability was also 
addressed. However, this cannot be confirmed by these data as access to foot care 
clinical records were not available.  
 
Overall, the majority who had accessed podiatry services reported to be satisfied 
with the care they received. In contrast, half of those who had undergone foot 
surgery reported to be dissatisfied with the outcomes of surgical intervention. The 
perceived benefits of foot surgery in RA differ between patients and the surgeons 
(Backhouse et al, 2012). The patients’ experiences of care received by orthotics 
services were not explored directly in this study. However, the proportion of patients 
who had stopped using their devices and orthoses was very high. Reasons for not 
wearing the prescribed footwear issued included poor fit and aesthetical 
unacceptable by the patients. Similar findings relating to poor usage of prescribed 
footwear have been reported previously (Williams and Meacher, 2001; Williams, 
Rome and Nester, 2007; de Boer et al, 2009). Further work in relation to clinical 
practice and prescribing of orthoses, devices and footwear seems advisable.  
 
The majority of patients who had not accessed foot care perceived it to be 
unnecessary (e.g. feet not a problem). This is not unreasonable as, for example, 
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asymptomatic stage 1 hallux valgus which can be accommodated in footwear is not 
likely be clinically significant and therefore no treatment would be indicated. 
However, some patients’ reasons for not accessing care included access hindered 
by their perception (e.g. lack of knowledge of how to access NHS podiatry). 
Additionally some patients considered if their foot problem warranted specialist care, 
then their rheumatology clinicians would have initiated a referral. The aesthetics of 
prescribed footwear was the most common reason for not accessing orthotics.  
 
While this study had demonstrated that the self-report of most foot problems can be 
utilised with a high degree of confidence, knowing the prevalence of foot problems 
alone will not necessarily provide an indication of clinical significance. Two fifths of 
patients were assessed as requiring further foot care, of which half had immediate 
foot care needs. These clinical conclusions were lower compared to an earlier report 
by Williams and Bowen (2004) but this earlier work was a service evaluation, not 
specific for RA. This was a worrying finding. Further, some patients requiring further 
care said they were currently under regular podiatry care, raising issues regarding 
the quality of care received. However, it is not possible to examine this more deeply 
in the present study as data relating to the clinical presentation of foot problems at 
the time when foot care was accessed are not available. These data demonstrate 
that many patients had foot problems that were not being addressed. The most 
common reason for intervention (observer’s recommendation) was for the treatment 
of cutaneous lesions. 
 
6.7 Strengths and limitations 
This study has provided novel data: 1) a detailed clinical description of current 
prevalence of foot problems in a selected sub-set from a random sample of patients 
with RA; 2) evidence that self-report of most common foot problems is reliable and 
can be ustilised with a high degree of confidence; 3) a clear indication that a direct 
examination of patients feet is required to detect for numbness, pes planus and 
most importantly for joint swelling; 4) the number of patients with immediate foot 
care needs was high; 5) patient satisfaction and perceived benefits with care 
received differs between foot care services.  
 
The independent podiatrist conducting the clinical assessment in this study had 
extensive clinical experience specialising in diabetes, care of the elderly and also 
general podiatric practice. Following training provided by an academic podiatrist 
(JW), Professor of Rheumatic Diseases (JK) and the researcher, the independent 
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podiatrist was confident in conducting a detailed regional musculoskeletal and foot 
examination. This podiatrist had no previous connection with rheumatology foot care 
services and was not subsequently part of such services. She was therefore able to 
remain an independent observer impartial in the study outcomes and their 
implications for rheumatology care. 
 
That the study did not use techniques such as imaging (x-ray, MRI and or 
ultrasound) to identify foot problems may be considered a limitation. However, the 
overall aim of this study was to identify current foot problems by clinical examination, 
not to inform clinical care (e.g. decision to refer for surgery). For this purpose, 
exposing patients to additional diagnostic imaging was therefore unnecessary (and 
consequently unethical) and would incur unnecessary financial costs. 
 
Data were not collected in this study in relation to further exploration of foot 
problems affecting patients’ ability to work. In retrospect and because foot problems 
were interfering with patients’ ability to work turned out to be an important issue for 
some patients in Study 2, it may have been useful to have done this. However, 
recruitment for Study 2 (postal survey) and Study 3 were conducted simultaneously. 
Analysis of the data generated by Study 2 was only conducted once recruitment to 
Study 3 had been completed and thus the high proportion of patients reporting that 
their foot problems were affecting their ability to work was therefore an unexpected 
result and could not have been anticipated a priori. Nonetheless analysis of the free 
text data further supports the notion that foot problems impact on many aspects of 
patients’ lives, including ability to work. 
 
The matching process for disease duration meant that there was no automatic 
expectation that the study sample would reflect the general RA patient population. 
However, as it transpired the general patient characteristics (age, gender, hospital 
site and deprivation scores) were similar to the Study 2 responder sample. 
Moreover, the RA characteristics (disease duration, arthritis medications and current 
disability) of patients in Study 3 were similar to responders to Study 2. This is 
because none of these data distinguished the AFC and NAFC groups in any 
important way. Consequently the observations made on the state of patients’ feet 
may be generalised to the whole RA patient population. This study has 
demonstrated that the self-report of most common foot problems is accurate and so 
the self-report of these in Study 2 would be valid in any case. 
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The broad range of clinical assessments conducted in this study is an additional 
strength and the data presented provides the most comprehensive description of 
current foot problems in a selected sample of patients with RA to date. The clinical 
assessments lasted approximately 30 minutes which included obtaining informed 
written consent, the collection of patient demographic data, conducting foot 
examinations, exploring patients’ reasons for accessing or not accessing care, 
description of foot care received and completion of standardised outcome measures 
(FIS and HAQ). The conduct of the direct examination of patients’ feet took 
approximately 10 minutes to complete. It is therefore likely that the conduct of the 
foot assessment described in this study can be achieved in routine clinical practice, 
particularly in podiatry and orthotics clinical consultations.  
 
A further strength of this study was the independent podiatrist’s extensive clinical 
experience in managing podiatric high risk patients. This therefore ensured both 
clinical governance and research ethics were maintained. Data have been 
presented regarding the categories of foot problems requiring intervention. All 
patients who were considered to require additional foot care were advised by the 
independent podiatrist of her clinical conclusions. Further, those patients who 
required immediate foot care were provided with information on how to access the 
local NHS podiatry service. 
 
6.8 Summary 
 
This chapter strengthens the existing literature showing that foot problems are 
common in patients with RA and here for the first time the prevalence in the whole 
population can be inferred from the representative nature of the study sample. All of 
the patients had one or more current foot problems. Nearly half of the participants 
were considered by the independent podiatrist to require foot care. Further this 
study demonstrates self-report of most foot problems can be utilised with a high 
degree of confidence. Nonetheless this study also supports the need for some 
aspects of foot pathology to be assessed by examination, particularly in relation for 
signs of inflammation involving the foot joints. This study also provides valuable 
insight into patients’ reasons for accessing or not accessing foot care. As expected, 
some patients had not accessed foot care as they did not consider they had any 
problems which would warrant accessing care. Of the patients who had accessed 
foot care, the most common reasons were for treatment of cutaneous lesions (e.g. 
calluses) and inability to self-care their foot health needs (e.g. cut their toe nails). 
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The perceived benefits (patient perspective) of care received differed in relation to 
individual services accessed. The proportion of patients who had been issued with 
foot orthoses was high. However, the majority had ceased using the devices issued. 
Difficulty accommodating devices in footwear was the most frequent reason for 
cessation. Clinicians need to consider the accommodate features of patients 
footwear when prescribing foot orthoses. For the clinical benefits of foot orthoses to 
be achieved, patients need to be able use devices issued.  
 
This chapter completes the investigation of the prevalence, impact and care of foot 
problems in people with RA. Almost all patients have foot problems, some of 
substantial importance, and many patients had accessed foot care. However, many 
of those who had done so had continuing foot care problems, some requiring 
immediate attention. An abstract of Study 3 has been presented as an oral 
presentation at the EULAR meeting 2015 (Wilson et al, 2015) and a copy can be 
found in Appendix J3.  
 
The findings of the three studies taken together are considered and their 
implications for clinical practice, organisation and delivery of foot care services and 
areas for further research are explored further in Chapter 7.  
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Chapter 7: Discussion  
The results of each of the three interlinked studies presented in this thesis were 
discussed at the end of each relevant chapter. The findings of all three studies taken 
together as one body of work are now addressed. The evaluations and 
interpretations of all three studies are drawn together, their combined contributions 
to the issues raised in the introduction are discussed, and the implications of the 
overall findings for clinical practice, health policy and further research considered.  
 
7.1 How this work adds to previous reports of foot involvement in RA 
 
The common occurrence of foot problems in patients with RA, caused by a 
combination of disease processes and altered foot mechanics, is supported by 
population-based studies (Grondal et al, 2008; Otter et al, 2010; Jurez et al, 2010) 
and observational studies (Michelson et al, 1994; Rome et al, 2009; Borman et al, 
2012). Evidence for the benefits of non-pharmacological interventions such as foot 
orthoses and prescribed footwear is accumulating and national guidelines advocate 
examination of patients’ feet and timely access to foot care (Luqmani et al, 2006; 
NICE CG79). However, surveys of rheumatology departments in the UK have found 
that access to dedicated foot care services for patients with RA is variable (Williams 
and Bowden, 2004; Redmond, Waxman and Helliwell, 2006). There are some 
important limitations to previous work on both the prevalence of foot problems and 
access to foot care services. These weaken their generalisability and 
comprehensiveness. Perhaps the most important limitation is the sampling 
strategies that have been used. The majority of these earlier studies were either 
based in hospital rheumatology departments, used patients specifically referred for 
foot evaluation, and/or or sampled patients attending foot care services of some 
kind. These selected populations may not represent the overall population of RA 
patients, and the studies risk overestimating the prevalence and extent of foot 
problems. Further, many studies reported only a limited classification or 
categorisation of foot problems and in some instances the reports were not RA 
specific. A study of patients representing the whole population was required in order 
to establish the true prevalence and nature of foot problems in RA, the impact they 
have on the lives of patients, and the extent to which patients in general access foot 
care services. The main aim of the work reported here was to undertake such a 
study. 
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A survey of a large randomly selected cohort of patients taken from all those in a 
known geographical area was required, reflecting access to both secondary 
(hospital based) and primary (community based) care foot care services. The target 
sample therefore was identified from patients with RA who were currently being 
clinically managed in secondary care but whom all had access to the same 
community based services. This was conducted in Study 2 and was a postal 
questionnaire survey. However, in order to capture the consequences and important 
issues of foot problems in RA from the patient perspective a preceding qualitative 
study was conducted. This was Study 1, a qualitative analysis of interviews with 
patients to inform the content of the questionnaire. As data collected in Study 2 
would be based on self-report, a third investigation (Study 3) was conducted to 
investigate the reliability of the self-report of foot problems, and also to provide a 
detailed clinical description of current foot involvement in a selected sample of 
patients (responders to Study 2). Study 3 also provided an opportunity to further 
explore patients’ reasons for accessing or not accessing foot care, and to provide a 
description of the foot care received. In order to compare patients who had or had 
not accessed foot care services, and because foot problems and the opportunity to 
access foot care might be strongly linked to disease duration, participants (patients) 
were matched to ensure a similar distribution of disease duration in both patient 
groups. 
 
7.2 Thesis aims: 
 
1. Measure the prevalence of self-reported foot problems in RA by examining a 
large sample of patients in a postal survey. 
2. Quantify the nature and types of foot problems experienced by patients.  
3. Measure the impact of current foot problems. 
4. Identify the proportion of patients who have accessed foot care services. 
5. Discover patients’ reasons for accessing or not accessing foot care services. 
6. Identify factors associated with accessing foot care. 
7. Provide a description of the foot care patients have received. 
8. Identify self-care and self-management strategies adopted by patients to 
manage foot problems.  
9. Validate self-report of current foot problems (or lack of foot problems). 
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7.3 Influence of methodological considerations 
 
Often it is not possible (practically or economically) to collect data from every 
individual in the population of interest. Studies therefore generally identify and select 
a sample of the population (Bowling, 2014). The transferability of the findings from 
population samples to the entire population of interest is widely discussed in the 
literature. Demographic and clinical characteristics are reported to influence 
response rates to health surveys (Hoeymans et al, 1998; Rupp et al, 2002; Turrell et 
al, 2003). If patients who participate in research studies are different to the general 
patient population the generalisability of findings may not reflect or be applicable to 
the wider patient group (Anderson and Mantel, 1983; Gluud, 2006). Common 
categories of bias in clinical research studies, which may result in researchers 
reaching incorrect conclusions about the topic of interest, include selection bias 
(how the participants were identified and sampled) and measurement bias (how the 
outcome / topic of interest was measured) (Krishna, Maithreyi, Surapaneni, 2010). 
Female gender, social deprivation, and clinical disease features are reported as 
determinants of which patients with RA are likely to participate in clinical research 
(Reisine, Fifield and Winkleman, 2000). The issues of selection bias and 
measurement bias were therefore identified and addressed in the methodological 
approaches for all three studies. 
 
In Study 1, patients were purposively selected / sampled who had experienced foot 
problems at some time since developing RA and had accessed foot care or not. This 
sampling strategy was appropriate to explore patients’ individual accounts and 
experiences of foot problems to inform the content of the postal questionnaire. Study 
2 directly addressed the issues raised by Starr (2012), who proposed responders to 
surveys are a self-selected group, therefore recommends comparing characteristics 
of responders and non-responders. Overall no significant difference was detected in 
Study 2 between the target population (patients invited to participate) and the study 
sample in relation to hospital site, gender or age. The frequencies of social 
deprivation categories were very similar for responders and non-responders. Given 
these data, responders to Study 2 are considered to be a representative sample of 
all patients with RA in Bristol. Furthermore the general patient demographics 
(gender, age, social deprivation, hospital site) and clinical characteristics (disease 
duration, arthritis medications, disability, and additional morbidity) were similar for 
Study 2 responders and Study 3 participants.  
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One source of participation bias to be considered for all three studies is that patients 
with foot problems may have been more likely to participate in the studies as they 
were experiencing the overall topic of interest of this thesis (Sica, 2006). There is 
potential for this bias in Study 2 and Study 3, which is acknowledged, but given the 
characteristics of sample population, responders and participants any bias is likely 
to be small.  
 
Firm conclusions and inferences from research studies can only technically be 
applied to the patients who participated in the study. It is not possible to conclude 
with confidence how applicable the prevalence of foot problems reported in this 
thesis reflects patients with RA in other urban areas of the UK or indeed patient 
populations internationally. However, the study sample for Study 2 seems to be a 
representative sample of patients with RA. This thesis therefore may guide the 
generalisability of epidemiology data from a single population to other defined RA 
populations or indeed the whole population.  
 
An additional consideration is the influence of measurement bias. All foot 
examinations in Study 3 were performed by a single observer (podiatrist). To 
minimise the effect of observer bias the independent observer was trained in the 
conduct of the foot examination by the researcher and two of the academic 
supervisors. Additionally the independent podiatrist was fully aware of the study 
protocol and used a standardised case record form for all data collection which she 
autonomously trialled the case record form with patient volunteers before use. 
Furthermore she was unaware if a participant had accessed foot care or not until 
after the clinical assessments had been completed. All case record forms were fully 
completed with no missing data, indicating the independent podiatrist was familiar 
and competent with both the conduct of the foot examination and the data collection 
process. It is possible that because the participants were aware of the independent 
observers’ clinical background this may have influenced their behaviours and 
responses to the clinical interview questions (Monahan and Fisher, 2010). This 
potential observer effect is acknowledged.  
 
The response rate of 56% in Study 2, although similar to response rates in other UK 
based surveys of patients with RA (Neame and Hammond, 2005; Otter et al, 2010), 
was lower than the anticipated rate of 70%. The estimated response rate was based 
on an earlier survey of patients with RA carried out in the same geographical region 
(Nicklin et al, 2010). However, recruitment for this earlier study was by face-to-face 
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approach by the researcher in clinic. The accuracy of patient information (Study 2) 
was checked as one of the NHS hospital sites appeared to hold errors in relation to 
a small number of patients (e.g. patients’ contact details). This was highlighted by 
the return of one questionnaire indicating the recipient no longer resided at the 
postal address. Any further errors in relation to patients contact details were 
identified by the researcher by cross checking the study data base with hospital data 
bases. This not only ensured patients’ details were accurate but also added to the 
quality of the research process. Errors in patient contact details are therefore 
unlikely to have been associated with response rates. 
 
A major strength of this thesis was the collaboration with patients at each stage of 
the research process. Patient (service user) involvement in clinical research is 
widely advocated (Hewlett. et al, 2006; de Wit et al, 2011). Patient involvement in 
this thesis was achieved firstly from valuable discussions with the initial thesis 
research advisory group (RAG). The RAG included members of the rheumatology 
clinical team and patients. Secondly, support from the patient research partners 
linked to all three studies. Patient involvement was therefore incorporated in all parts 
of the research process including the overall approach of the three studies, wording 
and content of items in the questionnaire, trialling of the questionnaire and 
interpretation of the overall findings of each of the studies. For example of the Study 
2 questionnaires returned, only two were considered inadmissible due to large 
amounts of missing data. It was therefore considered that patients found the items in 
the questionnaire straightforward; supporting the benefits of including patients in the 
design and wording of the questionnaire.  
 
Capturing the patient perspective in relation to foot problems in RA has received 
attention in recent years. However, previous works have tended to focus on specific 
areas of interest such as: experiences of prescribed footwear (e.g. Naidoo et al, 
2011), factors influencing patients’ decisions to access foot care (Blake, Mandy and 
Stew, 2013) and patients perceptions of foot problems being overlooked in clinical 
consultations (Williams and Graham, 2012). The primary aim of Study 1 (interviews) 
was to capture important issues of foot problems in RA from the patient perspective 
to inform the content of the postal questionnaire (Study 2). However, Study 1 also 
provided a rich description of the complex nature of foot problems in RA, 
consequences and importance of foot problems, factors influencing patient’s 
decisions to access foot care or not, their experiences of accessing foot care, and 
beliefs regarding benefits of care received. The global nature of the consequences, 
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impact and care of foot problems from the patient perspective has not been fully 
investigated in previous work.  
 
7.4 Findings on the prevalence and impact of foot problems in patients 
with RA (aims 1-3 and 9) 
 
Following a narrative review of the literature and from clinical experience it was 
expected a priori that foot problems were likely to be common in patients with RA. 
Additionally, Study 1 participants reported the occurrence of a wide range of foot 
problems since being diagnosed with RA. These included articular features (e.g. 
pain), cutaneous lesions (e.g. presence of callosities), structural deformity (e.g. 
bunions / hallux valgus), and extra-articular features (e.g. nodules), indicating that 
patients recognise many different foot problems. The patient comments also 
supported the literature reports that foot problems can be multiple and complex in 
clinical presentation and may follow a variable fluctuating clinical pattern. 
 
7.4.1 Prevalence of foot problems by self-report 
The vast majority of responders to the postal survey in Study 2 and all of the 
participants in the clinical assessment in Study 3 reported one or more current foot 
problems. The proportion of survey patients reporting current foot pain, numbness 
and ulceration were in keeping with previous work (Otter et al, 2010; Firth et al, 
2008). However, the proportions of responders reporting current joint stiffness and 
joint swelling were higher than earlier reports. Otter et al (2010) reported the 
prevalence of joint swelling and joint stiffness as “never”, “sometimes” or “always”. 
The term “sometimes” may reflect current joint stiffness and joint swelling, therefore 
the proportions of responders reporting current joint stiffness and swelling cannot be 
deduced from the report. It is therefore possible that the data reported by Otter et al, 
may be an underestimation of the current prevalence of joint swelling and joint 
stiffness in the patient population. Nevertheless both Otter et al and Firth et al 
provide important data for the literature estimating the prevalence of foot pain, 
numbness, swelling, stiffness and ulceration in the feet of patients with RA. 
Additionally both studies were population based and although they were non-
random samples both had relatively large sample sizes. Overall Study 2 
demonstrates that foot problems are common in a random sample of the population. 
Furthermore, these findings provide novel data in relation to the broad range of 
categories of foot problems currently experienced by patients with RA. Based on the 
results Study 2, the prevalence of one or more current foot problems in patients with 
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RA by self report is estimated to be 91%. It is evident that the classification and 
categorisation of foot problems adopted in this thesis provides the most 
comprehensive estimation of the prevalence of foot problems in RA to date. 
However, the clinical significance and the proportion of patients requiring foot care 
cannot be extrapolated from these data, but rather require evidence from direct 
clinical examination. 
 
7.4.2 Prevalence of foot problems by clinical exanimation 
Study 3 included a foot examination by a trained podiatrist (observer). Feet were 
examined for pathological changes due to RA (e.g. joint swelling) and presence of 
common foot problems (e.g. foot deformities and cutaneous lesions). The majority of 
patients had one or more tender and/or swollen joints in the feet and nearly half 
were MTP squeeze test positive. Additionally over half had one or more subluxed 
MTP joints. An early arthritis cohort study conducted by van der Leeden et al, (2008) 
reported that 40% of the study participants had joint involvement of one or more 
MTP joints. In contrast by Borman et al (2012) reported similar findings to Michelson 
et al (1994), where foot problems in RA were more common in the rear foot than the 
forefoot (42% versus 28%). However, Borman et al report data collected by three 
examiners and interrater levels of agreement were not considered. Michelson et al 
(1994) reported data from a hospital based sample, which were collected prior to the 
development of the current pharmacological management of RA (e.g. introduction of 
biologic therapies). Nonetheless, despite recent advances in the pharmacological 
management of RA, data from Study 3 indicate many patients have clinical evidence 
of inflammatory features in their feet. This is a clinically important result as it 
provides an indication of the presence of current foot problems which are 
attributable to RA. Indeed Woodburn et al (2010) propose the care of foot problems 
in RA should parallel the medical management of RA, so that foot problems are 
detected and diagnosed early in order for care to be targeted. Similar conclusions 
are proposed for targeted treatment of extra-articular disease features involving the 
forefoot by Hooper et al (2012). The results from the clinical examination in Study 3 
add strong support to the call for feet to be examined for timely and appropriate 
management of foot problems. Additionally the findings of Study 3 provide a detailed 
clinical description of the features (articular, extra-articular, cutaneous lesions and 
structural deformity) of current foot problems in this sample of patients with RA.  
 
Peripheral sensory neuropathy is reported to occur in RA (Ferguson and 
Hollingsworth, 1993). A fifth of Study 3 patients were classified as having reduced 
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peripheral sensation. The proportion of patients with reduced sensation was lower 
than a previously reported prevalence of 59% (Wilson and Kirwan, 2006). However, 
this earlier study was hospital based and used “convenience” sampling. The 
phathophysiology, clinical progression and indeed the clinical significance of 
reduced protective sensation in RA is unclear. The clinical progression and most 
importantly the clinical significance of sensory deficit in the feet of patients with RA 
warrants further study.  
 
7.4.3 Validation of the self-report of foot problems 
Self-report is a widely used method for gathering information regarding population 
characteristics, health status, and utilisation of health services (Bhandari and 
Wagner, 2006). However, there are limitations for data collected by self-report. For 
example responders may misinterpret questions, inaccurately recall past events and 
develop response acquiescence (Kimberlin and Winterstein, 2008). Nonetheless 
there is evidence supporting the reliability of self-report of health conditions (Siorda, 
2013). Levels of agreement between self-report and clinical examination of foot 
problems have not previously been reported for RA and so an assessment in 
relation to the accuracy of the self-report of foot problems was required.  
 
All 110 patients who participated in Study 3 completed a new questionnaire 
reporting current foot problems immediately prior to having their feet examined. As 
the observer recorded patients’ report of foot problems on the case record form she 
was therefore aware of their responses. However, she was unaware that 
comparisons were to be made investigating levels of agreement between self-report 
by patients and her clinical assessment. Further, the observer did not undertake any 
of the data entry, analyses and/or interpretation of the findings. As reported in detail 
in Chapter 6, overall high levels of agreement occurred for most foot problems. 
However levels of agreement for numbness and pes planus were only fair and 
(rather surprisingly) only chance agreement was detected for joint swelling. 
Analyses were conducted using the Kappa statistic. As discussed in Chapter 6 there 
can be limitations in interpreting the value of the Kappa statistic particularly in 
relation to situations were subjective observer interpretation is required, such as 
clinical examinations (Viera and Garrett, 2005). For example false negative reporting 
can have important clinical consequences for patients’ foot health. Patients’ failing to 
identify foot ulceration and/or soft tissue infection could lead to delays in both 
accessing care and receiving care. Therefore levels of agreement were also 
calculated in relation to comparisons of true positives (positive self-report and 
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positive observation); false negatives (negative self report but positive observation); 
false positives (positive self-report but negative observation); and true negatives 
(negative self-report and negative observation) for the presence of current foot 
problems. Overall, the proportions of agreement for true negatives and true positives 
for the presence of: nodules, callus, corns, ingrown-toe nails, thickened toe nails; 
hallux valgus and misshapen toes were high. These results indicate that if patients 
report any of these foot problems, their report is reliable. 
 
However, a third of the patients found to have reduced sensation on clinical 
examination (insensate to light touch) failed to report numbness in their feet. In 
diabetic foot disease, sensory neuropathy is a serious clinical feature which 
develops gradually and insidiously. Often patients are unaware of initial sensory 
deficit (e.g. Boulton, 2005). Screening for peripheral neuropathy (sensory deficit) in 
diabetic feet is recommended and well established in clinical practice (e.g. Perkins 
and Bril, 2003). Peripheral sensory deficit is a clinical feature of RA and the reliability 
of a clinical screening tool to detect reduced sensation in the feet has been 
demonstrated (Wilson and Kirwan, 2006). Sim et al (2014) comment that 
differentiating between general neurological symptoms and peripheral neuropathy 
can be challenging in patients with RA. The long term clinical significance of 
reduced foot sensation in RA has yet to be established, but the lack of reliable self-
report identified in this thesis indicates that further investigations will need to employ 
direct clinical examination. 
 
The prevalence of pes planus in RA has been estimated at 64% (Michelson et al, 
1994) but in Study 2 only a fifth of responders reported to have fallen arches (the 
commonly used description of pes planus). In Study 3, a quarter of the patients 
examined had pes planus but half failed to report fallen arches. Allowing for this 
under-reporting suggests a prevalence of pes planus to be about 40%. Variation in 
the estimated prevalence of pes planus with earlier studies may be accounted for by 
sampling strategies. The study conducted by Michelson et al has limitations as 
discussed in 7.4.2. In contrast Study 2 was a population based sample of patients 
with RA in which the demographic characteristics of responders and non-responders 
were similar, indicating a high degree of representativeness. Pes planus can lead to 
alterations of gait, localized functional and structural changes (Turner et al, 2006). 
Additionally, pes planus can lead to other lower limb pathologies such as: Achilles 
tendinopathy and tibialis posterior tendinopathy, patello-femoral disorders and hip 
pain (Shibuya et al, 2014). Foot orthoses are recommended for the management of 
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pes planus (Franco, 1987), although high quality evidence to support their 
effectiveness is limited (Banwell, Mackintosh and Thewlis, 2014). Nonetheless pes 
planus is an important feature of the foot in RA. For further research and timely 
clinical interventions to reduce the clinical consequences of pes planus patient self-
report will be inadequate and direct examination of the feet is required. 
 
The self-report of joint swelling in the feet was different between Study 2 and Study 
3 (53% and 28%, respectively). Additionally Study 3 demonstrated that many 
patients who do have joint swelling did not report it on their questionnaire. Of the 
study 3 participants, two thirds were assessed to have one or more swollen joint in 
their feet. Of these patients only a third reported to have joint swelling. Random 
variation may account for the difference in self-report in Studies 2 and 3, but the 
very large discrepancy between the low self-report prevalence and the high 
prevalence of joint swelling on clinical examination means self-report of joint 
swelling cannot be relied on with confidence. Therefore direct observation / 
assessment is required to detect for the presence of foot joint swelling in a particular 
clinical or research situation. In relation to this it may be noted that omitting the feet 
in measures of disease status can result in patients being misclassified as in 
remission (van der Leeden, van Schaardenburg and Dekker, 2010).  
 
Investigating levels of agreement of multiple assessors in conduct of the foot 
examinations performed in Study 3 was beyond the scope of this thesis. Interrater 
agreement in relation to the conduct of foot examinations has received attention. For 
example high levels of interrater agreement for assessing for peripheral neuropathy 
are reported (Rayman et al, 2011). However, a systematic review conducted by 
Wrobel and Armstrong (2008) conclude levels of agreement between multiple 
assessors of physical examinations of the foot is variable. Examining the level of 
agreement between multiple assessors conducting the clinical examination 
described in Study 3 could be the focus of future study.  
 
7.4.4 Consequences of foot problems 
There emerged from the interviews in Study 1 a description of consequences of foot 
problems on patients’ lives that are not included in the Foot Impact scale (FIS). One 
such issue was how footwear influences the choice of which clothing to wear. 
Further, the importance of footwear was also interlinked with identity and body 
image particularly when attending social functions, and was not gender specific. 
Additionally less than half of the patients in Study 3 were wearing good or adequate 
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footwear. Footwear is an important factor in maintaining foot health in general 
populations and patients with long term conditions, and affects the risk of falls in 
vulnerable groups (Williams, Rome and Nester, 2007; Menant et al, 2008; Koepsell 
et al. 2004). However, this thesis has indicated that sourcing adequate and 
appropriate footwear is a challenge for many patients with RA. Indeed nearly all of 
the Study 1 participants described difficulty at some time in sourcing commercially 
available footwear which would accommodate fluctuating foot problems and 
deformity and which were aesthetically acceptable. Patients with RA experiencing 
difficulty with high street footwear and the negative consequences of footwear in 
relation to body image and clothing choice has been reported relatively recently 
(Naidoo et al, 2011, Goodacre and Candy, 2011).  
 
7.4.5 The impact of foot problems in RA 
The ‘impact’ of a disease or condition has not always been the central outcome 
measure used in clinical care and clinical research of foot problems. In clinical 
practice, particularly podiatric practice there is a tendency to consider impact of foot 
problems in relation to subjective clinical assessment, severity and prevention to 
improve symptoms, maintain function and improve quality of life for patients 
(Woodburn and Helliwell, 1997). However, the evidence demonstrating that contact 
with a podiatrist reduces consequences and impact of foot problems is limited 
(Buckley et al, 2013). There have been calls for the assessment and delivery of care 
for people with long term conditions to be reconsidered (Bodenheimer, Wagner and 
Grumback, 2002a; Lewis and Dixon, 2004). The focus should be on the provision 
and delivery of care which is patient centred, to address both the individual’s clinical 
needs and personal priorities. A recent example of a revised model of care for 
people with long term conditions is the “House of Care” model (Coulter, Roberts and 
Dixon, 2013). The model recommends that care should be holistic, preventative and 
patient centred. In order for this to be achieved patients need to assume an active 
role in their care. The model also challenges the traditional approach to medical 
care in which the clinician is viewed as being responsible for clinical management. 
Instead the “House of Care” promotes a partnership approach to clinical 
consultations with the inclusion of the patient perspective. The importance of the 
patient perspective in the management of RA is well recognised particularly in 
relation to improving outcome measurement in rheumatology (Tugwell et al, 2007). 
Patient reported outcome measures (PROMs) are widely used in rheumatology 
clinical research and practice. Nonetheless disparity of view between clinicians and 
patients in relation to the consequences of RA has been reported (Scott, Smith and 
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Kingsley, 2005). There is a growing interest within the rheumatology community to 
consider the consequences and impact of RA from the patient perspective (Lempp, 
Scott, and Kingsley, 2006). Indeed Sanderson et al (2011) propose a concept of the 
personal impact of RA as comprising three overlapping aspects of a condition: 1) the 
severity of the symptoms or effects of the condition; 2) the importance these effects 
have for an individual; 3) and the individual’s ability to cope with the symptoms or 
effects (the ‘Impact Triad’). Foot health clinicians need to consider the value of the 
inclusion of individual patients’ priorities and the personal impact of foot problems 
during clinical consultations. Such dialogue could then provide the opportunity to 
devise treatment plans which are not only appropriate and timely but acceptable to 
the individual patient.  
 
The importance of foot problems to patients with RA was highlighted in the Study 1 
interviews where some patients considered their foot problems to be central. The 
impact of foot problems in RA has been recognised with the development of the 
Foot Impact Scale (FIS) (Hellwell et al, 2005). The FIS has not previously been used 
in a postal survey thus comparisons with results from Study 2 with previous work are 
not possible. However, the FIS has been used in an earlier observational study 
investigating forefoot related disability in RA (Hooper et al, 2012). The FIS scores 
obtained in Study 3 (clinical assessment) were similar in numerical values reported 
by Hooper et al. However direct comparisons may be limited between values in 
measures of central tendency reported by Hooper et al and Study 3, mean versus 
mode. Nevertheless FIS scores in both Study 2 and Study 3 show that even in this 
very wide population sample the impact of foot problems was considerable.  
 
Since the development of the FIS outcome measurement methodology has 
increasingly recognised the need to consult with appropriate stakeholders in 
developing measurement tools such as questionnaires (de Wit et al, 2011). An 
important outcome of Study 1 was the clear indication that the FIS does indeed 
include foot problems which impact on patients’ lives (such as difficulty with 
footwear; reduced participation in valued activities; and ability to walk), providing 
external validity to the content of the FIS. However, patients also reported that foot 
problems were impacting on other aspects of their lives, including psychological 
well-being and ability to work. Furthermore, Study 1 participants described these 
impacts as important, severe and difficult to cope with. These descriptions are 
additionally consistent with the Impact Triad proposed by Sanderson et al (2011). 
The present studies were not intended to further validate the FIS or to develop an 
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enhanced scale to measure impact of foot problems in RA. However, the findings of 
Study 1 indicated that some very important issues relating to impact from the patient 
perspective are not captured by the FIS. Therefore additional measures of impact, 
concentrating on these issues, were included as items in the Study 2 questionnaire. 
Considerable impact was detected using these additional measures in Study 2, 
particularly work related disability. Of the Study 2 responders one third reported their 
foot problems were impacting on their ability to work. Work related disability is a 
recognised consequence of RA (Young et al, 2002). Foot problems impacting on 
patients’ ability to work has not been previously reported, but the results presented 
in this thesis suggest that work disability due to foot problems could be an important 
contributing factor.  
 
7.4.6 Discussing foot problems 
An annual review of patients’ feet is recommended in national guidelines (Luqmani 
et al, 2006; NICE CG79). However, these results of Study 1 and Study 2 indicate 
patients perceive foot examinations to be variable and raise issues of concordance 
of national guidelines in clinical practice. Indeed Otter et al (2010) report similar 
inconsistency in regular conduct of foot examinations.  
 
7.4.7 Overview of the prevalence and impact of foot problems in patients with 
RA 
The results of all three studies indicate that foot problems are not only common, but 
can be complex in clinical presentation. Further, data from Study 3 provide a 
detailed clinical description of patients’ current foot function (joint range of motion), 
assessment of disease features (e.g. joint tenderness; vascular and neurological 
status) footwear suitability and confirms that, for patients as a whole, foot problems 
are a common feature of RA. Not only are they common, they are important for 
patients and impact on many aspects of their personal lives. However, foot problems 
can be overlooked in clinical practice as they are not included in many measures of 
disease status. Clinicians need to be mindful of foot problems and their important 
consequences for patients. 
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7.5 Foot care received and self-care / self-management strategies 
adopted by patients (aims 4-8) 
 
7.5.1 Access to foot care services 
Based on comments in the literature, experience from a rheumatology outpatient 
department, discussions within the research team (including with the patient 
research partners) and published findings on access to health care services in 
general, we anticipated that a small proportion of patients would have accessed foot 
care services and that such patients would be more likely to be women and from 
affluent (low deprivation) groups. The results of the Studies 2 and 3 showed that 
these expectations were in general incorrect.  
 
Of the responders to Study 2, 70% reported they had accessed one or more foot 
care service. Access to foot care was defined in this thesis as accessed podiatry, 
orthotics and/or orthopaedics. This broad definition of access to foot care may have 
accounted for the higher than anticipated proportion of patients reporting to have 
accessed foot care. However, two thirds of responders reported they had accessed 
podiatry and orthotics and a third had accessed orthopaedics. The proportion of 
patients who had accessed podiatry was similar to an earlier postal survey of 
patients with RA (Otter et al, 2010). In contrast a longitudinal cohort study of patients 
with earlier RA, only 30% of study participants reported to have accessed podiatry 
and 4% orthopaedics (Backhouse et al, 2011). The mean age of participants at base 
line in Backhouse et al report was 55 years. The mean age of Study 2 responders 
and the accessed foot care group was 64 years and 65 years, respectively. The 
older age of responders to Study 2 is not an unexpected result as they were a 
sample of all patients with RA. In contrast the focus of Backhouse et al, study was 
patients with early RA. As the patients in Study 2 were older and had longer disease 
duration it is likely that they would have more opportunity to access foot care. 
Additionally as Study 2 responders were a population based random sample of all 
patients with RA, the proportions of patients who had accessed foot care is likely to 
be a more accurate estimation.  
 
One reasonable conclusion of why some responders to Study 2 had not accessed 
foot care is they have not had a clinical need. Indeed the emergent sub-theme of 
“Access perceived unnecessary” was identified in Study 1. This finding is further 
supported through the analyses of the clinical interviews conducted in Study 3. 
However, many of the patients who had not accessed foot care reported that they 
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would like to have been referred (Study 2). This was most notable for podiatry 
services. Of the 413 responders to Study 2, 204 had accessed podiatry. Of the 
patients who had not accessed podiatry, over one half indicated they would 
welcome a referral. Similar results are reported by Martin and Griffiths (2006). 
However, half of the patients in Study 2 who had accessed podiatry had sourced 
independent sector care (self-funded). This was an unexpected result. Data 
generated from Study 1 and from Study 3 therefore provides novel information 
regarding patients’ reasons for accessing independent sector foot care. Flexibility of 
appointments, continuity of receiving care from the same clinician and 
dissatisfaction with NHS podiatry service providing routine foot care (nail care), were 
reasons given for accessing independent care. Similar findings were reported by 
White and Mulley (1989) as factors influencing patients’ decisions to self-fund foot 
care. The high proportion of patients who had accessed foot care and their 
willingness to self-fund add weight to the argument that foot problems were seen by 
many patients as important health care needs. 
 
By comparing the characteristics of those patients who had and had not accessed 
foot care services, the strongest determinants of access identified in the multivariate 
analyses in Study 2 were age, disease duration and gender. However, the effect 
size for both age and disease duration was small (2% and 4% per year, 
respectively). The highest predictor of access to foot care was female gender with 
an odds ratio of 1.74. Female gender as a determinant of access to podiatry and 
orthopaedics has been reported (Backhouse et al, 2011). However, variation in 
mean age was detected in foot care services accessed between Study 2 (podiatry 
68 years, orthopaedics 67 years) and Backhouse et al report (podiatry 59 years, 
orthopaedics 49 years). Discordance of the Study 2 results with data reported by 
Backhouse et al may be accounted for by variation in patient populations. Reporting 
foot care service access in a restricted patient sample (early arthritis cohort) may not 
give an indication of access to foot care in the wider patient population. Additionally 
Backhouse et al present retrospective data prior to the introduction of modern 
treatment paradigms (e.g. biologic therapies) and may not reflect the current 
population. Nonetheless this earlier work is strengthened by the large sample size 
and being a multicentre UK based study with a protracted follow up period. Overall, 
given these results women are more likely to access foot care but gender as a 
determinant of access to foot care was not as influential as anticipated.  
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The routes by which patients accessed foot care differed between men and women. 
For example in relation to access to podiatry, women were more likely to self-refer to 
NHS podiatry and/or self-fund care. In contrast men more often reported attending 
podiatry after referral by a clinician. There was a tendency for hospital-based 
clinicians to refer patients to hospital-based foot care services (e.g. orthotics and 
orthopaedics) but we have no information about why they did this. It is possible if 
hospital-based clinicians were more aware of the provision of and access to 
community-based services for care of foot problems in patients with RA (e.g. 
podiatry), this may influence referral rates. Additionally informing clinicians of both 
empirical evidence (e.g. clinical trials and patient reported outcome measures) and 
anecdotal evidence (e.g. clinician’s and patients’ perspective) may influence referral 
rates. Clinicians’ knowledge of and access to community foot care services could be 
explored in future research. Identifying the characteristics of which patients are likely 
to access care and routes of access to foot care is of interest in general terms, but in 
contrast to our early assumptions it seems that most patients do (one way or 
another) gain access to foot care services. 
 
It is widely recognised that social deprivation is associated with poor health and 
subsequently influences health care needs. Indeed a large body of literature is 
devoted to the topic. However, the influence of social deprivation as determinants of 
access to and use of health care varies in different health care systems (Fitzpatrick 
et al, 2004). Access to and use of health care is a complex issue. Field and Briggs 
(2001) propose a combination of social demographic characteristics (e.g. social 
class) and geographical factors (e.g. residential location) influence utilisation of 
health care services. A population survey conducted by Veugelers and Yip (2003) 
report highly deprived groups to be frequent users of general practitioners and 
hospital based services, yet accessed fewer specialist services. In contrast, the 
uptake of screening programmes is higher in less deprived groups (Moser, Patnick 
and Beral, 2009). Social deprivation is reported to be an important factor associated 
with negative outcomes in patients with diabetes (Venermo et al, 2013). Additionally 
there is emergent evidence indicating quality of care in diabetes to be variable in 
relation to social deprivation (Grintsova, Maier and Mielck, 2014). There is a dearth 
of evidence regarding the association of social deprivation and access to foot care 
both in general UK populations and patients with RA. Investigation of social 
deprivation and access to foot care was therefore required. Comparisons of local 
deprivation were conducted in Study 2. The distributions of frequencies for all 
categories of social deprivation were similar between the accessed foot care group 
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(AFC) and the not accessed foot care group (NAFC). In particular the proportions 
from more deprived areas were similar for the AFC group (36%) and the NAFC 
group (40%). Given these results social deprivation is not likely to be a determinant 
of access to foot care for these patients with RA. Individuals with long term 
conditions often require complex and integrated health care from a range of 
disciplines (Beatty et al, 2003). The medical management of RA usually involves 
continuing contacts with rheumatology department clinicians over many years and 
often requires regular interaction with the health care system (e.g. for 
haematological monitoring). It is possible that these repeated and long term 
interactions with the clinical care team help to overcome barriers and thus patients 
with RA are more likely to access additional health services including foot care.  
 
A substantial body of literature is devoted to discussing factors associated with 
access to and utilisation of health care. Indeed a number of models and theories 
have been developed to explore and understand health behaviour, access to and 
use of health care services. The Health Belief Model (Rosenstock, Stretcher and 
Becker, 1988) proposes an individual’s perceived susceptibility, perceived severity, 
perceived benefits of health behaviour, perceived barriers to performing the health 
behaviour, cues for action such as symptom severity and confidence in their ability 
to perform the behaviour. It would therefore seem reasonable to consider an 
individual’s health beliefs may influence health behaviour such as deciding to 
access and use health care. However, analyses of the qualitative data collected in 
all three studies does not fully support components of the Health Belief Model as 
factors associated with deciding to access foot care. Although patients in all three 
studies described and reported foot problems to be severe and important issues 
many patients had not accessed foot care. Additionally the susceptibility of 
developing foot problems as a consequence of RA was only discussed by two 
patients in Study 1, and both of these patients had older relatives with arthritis. 
Despite reporting that their foot problems were impacting on their lives neither of 
these two participants had accessed foot care. Theories and models of health 
behaviour therefore do not appear to fully explain why patients with RA do or do not 
access foot care.  
 
7.5.2 Foot care received and current clinical foot care needs 
The clinical management of foot problems in RA aims to reduce pain and maintain 
function (Jaakkola and Mann, 2004). Of the patients in Study 2 who had accessed 
foot care (AFC) a range of categories of care were reported. The most frequently 
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reported category of care received was devices (e.g. insoles and prescribed 
footwear (76%)). Of the accessed foot care group (AFC) two thirds reported to have 
been issued with insoles and a quarter had received prescribed foot wear. These 
results indicate that foot care clinicians appear to consider the benefits of devices in 
the management of foot problems in RA. 
 
A third of the AFC group (Study 2) reported to have received treatment for 
cutaneous lesions. Of these, over half reported to have received treatment for 
callosities (corns and calluses). Sharp (scalpel) callus debridement is a standard 
clinical treatment performed by podiatrists in the UK. The clinical effectiveness of 
sharp callus debridement in patients with RA has received attention. A blinded 
randomised controlled trial (RCT) of sharp debridement of forefoot calluses versus 
sham debridement (reduction not performed) found no clinical benefits in pain, 
plantar pressure reduction or improvement in walking function (Davys et al, 2005). A 
more recent RCT investigated the clinical benefits of sharp callus debridement in 
patients with RA over an 18 month period (Siddle et al, 2013). The study recruited 
patients with self-reported painful forefoot callosities. Participants in both arms of the 
trial received combination individualised therapeutic care as required (footwear 
advice, prescribed footwear, and/or bespoke orthoses, and advice on self-care and 
self-management of calluses). Participants in the control arm did not receive any 
sharp callus debridement. At study exit no major differences were noted in the 
outcome measures between the groups (e.g. foot function, foot pain, impact or gait 
parameters). The authors therefore question the clinical value and effectiveness of 
sharp callus debridement. These studies are of interest. Firstly they provide for the 
literature evidence from well constructed RCTs. Secondly, Siddle et al report data 
from a trial with a protracted follow up period. However, evidence from two RCTs 
recruiting relatively small numbers of patients (38 and 65, respectively) is unlikely to 
provide significant evidence to influence alteration in established podiatric practice 
nationally. Additionally the influence of self-care and self-management of callosities 
(filing and applying emollients) cannot be ignored. It is possible the regular filing and 
applying emollients to calluses alone may contribute to improvement in symptoms 
patients’ experience from painful callosities. Data from all three studies in this thesis 
indicate the conduct of callus debridement appears to be common in clinical 
practice. Furthermore this thesis demonstrates that patients with RA face challenges 
sourcing suitable footwear which will accommodate deformities and/or orthoses 
(Study 1 and Study 3). However, footwear as a constraint to a combined therapeutic 
approach to the management of calluses in clinical practice cannot be extrapolated 
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from these data. Patients may prefer possible short term clinical benefits of callus 
reduction (that would not show up in the trials reported so far) rather than being 
required to change their footwear and/or use foot orthoses. The patients’ perception 
of the benefits of callus debridement could be the focus of future research.  
 
Data collected in the clinical assessment (Study 3) provides a detailed exploration of 
foot care received. The categories of foot care patients reported to have received 
were similar to the self-report in Study 2. Overall a wide range of foot care 
interventions received was reported in both Study 2 and Study 3. However, only a 
quarter of patients reported they had received advice from foot care clinicians 
regarding their foot problems. Providing advice in relation to adverse events (e.g. 
new pain on commencing using devices) and self-care and self-management (e.g. 
use of emollients and filling calluses) are fundamental principles of clinical care. The 
majority of the AFC group (Study 2) did not report having received any foot health or 
foot care education. Similar conclusions are reported by Graham and Williams 
(2015). It is possible that foot care clinicians did provide verbal and/or written foot 
health education but this has been forgotten. These data indicate that patients’ 
perception and/or recall of the provision of foot health education may be variable in 
clinical consultations. On the whole the findings of all three studies provide the most 
comprehensive description to date regarding the self-report of foot care received by 
patients with RA. 
 
7.5.3 Experience of foot care 
Despite accessing foot care many patients reported and were observed to have 
current foot problems (see 7.3.3). These results raise potential issues regarding the 
quality and effectiveness of care received. Indeed, of the Study 3 patients nearly half 
were considered by the independent podiatrist to have immediate foot care needs. 
Of these patients, two thirds had accessed foot care at some time since being 
diagnosed with RA. However, the trajectory of RA follows a variable and 
unpredictable clinical course with fluctuations of the inflammatory process and 
periods of remission. As data by self-report and/or clinical examination at the time 
foot care was accessed was not available (and nor were data in relation to the 
clinical significance of foot problems at the time foot care was accessed, or clinical 
records of care provided), firm conclusions regarding the quality of care received 
cannot be drawn directly. 
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A further issue regarding the quality and effectiveness of foot care received relates 
to the issue of devices (insoles / foot orthoses and prescribed footwear). Many 
patients in Study 2 reported to have been issued with these but in the subset later 
seen in Study 3, the majority reported they had stopped using the foot orthoses 
and/or wearing the prescribed footwear. Evidence indicating the clinical benefits of 
foot orthoses and insoles is available (Hennessy, Woodburn and Steultjens, 2012). 
However, the application of the results from clinical trials with stringent inclusion 
criteria and controlled conditions may not carry through to general patient 
populations (Rothwell, 2005). Foot care clinicians need to consider the 
accommodative features of patients’ footwear prior to issuing devices. 
Dissatisfaction and low usage of prescribed footwear has received attention (e.g. 
Williams and Meacher, 2001). Data from Study 1 and Study 3 provide 
supplementary evidence to the existing literature in relation to low satisfaction and 
usage of prescribed footwear. Prescribing and issuing foot orthoses and prescribed 
footwear incur financial costs to service providers. In order to reduce wastage of 
public funds, patients need to be issued with devices that they can accommodate in 
their footwear and/or be prescribed footwear which are both acceptable and 
effective. Collaboration with patients in relation to treatment planning may enhance 
quality outcomes of care provided. If clinicians are considering referring patients for 
foot orthoses and/or prescribed footwear it may be valuable initially to explore the 
patients expectations and if they would like to receive these devices, prior to 
generating a referral.  
 
The findings of Study 1 suggest that patient satisfaction with foot care received 
influenced further interaction and use of foot care services. Patients who had a 
positive experience of care received appear to continue to use foot care. In contrast 
patients with a negative experience did not continue to utilise services. Customer 
(patient) satisfaction of health care received has been proposed as an important 
determinant of continued usage of health care by patients (Andersen, 1995). The 
importance of patient satisfaction is acknowledged as an important outcome 
measure to monitor access and quality of care (Williams, 1994). In relation to 
orthopaedics, the majority of patients who had undergone foot surgery reported they 
were satisfied with the outcome, with proportions similar across Study 2 and Study 
3. Data were not specifically collected in relation to satisfaction with orthotic 
interventions in Study 2. However, it is likely that satisfaction with orthotics was low 
due to the number of patients who reported they had ceased using the devices 
issued in Study 3. The majority of patients in both Study 1 and Study 3 reported that 
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they found podiatry care beneficial. It is possible that disclosure of the independent 
observers’ clinical background may have influenced patients’ response (Richards 
and Emslie, 2000). However, the researcher did not disclose her clinical background 
to participants in Study 1 until after data collection was completed. The findings of 
Study 1 support the data in Study 3 in relation to overall positive experiences of care 
received when podiatry was accessed. Therefore disclosure of professional 
background did not appear to influence patients’ responses. Of note a small number 
of patients in both studies reported concerns regarding clinicians’ levels of expertise, 
the lack of continuity of care (receiving treatment from different clinicians each time) 
and being unable to access care when needed. 
 
Issues related to foot care being provided by non-specialist clinicians have been 
discussed in earlier reports (Rome et al, 2009; Hendry et al, 2013). Additionally non-
specialists’ knowledge of national guidelines for the management of foot problems in 
rheumatic diseases shows wide variation (Williams et al, 2013). This thesis has 
demonstrated that many patients with RA do access foot care. However, within the 
geographical area of the studies there is currently a dearth of podiatrists and 
orthotists specialising in inflammatory arthritis. Whilst it could be argued that some 
of the categories of foot problems reported and observed in all three studies are not 
specific to RA, questioning the need for specialist foot care services. Current foot 
problems were very common in Study 3 patients. Two thirds were assessed to have 
one or more tender and swollen joints in their feet, over half were MTP squeeze test 
positive and a fifth had reduced protective sensation. The presence of joint swelling 
and involvement of the MTPs are well recognised clinical features of RA (Emery et 
al, 2002). Additionally early review with rheumatology specialist services has 
demonstrated improvement in clinical outcomes for patients (Nell et al, 2004). 
However, for this to be achieved there is a need for collaboration between primary 
care based and secondary care based clinicians. In order for patients to be reviewed 
by rheumatology specialists there is a requirement for non-specialist clinicians to 
have the clinical skills to assess and identify patients who require specialist review. 
This can be achieved through education and training of non-specialist clinicians by 
specialist clinicians (Scott et al, 1998), specifically those with knowledge and 
expertise in rheumatology. This issue warrants further enquiry. Developing the 
clinical assessment skills of non-specialist foot clinicians to a level which recognises 
the need for specialist referral could probably be achieved through relatively brief 
training and education provided by clinical specialists, as advocated by Scott et al. 
Indeed the independent observer in Study 3 had limited previous clinical experience 
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of assessing patients with inflammatory arthritis. Nevertheless after concise training 
she was competent and confident in assessing patients’ feet for clinical indications 
of inflammation.  
 
Variation in provision of specialist foot care services for patients with rheumatic 
diseases has been reported (Redmond, Waxman and Helliwell, 2006). In contrast, 
the role of the diabetes specialist podiatrist is widely implemented in the UK, and 
specialist podiatrists are widely viewed as an essential member of the 
multidisciplinary team in managing “diabetic foot disease” (e.g. Singh, Armstrong 
and Lipsky, 2005). Many of these specialist podiatrists are based in secondary care 
(hospital based) as recommended in national guidelines (NICE NG19). Hospital 
based specialist podiatry provides opportunities for close collaboration with all 
members of the multidisciplinary team (MDT). Additionally, Integrated Care 
Pathways (ICPs) are advocated for many health conditions to facilitate translation of 
national guidelines into clinical practice to improve both patient outcomes and 
patient “flow” through the health care system (Campbell et al, 1998). Local ICPs 
have been developed and implemented for the management of diabetic foot 
disease. The provision of foot care services for patients with RA could be organised 
to reflect the diabetes model. The implementation of specialist foot care clinicians 
(podiatrists and orthotists) in RA would provide the opportunity to support non-
specialist foot care clinicians through education and training as described above. 
Additionally specialist clinicians based within rheumatology departments would 
enable close collaboration with the MDT, facilitating opportunities for a 
multidisciplinary approach to the care of foot problems in patients with RA. Indeed 
close collaboration between clinicians for the assessment and management of foot 
problems in patients with arthritis has long been advocated (Helliwell, 2003) and 
national guidelines are available for the management of foot problems in RA (NICE 
CG 79). Examples of rheumatology ICPs are available (e.g. Williams et al, 2011). 
However, for local ICPs to be implemented there needs to be support and “buy in” 
from all stakeholders (clinicians, commissioners and service providers, as well as 
patients). If specialist foot care services are not available locally the benefits to 
improving patient care and outcomes through the introduction of a local ICP will not 
be possible or achievable. 
 
7.5.4 Self-care and self-management strategies adopted by patients 
The self-care and self-management strategies adopted by patients to manage foot 
problems have not been previously reported. This thesis therefore presents novel 
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contributions to knowledge regarding self-care and self-management strategies 
patients with RA adopt to manage foot problems. A wide range of strategies were 
reported by patients in Study 2. Self-management programmes are effective in 
improving health behaviours and health outcomes, and reducing health care costs in 
patients with RA (Lorig, Mazonson and Holman, 1993). Self-management is 
advantageous in other long term conditions, for example in improving glycaemic 
control and health outcomes for patients with diabetes (McMurray et al, 2002). Self-
management programmes have not, however, been shown to be effective at 
reducing foot problems in diabetes (Apelqvist and Larsson, 2000). Semple et al 
(2009) conducted a small study (n=30) to evaluate the benefits of a self-
management foot care programmes for patients with RA and found half of the 
participants were unable to perform basic self-care and self-management of their 
feet (e.g. cut toe nails and/or inspect their feet) due to physical disability. Although 
the study sample was small it raises an important clinical issue regarding patients 
with RA having the ability to self-care their basic foot health care needs. It is not 
possible to conclude whether the self-management and self-care strategies reported 
in Study 2 were self-initiated or recommendation by clinicians. Nonetheless some 
strategies reported could be detrimental to patients’ foot health, particularly in feet 
with poor tissue viability (e.g. commercially sourced topical keratolytics). Patients 
with RA have to live and manage their condition and Bodenheimer et al (2002 b) 
suggest patients with long term conditions make decisions on a daily basis on how 
to do this. There is a body of literature describing and discussing personal, social 
and environmental factors associated with participation and non-participation in self-
management of long term conditions. The factors influencing patients’ decisions to 
self-care and self-manage their foot problems is beyond the scope of this thesis.  
 
7.5.5 Overview of foot care received and self-care and self-management 
strategies adopted by patients 
This thesis raises important issues regarding foot care received. Firstly, although 
data are not available regarding the classification, severity and/or clinical 
significance of foot problems at the time when care was accessed, a number of 
patients who had accessed foot care were deemed on examination to have foot 
health care needs requiring immediate attention (Study 3). Secondly, the most 
frequent category of foot care reported was the issue of devices (insoles / foot 
orthoses and prescribed footwear) but, many patients were no longer using the 
devices issued. Thirdly, the role of patient satisfaction in relation to care already 
received is an important determinant of future action, as those who had positive 
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experiences and high satisfaction of care received were more likely to continue to 
access foot care.  
 
To condense the findings of this thesis into the briefest of statements: overall access 
to foot care for patients with RA is (for a variety of reasons) less of a concern than 
first thought, but the provision of effective, timely and targeted care appears to be 
the more pressing issue for both research and clinical care.  
 
7.6 Limitations 
 
The strengths and limitations of each study have been addressed in detail in the 
chapters for the individual studies. Potential limitations (some touched on briefly 
above) inherent in the studies which might relate to the overall collective findings on 
the impact, prevalence and care of foot problems in RA is discussed below in 
relation to: data when foot care was accessed; sample bias; and clinicians’ 
perspective. 
 
Of the patients in Study 2 and study 3 who had accessed foot care, many reported 
one or more current foot problems; potentially raising issues regarding the quality 
and effectiveness of care received. However, data were not collected at the time 
when foot care was accessed, which is a limitation of the study. Further a 
description of the nature and clinical severity of those foot problems prior to and 
after care was not available. Cross checking with medical records could have 
provided the opportunity to extrapolate historical clinical data in relation to the 
presence, clinical importance and care of foot problems at the time of the original 
foot care episode. This was considered to be unachievable. Firstly, because many 
patients had accessed independent sector foot care and access to private 
practitioners’ clinical records was not possible. Secondly, the method of recording 
clinical features may vary between health professions and health professionals, as it 
has done in previously published research. Thirdly, during the current study’s data 
collection the community podiatry service implemented use of electronic patient 
records, meaning that the earlier paper records were no longer readily available. It is 
also possible that a small number of patients may have received foot care from 
outside the geographical boundary, further limiting access to foot care clinical 
records. 
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As discussed in 7.3 it is possible that participation in both Study 2 and Study 3 was 
subject to some bias because patients with foot problems and/or foot related 
disability might be more likely to participate as these patients were experiencing the 
very topic that was described in each study’s invitation letter and patient information 
sheets. Almost all patients reported (Study 2) or were observed (Study 3) to have 
one or more current foot problems. It is therefore possible to conclude that data in 
both studies can only be directly attributable to the participants in each study. 
Nevertheless Study 2 was a population based sample of patients with a large 
sample size. Additionally the general characteristics (gender, social deprivation and 
hospital site) were similar for Study 2 non-responders, Study 2 responders, Study 3 
non-participants, and Study 3 participants. Furthermore the clinical characteristics 
(age, disease duration, disability; arthritis medications and additional morbidity) were 
comparable for both Study 2 responders and Study 3 participants. Also the 
categories of foot problems reported in both Study 2 and observed in Study 3 were 
similar. Finally the self-report of most foot problems is reliable. Therefore the self-
report of foot problems in Study 2 can be utilised with a high degree of confidence. 
Even if not all patients within the target population had current foot problems this 
thesis has demonstrated that they are widely prevalent in a sample of the 
population. 
 
Failure to capture the clinicians’ perspective regarding the prevalence, impact and 
care of foot problems may be considered a further limitation of this thesis. As 
discussed above, the time at which foot care was accessed was unknown. 
Additionally, identifying which clinicians assessed patients, provided care and their 
clinical evaluation of the effectiveness and benefits of treatment provided was not 
possible. Clinicians and patients may have differing priorities in the outcome of 
clinical care (Sandersen et al, 2010). However, clinician input into the study design 
was obtained from members of the clinical rheumatology teams at both hospital 
sites and a representative of the community based podiatry service. Collaborations 
with clinicians were conducted at the initial research advisory group (RAG). The 
level of clinical research experience differed between the clinicians. However, the 
clinical members of the RAG provided valuable comments and insight to the overall 
approach and the conduct of each of the studies. Capturing the clinicians’ 
perspective was not identified as a topic to be investigated. However, this could be 
addressed in future research. 
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7.7 Implications for clinical practice 
 
Rheumatology clinicians need to be aware that foot problems in patients with RA are 
common, can be variable and complex in clinical presentation, and follow a 
fluctuating clinical presentation. Additionally, foot problems impact on many aspects 
of patients’ lives including work related disability. Foot problems are important 
issues for patients and should not be trivialised.  
 
Non-specialist foot clinicians need to be conscious of the wide range of the clinical 
presentation of RA foot problems, and have the clinical skills to differentiate between 
these features in order to provide timely and appropriate care. Clinicians also need 
to consider if a foot problem is mechanical or inflammatory in nature. For example 
prescribing foot orthoses for a patient with inflammatory foot pain may be beneficial 
as a method for joint protection. Study 3 demonstrated that the self-report of most 
foot problems was reliable. However, rheumatology clinicians and non-specialist foot 
care clinicians need to consider a direct examination of patients’ feet is required to 
identify reduced sensation, pes planus and most importantly joint swelling. 
Furthermore non-rheumatology specialist foot care clinicians need to identify and 
recognise the presence of joint swelling. If joint swelling is detected, a review with 
rheumatology clinicians could then be initiated. Non-specialist clinicians need to 
consider the importance of the pharmacological management of disease in 
conjunction with non-pharmacological management. 
 
Assessment of the disease features are fundamental components of the remit of 
rheumatology clinicians. However, patients in all three studies perceived that the 
feet can be ignored in rheumatology clinical practice. This may be an unintended 
consequence of the omission of the feet in validated measures of disease status 
(van der Heijde et al, 1993). Additionally, asking patients to remove footwear and 
hosiery can incur extra time during clinical consultations. Nevertheless, clinicians 
need to consider conducting direct examination of patients’ feet for more complex 
foot problems and disease features as discussed previously. Foot examination can 
be performed relatively quickly and does not require expensive assessment tools 
(Boulton et al, 2008). The clinicians’ perspective of the clinical value in the conduct 
of foot examinations, the timing of when they should be performed and/or the value 
of clinicians asking patients if they have any foot problems during clinical 
consultations is not known. These issues warrant further inquiry. 
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Clinical experience indicates PROMs utilised in clinical practice do not capture foot 
problems in RA. Rheumatology specialist clinics are often supported by health care 
assistants who provide valuable contributions to both clinicians and patients (e.g. 
collecting PROMs data). However, community NHS podiatry clinics and hospital 
based orthotic services locally are not supported by healthcare assistants. The 
collection of PROMs data may therefore be a challenge in routine clinical foot care 
practice. The use of validated outcome measures (e.g. FIS) in clinical practice by 
both rheumatology clinicians and non-specialist rheumatology clinicians and their 
further development could be the focus of future study. 
 
7.8 Implications for health policy and commissioners of health care 
 
Clinical research provides evidence to improve care and clinical outcomes. These 
aims can be achieved through development of diagnostic tools, screening 
programmes, novel therapies, effective interventions and estimates of cost (Clancy, 
Glied and Lurie, 2012). Clinical research can then be used by policy makers and 
commissioners of health care services to help inform decisions regarding the 
funding, organisation and delivery of health care for the population. However, the 
budget for the NHS is under immense strain due to increasing demands coupled 
with variation in levels of public funding in recent years (Lafond, Charlesworth and 
Roberts, 2015). An aging population and the proportion of the population living with 
one or more long term conditions are likely to have future economic consequences 
for the funding and provision of health care (Wiener and Tilly, 2002). In this regard 
that the majority of patients in Study 2 reported to have at least one or more co-
morbidity is therefore relevant. The care of patients with long term health conditions 
is complex and often involves care being provided by multiple clinicians at more 
than one site (e.g. community based clinicians and hospital based clinicians). 
Schoen et al (2009) suggest co-ordination of care across the primary care and 
secondary care providers can be challenging and potentially sub-optimal. These 
challenges may result in consequences which are detrimental to patients. Ensuring 
coordinated care across different health disciplines, the community and hospitals 
could form part of the role of a specialist foot clinician. 
 
Diabetes is an example of a long term condition with many clinical features (e.g. 
cardiovascular disease, renal disease, retinal disease and foot disease) requiring 
complex and co-ordinated health care. Diabetes has been reported to account for 
approximately 10% of the entire NHS budget, with foot ulceration and lower limb 
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amputations estimated to account for 0.7% of the total NHS budget (Hex et al, 
2012). This substantially increases when indirect costs (e.g. work related disability) 
are considered (McInnes, 2012). Diabetic foot disease is therefore receiving interest 
at a national policy level and with local commissioning groups of health care in the 
UK. The negative consequences of diabetic foot disease tend to be reported in 
terms of hospital episode statistics (e.g. amputation rates and hospital days of 
inpatient stay). In contrast musculoskeletal problems are reported to have the 4th 
largest budget spend by the NHS. Of this budget, an estimated £3.8 million - £4.75 
million is spent on RA in terms of both direct and indirect costs (NICE CG79). An 
estimation of the economic cost of foot problems in RA and other long term 
conditions in relation to the NHS budget is not available. The proportion of patients 
in Study 2 reporting an episode of foot ulceration since being diagnosis with RA was 
9%. The prevalence of foot ulceration in RA has elsewhere been estimated to be 
approximately 10% (Firth et al, 2008). However, an association between foot 
ulceration and lower limb amputation in patients with RA has not been established. 
Nonetheless this thesis has demonstrated that foot problems are both common in 
RA and important issues for patients. Additionally many patients reported that their 
foot problems were important, severe and they were not coping well with them. 
Furthermore foot problems impact on many aspects of patients’ lives including their 
ability to work. Policy makers and commissioners of foot care services need to 
consider that diabetes is not the only condition in which significant and important 
foot problems are common clinical features. Recognition of the value of the patient 
perspective and patient reported data rather than reliance on administrative data 
(e.g. hospital inpatient days) would enable more equitable care provision. Finally, 
providers of foot care for patients with RA need to consider the effectiveness and 
quality of care provided. If policy makers, commissioners and clinicians considered 
severity, patient priorities and impact of foot problems across all long term 
conditions then services could be commissioned and organised to address a wider 
patient population, not just patients with diabetes. 
 
Access to foot care in this study was higher than anticipated. However, despite 
accessing foot care many patients reported high levels of current foot problems, 
variable perceived benefits of foot care received and high levels of stopping using 
foot orthoses and wearing prescribed footwear. The development of the role 
specialist foot care clinicians in rheumatology warrants consideration. Specialist foot 
care clinicians (e.g. specialist podiatrists) would have clinical expertise in the 
assessment, clinical management and co-coordination of care which would be 
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tailored to the individual patient’s needs. As the demands on health service budgets 
are likely to increase, the economic costs of developing specialists roles requires 
justification. However, these costs are likely to be considerably less then 
redesigning current foot care services through employing additional non-specialist 
clinicians and training them sufficiently well to deal with rheumatological problems. 
The monetary implications could be offset against improvements in the organisation 
and delivery of care coupled with education and training of non-specialist foot care 
clinicians to better manage the more straightforward, less specialised problems. 
Evaluation of foot care services provided by specialist clinicians in relation to 
improving clinical outcomes for patients, including economic evaluation and the 
effectiveness of care received from the patient perspective would then be required. 
 
A further consideration for health policy and commissioners of health care relates to 
the training aspect of specialist foot health care clinicians. Modernisation of health 
services including promoting inter-professional practice has received attention from 
health policy makers in the UK. This has seen the emergence of extended scope 
non-medical practitioners. Indeed extending the role of non-medical clinicians is 
viewed as being essential for developing a flexible health work force (McPherson et 
al, 2006). In relation to podiatry in the UK there have been developments in 
extended scope practice in relation to post graduate training and qualifications in 
podiatric surgery, non–medical prescribing, requesting and interpretation of imaging 
and intra-articular injections. Although these extended roles are welcomed and may 
support a more flexible work force, other issues need to be considered. For example 
in the UK the post graduate training of orthopaedic surgeons follows a formal and 
structured programme with successful completion of which being the award of a 
Certificate of Completion in Training (Frostick et al, 2013). Formal training is not only 
a prerequisite registration with the General Medical Council but fully funded and 
supported by the NHS. In contrast post graduate training of non-surgical foot care 
specialists does not receive the same formal recognition as the training of surgical 
colleagues. The maintenance and further development of specialist foot care roles 
therefore requires not only recognition from policy makers and funding by 
commissioners of health care but the wider health care community. Such recognition 
and support is vital to improve clinical outcomes for patients with foot problems as 
consequence of RA. 
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7.9 Future research 
 
There are many issues of the impact, prevalence and care of foot problems in RA 
that warrant further investigation. The specific areas for further research will be 
considered in relation to each of those in turn.  
 
7.9.1 Prevalence of foot problems 
The data in this thesis were collected from a random sample an RA patient 
population but they were within a fixed geographical area. As the organisation, 
delivery and funding of health care in general, varies nationally and internationally 
so too might the provision of and access to foot care for patients with RA. In order to 
expand on the generalisability of the data from the studies reported here it would be 
appropriate for further research be conducted in other locations. This could be 
investigated through multi-centre based studies in other areas of the UK. Any 
geographical variation in patient populations and access to foot care or not could 
then be investigated. Population based surveys conducted on other patient 
populations in fixed geographical areas reflecting primary and secondary care foot 
care provision are therefore warranted. 
 
7.9.2 Impact of foot problems in RA 
The Foot Impact Scale (FIS, Helliwell et al, 2005) provides the opportunity to 
capture the impact of foot problems in patients with RA. However, the findings of 
Study 1 indicated that the FIS did not capture all important issues regarding impact 
(e.g. severity and ability to work). Additionally analyses of those extra measures of 
impact that were incorporated into Study 2 indicated that they provided additional 
information not included in the FIS. However the length of the FIS may limit its 
usage in clinical practice (although there is currently no information regarding the 
use of PROMs capturing impact of foot problems in general clinical practice). 
Development of a shorter validated questionnaire using current methodological 
techniques and capturing important issues of foot problems from both the patient’s 
and the clinician’s perspective warrants further investigation.  
 
7.9.3 Care of foot problems in RA 
The most important area to be considered for further research relates to care of foot 
problems in RA. The findings of Study 1 indicated patients perceived that foot 
problems can be overlooked in clinical practice as they are not included in measures 
of disease activity. Annual assessment of patients’ feet is recommended in national 
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guidelines (Luqmani et al, 2006; NICE CG79). However, the conduct of foot 
examinations appears to vary in clinical practice (Study 1 and Study 2). Data were 
not collected from the clinicians’ perspective regarding the frequency and rationale 
for conducting foot examinations. Nonetheless, Study 3 demonstrated that the self-
report of most foot problems is reliable. The value of a simple screening question 
enquiring about the presence of foot problems such as; “Do you have any problems 
with your feet?” could be the focus of further study. 
 
Additionally there is increasing evidence supporting the clinical benefits of foot 
orthoses for patients with RA. The results of Study 2 indicated foot orthoses / insoles 
were the most common foot care intervention received by patients but during the 
clinical interviews conducted in Study 3 many patients reported to have ceased 
using the devices issued. Reasons for cessation of use included: difficulty 
accommodating the devices in footwear, devices increased pain levels and/or were 
not effective. For the clinical benefits of foot orthoses to be fully established, patients 
need to firstly be issued with devices which can be accommodated in footwear. 
Secondly, foot orthoses need to be effective in reducing symptoms. Research 
programmes are required to develop devices to address these issues which include 
the patent perspective and avoid subsequent wastage of health care resources. 
 
7.9.4 Clinicians’ and patients’ perspectives 
To date the focus of the literature regarding best practice for the management of 
foot problems in patients with RA has been on empirical evidence and expert clinical 
opinion. Rheumatology clinicians and non-specialist foot care clinicians’ perspective 
of the provision and effectiveness of dedicated foot care services for patients with 
RA has not been fully investigated. Additionally non-specialist clinicians’ opinions 
regarding the need for training and education on the assessment and management 
of foot problems as a consequence of RA are not known. The clinical benefits of 
non-pharmacological interventions improving outcomes for patients with RA have 
been demonstrated (e.g. orthopaedic surgery). However, there is a paucity of 
evidence demonstrating the perceived benefits of foot care from the patient 
perspective. This could be the focus of future research.  
 
7.9.5 Future research summary 
To summarise, fruitful areas of future research include firstly confirmation of the 
prevalence and categories of foot pathology and patients’ access to foot care 
services in other geographical regions. Secondly, build on the FIS to develop a more 
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comprehensive PROM to measure the effects of RA foot problems. Thirdly, integrate 
the perspective and intentions of clinicians with those of patients in relation to foot 
problems. Fourthly, find simple ways to bring foot problems and resources for 
dealing with them to the attention of clinicians. Finally, explore the likely benefits of 
supporting community based podiatrists with the provision of a specialist 
rheumatology podiatry service for education and referral of more complex problems. 
 
7.10 Personal reflections 
 
Undertaking this work has been an immensely challenging but rewarding journey. 
The academic training and supervision I have received have been vital to enhance 
my knowledge of the research process and overcome challenges encountered. As a 
podiatrist with a clinical interest in long term conditions, I was concerned that my 
professional background would bias my approach to the research process. That is, 
my own personal clinical experiences and knowledge of foot involvement in long 
term conditions might be at the forefront driving the process, rather than the 
patients’ experience. I was therefore particularly aware that my own personal 
experiences and clinical background had to be acknowledged. I was also concerned 
how I would feel and cope if participants disclosed negative experiences of foot care 
received.  
 
My interactions with patients prior to conducting this work had primarily occurred 
during clinical consultations. I have conducted previous research activities involving 
patients with RA. However, these earlier works involved clinical examinations and I 
had no prior experience of conducting qualitative research. My relationship and 
discussions with patient research partners were of great value to facilitate my 
transition from a podiatrist to a clinical researcher. Throughout the Study 1 
interviews, data collection and analyses I endeavoured to maintain a neutral 
position. I have no way of knowing the effect of my influence on the research 
process, particularly in this qualitative phase. However, this is an issue for all 
researchers utilising qualitative research methods. I therefore recognised the need 
for reflection and reflectivity in my overall approach to the work. Further, 
acknowledging I was an integral part of the research process at an early stage was 
essential. This was achieved by accepting I am who I am. 
 
Despite having limited qualitative research experience, Study 1 had the greatest 
impact on me both personally and professionally. In spite of my clinical work over 
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many years, the full extent of the impact of foot problems and how they affect so 
many aspects of patients’ lives were issues that I had not fully appreciated. In 
particular, the impact of foot problems on activity levels, participation in valued 
activities, relationships with others and ability to work. Furthermore, patients’ choice 
of clothes being dictated by what shoes they could wear was an unexpected insight. 
Exploring the patient experience of foot involvement as a consequence of RA has 
led to alterations in my clinical practice. During clinical consultations I have always 
strived to discuss all treatment options with patients, in order for them to be able to 
make informed decisions about their care. As a clinician I appreciate the clinical 
benefits of prescribed footwear and orthotics can have in relation to improving foot 
symptoms. However, in order for patients to accommodate foot orthoses in their 
shoes this can often require changes in current footwear selection or require 
prescribed footwear. I now have a greater understanding of the challenges patients 
encounter in relation to obtaining footwear that is comfortable and aesthetically 
acceptable, and how this has consequences for a patient’s identity and choice of 
clothing. 
 
The greatest intellectual challenge of this research was conducting the quantitative 
analyses. I had no previous experience of working with and analysing large data 
sets. Becoming familiar with the functions of SPSS was a lengthy process. I now 
appreciate both the strengths and weakness of the package. I also was required to 
learn and be familiar with a variety of statistical techniques, as well as being able to 
interpret results. I am incredibly grateful to both Professor John Kirwan and Dr Jon 
Pollock for their guidance and patience with a quantitative novice.  
 
My academic training has altered how I process ideas and make decisions, and 
ultimately encourages me to think more laterally. The knowledge and skills I have 
developed during this piece of work will strengthen my future academic work and 
clinical practice.  
 
7.11 Thesis summary 
 
This thesis builds on the literature that foot problems are common in patients with 
RA and impact on many aspects of patients’ lives. The findings presented here 
provide a more accurate estimation of the prevalence and nature of foot problems in 
RA than previous publications. This can be demonstrated firstly by the 
representativeness of responders to the main study (Study 2) to the target 
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population. The classifications and categories of foot problems (reported and 
observed by direct clinical examination in Study 3) provide the most comprehensive 
description of current clinical foot features in RA to date. Additionally foot problems 
are important issues for patients. However, many patients perceive that foot 
problems can be ignored in clinical practice.  
 
Access to foot care services was greater than anticipated, but despite accessing 
foot care many patients reported current foot problems, raising issues regarding the 
quality of care received. Additionally, satisfaction of care received was variable 
particularly in relation to many patients ceasing to use devices issued (e.g. foot 
orthoses and prescribed footwear), further raising issues of the quality and 
effectiveness of foot care received.  
 
This thesis has demonstrated that the self-report of most common foot problems is 
reliable. However, a direct examination is required for more complex foot problems 
such as pes planus) and most importantly for joint swelling. Nonetheless the self-
report of foot problems can be used in clinical practice with a high degree of 
confidence. In conclusion foot problems are common in patients with RA taken from 
a random sample of the population. 
 
To improve outcomes for patients, future work is required not only to develop further 
interventions which are both effective and acceptable to patients but to support the 
provision specialist foot care services for patients to receive timely, appropriate, 
clinically effective and cost-effective care. 
 
“It's actually my feet is what's preventing me from getting around.” (BR09M) 
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Appendix A1: Study 1 patient information sheet 
A Research Study to Explore the Experience and Impact of Foot Problems in 
people with Rheumatoid Arthritis.  
Patient information sheet 
 
Introduction 
You are being invited to take part in a research study to explore the experience and 
impact of foot problems in rheumatoid arthritis (RA) and accessing foot care 
(podiatry, chiropody, insoles and hospital issued footwear). 
 
Rheumatoid arthritis is a disease which causes pain, swelling and deformity in the 
joints. The feet are often involved. This can lead to difficulty obtaining comfortable 
shoes and developing skin problems such as corns and callus (hard skin), which 
can make walking very painful. 
 
There are many ways to improve symptoms in the feet of people with RA, such as 
the use of insoles, special shoes and regular foot care. However, we do not know 
how many patients need professional foot care and if they actually receive it. 
 
Before you decide to take part in our research, it is important to understand why the 
research is being done and what it will involve. Please take time to read the 
following information sheet carefully and discuss it with others if you wish. Please 
ask if there is anything that is not clear or you would like more information. 
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Who is asking me to take part? . 
I am Oonagh Wilson, a PhD student at the University of the West of England. This 
research study is the first of three research studies which will form part of my PhD. 
 
What is the purpose of the study? 
We want to find out how foot problems affect people with RA and how people with 
RA feel about their foot problems and foot care services. 
 
What will happen during the study? 
You will be asked to attend for a one to one interview with the researcher at the 
Bristol Royal Infirmary or North Bristol NHS Trust Rheumatology Departments.  
Before the interview, the researcher will ask you to read and sign the consent form 
and ask you some questions about your medical history. 
 
In the interview, she will invite you to discuss the problems you have with your feet, 
what it feels like to have problems with your feet, whether you have received any 
treatment for these problems and if you did, what was your experience. You can say 
as much or as little as you like, there are no right or wrong answers - we are looking 
for your own individual experience. The discussions will last for about an hour. We 
will offer you refreshments and are happy to pay your travel costs. 
 
The interviews will be audio recorded, transcribed (typed) and then analysed. This 
means we will examine the typed transcripts for different themes about foot 
problems and accessing foot care. All the information in the transcripts will be 
anonymous so the only person who will know who the transcript belongs to is the 
researcher.  
 
Why have I been chosen? 
You have been chosen because you have a diagnosis of RA and have problems 
with your feet. 
 
We will be inviting a maximum of 20 patients to take part within the Bristol area from 
both Bristol Royal Infirmary and North Bristol NHS Trust Rheumatology 
Departments. 
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Do I have to take part in the study? 
No, you do not have to take part. If you do decide to take part you will be given a 
copy of the information sheet and a signed consent form to keep and a copy will be 
kept in your hospital records. 
 
If you decide to take part, you are still free to withdraw from the study at any time 
and do not need to give a reason for doing so. If you decide to withdraw or not take 
part, this will not affect the standard of care you receive from any hospital or your 
GP. 
 
What are the risks or benefits of the study? 
We do not believe there are any risks in being involved in this study. We appreciate 
that there may be some inconvenience to you by having to come into the hospital for 
the interview. However we will try and minimize this by arranging a suitable date and 
time for you to come which is convenient. 
 
The benefits of taking part in this study are that you will be helping us to have a 
clearer understanding of the impact of foot problems in patients with RA and 
accessing treatment for foot care, and this will help us to improve treatment. 
 
Will my taking part in the study be kept confidential? 
Yes. When the audio recording of the interview is written up, your name will be 
replaced by a code. No one will be able to identify you from the typed transcript. The 
study reports will include quotations from the interviews but no names will be used. 
The recordings will be kept securely for 6 years and then destroyed, in accordance 
with best practice in research guidelines. The analysis of the transcripts will be done 
by the research team.  
 
What will happen to the results of this research study? 
Results will be presented at conferences and in professional journals. The results 
should be ready for publication about 12 months after the completion of the study.  
No identification of any of the study participants will be possible from any 
publications of the research. The findings of the study will help with the design of the 
next stages of research studies in this area. We will also offer participants the 
opportunity to hear the results at the end of the study. 
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Who is funding the research and who has reviewed the research? 
The research has been funded by the National Institute for Health Research (NIHR). 
The study has been peer reviewed by the NIHR and the University of the West of 
England Research Degree Committee and has been approved by the South West 4 
Research Ethics Committee. A research ethics committee is a group of people who 
look at trial plans to see whether they have been properly thought out and prepared. 
The committee usually includes doctors, nurses, lawyers and members of the public. 
They are responsible for checking that the best interests of patients have been 
considered. The Research and Development Department at the University Hospitals 
Foundation Trust have also reviewed and approved this study.  
 
What do I do now? 
Thank you for considering taking part in this research. Please complete the slip if 
you are interested in taking part and either hand it in to the clinic nurse, or return it in 
the pre-paid reply envelope. A researcher will then contact you with further 
information. 
 
If you have any concerns about participating in this study and would like to receive 
free independent advice please contact PALS (Patient Advice and Liaison Service) 
NHS Bristol on 0117 900 3433, email pals@bristolpct.nhs.uk or by post: 
PALS, NHS Bristol, South Plaza, Marlborough Street, Bristol, BS1 3NX. 
 
Researcher details: 
 
Oonagh Wilson  
Academic Rheumatology Unit, 
Bristol Royal Infirmary 
Bristol 
BS2 8HW 
0117 342 4972 
Oonagh2.Wilson@uwe.ac.uk 
 
Professor John Kirwan 
Academic Rheumatology Department 
Bristol Royal Infirmary 
Bristol 
BS2 8HW 
0117 342 2901 
John.Kirwan@bristol.ac.uk 
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Research team: 
 
Oonagh Wilson, NIHR Clinical Doctoral Research Fellow, UWE Bristol 
Professor John Kirwan, Professor of Rheumatic Diseases, UoB Bristol 
Professor Sarah Hewlett, Professor of Rheumatology Nursing, UWE Bristol 
Dr Jon Pollock, Reader in Epidemiology, UWE Bristol 
Professor Jim Woodburn, Professor of Rehabilitation GCAL Glasgow 
Dr Emma Dures, Research Fellow, UWE Bristol 
Mrs Enid Quest, Patient Research Partner 
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Appendix A2: Study 1 reply slip 
 
 
 
 
YES. I am interested in helping with the experience and impact of foot problems in 
RA 
study and may be contacted by Oonagh Wilson. 
 
Name:  
___________________________________________________________________ 
 
Address:  
___________________________________________________________________ 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
Phone number: 
___________________________________________________________________ 
 
Email address: 
 
 
Thank you for your interest. 
 
 
Oonagh Wilson 
Researcher  
Academic Rheumatology Unit 
Bristol Royal Infirmary 
0117 342 4972 
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Appendix B: Study 1 participant consent form 
 
 
 
A Research Study to Explore the Experience and Impact of 
Foot Problems in people with Rheumatoid Arthritis.  
Consent form for research study 
 
  Please initial each box 
1 I confirm that I have read and understand the information sheet             
version 2 dated 29th June 2010 for the above study. 
2         I understand that my participation is voluntary and that I am free to  
withdraw at any time without my medical care or legal rights being  
affected. 
3 I am willing for the interview to be audio-recorded. 
4 I understand that quotes from the interview will be anonymised and 
may be used in publications and conference presentations. 
5  I understand that relevant sections of my medical notes and study  
data may be accessed (in confidence) by the study research team,  
regulatory authorities or relevant members of the NHS Trust. I give  
permission for these individuals to have  access to my records. 
6 I agree to take part in the above study. 
 
 
 
 
 
 
Name of patient 
Name of researcher 
Signature 
Signature 
Date 
Date 
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Appendix C: Topic guide for Study 1 one-to-one interviews 
I am interested in people’s thoughts and experiences about foot problems in 
rheumatoid arthritis (RA). 
 
 Before we go on to talk about your feet can you tell me a couple of 
sentences about you and your arthritis, so I can understand a bit more. 
 
 Tell me the story about your feet? 
o How important are your foot problems to you? 
o Were you surprised when you developed foot problems? 
o Have you discussed your foot problems with anyone? 
o If you were having foot problems who would you talk to? 
o What would prompt you to talk to someone about your feet? 
 
 What are your foot problems?  
o Have your feet changed? 
o Are you feet painful?  
o Can you describe the pain? 
o Can you tell me what part of your feet, cause you problems? 
o Has anyone examined your feet? 
 
 Are you able to manage your foot problems? 
o Can you give an example? 
o Have you tried any other treatments e.g. hot, cold, massage? 
o How much do you think you have spent on your feet? 
 
 Have you had any experience of foot care services? 
o If so, how did you access care? 
o Was it easy / difficult? 
o How long did you have to wait to get an appointment? 
 
 How much do your foot problems affect your activity? 
o Are you able to drive, work, and take part in leisure activities? 
o How do you feel about your foot problems affecting your activity 
levels? 
o Do your foot problems affect the way you feel about things? 
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o Do your foot problems impact on your choice of shoes and clothes? 
o Have you feet problems made you feel less feminine / masculine? 
o Do you think foot problems have the same impact on men / women? 
o How do you feel about your feet? 
 
 Have you been given prescribed shoes? 
o How much did you feel included about your opinions of them? 
o Did you wear them? If not why not? 
o Do you have any concerns / worries about not wearing them? 
o Would men be more likely to wear hospital shoes? 
 
 What advice would you give someone about their feet if they have just been 
diagnosed with RA? 
 
 If we could make things better, do you have a wish list for foot care services? 
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Appendix D1: Demographic and clinical data Study 1 (one-to-one 
interviews) 
 
 
Pre-interview case record form 
 
Study ID: ................... 
Date: ............... 
Date of birth (dd/mm/yyyy): ......../.........../............. 
Gender (please circle):  male / female 
Disease duration (Years) …….. 
Current arthritis medication: 
......................................................................................................... 
........................................................................................................ 
......................................................................................................... 
Scores: 
Q1…….. 
Q2…….. 
HAQ…….. 
Interview start time ………… 
Interview end time………….. 
 
Q1 Please circle the number which shows how much of a problem (on average) 
your feet have been in the last week. 
No problem 0 1 2 3 4 5 6 7 8 9 10 Severe problem 
 
Q2 Considering all the ways your arthritis affects you, please circle the number 
which shows how well you are doing:    
Very well 0 1 2 3 4 5 6 7 8 9 10 Very badly 
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Appendix D2 Health Assessment Questionnaire 
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Appendix D3: Full coding tree overview impact and foot problems in RA  
Codes Subthemes Organising themes Under pinning 
theme 
Global theme 
1st foot symptoms Feet first Foot symptoms Impact Decision to access 
foot care of not Balls of feet painful 
Couldn’t walk 
Feet and toes stiff 
Feet changed shape 
Feet painful at rest 
Feet sensitive 
Feet were bad 
Feet were really uncomfortable 
Foot problems came later 
Foot problems didn’t go away 
Pain started in feet 
Started (RA) in feet 
Surprised by foot involvement 
Swelling in feet 
Ankle problems Articular involvement 
Bunions 
Current foot problems 
Fallen arches 
Feet ache 
Feet always hurting 
Feet painful at rest 
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Feet painful in the morning 
Feet throb 
Feet uncomfortable 
Foot deformity 
Foot pain 
Foot pain crippling 
Consequences of foot pain 
Misshapen toes 
No foot deformity 
Pain like a broken bone 
Secondary OA 
Burase Extra articular 
Feet burn 
Nodules 
Numbness in feet 
Swelling in feet 
Advise for patients newly diagnosed with 
RA  
Other features RA 
Concerns about the future 
Fatigue 
Feet part of whole RA 
General RA symptoms 
Hand problems 
Morning stiffness 
Other joints 
Pain 
RA and activities of daily living 
RA and pregnancy 
RA and relationships with others 
Blisters Cutaneous lesion 
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Calluses / hard skin 
Corns / stone bruises 
Ingrown toe nails 
Nails changed 
Skin infections 
Skin problems 
Driving Activities Consequences 
Can’t brake suddenly  
Can’t depress clutch 
Can’t stand for long 
Reliance on others 
Social life 
Couldn’t stand for long Work 
Couldn’t wear safety boots 
Falls at work 
Feet and work 
Had to stop work 
Receiving financial assistance 
Retired 
Work adaptations 
Work not an issue 
Can’t walk around the shops Walking 
Can’t walk as far as I used to 
Can’t walk far 
Can’t walk up hills 
Feet stopping me getting around 
Feet stopping me walking 
Have to plan ahead 
Have to walk more slowly 
Painful to walk 
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Steps difficult 
Walking on bag of bones 
Walking on glass 
Walking on pebbles 
Walking on uneven surfaces 
Benefits of exercise Exercise 
Can’t exercise because of feet 
Cycling and feet 
Exercise and feet 
Exercise and mood 
Feel depressed when can’t exercise 
Had to look for other types of activity 
Choice of clothes Footwear 
Comfortable footwear 
Difficult to get shoes 
Difficult to get shoes to fit 
Femininity and masculinity 
Fluctuating comfort of shoes 
Foot deformity and footwear 
Footwear and body image 
Footwear and gender 
Footwear and identity 
Footwear and walking 
Footwear and work 
Footwear soles 
Given shoes away 
Had to stop wearing certain shoes 
Footwear fastenings 
Importance of shoes fitting 
Improvements to footwear 
Looking for shoes disheartening 
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Need different types of shoes 
Not ready to get rid of shoes 
Visual appearance of footwear 
Can’t dance anymore Participation 
Can’t do what my friends do 
Can’t participate in team sports 
Don’t go out any more 
Don’t the things I used to 
Everyone else having a conversation 
Isolation 
Missing out 
Can’t be a good parent Social and emotional well 
being 
Cost 
Don’t like situation 
Embarrassed about appearance of feet 
Embarrassed to show feet 
Feet frustrating 
Feet make me look old 
Foot problems annoying 
Holding everyone back 
Makes me snappy 
Reliance on others 
Cost of insoles Financial detriment 
Cost of shoes 
Had to change type of car 
Had to give up work 
Money spent on feet 
Comes and goes Fluctuations and 
combinations 
  
Evolving foot symptoms 
Feet and arthritis medications 
Feet and flare 
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Fluctuating foot symptoms 
Foot problems unpredictable 
It varies (foot symptoms) 
Today is a good day 
Concern about foot problems developing Personal importance 
Current foot symptoms big problems 
Feel trapped 
Feet biggest problem of RA 
Feet effect everything 
Feet not a problem 
Feet ok at the moment 
Have to get on with it 
Importance of foot problems 
Importance of looking after feet 
Individual symptoms and need 
Something I have to put up with 
Worst bit of me 
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Appendix D4: Full coding tree decision to access foot care 
Codes Subthemes Organising themes Global theme 
Acceptance Another complication of RA  Access hindered by 
patient’s perception 
Decision to access foot 
care or not Been lucky 
Feet minor part of RA 
Fluctuating symptoms 
Foot problems due to RA 
Foot problems unpredictable 
Least of my worries 
Loss 
More appointments 
Other priorities 
Other RA symptoms a priority 
Terrible disease 
Bombarded with information MDT will refer if needed 
Changed my life 
Clinicians very helpful 
Doctor knows best 
Doctor organised education sessions 
Doctor organises what I need 
Doctor very good 
Doctor very thorough 
Doctor will refer if I need it 
Don’t want RA care anywhere else 
Focus on development and research 
Grateful for treatment 
Lots of support 
Miracle cure 
Physiotherapy helped 
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RA well managed 
Referred to OT 
Very grateful for care 
Can’t arrange an appointment myself Lack of knowledge how to 
access foot care Didn’t know could get help 
Doctor has to organised it 
Doctor hasn’t arranged it 
Don’t know how to get an appointment 
Don’t know how to get to see a podiatrist 
Don’t know what an orthotics is 
Lack of knowledge of service location 
Nobody has suggested 
Thought they were all private 
Another nail in the coffin Feet ignored 
Been recommended but resisting 
Clinicians focus on hands 
Clinicians focus on large joints 
Didn’t associate foot problems with RA 
Don’t want prescribed shoes 
Don’t want surgery 
Feet not examined 
Feet not examined regularly 
Feet not obvious 
Feet not on any questionnaires 
Feet not on assessments 
Frankenstein boots 
Limited clinical experience of assessing feet 
Limited clinical experience of foot problems 
No advise about foot problems 
Not asked about feet 
Not ready for prescribed shoes 
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Not ready for surgery 
Not talked about feet 
RA only affects joints 
Don’t know what they do Limited awareness of 
treatment options Don’t know what will help 
Everyone’s different 
It’s an operation or nothing 
Just cut toe nails 
Just plodded on 
Need a magic wand 
No advise about treatment options 
Nothing can be done 
Podiatrist only cut corns 
Comes and goes Fluctuating symptoms  Access perceived 
unnecessary by patient Enough pain for one day 
Feet came later 
Feet more painful in the morning 
Feet bad today 
Pain usually somewhere 
Pain not everyday 
Some days I can’t walk 
Some days ok 
Sometimes can’t get shoes 
Sometimes need crutches 
Swelling (feet) varies 
Today is a good day 
Varying degrees of pain 
Worried will end up in wheelchair 
Worse (feet) in the morning 
Feet just uncomfortable Feet not a problem 
Feet not a big problem 
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Feet not changed shape 
Feet ok today 
Foot problems calmed down 
Foot problems improved when RA controlled 
Injections helped 
Never had calluses 
Not much of an issue (feet) 
Bought my own insoles Can self-manage 
Cream my feet 
Cycling helps foot pain 
Experiment with shoes 
Family help me (with feet) 
Good shoes important 
Know how to look after my feet 
Know which shoes I need 
Massage my feet 
Old lady shoes 
Take a second pair of shoes 
Use a foot file 
Use cold 
Use heat 
Wear comfortable shoes 
Could be worse Positive coping 
I’m lucky 
Meet them half way 
Not as bad as others 
Not on my own 
You’ve got to try 
Can’t manage feet because of hands Can’t self-manage Access supported by 
patient and clinician Can’t reach feet 
Can’t tie shoe laces because of hands 
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Don’t know which insole to try 
Foot care helped others 
Have to rely on others 
Husband told me to go and see someone 
Other joint problems 
Wife won’t cut toe nails 
Always tell the doctor feet bad Talked about feet in clinic  
Clinician asked about feet 
Foot pain severe 
Others told me insoles helped 
The bunion was hurting 
Told foot problems due to RA 
Told nurse about feet 
Wife told me to tell them about ankles 
Bare foot examinations Feet examined 
Feet examined at diagnosis 
Had scan of feet  
Had x-rays of feet  
Regular foot examination 
Calluses painful Foot problems a priority 
Can’t cut toe nails 
Can’t do what I want to do 
Can’t get shoes to fit 
Can’t stand for long 
Can’t walk 
Can’t walk round the shops 
Don’t want them (feet) to get bad 
Feet so painful 
Feet stopping me being a parent 
Feet stopping me doing things 
Feet stopping me getting about 
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Feet stopping me working 
Foot problems getting worse 
Need to do something about feet 
Suffer if I walk to far 
Took shoes off and showed the nurse 
Trapped in the house 
Walk more slowly 
Feet worst part of me 
Can wear nice shoes again Positive experience Continue to access foot 
care Due for new insoles 
Feet better after surgery 
Foot problems improved 
It helps 
Lucky to have insoles made 
Podiatrist gives advice 
Podiatrist keeps an eye on feet 
Podiatrist treats problems as they occur 
Worth the money 
Insoles didn’t help Negative experience 
Couldn’t afford to keep paying for podiatry 
Couldn’t be bothered to argue about shoes 
Couldn’t get an appointment when needed 
Couldn’t get insoles in shoes 
Difficult to get appointments 
Disappointed with podiatry 
Didn’t cut toe nails 
Hated the shoes 
Long time to recover after surgery 
Nice (podiatrist) but inexperienced 
No advice given 
No follow up care 
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Not much benefit from podiatry 
Only shaved hard skin off 
Operation didn’t help 
Poor follow up care 
Post surgery complications 
Shoes didn’t fit 
Shoes looked awful 
Shoes too heavy 
Waited a long time to be seen 
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Appendix E: Foot survey patient information sheet 
 
Learning about feet in rheumatoid arthritis 
 
Foot survey - Patient information sheet 
 
Introduction: 
You are being invited to take part in a research study to explore how many people 
with rheumatoid arthritis (RA) have problems with their feet. We would like both 
people who do and people who do not have foot problems to take part in the study. 
We also want to find out the impact of their foot problems and if they have received 
any foot care such as seeing a podiatrist, chiropodist or being given insoles or 
hospital issued footwear. 
 
Rheumatoid arthritis is a disease which causes pain and in the joints. The feet are 
often involved and in some people this can be very troublesome. This can lead to 
difficulty obtaining comfortable shoes and the development of skin problems such as 
corns and callus (hard skin), which can make walking very painful. 
 
There are many ways to improve symptoms in the feet of people with RA, such as 
the use of insoles, special shoes and regular foot care. However, we do not know 
how many people need professional foot care, nor if they actually receive it. 
 
Before you decide to whether or not take part in our research, it is important to 
understand why the research is being done and what it will involve. Please take time 
to read the following information sheet carefully and discuss it with others if you 
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wish. Please ask if there is anything that is not clear or you would like more 
information. 
 
Who is asking me to take part? 
I am Oonagh Wilson, a PhD student at the University of the West of England. This 
research study is the second of two research studies which will form part of my PhD. 
 
What is the purpose of the study? 
We want to find out about the type of foot problems which can affect people with RA 
and if people with RA have received any treatment for their foot problems. 
 
What will happen during the study? 
The study involves completing a questionnaire about your feet. We would like both 
people who do and people who do not have foot problems to fill out a questionnaire. 
The questionnaire will also ask about your arthritis in general, and whether you have 
had any care to help with any foot problems.  
 
Later on we will be inviting some people who complete the questionnaire to attend 
their rheumatology department for a research appointment. This will involve a one-
off clinical interview and foot examination. If you are invited later on to come for a 
research appointment, you will be able to decide then whether or not you wish to 
take part in the second part of the research. 
 
Why have I been chosen? 
You have been chosen because you have a diagnosis of RA.  
 
We are inviting approximately 500 people to take part within the Bristol area from 
both Bristol Royal Infirmary and North Bristol NHS Trust Rheumatology 
Departments, selected at random (by chance). We want everyone to answer our 
questionnaire, whether or not they have foot problems, otherwise we will not be able 
to calculate how widespread the problem is. 
 
Do I have to take part in the study? 
No, you do not have to take part. If you do decide to take part please complete the 
enclosed questionnaire and return it to us in the prepaid stamped address envelope.  
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If you decide to take part, you are still free to withdraw from the study at any time 
and do not need to give a reason for doing so. The only personal information that 
will be kept will be your age, post code and whether you are male or female. If you 
decide to withdraw or not take part, this will not affect the standard of care you 
receive from any hospital or your GP. 
 
What are the risks or benefits of the study? 
We do not believe there are any risks in being involved in this study.  
 
There are no personal benefits to you in taking part. However, you will be helping us 
to get a clearer understanding of how many people with RA have foot problems. It 
will help us understand the type of problems people have and whether they have 
been able to access foot care. This will help us plan future services and understand 
how to improve access to foot care services, and to provide people with RA better 
help in the future. 
 
Will my taking part in the study be kept confidential? 
Yes. Names on the questionnaires will be replaced by a code by the principal 
investigator (Oonagh Wilson). No one will be able to identify you from the 
questionnaires apart from the principal investigator.  Your name will not be used in 
the study reports. The study records will be kept securely for 6 years and then 
destroyed, in accordance with best practice in research guidelines.  
 
What will happen to the results of this research study? 
Results will be presented at conferences and in professional journals. The results 
should be ready for publication about a year after the completion of the study.  You 
will not be identified from any publications of the research. The findings of the study 
will help with recommendations for the care of foot problems in people with RA. We 
will also offer participants the opportunity to hear the results at the end of the study. 
 
Who is funding the research and who has reviewed the research? 
The research has been funded by the National Institute for Health Research (NIHR), 
the research arm of the NHS. The study has been peer reviewed by the NIHR and 
the University of the West of England Research Degree Committee and has been 
approved by a NHS Research Ethics Committee (South West 4). A research ethics 
committee is a group of people who look at research study plans to see whether 
they have been properly thought out and prepared. The committee usually includes 
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doctors, nurses, lawyers and members of the public. They are responsible for 
checking that the best interests of people taking part in research have been 
considered. The Research and Development Department at two local hospital trusts 
have also reviewed and approved this study.  
 
What do I do now? 
Thank you for considering taking part in this research. Please complete the 
questionnaire if you are interested in taking part and return it in the pre-paid 
addressed envelope. 
 
If you have any concerns about participating in this study and would like to receive 
free independent advice please contact PALS (Patient Advice and Liaison Service) 
NHS Bristol on 0117 900 3433, email pals@bristolpct.nhs.uk or by post: 
PALS, NHS Bristol, South Plaza, Marlborough Street, Bristol, BS1 3NX. 
 
Researcher details: 
 
Oonagh Wilson  
Academic Rheumatology Unit, 
Bristol Royal Infirmary 
Bristol 
BS2 8HW 
0117 342 4972 
Oonagh2.Wilson@uwe.ac.uk 
 
Professor John Kirwan 
Academic Rheumatology Department 
Bristol Royal Infirmary 
Bristol 
BS2 8HW 
0117 342 2901 
John.Kirwan@bristol.ac.uk 
 
 
Research team: 
 
Oonagh Wilson, NIHR Clinical Doctoral Research Fellow, UWE Bristol 
Professor John Kirwan, Professor of Rheumatic Diseases, UoB Bristol 
Professor Sarah Hewlett, Professor of Rheumatology Nursing, UWE Bristol 
Dr Jon Pollock, Reader in Epidemiology, UWE Bristol 
Professor Jim Woodburn, Professor of Rehabilitation GCAL Glasgow 
Mrs Enid Quest, Patient Research Partner 
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Appendix F1: Study 2 invitation letter (example) 
 
. 
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Appendix F2: Study 2 questionnaire 
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Followed by HAQ (as in Appendix D2). 
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Appendix G1: Study 3 Patient information Sheet 
 
 
Learning about feet in rheumatoid arthritis  
 
Clinical assessment - Patient information sheet 
 
Introduction: 
You recently took part in a survey to find out how many people with rheumatoid 
arthritis (RA) have problems with their feet. We are now inviting some of the people 
who took part in the survey to help us once more, by coming in to have their feet 
examined. 
 
Before you decide to take part in our research, it is important to understand why the 
research is being done and what it will involve. Please take time to read the 
following information sheet carefully and discuss it with others if you wish. Please 
ask if there is anything that is not clear or you would like more information. 
 
Who is asking me to take part? 
I am Oonagh Wilson, a PhD student at the University of the West of England. This 
research study is the second of two research studies which will form part of my PhD. 
 
What is the purpose of the study? 
We have conducted a questionnaire survey to find out about the type of foot 
problems which can affect people with RA. Thank you for your help with that survey. 
We now want to check the feet of some of the people who told us they had foot 
problems, and some who felt they had not. This will help us understand the type of 
foot problems people have and whether they have been able to access foot care. 
This will help us plan future services. 
 
What will happen during the study? 
You will be asked to attend your rheumatology department for a research 
appointment. This will involve a clinical interview when you will be asked about your 
arthritis in general and your feet examined. The research appointment will be with a 
podiatrist (a health professional who manages problems with the feet and ankle). 
Before the research appointment, the podiatrist will ask you to read and sign the 
consent form and ask you some questions about your medical history. 
 
You will be asked about your arthritis and your feet, whether you have received any 
treatment for these problems and if you did, what was your experience. You will also  
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have your feet examined (no treatment will be given). The research appointment will 
last for about an hour. We will offer you refreshments and are happy to pay your 
travel costs. 
 
The podiatrist will make a record of your foot problems and if you have received any 
treatment for your feet. All the information from the research appointment will be 
confidential. The only people who will know which research appointment record 
belongs to each patient will be the podiatrist and the principal investigator (Oonagh 
Wilson). 
 
Why have I been chosen? 
You have been chosen because you have a diagnosis of RA and because you 
kindly replied to our earlier survey.  
 
We will be inviting approximately 120 people to take part within the Bristol area from 
both Bristol Royal Infirmary and North Bristol NHS Trust Rheumatology 
Departments. 
 
Do I have to take part in the study? 
No, you do not have to take part. If you do decide to take part you will be given a 
copy of the information sheet and a signed consent form to keep and a copy will be 
kept in your hospital records. 
 
If you decide to take part, you are still free to withdraw from the study at any time 
and do not need to give a reason for doing so. If you decide to withdraw or not take 
part, this will not affect the standard of care you receive from any hospital or your 
GP. 
 
What are the risks or benefits of the study? 
We do not believe there are any risks in being involved in this study. We appreciate 
that there may be some inconvenience to you by having to come into the hospital for 
a research appointment. However we will try and minimize this by arranging a 
suitable date and time for you to come which is convenient. 
 
If the podiatrist who examines you feels you have a foot problem that requires 
treatment, you will be advised to contact your GP or rheumatology department via 
your specialist nurse telephone helpline. 
 
There are no personal benefits to you in taking part in this study. However, you will 
be helping us to have a clearer understanding of how many people with RA have 
foot problems, the type of problems they have and whether they have been able to 
access foot care services. This will help us plan future services and understand how 
to improve access to care, and to provide people with RA better help in the future.  
 
Will my taking part in the study be kept confidential? 
Yes. When the record of the research appointment is given to the principal 
researcher (Oonagh Wilson), your name will be replaced by a code. No one will be 
able to identify you from the research appointment record. The study reports will 
include a summary of foot problems and how many people are receiving foot care 
and if not why not. Your name will not be used in the reports. The study records will 
be kept securely for 6 years and then destroyed, in accordance with best practice in 
research guidelines.   
 
What will happen to the results of this research study? 
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Results will be presented at conferences and in professional journals. The results 
should be ready for publication about a year after the completion of the study. No 
identification of any of the study participants will be possible from any publications of 
the research. The findings of the study will help with recommendations for the care 
of foot problems in people with RA. We will also offer participants the opportunity to 
hear the results at the end of the study. 
 
Who is funding the research and who has reviewed the research? 
The research has been funded by the National Institute for Health Research (NIHR), 
the research arm of the NHS. The study has been peer reviewed by the NIHR and 
the University of the West of England Research Degree Committee and has been 
approved by a NHS Research Ethics Committee (South West 4). A research ethics 
committee is a group of people who look at research study plans to see whether 
they have been properly thought out and prepared. The committee usually includes 
doctors, nurses, lawyers and members of the public. They are responsible for 
checking that the best interests of people taking part in research have been 
considered. The Research and Development Department at two local hospital trusts 
have also reviewed and approved this study.  
 
What do I do now? 
Thank you for considering taking part in this research. Please complete the slip and 
return it in the pre-paid reply envelope. The principal researcher (Oonagh Wilson) 
will contact you with further information. 
  
If you have any concerns about participating in this study and would like to receive 
free independent advice please contact PALS (Patient Advice and Liaison Service) 
NHS Bristol on 0117 900 3433, email pals@bristolpct.nhs.uk or by post: 
PALS, NHS Bristol, South Plaza, Marlborough Street, Bristol, BS1 3NX. 
 
Researcher details: 
Oonagh Wilson  
Academic Rheumatology Unit, 
Bristol Royal Infirmary 
Bristol 
BS2 8HW 
0117 342 4972 
Oonagh2.Wilson@uwe.ac.uk 
 
Professor John Kirwan 
Academic Rheumatology Department 
Bristol Royal Infirmary 
Bristol 
BS2 8HW 
0117 342 2901 
John.Kirwan@bristol.ac.uk 
 
 
Research team: 
Oonagh Wilson, NIHR Clinical Doctoral Research Fellow, UWE Bristol 
Professor John Kirwan, Professor of Rheumatic Diseases, UoB Bristol 
Professor Sarah Hewlett, Professor of Rheumatology Nursing, UWE Bristol 
Dr Jon Pollock, Reader in Epidemiology, UWE Bristol 
Professor Jim Woodburn, Professor of Rehabilitation GCAL Glasgow 
Mrs Enid Quest, Patient Research Partner 
 Mrs Wendy Briggs HPC Registered Podiatrist 
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Appendix G2: Study 3 invitation letter 
 
 
 
 
Date 
 
 
 
Dear  
 
 
Learning about feet in rheumatoid arthritis – Clinical assessment 
 
 
You recently took part in a survey to help us find out how many people with 
rheumatoid arthritis (RA) have problems with their feet. Thank you very much for 
helping us with the survey.  
 
We are now inviting some of the people who took part in the survey to help us once 
more, by having their feet examined. 
 
Enclosed with this letter is a patient information sheet that explains about the 
research study. If you would like to take part, please complete the reply slip and 
return it in the stamped addressed envelope provided. 
 
Thank you for your interest and I hope you will be able to help us again by taking 
part in this last phase of the study. 
 
 
Yours sincerely 
 
 
 
Oonagh Wilson 
NIHR Clinical Doctoral Research Fellow 
University of the West of England, Bristol 
Academic Rheumatology Unit, The Court Yard 
Bristol Royal Infirmary, BS2 8HW 
Tel: 0117 342 4972 
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Appendix G3: Study 3 reply slip 
 
 
 
 
 
 
 
Appendix G3 
Learning about feet in rheumatoid arthritis 
 
Clinical assessment study – reply slip 
 
 
YES              I am interested in helping with the study and may be contacted by  
                     Oonagh Wilson 
 
NO                 I am not interested in helping with the study 
 
 
Name:  
 
 
 
Thank you for your interest 
 
 
 
Oonagh Wilson 
Researcher  
Academic Rheumatology Unit 
Bristol Royal Infirmary 
0117 342 4972 
 
 
 
Study ID  
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Appendix G4: Study 3 appointment letter 
 
 
 
 
Date 
 
 
Dear  
 
 
Learning about feet in rheumatoid arthritis – Clinical assessment study 
 
 
You recently took part in a survey to help us find out how many people with 
rheumatoid arthritis (RA) have problems with their feet. Thank you very much for 
helping us with the survey.  
 
We are now inviting some of the people who took part in the survey to help us once 
more, by having their feet examined. An appointment has been arranged for you to 
attend the Rheumatology Department at the BRI for a foot examination on: 
 
 
 
 
Thank you for your interest and for helping us again by taking part in this last phase 
of the study. 
 
 
Yours sincerely 
 
 
 
Oonagh Wilson 
NIHR Clinical Doctoral Research Fellow 
University of the West of England, Bristol 
Academic Rheumatology Unit, The Court Yard 
Bristol Royal Infirmary, BS2 8HW 
Tel: 0117 342 4972 
Email: Oonagh2.Wilson@uwe.ac.uk 
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Appendix H1: Study 3 consent form 
 
 
 
Appendix H1 
Learning about feet in rheumatoid arthritis – clinical 
assessment study. 
 
Consent form for research study 
Please initial each box 
 
1 I confirm that I have read and understand the information sheet version 1 
 dated 13th September 2011 for the above study. 
 
2         I understand that my participation is voluntary and that I am free to  
withdraw at any time without my medical care or legal rights being  
affected. 
 
3 I am willing to have my feet examined and be asked questions about my   
medical history. 
 
4 I understand information from the interview will be anonymised and 
may be used in publications and conference presentations. 
 
5  I understand that relevant sections of my medical notes and study  
data may  be accessed (in confidence) by the study research team,  
regulatory authorities or relevant members of the NHS Trust. I give  
permission for these individuals to have  access to my records. 
 
6 I agree to take part in the above study. 
 
Name of patient 
Name of researcher 
Signature 
Signature 
Date 
Date 
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Appendix H2: Study 3 case record form 
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Followed by FIS (as in Appendix F2). 
Followed by HAQ (as in Appendix D2).
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Table 1: Frequency of co-morbidity categories according to foot care service 
accessed Study 2 
 Type of 
co-morbidity 
Podiatry 
(n=204) in this 
category 
Number (%) 
Orthotics 
(n=192) in this 
category 
Number (%) 
Orthopaedics 
(n=92) in this 
category 
Number (%) 
Diabetes 
Thyroid disease 
Paget’s disease 
Osteopinia 
Endocrine 39 (19.1) 34 (17.7) 13 (14.1) 
Myocardial infarction 
Cerebrovascular accident 
Hypertension 
Arrythmia 
Deep vein thrombosis 
Raynaud’s 
Peripheral vascular disease 
Hypercholesterolemia 
Cardiovascular 
disease 
84 (41.2) 67 (34.9) 34 (37.0) 
Asthma 
Chronic obstructive pulmonary 
disease 
Brochiectasis 
Sleep apnoea 
Pulmonary 
disease 
30 (14.7) 26 (13.5)  
 
12 (13.0) 
Anxiety 
Depression 
Schizophrenia 
Mental health 3 (1.5) 8 (4.2) 1 (1.1) 
Eczema 
Psoriasis 
Herpes simplex 
Urticaria 
Dermatology 7 (3.4) 5 (2.6) 3 (3.3) 
Glaucoma 
Retinopathy 
Ocular toscocariasis 
Eye 4 (2.0) 5 (2.6) 2 (2.2) 
Basal cell carcinoma 
Breast cancer 
Prostate cancer 
Cancer 3 (1.5) 3 (1.6) 1 (1.1) 
Anaemia 
Thrombocytopenia 
Haematology 3 (1.5) 4 (2.1) 2 (2.2) 
Ulcerative colitis 
Crohn’s disease 
Hiatus hernia 
Oesophageal reflux 
Gastrointestinal 10 (4.9) 9 (4.7) 3 (3.3) 
Multiple sclerosis 
Dystonia 
Neurology 0 (0) 0 (0) 0 (0) 
Ankylosing spondylitis 
Juvenile idiopathic arthritis 
Gout 
Osteoarthritis 
Giant cell arteritis 
Systemic lupus erythematosus 
Sarcoidosis 
Sjogrens 
Other 
rheumatological 
diagnosis 
17 (8.3) 18 (9.3) 6 (6.5) 
Osteoporosis 
Spinal stenosis 
Sciatica 
Degeneration of spine 
Back problems 13 (6.4) 15 (7.8) 11 (12.0) 
Fibromyalgia Chronic pain 2 (1.0) 4 (2.1) 1 (1.1) 
Table 6.16 Co-morbidity condition categories according to foot care service 
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 Type of 
co-morbidity 
Podiatry 
(n=204) in this 
category 
Number (%) 
Orthotics 
(n=192) in this 
category 
Number (%) 
Orthopaedics 
(n=92) in this 
category 
Number (%) 
Primary bilary cirrhosis Heptology 1 (0.5) 0 (0) 0 (0) 
Tendinopathy 
Fracture 
Foot deformity not RA related 
Other MSK 
 
2 (1.0) 0 (0) 1 (1.1) 
Chronic kidney disease Renal disease 3 (1.5) 0 (0) 0 (0) 
 Any category 145 (71.1) 99 (51.6) 66 (71.7) 
Table 6.16 Co-morbidity condition categories according to foot care service 
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Table 2 Co-morbidity condition categories Study 3 
 
 
Co-morbidity condition Type of  
co-morbidity  
Total selected 
patients 
n=110 (%) 
AFC  
n=65 (%) 
NAFC  
n=45 (%) 
Diabetes 
Thyroid disease 
Paget’s disease 
Osteopinia 
Endocrine 8 (7) 5 (8) 3 (7) 
Myocardial infarction 
Cerebrovascular accident 
Hypertension 
Arrythmia 
Peripheral vascular disease 
Cardiovascular 
disease 
26 (24) 17 (26) 9 (20) 
Asthma 
Chronic obstructive pulmonary 
disease 
Bronchiectasis 
Sleep apnoea 
Pulmonary 
disease 
12 (11) 7 (11) 5 (11) 
Anxiety 
Depression 
Schizophrenia 
Mental health 4 (4) 3 (5) 1 (2) 
Eczema 
Psoriasis 
Herpes simplex 
Urticaria 
Dermatology 2 (2) 2 (3) 0 (0) 
Glaucoma 
Retinopathy 
Ocular toscocariasis 
Eye 1 (1) 0 (0) 1 (2) 
Basal cell carcinoma 
Breast cancer 
Prostate cancer 
Cancer 1 (1) 1 (2) 0 (0) 
Anaemia 
Thrombocytopenia 
Haematology 0 (0) 0 (0) 0 (0) 
Ulcerative colitis 
Crohn’s disease 
Hiatus hernia 
Oesophageal reflux 
Gastrointestinal 4 (4) 3 (5) 1 (2) 
Multiple sclerosis 
Dystonia 
Neurology 0 (0) 0 (0) 0 (0) 
Ankylosing spondylitis 
Juvenile idiopathic arthritis 
Gout 
Osteoarthritis 
Osteoporosis 
Psoriatic arthritis 
Systemic lupus erythematosus 
Other 
rheumatological 
diagnosis 
33 (30) 24 (37) 9 (20) 
Spinal stenosis 
Sciatica 
Degeneration of spine 
Back problems 11 (10) 8 (12) 3 (7) 
Fibromyalgia Chronic pain 1 (1) 1 (2) 0 (0) 
Primary bilary cirrhosis Heptology 1(1) 1 (2) 0 (0) 
Tendonopathy 
Fracture 
Foot deformity not RA related 
Other MSK 
 
21 (19) 11 (17) 10 (22) 
Chronic kidney disease Renal disease 3 (3) 3 (5) 0 (0) 
 Any category 79 (72) 48 (74) 31 (69) 
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Appendix J1: Abstract British Society for Rheumatology conference 
2012 and Society of Chiropodists and Podiatrists conference 2012 
 
Wilson, O., Kirwan, J., Dure, E., Quest, E.,& Hewlett, S. (2012a). “Just do 
something about my feet”: Foot problems and access to foot care in people 
with rheumatoid arthritis [abstract] Rheumatology, 51 (Suppl. 3), iii53-iii54. 
 
and  
 
Wilson, O., Kirwan, J., Dure, E., Quest, E.,& Hewlett, S. (2012b). “Just do 
something about my feet”: Foot problems and access to foot care in people 
with rheumatoid arthritis [abstract] Society of Chiropodists and Podiatrists 
Annual Conference. Glasgow 2012. 
 
Background: The foot is often involved in RA but the impact of foot involvement in 
patients with RA and patients’ beliefs regarding access to and efficacy of foot care 
services are unknown. 
 
Objective: To explore patients with RA experiences of foot problems and their 
access to foot care provision. 
 
Methods: Inductive thematic analysis of the transcripts from semi structured face-to-
face interviews with patients purposively sampled for self-reported foot problems 
and a range of personal/disease characteristics.  Themes were identified within and 
across data sets. Analysis was by OW with a subset independently analysed (SH, 
ED and patient partner EQ). Emerging themes were discussed and agreed by all 
authors.  
 
Results: 12 patients (7F); aged 29-72 yrs (mean 56.8); 42% accessed foot care 
services; disease duration 2-27 yrs (mean 12); with 92% on DMARDs; 42% on 
biologics; HAQ 0-2.875 (mean 1.58); and global opinion numerical scale 0-9 (mean 
5.9). An overarching theme of Access to Foot Care was identified, comprising three 
themes.  
 
Access supported. “I’d put them [feet] top priority”: This included proactive 
discussions of foot problems generated by patients and health care professionals 
(“He generally asks”); having feet examined (“Took my shoes and socks off and 
showed the woman”); previous positive experiences of foot care (“The podiatrist is 
keeping an eye on them”); and continuing access to foot care (“It helps”).  
 
Access perceived unnecessary. “It’s not where I want to go [prescribed footwear], 
another nail in the coffin”: This included: fluctuating foot symptoms (“Some days I 
can’t walk, then it goes”); general RA disease activity (“Just took it as part of the 
RA”); ability to self–manage foot problems (“I know how to look after my feet”); feet 
not being considered a major concern (“Not a big problem”). 
 
Access hindered. “It seems to be an area where medical staff don’t know an awful 
lot do they?”: This included patients’ perceptions of feet being ignored in clinical 
practice (“Not on any RA form”); limited knowledge of how or when to access care 
foot care (“Didn’t know you could access it on the NHS”); expectations that the 
rheumatology team would initiate access to foot care (“He will refer me”); 
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assumptions that no treatment options were available (“I’ve just plodded on”); and 
previous negative experiences of foot care (“All they did was cut my nails”). 
 
Conclusions: Patients who had accessed foot care services prioritised their foot 
problems as an important health care need. However, for others who would like foot 
care services, personal knowledge and values, and perceived barriers in clinical 
practice, appear to interact to inhibit foot care access. The extent which these 
interactions affect overall access to foot care in RA patients in general now needs to 
be quantified to help to inform and improve the effectiveness of the organisation and 
delivery of foot care. 
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Appendix J2: Abstract British Society for Rheumatology conference 
2014 and Society of Chiropodists and Podiatrists conference 2014 
 
Oonagh Wilson, Sarah Hewlett, Jon Pollock, James Woodburn, Enid Quest, 
Caroline Swales, John Kirwan (2014). Population survey of prevalence, impact 
and care of foot symptoms in people with rheumatoid arthritis. Rheumatology. 
51 (suppl. 1): i42  
 
and 
 
Oonagh Wilson, Sarah Hewlett, Jon Pollock, James Woodburn, Enid Quest, 
Caroline Swales, John Kirwan (2015). Population survey of prevalence, impact 
and care of foot symptoms in people with rheumatoid arthritis. Journal of Foot 
and Ankle Research. 8 (Suppl 1): A9 
 
Background: Foot symptoms in rheumatoid arthritis (RA) derive from a combination 
of inflammation, altered foot mechanics, deformity and secondary skin lesions. 
Guidelines recommend regular review of patients’ feet, the extent to which the 
general population of RA patients report foot symptoms and access foot care has 
not been established.  
 
Methods: All RA patients under hospital care in a defined geographical area (Bristol 
Community Health) were identified from relevant departmental records. A random 
sample was sent a postal survey (reminder after 3 weeks) about presence of 
symptoms, disability (HAQ) and patient characteristics (age, disease duration, 
arthritis medication and co-morbidities). Measures of impact (Foot Impact Scale 
(FIS)) with additional questions (numerical rating scales) related to importance, 
severity, coping and ability to work derived from a previous study. For each patient 
an Indices of Multiple Deprivation (IMD) score (a measure of socio-economic status) 
was derived from postcodes. 
 
Results: Of 739 patients sent the survey, 413 (56%) replied. Responders and non 
responders were similar for age (63.5 vs.61.5 years), gender (74.1%F vs. 75.2%F) 
and socio-economic status (IMD highest deprivation quintiles 13.3% vs.15.9%). 
Responders’ median (inter-quartile range) disease duration was 10 (5-20) years and 
HAQ score 1.5 (0.75-2.0). Most responders (394, 95.4 %) were taking arthritis 
medication and 273 (66.1%) reported additional medical conditions (including 28 
(6.8%) with diabetes). Almost all (377) reported current foot symptoms (91.3%) or 
previous foot symptoms (6.3%), 10 (2.4%) reported never having foot symptoms. 
Current symptoms included: articular features 73.8%; extra-articular features 42.6%; 
cutaneous lesions 65.4%; structural deformity 57.6%; infection 7.5%. Median (IQR) 
FIS impairment footwear score 10/21 (6-14); and FIS activities participation score 
16/30 (7-23). Median (IQR): importance was 6 (3-8); severity 6 (3-8); and coping 5 
(3-7). Overall, 37.8% reported that foot symptoms affected their ability to work. 
Of respondents, 69.5% had accessed foot care. This was similar for men and 
women (62.3%M vs. 72.0%F) (chi test p=0.80, NS), as were the proportions who 
accessed podiatry (42.1%M vs. 52.0%F), orthotics (39.3%M vs.49.2%F) and 
orthopaedics (15.0%M vs. 24.8%F). There was no difference in foot care access in 
relation to socio-economic status.  
 
Conclusions: Unlike previous studies this was representative of all hospital patients 
with RA and almost all reported foot symptoms. Although FIS scores were slightly 
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lower than in previous studies based on patients recruited at hospital or foot care 
clinic appointments, nevertheless substantial impact was reported including affecting 
ability to work. In spite of this, 30% of patients had never accessed foot care. 
Further research is required to compare self-report of foot symptoms with clinical 
observations and explore the reasons why patients do and do not access foot care. 
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Appendix J3: Abstract European League Against Rheumatism conference 
2015 
 
Oonagh Wilson, Wendy Briggs, Sarah Hewlett, Jon Pollock, James Woodburn, 
Enid Quest, Caroline Swales, John Kirwan. (2105) DOES SELF-REPORT OF FOOT 
PROBLEMS AGREE WITH CLINICAL EXAMINATION IN PEOPLE WITH 
RHEUMATOID ARTHRITIS? Annals of the Rheumatic Diseases. 74 (Suppl 2): 
106.2  
 
Background: Data about the frequency of foot problems in rheumatoid arthritis (RA) 
can be obtained through self-report or clinical examination. The level of agreement 
between these two approaches has not been established in RA.  
 
Objectives: Data about the frequency of foot problems in rheumatoid arthritis (RA) can 
be obtained through self-report or clinical examination. The level of agreement between 
these two approaches has not been established in RA.  
 
Methods: A random sample of RA patients who had self-reported foot problems in a 
questionnaire underwent a structured foot examination and clinical interview conducted 
by a single observer (podiatrist). Data collected included: patient demographics and 
clinical characteristics; whether they had accessed foot care (AFC) services (podiatry, 
orthotics and / or orthopaedics); impact of foot problems (Foot Impact Scale: 
Impairment/Footwear (FISIF) and Activities/Participation (FISAP) subscales); and 
presence of foot problems on examination. Extent of agreement between self-report 
and clinical examination was measured by the kappa statistic (k). 
 
Results: Of 235 patients invited to participate, 110 (47%) attended; 65 AFC (59%); 77 
Female (70%); mean (SD) age 63.1 (11.2) years; median (IQR) disease duration 8.5 (1, 
51) years; HAQ 1.25 (0.375, 2.00); FISIF 9 (5, 13); and FISAP 15 (3, 22).  
The overall frequency of reported and examined foot problems were: toe deformities - 
66% and 69%; hallux valgus - 35% and 33%; pes planus - 26% and 56%; callus - 56% 
and 53%; corns - 12% and 12%; blisters - 5% and 2%; thickened toe-nails - 57% and 
45%: ingrown toe-nails - 16% and 15%; joint swelling - 28% and 65%; nodules - 23% 
and 16%; numbness - 27% and 19%. 
High agreement occurred for: corns (98%, k=0.913); ingrown toe-nails (97%, k=0.893); 
and hallux valgus (98%, k= 0.959); nodules (92%, k=0.724); callus (84%, k=0.670); toe 
deformities (86%, k=0.67); and thickened toe nails (80%, K=0.606). Fair agreement was 
detected for numbness and pes planus (79%, k=0.418 and 76%, k=0.377) but only 
chance agreement for joint swelling (49%, k<0.01).  
 
Conclusions: Overall, high levels of agreement were detected between self-report and 
clinical examination for many foot problems, suggesting self-report can be utilised with 
a high degree of confidence. However, levels of agreement for more complex foot 
problems (e.g. pes planus) were only fair and patients substantially under-reported 
features of disease activity (e.g. joint swelling), indicating that clinical examination is 
required for these features. 
 
 
